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The eukaryotic cell is divided into different compartments. The biggest compartment is the 
nucleus which is formed by one lipid bilayer folded into two membranes: the outer nuclear membrane 
(ONM) and the inner nuclear membrane (INM). The ONM is continuous with the endoplasmic reticulum 
(ER) membrane and merges with the INM at a curved piece of membrane at the level of the nuclear 
pore complex (NPC). The NPC controls the exchange of proteins or other molecules between the 
cytoplasm and the nuclear compartment. While the active transport of soluble proteins via the NPC 
mediated by transport factors is well studied, less is known about the targeting of membrane proteins to 
the INM.  
Most membrane proteins are first inserted into the ER-membrane before they are targeted to their 
destination. A nascent polypeptide chain can be inserted into the ER-membrane during translation in a 
co-translational manner or post-translationally after termination of translation. The best described route 
of post-translational insertion into the ER-membrane of tail-anchored proteins, which are membrane 
proteins with a very short C-terminus, is the TRC (transmembrane domain-recognition complex) 
pathway. In this study, the insertion mechanism of the single-pass membrane protein LRRC59 (leucine-
rich repeat-containing protein 59) into the ER-membrane is analyzed by in vitro microsome integration 
assays. LRRC59 is shown to be a tail-anchored protein, which can be post-translationally inserted 
independently of the TRC pathway.  
In former studies, LRRC59 was found at the ER-membrane and the nuclear envelope, a 
localization that was suggested to depend on the nuclear transport factor importin . In this thesis, by 
usage of rapamycin-induced dimerization assays, a localization to the INM could be confirmed. 
However, INM targeting of LRRC59 is independent of importin . Additionally, the extraluminal region 
of LRRC59 does not contain a nuclear localization signal. Instead, the efficiency of INM targeting of 
LRRC59 was shown to depend on the size of the extraluminal domain, suggesting passive diffusion of 
LRRC59 to the INM by peripheral channels of the NPC.  
In addition to LRRC59, the ER located integral membrane proteins Sec61, DDOST and Ube2j1 
were shown to reach the INM mainly by passive diffusion. The INM targeting of these proteins were not 
only dependent on the size of the extraluminal domain but also on the geometry of the inserted tags in 
the rapamycin-induced dimerization assay. These results suggest that some ER-membrane proteins 
might reach the INM by diffusion as long as they fulfill the size restriction to pass the peripheral channels 





One of the main characteristic features of a eukaryotic cell is its compartmentalization. The 
biggest compartment is the nucleus, which contains the majority of genetic material. The nucleus 
spatially separates transcription of DNA into mRNA from translation, the process of protein synthesis, 
which occurs in the cytoplasm (Moog and Maier, 2017). The division of the cell into a nuclear region and 
the cytoplasm requires an active transport mechanism between these two compartments (Wente and 
Rout, 2010; Purves et al., 2006b). The following chapter of the introduction will focus on the structure of 
the nucleus and its nuclear pore complexes (NPCs) mediating a regulated active transport together with 
transport factors. Additionally, an overview is given about insertion of membrane proteins into the 
endoplasmic reticulum (ER) membrane and the current status in research about nuclear targeting of 
some of these membrane-embedded proteins to the inner nuclear membrane. This chapter will 
introduce the model protein LRRC59 and outline the aims of this thesis.  
 
1.1 The Nucleus and the Nuclear Envelope 
The nucleus is formed by a single phospholipid bilayer, which is folded into two membranes, an 
outer nuclear membrane (ONM) and an inner nuclear membrane (INM). The ONM is continuous with 
the ER-membrane and also merges with the INM at a curved piece of membrane adjacent to the nuclear 
pore complex (NPC). The INM and the ONM are separated by 10-50 nm with a luminal/perinuclear 
space (Moog and Maier, 2017; Gruenbaum, 2015; Schooley et al., 2012). The membrane protein 
composition of the ONM is different from the INM. While the ONM and the membrane of the rough ER 
share many membrane proteins with the exception of specific ONM protein complexes, the INM contains 
a specific set of membrane proteins (Lusk et al., 2007). Some of these INM proteins can directly interact 
with chromatin or peripheral associated INM proteins (Katta et al., 2014; Ungricht and Kutay, 2015; 
Murthi and Hopper, 2005; Lai et al., 2009). 
The nuclear envelope (NE) is defined as the ONM and INM, the luminal space and the sum of 
the NPCs (Ungricht and Kutay, 2017) (figure 1). The interior of the nucleus, also called the nucleoplasm, 
stores the majority of genetic material of the cell and is organized in several membraneless 
suborganelles e.g. the nucleolus, which contains ribosomal genes and is the place of ribosomal 
biogenesis (Tsekrekou et al., 2017). The DNA containing genetic information is organized in 
euchromatin and heterochromatin. While euchromatin is defined as DNA-regions in a less-condensed 
form, heterochromatin is highly condensed (Solovei et al., 2016). Underneath the INM, intermediate 
filaments or lamins, form a meshwork. Within this meshwork, there are different types of lamins, A-type 
(lamins A and C) and B-type lamins (lamins B1 and B2), which overlap each other. Lamins maintain and 
stabilize the nuclear shape and anchor chromatin to the NE as well as the membrane-embedded NPCs. 
Lamins are peripheral associated INM proteins and can be bound by INM proteins such as emerin 
(Burke and Stewart, 2013; Schooley et al., 2012; Shimi et al., 2010). The LINC (linker of nucleoskeleton 
and cytoskeleton) complex, consisting of SUN (Sad1-UNC-84 homology) domain containing proteins, 
interacts with the lamins resulting in an indirect connection of nuclear and cytoplasmic architecture 
(Schooley et al., 2012; Starr and Fridolfsson, 2010; Burke, 2012).  
Within the NE, many NPCs are embedded in the concentric membrane-bilayer (in U2OS cells: 
3000 ± 1000 NPC (Beck et al., 2011)) and control the import of proteins from the cytoplasm into the 
nucleus and export from the nucleus into the cytoplasm (Beck and Hurt, 2017). The NPC acts as a 
highly selective bidirectional gatekeeper, which inhibits free diffusion of proteins with a molecular mass 
higher than ~40 kDa from one compartment to the other (Wente and Rout, 2010). Therefore, an active 
transport mechanism for cargos mediated by transport factors is needed in eukaryotic cells. Proteins 
with a smaller molecular mass, ions, water and small metabolites can enter the nucleus through the 
NPC using passive diffusion (Beck and Hurt, 2017; Terry and Wente, 2009). For further information 





Figure 1: Schematic overview of a eukaryotic cell with focus on the NE. 
(A) The simplified overview of a eukaryotic cell shows the endoplasmic reticulum (ER), the nucleus, 
the nucleolus, the cytoplasm and the plasma membrane. The rectangle indicates the area of interest 
for (B). (B) The scheme shows the nuclear pore complexes (NPCs) embedded into the inner (INM) 
and outer (ONM) nuclear membrane. In the membranes of ER and nucleus, different types of 
membrane proteins containing at least one transmembrane domain (TMD) are represented by 
various examples in the scheme. Located in the INM, these proteins can interact with lamins, 
chromatin or peripheral associated INM proteins. For instance, the LEM (LAP2, emerin, MAN1) 
domain containing proteins emerin or LAP2 (lamina-associated polypeptide 2) interact with BAF 
(barrier of autointegration factor), a peripheral chromatin-associated protein (Lee et al., 2001; 
Shumaker et al., 2001). In addition, soluble proteins can be found in all compartments of the 
eukaryotic cell. Scheme inspired by Schooley et al., 2012. 
 
1.1.1 Nuclear Pore Complex 
In mammalian cells, the NPC has a molecular mass of around 120 MDa (Beck and Hurt, 2017) 
and is so far the largest identified protein complex. In contrast to ion channels or translocons, which 
permeate the membrane via a hydrophobic stretch, the NPC perforates the double lipid bilayer of ONM 
and INM creating pores of 100 nm diameter in the membrane (Weberruss and Antonin, 2016). This 
special way of membrane embedding leads to the curvature of the nuclear membrane next to the NPC. 
Within the NE, the number and density of embedded NPCs can vary between organisms of different 
species, but also within one organism according to the cell type, phase of the cell cycle and the 
developmental stage of a cell (Grossman et al., 2012). For instance, cells of vertebrates contain around 
10-20 pores/µm2 each nucleus (2000-5000 pores/nucleus), while Xenopus laevis oocytes have 
~60 pores/µm2 and yeast cells have 12 pores/µm2 (Winey et al., 1997; Görlich and Kutay, 1999; Fabre 
and Hurt, 1997; Grossman et al., 2012; Beck et al., 2011). 
The main function of the NPC is the controlled exchange of proteins or other molecules between 
the cytoplasm and the nuclear compartment (Beck and Hurt, 2017; Christie et al., 2016). The 
nucleocytoplasmic transport occurs via the central channel of the NPC, which is around 50 nm in 
diameter, while the overall dimensions of the NPC itself is approximately 120 nm in width and around 
85 nm in height (Grossman et al., 2012). In addition to the central channel of the NPC, lateral channels, 
also called peripheral channels, with a diameter of 5-10 nm have been identified by electron microscopy 
to be adjacent to the membrane (Hinshaw et al., 1992; Beck et al., 2007; Maimon et al., 2012). In 
addition to nucleocytoplasmic transport, the NPC is also involved in regulation of gene expression (Ptak 
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et al., 2014; Van de Vosse et al., 2011) and cell cycle (Capelson et al., 2010), chromatin organization 
(Krull et al., 2010) and DNA repair (Therizols et al., 2006). 
 
Schematic subdivision of the NPC 
With the progression in transmission electron microscopy, the understanding of the structure of 
the NPC has increased. It could be shown that the NPC consists of only approximately 30 different 
components (Cronshaw et al., 2002; Schwartz, 2016). These proteins are named nucleoporins (Nups) 
and have a molecular mass up to 358 kDa. The high molecular mass of the NPC is due to (multiple) 8-
fold copies (8-64) of the conserved Nups within a single NPC (Beck and Hurt, 2017; von Appen and 
Beck, 2016). In a view on top of the pore, the NPC is assembled of eight asymmetric spokes. In a side 
view (figure 2), each spoke is composed of a cytoplasmic and a nucleoplasmic half, connected at the 
equator of the NPC (Hinshaw et al., 1992; Akey and Radermacher, 1993). The structural motives of the 
Nups dictate their localization within these spokes. Nucleoporins can therefore be divided into three 
classifications (Grossman et al., 2012; Weberruss and Antonin, 2016): membrane anchored Nups 
contain a transmembrane domain (TMD), barrier Nups are defined by the presence of phenylalanine-
glycine-rich (FG) repeats, and scaffold Nups, which form three parts, an outer and an inner ring and a 
linker. The scaffold is reflected at the equator of the NPC, one copy is facing the cytoplasm (cytoplasmic 
ring) and the second is located at the nuclear side (nucleoplasmic ring). In addition to these symmetric 
parts, the NPC also comprises asymmetric segments: the cytoplasmic filaments assembled by 
FG-repeat containing Nups and nuclear Nups forming a basket-like structure (Grossman et al., 2012; 
Suntharalingam and Wente, 2003; Alber et al., 2007) (figure 2). 
 
Figure 2: Several proteins assemble into the large protein complex of the NPC. 
Schematic sideview of the NPC dividing the complex into several structural parts. The symmetric part 
of the NPC is assembled by scaffold, transmembrane domain containing and barrier nucleoporins. 
The asymmetric segments are comprised of cytoplasmic filaments and nuclear nucleoporins forming 
a basket-like shape. The different nucleoporins are assigned to the classifications by color. Scheme 
modified according to Weberrus and Antonin, 2016, Wente and Rout, 2010 and Grossman et al., 
2012. 
 
The main function of the scaffold nucleoporins is to connect the TMD-containing Nups to the 
barrier Nups for stabilization of the NPC (Grossman et al., 2012). Most Nups of the scaffold structure 
are incorporated in the NPC for the entire life span of nondividing cells (D'Angelo et al., 2009). The outer 
ring of the scaffold Nups is formed by copies of the Nup107-Nup160 complex, also called the Y-complex, 
which consists of the ten nucleoporins Nup160, Nup37, ELYS, Nup96, Sec13, Nup85, Seh1, Nup43, 
Nup107 and Nup133 (Hoelz et al., 2016). A conformational change within the Y-complex seems to allow 
the passage of large cargos through the NPC (Nagy et al., 2009; Grossman et al., 2012). The inner ring 
and the linker are formed by the assembly of Nup205, Nup188, Nup155, Nup93 and Nup88, which 
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connects FG-containing nucleoporins to membrane-associated Nups (Vollmer and Antonin, 2014; 
Weberruss and Antonin, 2016; Grossman et al., 2012).  
Three Nups are classified as TMD-containing nucleoporins, which anchor the NPC to the NE 
and interact with the nuclear membrane: Pom121, NDC1 and Nup210, also called gp210 (Weberruss 
and Antonin, 2016; Grossman et al., 2012; Lusk et al., 2007). 
The nuclear transport is restricted and regulated by the barrier nucleoporins. They localize to 
the central channel of the NPC with expansions towards the cytoplasm and nucleoplasm. These Nups 
are mainly anchored to the inner ring or the linker and are comprised of multiple FG-repeats with the 
following combinations: GLFG, FxFG, PxFG or SxFG, with F representing the amino acid phenylalanine, 
G glycine, L leucine, P proline, S serine and x any amino acid (Frey and Görlich, 2007; Aramburu and 
Lemke, 2017). Nups with FG-repeats directly interact with transport receptors with a low affinity to enable 
nucleocytoplasmic transport. (Radu et al., 1995a; Radu et al., 1995b; Katahira et al., 1999; Aramburu 
and Lemke, 2017; Grossman et al., 2012). However, the network of FG-containing Nups provides a 
diffusion barrier (Ribbeck and Görlich, 2002; Li et al., 2016; Kabachinski and Schwartz, 2015). 
Barrier, TMD- and scaffold Nups are assembled in a symmetric manner, while the structures of 
the NPC facing the nucleoplasm and the cytoplasm differ from each other. The cytoplasmic filaments 
are structurally unordered elongated peptides, which can interact with transport complexes (Beck and 
Hurt, 2017; Marelli et al., 2001; Suntharalingam and Wente, 2003). The nuclear basket facing the 
nucleoplasm is also able to interact with transport factors. This structure is assembled of Nup153, Nup50 
and Tpr, which form eight elongated filaments from the nucleoplasmic ring (Goldberg and Allen, 1992; 
Grossman et al., 2012). These nucleoporins are involved in export of mRNA, retention of non-spliced 
RNA, spindle pole assembly and telomere organization (Xu et al., 2007; Frosst et al., 2002; Grossman 
et al., 2012). In contrast to the scaffold Nups, nucleoporins constituting the nuclear basket are 
continuously renewed (D'Angelo et al., 2009). 
 
1.1.2 Transport of soluble cargos into the nucleus 
The NPC is a barrier for biomolecules entering or leaving the nucleus. Formerly, molecules 
smaller than 40 kDa or 5 nm in diameter, ions, water and metabolites were suggested to pass this 
gatekeeper by passive diffusion (Akey and Radermacher, 1993; Keminer and Peters, 1999). For larger 
proteins and molecules like RNA, ribosomal subunits or viral particles, an active transport mechanism 
is required (Cautain et al., 2015; Wente and Rout, 2010; Grossman et al., 2012). However, latest findings 
indicate that the passage of the NPC is also determined by the surface properties of the cargo protein. 
While hydrophobic residues, cysteine, histidine and positively charged arginine promote transport 
through the NPC, negative residues and lysine inhibit passage through the pore (Frey et al., 2018). As 
cargos need to be targeted from the cytoplasm into the nucleus (import) and, at the same time, nuclear 
cargos have to be exported into the cytoplasm (export), a bidirectional transport system is necessary 
(Feldherr et al., 1984) (figure 3). 
 
The -karyopherin family 
A family of -karyopherins consisting of at least 20 proteins in humans mediates 
nucleocytoplasmic transport of cargo proteins (Kim et al., 2017). These proteins have an NPC-binding 
domain, which mediates the interaction with the FG-repeat containing Nups, a cargo-binding site and a 
binding domain at the N-terminus for the small Ras-like GTPase Ran (Wente and Rout, 2010). The 
members of this protein family are also termed transport receptors/factors or, more specific, importins 
or exportins depending on the direction of transport they are mediating (Görlich et al., 1994; Stade et 
al., 1997; Cautain et al., 2015). They are able to recognize special signal sequences within a cargo 
protein, which are required for transport. These signals are termed nuclear localization signal (NLS) 
(Kalderon et al., 1984; Lanford and Butel, 1984; Robbins et al., 1991) necessary for nuclear import or 
nuclear export signal (NES) required for export events (Fornerod et al., 1997; Fukuda et al., 1997; 
Ossareh-Nazari et al., 1997; Stade et al., 1997). After the binding of the karyopherin to the signal within 
the cargo protein, the assembled complex is able to cross the NPC (Tetenbaum-Novatt and Rout, 2010). 
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One of the best studied members of the -karyopherin family is importin  (also known as 
karyopherin 1). It was first described to bind via the adaptor protein importin  to cargo proteins 
containing a basic classical nuclear localization signal (cNLS) as, for instance, the monopartite NLS of 
SV40 T antigen or the bipartite NLS of nucleoplasmin (Görlich et al., 1995; Dingwall et al., 1988; Radu 
et al., 1995a; Chi et al., 1995; Imamoto et al., 1995). A monopartite NLS is a cluster of three to five 
positively charged amino acids, while a bipartite NLS contains an additional small cluster of 
lysine/arginine residues in a distance of 10 to 12 amino acids to the monopartite-like sequence (Dingwall 
and Laskey, 1991; Dingwall et al., 1988). These cNLSs are bound by the adaptor protein importin  
(also termed karyopherin ), which is then bound by importin  (Oka and Yoneda, 2018; Miyamoto et 
al., 2016). Importin  contains an importin  binding (IBB) domain at the N-terminus followed by an NLS 
binding domain (Cook et al., 2007). Upon binding of importin  to the NLS within the cargo, the 
C-terminus of importin  assembles with the IBB domain completing the import complex. The import 
mechanism via the importin /importin  pathway is often termed the classical import pathway. 
However, importin  was shown to be able to interact directly with some of its cargo proteins without the 
need of the adaptor protein (Kim et al., 2017; Görlich and Kutay, 1999; Miyamoto et al., 2016). Another 
protein of the -karyopherin family is transportin, which was shown to assemble into an import complex 
with the mRNA binding protein hnRNPA1 via the binding of its M9 sequence. This sequence is an NLS 
of 38 amino acids providing a positive charge, which interacts with the C-terminus of transportin (Pollard 
et al., 1996; Aitchison et al., 1996). 
 
Transport of the cargo-karyopherin complex through the NPC 
After the assembly of an import complex, the protein of the -karyopherin family interacts with the 
FG-repeat containing nucleoporins of the NPC. These Nups provide binding sites for the transport 
receptors with low affinity. Several models are discussed on how this interaction mediates the transport 
of the import complexes through the NPC (Grünwald et al., 2011; Grossman et al., 2012; Walde and 
Kehlenbach, 2010; Hayama et al., 2017). For instance, in a polymer brush model, the cytoplasmic, 
fishing polymers containing the FG-repeats collapse after binding of a karyopherin to the FG-repeats 
resulting in a pulling motion into the channel. In the central channel, the import complex is passed from 
the cytoplasmic to the nuclear side of the pore by the assembly and disassembly of karyopherin-
FG-repeat interactions (Lim et al., 2007). Another model, called the selective phase/hydrogel model, 
assumes that the FG-FG interactions within the Nups form a hydrogel, which only opens the mesh upon 
low affinity interactions of the cargo-carrying karyopherin with the FG-repeats. Within the hydrogel, the 
import complex passes the NPC through a solubility-diffusion process. Molecules, which are not able to 
interact with the FG-repeats, cannot permeate the hydrogel (Frey et al., 2006; Frey and Görlich, 2007, 
2009; Ribbeck and Görlich, 2002).  
 
Disassembly of the cargo-karyopherin complex in the nucleus 
When the import complex passes the NPC and reaches the nucleus, binding of RanGTP to the 
N-terminus of -karyopherins disassembles the complex resulting in the release of the cargo protein or 
the cargo-bound adaptor protein (Cavazza and Vernos, 2015; Cook et al., 2007). The 24 kDa protein 
Ran belongs to the Ras superfamily of small GTPases and has a guanine nucleotide-binding domain 
(G domain) (Bischoff and Ponstingl, 1991b; Drivas et al., 1990; Macara et al., 1996; Görlich and Kutay, 
1999; Cook et al., 2007). RanGTP is primarily found in the nucleoplasm, while the hydrolyzed form 
RanGDP is mostly in the cytoplasm (Cavazza and Vernos, 2015). The concentration gradient of 
RanGTP between the nucleus and the cytoplasm dictates the directionality of the karyopherin-mediated 
transport (Melchior et al., 1993a; Moore and Blobel, 1993). RanGDP is imported into the nucleus by 
NTF2 (nuclear transport factor 2) (Ribbeck et al., 1998; Smith et al., 1998). The nuclear RanGDP is then 
converted to a GTP-bound form catalyzed by the chromatin-bound Ran guanine nucleotide exchange 
factor (RanGEF) RCC1 (regulator of chromosome condensation 1) (Bischoff and Ponstingl, 1991a, b; 
Ohtsubo et al., 1987; Ohtsubo et al., 1989; Klebe et al., 1995; Moore, 2001; Kim et al., 2017). Within 
the cytoplasm, the RanGTPase-activating protein (RanGAP) and the coactivators RanBP1 and RanBP2 
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stimulate the GTP hydrolysis of Ran (Bischoff et al., 1994; Bischoff et al., 1995a; Bischoff et al., 1995b; 
Becker et al., 1995; Hopper et al., 1990; Mahajan et al., 1997; Matunis et al., 1996; Melchior et al., 
1993b; Richards et al., 1995; Wu et al., 1995; Yokoyama et al., 1995; Görlich and Kutay, 1999). 
Nucleotide hydrolysis is the energy providing step of the nucleocytoplasmic transport. The translocation 
of transport complexes through the NPC itself is energy independent and is mediated by diffusion 
(Schwoebel et al., 1998). In addition to RanGTP, the -karyopherin family member CAS/CSE1L seems 
to be involved in the release of cargos bound by the adaptor protein importin , transported by 
importin . Only after cargo release, RanGTP bound importin  as well as the importin -CAS complex 
can be recycled back into the cytoplasm. The GTP hydrolysis in the cytoplasm mediates a 
conformational change within Ran, which results in the release of the transport receptors and 
CAS/importin , which can be reused for the next import event (Solsbacher et al., 1998; Oka and 
Yoneda, 2018) (figure 3). 
 
 
Figure 3: The nucleocytoplasmic transport of soluble cargos. 
Nuclear import mechanism (red arrows). A soluble import cargo protein containing a nuclear 
localization signal (NLS) is transported into the nucleus upon recognition and binding by 
importin /importin  or directly by importin . The complexes are transported via the central channel 
of the nuclear pore complex (NPC). After import, binding of RanGTP to importin  disassembles the 
complexes and releases the import cargo proteins. Importin  in its RanGTP bound form and 
importin  bound by CAS-RanGTP are recycled back into the cytoplasm for another import event. 
Nuclear export mechanism (blue arrow). The binding of RanGTP increases the binding affinity of an 
exportin to a nuclear export signal (NES) containing export cargo protein. After export complex 
assembly, the complex is targeted through the NPC. In the cytoplasm, the hydrolysis of RanGTP to 
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RanGDP catalyzed by RanGAP (RanGTPase-activating protein) mediates the complex disassembly. 
The exportin is recycled back into the nucleus. RanGDP is imported into the nucleus by NTF2 
(nuclear transport factor 2, not illustrated). RanGEF (Ran guanine nucleotide exchange factor) and 
NTF2 maintain the RanGTP concentration difference between the nucleus and the cytoplasm. 
Scheme inspired by Grossman et al., 2012, Oka and Yoneda, 2018, Wente and Rout, 2010 and 
Caley et al., 2015. 
 
Nuclear export 
The RanGTP gradient between the cytoplasm and the nucleus is also the driving force of protein 
export. RanGTP binding increases the affinity of exportins, for instance Crm1 (chromosome region 
maintenance 1), to the cargo proteins containing an NES, which is rich in hydrophobic residues 
(Fornerod et al., 1997; Stade et al., 1997). After the export complex has translocated through the NPC 
and has reached the cytoplasm, RanGTP hydrolysis causes the dissociation of the export complex 
(Stade et al., 1997; Fornerod et al., 1997; Cavazza and Vernos, 2015) (figure 3). Afterwards, RanGDP 
is reimported into the nucleus by NTF2 (Kim et al., 2017). 
 
The nucleocytoplasmic transport is highly efficient 
Every NPC consists of approximately 200 FG-containing Nups within the central channel, each 
containing 5-50 FG-repeats. These provide potentially more than 1000 transport factor binding sites per 
pore, enabling 100-500 translocation events per second (Wente and Rout, 2010; Yang et al., 2004; 
Kubitscheck et al., 2005; Yang and Musser, 2006; Ribbeck and Görlich, 2001; Riddick and Macara, 
2005; Grossman et al., 2012). The NPC is able to translocate artificial substrates up to 39 nm in diameter 
due to its high flexibility and dynamics (Pante and Kann, 2002). For the transport of large complexes, 
such as ribosomal subunits, the NPC is suggested to undergo large structural changes to enable 
transport within the cellular compartments of the nucleus and cytoplasm (Stoffler et al., 1999; Pante and 
Kann, 2002; Fried and Kutay, 2003; Grossman et al., 2012). 
 
1.2 Membrane proteins 
In contrast to the nuclear import of soluble proteins, targeting to the INM of proteins containing 
transmembrane domain(s) (TMD(s)) is yet not well understood (Zuleger et al., 2012; Laba et al., 2014; 
Katta et al., 2014). The following chapter gives an overview of classes and the biogenesis of membrane 
proteins which are inserted into the ER-membrane. 
 
1.2.1 Classes of membrane proteins 
Proteins embedded in the phospholipid bilayer of a membrane are termed integral or intrinsic 
membrane proteins. They contain amino acids with hydrophobic side chains which are able to interact 
with fatty acyl groups of the membrane phospholipids. The membrane spanning domains comprise 
approximately 20 residues which permeate and anchor the protein to the membrane. These domains 
form either -helices or a -barrel consisting of multiple -strands (Shao and Hegde, 2011b; Lodish et 
al., 2000). A membrane embedded protein containing one TMD is termed bitopic, proteins with two or 
more TMD are referred to as polytopic (Arkin, 2002; Bocharov et al., 2017; Ott and Lingappa, 2002). 
Membrane proteins can be divided into five classes (figure 4): (1) bitopic type I membrane proteins have 
their C-terminus oriented to the cytoplasm, (2) type II membrane proteins, also single-pass 
TMD-containing proteins, orient their N-terminus towards the cytoplasm, (3) multi-pass transmembrane 
proteins with several TMDs, (4) lipid chain-anchored membrane proteins and (5) GPI 
(glycosylphosphatidylinositol)-anchored membrane proteins (Chou and Elrod, 1999; Chou and Cai, 
2005). In addition, external proteins can be peripherally attached to the membrane. These peripheral 
membrane proteins do not span the phospholipid bilayer. They interact directly with the lipid polar head 
groups or are indirectly bound to integral membrane proteins for their membrane attachment (Whited 




Figure 4: Classification of membrane proteins. 
(A) Bitopic type I membrane protein with its N-terminus in the lumen. (B) Bitopic type II membrane 
protein with its N-terminus in the cytoplasm. (C) A special type II membrane protein: a tail-anchored 
(TA) membrane protein with a very short C-terminus in the lumen of the ER. (D) Example of a multi-
spanning membrane protein. (E) Example of a lipid-anchored membrane protein. (F) GPI 
(glycosylphosphatidylinositol)-anchored membrane protein. (G) Protein peripherally attached to a 
membrane inserted protein. Inspired by Chou and Cai, 2005. 
 
1.2.2 Overview of membrane protein biogenesis 
The biogenesis of membrane proteins requires several steps to ensure successful membrane 
insertion. First, the nascent chain is targeted to the ER-membrane. Afterwards, the TMD(s) is/are 
translocated into the ER-lumen for recognition and correct orientation. Then, the TMD(s) is/are 
integrated into the phospholipid bilayer of the ER-membrane and, if applicable, followed by the assembly 
of multimeric complexes (Ott and Lingappa, 2002). The first critical step of membrane insertion, the 
targeting of the polypeptide to the ER-membrane, is mediated by a signal sequence that differentiates 
membrane proteins from cytoplasmic proteins. Signal sequences for ER-targeting can be subdivided 
into cleavable and uncleavable (“signal-anchor”) sequences.  
Cleavable signals are proteolytically removed from the mature protein after targeting of the 
protein to the ER-membrane. For membrane anchoring, the polypeptide contains an additional stop-
transfer sequence, which acts as a TMD. The C-terminus of signal peptide containing proteins faces the 
cytoplasm (type I membrane proteins) (Shao and Hegde, 2011b; Ott and Lingappa, 2002). 
Uncleavable signals act as targeting sequences to the ER-membrane and at the same time as 
the TMD, the “signal anchor” of the membrane protein to the phospholipid bilayer. Proteins with this kind 
of targeting signal can be type I or type II membrane proteins. The orientation of the protein within the 
membrane is determined by the distribution of charged amino acid residues that flank the hydrophobic 
core of the signal-anchor sequence. A special type of signal-anchor containing membrane proteins are 
tail-anchored (TA) proteins, which have their signal located at the very C-terminus of the amino acid 
sequence (figure 4) (Shao and Hegde, 2011b; Ott and Lingappa, 2002). This special localization within 
the protein requires a post-translational membrane insertion mechanism independent of the ribosome 
(High and Laird, 1997; Kutay et al., 1993). See section 1.2.4 for further explanations. 
 
1.2.3 Co-translational ER-membrane insertion via the Sec61 translocon 
Secretory and ER-membrane proteins with a cleavable or uncleavable signal sequence can be 
inserted into the ER-membrane during translation of the nascent peptide chain. This insertion pathway 
for poly- and bitopic membrane proteins is therefore called co-translational insertion and is highly 
conserved in all organisms (figure 5A) (Mandon et al., 2013; Grudnik et al., 2009; Shao and Hegde, 
2011b). During translation, the signal sequence (cleavable or uncleavable) emerges from the ribosome. 
The hydrophobic stretch is recognized and bound sequence-independently by the signal recognition 
particle (SRP), which can localize at the exit tunnel of the ribosome (Halic et al., 2004; Walter and Blobel, 
1980, 1982). Upon binding, the Alu domain of SRP, which binds close to the elongation factor binding 
site of the ribosome, slows down the translation process (Siegel and Walter, 1986; Lipp et al., 1987; 
Walter and Blobel, 1981; Halic et al., 2004). This allows the ribosome-SRP complex to be targeted to 
the ER-membrane and therefore prevents additional hydrophobic stretches of the nascent peptide chain 
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from emerging out of the ribosome into the cytosol (Lakkaraju et al., 2008; Mason et al., 2000). By 
binding of the SRP to the SRP receptor, which is located within the ER-membrane, the ribosome is 
targeted to the ER-membrane and results in the exposure of a part of the ribosome exit tunnel to the 
Sec61 complex (Akopian et al., 2013; Shao and Hegde, 2011b). This complex, also termed the 
translocon, is a heterotrimeric complex assembled by three subunits ,  and . The Sec61 subunit  
forms a dynamic translocon channel, which enables the movement of substrates in two dimensions: 
TMDs can be laterally inserted into the ER-membrane or peptide sequences can be translocated into 
the lumen of the ER (Hanein et al., 1996; Denks et al., 2014; Van den Berg et al., 2004). Therefore, the 
usage of the Sec61 complex is also the conserved route for translocation of proteins lacking a TMD or 
signal sequence into the ER-lumen (Ott and Lingappa, 2002). Upon GTP hydrolysis, the nascent chain 
is transferred from SRP to the Sec61 complex, the SRP-SRP receptor complex is then disassembled 
(Mandon et al., 2013) and the translocon forms a continuous channel with the ribosome exit tunnel 
(Beckmann et al., 1997; Prinz et al., 2000; Shao and Hegde, 2011b). As translation proceeds, the 
nascent chain continues to enter the translocon channel. The TMD(s) is/are oriented and inserted into 
the phospholipid bilayer by the lateral opening of the translocon channel (Martoglio et al., 1995; Shao 
and Hegde, 2011b). 
Some proteins have been identified to associate with the translocon: For the cleavage of 
N-terminal signal sequences, signal peptidases were shown to interact with the translocon. The 
oligosaccharyl transferase (OST) is Sec61 complex-associated for N-linked sugar addition to the 
nascent chain (Evans et al., 1986; Kelleher et al., 1992). The ER-lumen located chaperone BiP (Binding 
immunoglobulin protein) binds to the nascent chain upon translocation through the Sec61 complex 
channel to prevent back-sliding (Denks et al., 2014). 
 
1.2.4 Post-translational ER-membrane insertion via the TRC pathway 
Tail-anchored (TA) proteins are a class of bitopic, type II membrane proteins, which have their 
N-terminal region in the cytosol. The single TMD consisting of approximately 20 hydrophobic amino 
acids is located at or very close to the C-terminus and acts as a signal-anchor (Shao and Hegde, 2011b; 
Kutay et al., 1993; High and Laird, 1997). Approximately 300-400 membrane proteins (3-5% of 
membrane inserted proteins) in eukaryotic cells are defined as TA proteins (Beilharz et al., 2003; 
Kalbfleisch et al., 2007; Shao and Hegde, 2011b; Wattenberg and Lithgow, 2001). TA proteins have 
been identified in archaea, bacteria and eukaryotes (Beilharz et al., 2003; Kalbfleisch et al., 2007; 
Kriechbaumer et al., 2009; Borgese and Righi, 2010) and are involved in vesicular trafficking, protein 
translocation, apoptosis, protein maturation, degradation, organelle structure and lipid homeostasis 
(Borgese et al., 2003; Johnson et al., 2013; Borgese and Fasana, 2011; Shao and Hegde, 2011b; Ungar 
and Hughson, 2003; Osborne et al., 2005; Hockenbery et al., 1990). To fulfill these diverse functions, 
correct membrane insertion is important. However, ER-membrane insertion of TA proteins and very 
short TMD-containing proteins is problematic: Their hydrophobic TMDs emerge from the ribosome after 
termination of translation. As the SRP targets membrane proteins during their translation to the 
ER-membrane, this class of membrane proteins requires a post-translational membrane insertion 
mechanism, such as the TRC (TMD-recognition complex) pathway (figure 5B) (Borgese and Fasana, 
2011; Shao and Hegde, 2011b; Hegde and Keenan, 2011; Kutay et al., 1993; Johnson et al., 2013). 
Most components of this insertion pathway are conserved between mammals and Saccharomyces 
cerevisiae, in which it is termed GET (guided entry of tail-anchored proteins) pathway (Schuldiner et al., 
2008; Mateja and Keenan, 2018; Shao and Hegde, 2011b; Chartron et al., 2012). For homologues 
proteins of mammals and S. cerevisiae of these pathways see table 1 (Denic, 2012; Denic et al., 2013; 
Mateja and Keenan, 2018; Chio et al., 2017). 
 
Table 1: Overview of components of the mammalian TRC pathway and the yeast GET pathway 
Organism Pre-targeting complex ATPase Membrane receptors 
Mammal Bag6 Ubl4A TRC35 SGTA TRC40 CAML WRB 
S. cerevisiae Not present Get5 Get4 Sgt2 Get3 Get2* Get1 
* no sequence but function equivalence 
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In the TRC pathway (Mateja and Keenan, 2018; Chio et al., 2017; Johnson et al., 2013), SGTA 
binds to the TMD of the TA protein in a pre-targeting complex together with Bag6, TRC35 and Ubl4A 
(Leznicki et al., 2010; Winnefeld et al., 2006; Mariappan et al., 2010; Chang et al., 2010; Mateja and 
Keenan, 2018) (SGTA: small glutamine-rich tetratricopeptide repeat-containing protein alpha; Bag6: 
large proline-rich protein BAG6, also termed Bat3; TRC35: Golgi to ER traffic protein 4 homolog; Ubl4A: 
Ubiquitin-like protein 4A). Afterwards, the TA protein is transferred to TRC40 (TMD recognition complex 
of 40 kDa or Asna1) (Mariappan et al., 2010; Hegde and Keenan, 2011). Cytosolic TRC40 was shown 
to interact with several TA proteins in crosslinking experiments (Stefanovic and Hegde, 2007). The 
homodimer TRC40 is an ATPase, which binds as a chaperone to the TMD of TA proteins and undergoes 
conformational changes in a nucleotide-dependent manner. In its ATP-bound form, TRC40 has a closed 
conformation which provides a hydrophobic groove able to bind to the hydrophobic TMD of TA proteins. 
Upon binding of the TA protein to TRC40, the pre-targeting complex disassembles and TRC40 delivers 
the TA protein to the ER-membrane due to interaction with the ER-membrane embedded receptor 
composed of the proteins WRB (tryptophan-rich basic protein) and CAML (calcium-modulating 
cyclophilin ligand). In its TA protein bound form, TRC40 hydrolyzes ATP followed by interaction with 
CAML. Upon the release of ADP, TRC40 is in an open conformation enabling the interaction with WRB 
and the release of the TA protein (Chio et al., 2017; Hegde and Keenan, 2011). While the TA protein is 
inserted by the WRB-CAML complex (Schuldiner et al., 2008; Vilardi et al., 2011; Vilardi et al., 2014; 
Yamamoto and Sakisaka, 2012; Wang et al., 2014; Shao and Hegde, 2011b), TRC40 is recycled into 
the cytosol in a closed conformation upon ATP-binding (Hegde and Keenan, 2011). 
 
 
Figure 5: Co- and post-translational ER-membrane insertion. 
(A) Co-translational membrane insertion. During translation, the nascent polypeptide chain containing 
a signal peptide exits the ribosome. The signal peptide is bound by the signal recognition particle 
(SRP), which targets the ribosome to the SRP receptor at the ER-membrane. After transfer of the 
nascent chain from the SRP-SRP receptor complex to the Sec61 translocon, translation continues 
and the transmembrane domain (TMD) is correctly oriented and laterally inserted into the membrane 
by the translocon. (B) Post-translational membrane insertion. After the translation of the protein is 
completed, the tail-anchored (TA) protein is bound by a pre-targeting complex assembled by SGTA, 
TRC35, Ubl4A and Bag6. After transfer of the signal anchor (TMD) onto TRC40, the TA protein is 
targeted to the ER-membrane embedded receptors WRB and CAML, which insert the TA protein into 
the ER-membrane. Inspired by Johnson et al., 2013, Shao and Hegde, 2011, Hegde and Keenan, 




1.2.5 Further insertion mechanisms 
In addition to the classical co- and post-translational insertion pathways described above, further 
membrane targeting and insertion mechanisms have been identified in the past years. Many TA proteins 
have been shown to be able to insert into the ER-membrane in the absence of the TRC or GET pathway, 
however, with reduced efficiency (Hegde and Keenan, 2011). This observation might be explained by 
the diversity of additional targeting mechanisms for TA proteins to the ER-membrane (Chio et al., 2017; 
Rabu et al., 2009; Borgese and Fasana, 2011; Ast and Schuldiner, 2013), introduced in the following 
paragraphs. The discovery of alternative routes to the ER-membrane has demonstrated the complexity 
in membrane targeting of TA proteins. 
 
Crosslinking studies discovered that SRP is also able to bind the TMD of some TA proteins in a 
post-translational manner. The TA protein is released from the ribosome after translation termination 
and is bound by SRP. The complex of SRP and TA protein is targeted to the ER-membrane in a 
ribosome-unassociated but GTP- and SRP receptor-dependent manner for membrane insertion via the 
Sec61 translocon (Abell et al., 2004; Abell et al., 2003).  
 
The chaperones Hsp40 and Hsc70 were able to bind the TMD of TA proteins indicating an ATP-
dependent chaperone-mediated route. In in vitro studies, Hsp40 and Hsc70 were shown to mediate 
membrane insertion of some TA proteins with a low hydrophobic TMD in the absence of other cytosolic 
factors (Abell et al., 2007; Rabu et al., 2008). How this alternative pathway mediates targeting to and 
insertion into the ER-membrane still needs to be examined (Ast and Schuldiner, 2013). 
 
An additional insertion mechanism parallel to the SRP and TRC pathways was recently described 
as the SND pathway (SRP-independent targeting). By a visual screen in S. cerevisiae, the proteins 
Snd1, Snd2 and Snd3 were identified to be involved in the ER-membrane targeting of the model protein 
Gas1 (Aviram et al., 2016), a protein which is known to be inserted independently of SRP (Ast et al., 
2013) and partially GET-independent (Ng et al., 1996). While Snd1 is located in the cytosol and might 
interact with hydrophobic TMDs, Snd2 and Snd3 are located in the ER-membrane and form a complex 
together with the translocon. The SND pathway was shown to be a backup insertion mechanism, if the 
functionality of the SRP and GET pathway was lost (Aviram et al., 2016). In human cells, the membrane-
embedded protein hSnd2 (also termed TMEM208, yeast Snd2 ortholog) enables membrane-targeting 
of TMD-containing proteins (Hassdenteufel et al., 2017). The TRC pathway was shown to be not 
essential for the insertion of TA proteins (Rivera-Monroy et al., 2016). The SND pathway could be an 
alternative route, also in mammalian cells (Hassdenteufel et al., 2017; Casson et al., 2017). 
 
For membrane insertion of small secretory proteins and TA proteins with a moderate hydrophobic 
TMD, an insertion pathway dependent on calmodulin and the ER-membrane protein complex (EMC) 
assembled by six proteins was shown. Calmodulin can bind to signal peptides and preserves the TMD-
containing proteins from aggregation or degradation. Afterwards, the EMC seems to insert the TMD into 
the ER-membrane (Jonikas et al., 2009; Guna et al., 2018; Shao and Hegde, 2011a; Mateja and 
Keenan, 2018; Johnson et al., 2013; Chitwood et al., 2018). 
 
The mammalian TA protein cytochrome b5 was shown to insert into the ER-membrane in an 
unassisted insertion manner. This protein has a TMD with a low hydrophobicity which is inserted post-
translationally but independent of the TRC pathway (Favaloro et al., 2008; Favaloro et al., 2010; 
Stefanovic and Hegde, 2007). The membrane insertion of cytochrome b5 could require cytosolic 
proteins (Colombo et al., 2009; Yabal et al., 2003), perhaps the chaperones Hsp40 and Hsc70 (Rabu 
et al., 2008), but is not dependent on any membrane protein (Brambillasca et al., 2006; Brambillasca et 
al., 2005; Yabal et al., 2003; Rabu et al., 2009). 
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1.3 Proteins of the inner nuclear membrane 
1.3.1 Identification of inner nuclear membrane proteins and their importance in 
human diseases 
In 2002, less than 20 confirmed membrane proteins of the INM were identified. Most of them were 
shown to interact with lamins and/or chromatin (Burke and Stewart, 2002) suggesting a function in 
nuclear structure, organization and anchoring (Mekhail and Moazed, 2010; Katta et al., 2014). Until then, 
a connection between some human diseases and mutations in genes coding for nuclear-lamina and 
lamina-associated proteins was observed. These diseases were therefore called laminopathies (Burke 
and Stewart, 2002). One example of laminopathies is the Emery-Dreifuss muscular dystrophy (EDMD), 
which appears in weakness of skeletal and cardiac muscles (Emery and Dreifuss, 1966; Emery, 1989). 
This was the first described disease resulting from NE-specific defects (Bione et al., 1994; Nagano et 
al., 1996). Defects can be caused in two different ways, either by the mutation of the INM protein emerin 
leading to X-linked EDMD or by mutations in the gene coding for lamin A and C (LMNA) causing an 
autosomal-dominant form of the disease (Burke and Stewart, 2002; Bonne and Quijano-Roy, 2013). 
Emerin is a TA protein of 29 kDa (UniProt ID P50402) and has a LEM (LAP2, emerin, MAN1) domain 
which locates in the nucleoplasm and interacts with BAF (barrier of autointegration factor). BAF itself 
binds to chromatin. In addition, emerin interacts with A-type lamins. Together, these interactions are 
suggested to contribute to stabilization and organization of the nucleus. In the X-linked EDMD, emerin 
is lost from the NE due to nonsense or in-frame deletions of the emerin gene (Bione et al., 1994; Manilal 
et al., 1996; Nagano et al., 1996; Bonne and Quijano-Roy, 2013). Autosomal EDMD is caused by 
different mutations of LMNA, which lead to loss of function of lamin A and lamin C proteins due to folding 
defects.  
Several other human diseases have been linked to mutations coding for INM proteins or lamins, 
pointing out an important function of INM proteins (Bonne et al., 1999; Bonne and Quijano-Roy, 2013). 
A comparative study using MALDI-TOF mass spectrometry analysis (MALDI: matrix-assisted laser 
desorption/ionization; TOF: time of flight) identified 19 new membrane proteins of the NE (Dreger et al., 
2001). By multidimensional protein identification method (MudPIT) in a subtractive study of proteins 
detected in microsomal membranes or NE of rat liver, 67 uncharacterized proteins of the INM were 
identified. The identified proteins were suggested to be type II or multi-spanning membrane proteins 
with a cytoplasmic N-terminus. Confirmed INM proteins were termed “NET” proteins (nuclear envelope 
transmembrane protein; NET3, NET4, NET8, NET26, NET31, NET39, NET51, NET56). Twenty-three 
of the identified INM proteins were highlighted and mapped within chromosome regions, connecting 
them to different human diseases (Schirmer et al., 2003). Additional 87 potential INM proteins were 
identified with MudPIT by the comparison of NE proteins of leukocytes in two different states (resting 
and phytohemagglutinin activated state) followed by the confirmation of the INM localization of eleven 
of these identified proteins (Korfali et al., 2010). Another MudPIT study using fractions of rat skeletal 
muscles also identified several new NET proteins (Wilkie et al., 2011). Further screens identified 
hundreds of potential INM proteins in total, partially evaluated, whose composition is tissue specific 
(Malik et al., 2010; Korfali et al., 2012; Gomez-Cavazos and Hetzer, 2012; de Las Heras et al., 2013). 
Some of these INM proteins are involved in transcription, DNA repair and replication, recombination and 
signaling cascades (Ungricht and Kutay, 2015; Schirmer and Gerace, 2005) and were connected to 
further human diseases, underlining their importance in the NE (Chatzifrangkeskou et al., 2015; Dauer 
and Worman, 2009). 
 
1.3.2 Targeting to the reassembled inner nuclear membrane at the end of open 
mitosis 
Even though many INM proteins have been identified, the mechanism of their targeting to the 
INM still raises questions. In general, two ways to the INM can be distinguished with respect to the 
phase of the cell cycle. Membrane proteins can reach the INM at the end of mitosis, but also have to 




The cell cycle can be divided into two main segments, interphase and mitosis. During the 
interphase, DNA is replicated and other cellular components are produced to prepare for the division of 
the cell into two daughter cells. Interphase can be subdivided into the gap phase 1 (G1), the synthesis 
phase (S), which is the phase of chromosome replication, and the gap phase 2 (G2). After interphase, 
the cell undergoes mitosis (M), the phase of the cell cycle when the NE is dispersed, the synthesized 
material is rearranged and two spatially separated nuclear membranes are rebuilt around the divided 
genetic material. Subsequently, the cell can undergo cytokinesis, the division of the cytoplasm. After 
mitosis and cytokinesis, two daughter cells are equipped for cell growth of the interphase (McIntosh, 
2016; Purves et al., 2006a).  
 
Depending on the organism and cell type, eukaryotic cells can undergo an open or closed 
mitosis. Most fungi undergo closed mitosis in which the NE stays intact as the mitotic spindle, which 
segregates the duplicated chromosomes, is assembled inside the nucleus. In contrast, an open mitosis, 
which can be found in cells of plants and animals, is characterized by the disassembly of the NE before 
and a reassembly after the segregation of the chromosomes. In open mitosis, the NE is disassembled 
in the NE breakdown process which enables the accessibility of chromatin by the cytoplasmic mitotic 
spindle and its microtubules (Boettcher and Barral, 2013; Ungricht and Kutay, 2017).  
For the NE breakdown, protein interactions within NPCs, lamins, INM proteins and chromatin are 
disrupted by phosphorylation (Ungricht and Kutay, 2017). The NPC loses its barrier properties when 
Nup98 is phosphorylated by CDK1 (Cyclin-dependent kinase 1) (Dultz et al., 2008; Laurell et al., 2011). 
Chromatin is detached from phosphorylated INM and INM-associated proteins. For instance, the 
protein-protein interactions of BAF, which interacts with INM proteins containing a LEM domain and also 
with chromatin, are disrupted by its phosphorylation mediated by VRK1 (vaccinia-related kinase 1) 
(Molitor and Traktman, 2014; Gorjanacz et al., 2007). Also, lamins are phosphorylated by CDK1 and 
PKC (protein kinase C) during NE breakdown. Thereby, they lose their connection to the NE and 
chromatin, which leads to the solubilization of A-type lamins while B-type lamins are shifted to the 
ER-membrane (Gerace and Blobel, 1980; Goss et al., 1994; Peter et al., 1990; Heald and McKeon, 
1990). Due to the disruption of the retention in the INM, membrane proteins are retracted in the 
ER-membrane (Ungricht and Kutay, 2017).  
After separation of the sister chromatids, the NE has to be rebuilt. The phosphorylating enzymes 
are inhibited and counteracting protein phosphatases are activated, which enable new protein-protein 
interactions between NPC, lamins, chromatin, INM and INM-associated proteins. Due to the binding of 
INM proteins, which are located in the mitotic ER-membrane, to chromatin, the ER-membrane is 
wrapped around the chromatin reforming the NE (Ellenberg et al., 1997; Yang et al., 1997; Ulbert et al., 
2006; Anderson et al., 2009; Haraguchi et al., 2008; Yang et al., 2017). The formation of NPCs into the 
new NE differs from NPC assembly of interphase cells and is relatively fast. During the NE breakdown, 
nucleoporins are bound by importin  for solubilization. When chromatin and NE come in close proximity 
during NE reassembly, the chromatin-associated RanGEF RCC1 provides high concentration of 
RanGTP at the rebuilding NE causing a disassembly of importin  and the nucleoporins. These Nups, 
which may form subcomplexes, assemble into new NPCs. For the recruitment of the Y-complex to the 
assembling pore the Nup ELYS has been shown to be important (Wandke and Kutay, 2013; Hampoelz 
et al., 2019).  
 
1.3.3 Targeting to the inner nuclear membrane during interphase of the cell cycle 
Cells in interphase, as well as cells that undergo a closed mitosis, need to have a mechanism 
for targeting membrane proteins to the INM when the NE is intact (Antonin et al., 2011). Depending on 
the protein, several models are currently discussed for INM targeting of integral membrane proteins 
(Katta et al., 2014; Laba et al., 2014; Antonin et al., 2011; Burns and Wente, 2012; Ungricht and Kutay, 





Transport factor dependent INM targeting 
One proposed route for INM targeting of membrane proteins is the active transport-based model. 
Ohba and colleagues showed that the INM trafficking of TMD-containing reporters in a live cell assay 
was ATP- and temperature dependent (Ohba et al., 2004). Later, the NE proteins Heh1 and Heh2 of 
S. cerevisiae were shown to reach the INM in a transport factor- and energy-dependent manner. Heh1 
and Heh2 (homologues of metazoan MAN1 and LEM2, respectively) contain two TMDs each and 
localize to the INM, as shown by immunoelectron microscopy. In yeast strains where GTP binding and 
hydrolysis in the GTPase Ran were disrupted nuclear import of Heh1 and Heh2 was inhibited. 
Additionally, the dependency of INM targeting on the karyopherin Kap95 (yeast homolog of human 
importin ) and Kap60 (yeast homolog of human importin ) was shown for both INM proteins in deletion 
stains. Direct binding of Heh2 to Kap60 was demonstrated by pulldown experiments indicating an NLS 
in the N-terminus. When Nup170, an inner nuclear ring nucleoporin, was depleted, the INM localization 
of Heh1 and Heh2 was completely lost (King et al., 2006). To further analyze whether Heh2 passes the 
central channel of the NPC on its way to the INM, Meinema and colleagues created a protein containing 
the bipartite NLS, the linker region and the first TMD of Heh2 and analyzed its way through the pore by 
a trapping system (Meinema et al., 2011). They could trap the artificial protein in the central channel of 
the NPC, suggesting interactions with FG-containing Nups. They emphasized the importance of the 
length of the linker for INM targeting and that transient openings within the NPC have to exist to enable 
membrane-inserted proteins to pass the central channel in a karyopherin-bound form (Meinema et al., 
2011; Meinema et al., 2013). However, in a later experiment, the artificial protein could also be trapped 
at nucleoporins which are close to the membrane but not part of the central channel. Further, when the 
NLS or the linker was removed, the protein could still be trapped at the NPC. Consequently, the assay 
was assessed to be unable to clarify the route of the membrane protein through the NPC. The Heh2 
import was proposed to be closer to the membrane, but still suggested to be dependent on transport 
factors and the Ran GTPase cycle (Laba et al., 2015). 
Based on these findings, a transport factor mediated model for INM targeting of membrane 
proteins was suggested (figure 6A). To reach its destination in the nucleus, a membrane protein contains 
an NLS, which is bound by a karyopherin in the cytoplasm. After complex formation, the karyopherin 
shuttles the membrane-bound protein through the central channel of the NPC presuming a short-term 
disruption of the pore itself. A certain length of the linker, the amino acids between the TMD and the 
NLS, is an important requirement to bridge the distance between the central channel of the pore and 
the membrane. In the nucleus, the binding of RanGTP to karyopherin releases the cargo and the 
membrane protein accumulates in the INM against a concentration difference compared to the ONM 
(Katta et al., 2014; Ungricht and Kutay, 2015).  
 
Sorting motive mediated INM targeting 
Many INM proteins have been shown to contain potential NLS, but so far, their need for INM 
targeting could not be certainly clarified (Katta et al., 2014). For LBR (lamin B receptor) and nurim, an 
INM-sorting motive (INM-SM), a positively charged amino acid sequence adjacent to the TMD, was 
suggested to bind to importin--16. This truncated version of importin  lacks the IBB domain and is 
membrane associated in proximity to Sec61. In a sorting motive-mediated model (not illustrated), 
importin--16 binds to the INM-SM directly after translation and remains bound to the membrane protein 
after membrane insertion by the translocon. For targeting to the NPC, it was suspected that the complex 
of importin--16 and the INM-SM containing membrane protein interacts directly or indirectly with 
cellular motor proteins or that importin--16 mediates interaction with FG-repeats of the NPC. Further, 
it was suggested that importin--16 could dissociate from the INM-SM containing membrane protein 
before or after targeting to the INM via peripheral channels. Alternatively, importin--16 was suggested 
to be required for ONM accumulation of the membrane protein which is then bound by importin  and 





INM targeting via vesicles 
In a vesicle-mediated model (not illustrated), the ONM is suggested to bud into the perinuclear 
space. The bud contains the membrane proteins and fuses with the INM followed by the diffusion of the 
integral proteins into the INM (Katta et al., 2014; Laba et al., 2014; Burns and Wente, 2012). This NPC-
independent model could not be demonstrated so far for INM targeting. The model is based on a reverse 
pathway, the vesicular transport of herpesvirus from the nucleus into the cytoplasm. Upon infection of a 
cell by the herpesvirus, the nucleocapsids are transported to an NPC and the viral DNA is released and 
imported into the nucleus via the NPC. In the nucleus, the viral genome is replicated and packed into 
nucleocapsids, which are approximately 120 nm in diameter and consequently too big for export via the 
NPC (Hellberg et al., 2016; Ungricht and Kutay, 2017). Therefore, the nucleocapsids leave the nucleus 
through the nuclear membrane. First, nuclear lamins are dissolved due to phosphorylation by the viral 
kinase pUS3 and the cellular kinase PKC (Park and Baines, 2006; Muranyi et al., 2002). Then, the viral 
nuclear egress complex (NEC) is assembled and mediates the vesicle formation of the INM into the 
perinuclear space (Reynolds et al., 2001; Klupp et al., 2007; Bigalke and Heldwein, 2015; Hagen et al., 
2015) enclosing nucleocapsids. Afterwards, the bud is fused with the ONM and releases the capsids 
(Ungricht and Kutay, 2017). Another egress pathway from the INM to the ONM has been shown for the 
export of messenger ribonucleoprotein particles in Drosophila melanogaster (Speese et al., 2012).  
 
Diffusion and retention mediated INM targeting 
As the ER-membrane is continuous with the ONM, membrane proteins are suggested to diffuse 
freely after insertion into the ER-membrane to the NE. Several studies compared the mobility of INM 
proteins between the ER-membrane and at the NE and found that the mobility was rapidly decreased 
when the membrane proteins reached the NE. By FRAP (fluorescence recovery after photobleaching) 
experiments, Wu and colleagues showed that MAN1 is relatively immobile when localized to the NE 
compared to MAN1 in the ER-membrane (Wu et al., 2002). In mitotic cells, LBR is located in the 
ER-membrane during NE breakdown and is highly mobile. However, in interphase, when localized to 
the NE, LBR seems to be immobilized by binding to lamins compared to a rapidly diffusing and mobile 
subpopulation of LBR in the ER-membrane (Ellenberg et al., 1997). In FRAP and FLIP (fluorescence 
loss in photobleaching) experiments, emerin and BAF were shown to diffuse rapidly to the NE, but their 
mobility is decreased when located in the INM by binding to interaction partners in the nucleus (Shimi 
et al., 2004; Ostlund et al., 1999). The loss of mobility of integral membrane proteins after reaching the 
INM was suggested to be caused by interactions with lamins or chromatin (Katta et al., 2014; Ungricht 
and Kutay, 2015). An additional retention mechanism was shown for the INM proteins containing a 
luminal SUN domain. These proteins interact with the perinuclear space located tail of KASH (Klarsicht, 
ANC-1, Syne homology) domain proteins, specific ONM proteins. As KASH domain proteins bind to 
actin, microtubules and filaments in the cytoplasm, this interaction connects the nucleus to the 
cytoplasmic cytoskeleton as part of the LINC complex (Schooley et al., 2012; Starr and Fridolfsson, 
2010; Burke, 2012; Wilson and Foisner, 2010). The immobility of SUN domain containing INM proteins 
is therefore not only mediated by the interaction with lamins, but also due to anchoring to ONM proteins 
(Wilson and Foisner, 2010). 
For several proteins, when the cytoplasmic/nucleoplasmic region was increased to approximately 
60 kDa, the INM targeting was slowed down or was completely blocked, suggesting a size-dependency 
of INM localization of membrane proteins (Soullam and Worman, 1993, 1995; Wu et al., 2002; Ohba et 
al., 2004; Zuleger et al., 2011; Antonin et al., 2011; Katta et al., 2014; Ungricht and Kutay, 2015). For 
instance, reporter proteins with an extraluminal domain of 60-75 kDa were not able to reach the INM, 
while reporters with smaller cytoplasmic/nucleoplasmic regions did rapidly diffuse to the INM (Ohba et 
al., 2004). This size-dependency could be shown for all human INM proteins no matter whether they 
contain a predicted NLS or not (Boni et al., 2015; Ungricht et al., 2015; Ungricht and Kutay, 2015). The 
NPC is able to transport soluble proteins of a few megadaltons (Grossman et al., 2012) and artificial 
substrates up to a diameter of 39 nm via its central channel (Pante and Kann, 2002). As the sizes of the 
extraluminal domains of the examined INM proteins fall below this limit and the existence of an NLS was 
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mostly not crucial (Boni et al., 2015; Ungricht et al., 2015), the majority of INM proteins are suggested 
to reach the INM by passive diffusion. INM proteins are supposed to diffuse from the ONM to the INM 
by passing the NPC at peripheral channels, which are lateral gateways of approximately 10 nm in width 
adjacent to the NPC membrane (Maimon et al., 2012; Hinshaw et al., 1992; Beck et al., 2007; Reichelt 
et al., 1990; Ohba et al., 2004; Holmer and Worman, 2001; Katta et al., 2014; Ungricht and Kutay, 2015). 
Peripheral channels are suggested to be the bottleneck of the NPC, which restricts diffusion into the 
INM depending on the cytoplasmic/nucleoplasmic size of the membrane protein. Interestingly, when 
nucleoporins of the inner ring of the NPC or the transmembrane nucleoporin NDC1 were depleted, the 
size restriction in INM targeting was abolished and membrane proteins with enlarged extraluminal 
domains could freely diffuse into the INM (Theerthagiri et al., 2010; Boni et al., 2015; Ungricht et al., 
2015; Ungricht and Kutay, 2015). INM proteins with larger extraluminal regions or more TMDs reach the 
INM slower than membrane proteins with smaller cytoplasmic/nucleoplasmic regions, which could be 
explained by a more time-consuming threading and funneling into the peripheral channel (Ungricht and 
Kutay, 2015).  
Based on these discoveries, a diffusion and retention-mediated model for membrane protein 
targeting to the INM was suggested (figure 6B). A TMD-containing protein which needs to be targeted 
to the INM diffuses freely to the ONM after membrane insertion into the ER-membrane. The membrane 
protein passes the NPC by using the peripheral channels of the pore and further diffuses into the INM. 
The integral membrane protein can be retained in the INM upon interaction of its binding domains with 
lamins or chromatin. The diffusion into the INM via the peripheral channels is dependent on the size of 
the extraluminal region of the membrane protein (Katta et al., 2014; Ungricht and Kutay, 2015; Burns 
and Wente, 2012; Powell and Burke, 1990; Holmer and Worman, 2001). 
 
Figure 6: Models for INM targeting of integral membrane proteins. 
(A) Active-transport based model. The integral membrane protein exposes a nuclear localization 
signal (NLS) into the cytoplasm after insertion into the endoplasmic reticulum (ER). This NLS can be 
recognized by transport factors, which mediate the targeting from the outer nuclear membrane (ONM) 
to the inner nuclear membrane (INM). When the complex passed the central channel of the nuclear 
pore complex (NPC) and reached the INM, binding of nuclear RanGTP mediates dissociation of the 
complex. (B) Diffusion-and-retention based model. An integral membrane protein passively diffuses 
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from the ONM to the INM through peripheral channels of the NPC. At the INM, the membrane protein 
can interact with chromatin and/or the nuclear lamina. Inspired by Katta et al., 2014, Ungricht and 
Kutay, 2015. See also Blenski and Kehlenbach, 2019. 
 
Controversy in the discussion of membrane protein targeting to the INM 
With the current state of knowledge, a general mechanism for INM targeting of membrane 
proteins could not yet be identified. Most experimental results suggest that diffusion is the main targeting 
mechanism of integral membrane proteins to the INM. The integral membrane protein is then kept in 
the INM through interactions with lamins or chromatin (Ungricht and Kutay, 2015). However, there are 
experimental results, which suggest the possibility for other targeting mechanisms or intermediate 
variants. For instance, the INM localization of the SUN domain-containing protein UNC-84 
(Caenorhabditis elegans), which has an extraluminal domain of approximately 59 kDa, cannot only be 
explained by a diffusion mechanism if the peripheral channels restrict INM targeting in a size-dependent 
manner (Tapley et al., 2011; Katta et al., 2014; Ungricht and Kutay, 2015). Several motives in the 
extraluminal domain of UNC-84 were identified which are important for INM targeting. When all motives 
were disrupted, UNC-84 lost its NE localization (Tapley et al., 2011). Furthermore, the INM targeting of 
reporters in a live cell assay was shown to be ATP-dependent (Ohba et al., 2004), which is not in line 
with the energy-independent diffusion and retention model. Also, the INM targeting of Heh1 and Heh2 
was shown to be RanGTPase dependent (King et al., 2006). Additionally, the INM targeting of LBR was 
inhibited upon expression of RanQ69L (Zuleger et al., 2011), a dominant negative mutant of the GTPase 
Ran, which fails to hydrolyze GTP (Klebe et al., 1995). These results were taken as evidence for a 
different targeting mechanism other than the diffusion and retention model.  
However, also the active transport factor-dependent import of the S. cerevisiae protein Heh2 is 
questionable. Yeast lacks nuclear lamins, and therefore the retention of integral membrane proteins in 
the INM is suggested to occur via interaction with chromatin or other proteins. It is not known how Heh2 
is retained at the INM. Therefore, it is possible that the INM localization of Heh2 is dependent on a 
nuclear retention partner, which could be dependent on Kap60, Kap95 and RanGTPase for its nuclear 
import. The observed dependency of Heh2 INM targeting on transport factors and RanGTPase activity 
is likely an indirect effect. Furthermore, the experimental implementation cannot exclude a nuclear 
import of Heh2 as a soluble protein followed by integration into the INM (Ungricht and Kutay, 2015). 
Also, the ATP dependency in INM targeting of membrane proteins could be explained by effects on the 
mobility of the ER itself upon ATP-depletion, which could influence the INM targeting indirectly. 
Overexpression of RanQ69L might also affect the INM targeting of membrane proteins in an indirect 
manner, as soluble binding partners could be inhibited in their nuclear transport resulting in a lack of 
retention of the membrane proteins at the INM (Boni et al., 2015; Ungricht et al., 2015; Ungricht and 
Kutay, 2015).  
In mammals, the SUN domain-containing protein SUN2 was shown to contain a cNLS, which was 
suggested to be bound by importin  and importin . A cluster of four arginine residues in its N-terminus 
acts as an ER localization signal preventing accumulation in the Golgi. The cNLS was sufficient to target 
heterogenous proteins into the nucleus. However, it cannot be excluded that the cNLS works as a 
retention motif rather than an import signal for the importin /importin  pathway (Turgay et al., 2010). 
For the N-terminal extraluminal region of LBR, a direct Ran-sensitive interaction with importin , but 
independent of importin , could be detected (Ma et al., 2007). However, in semi-permeabilized cells 
the NE targeting of SUN2 and LBR was shown to be independent of transport factors or central 
FG-repeats of the NPC (Ungricht et al., 2015). 
For some INM proteins, one sole model might explain their nuclear trafficking mechanism. 
However, for other proteins, various elements of different models could be suitable to explain their INM 





1.4 The membrane protein LRRC59 
LRRC59 was first described as p34 (ribosome-binding protein p34), a protein of 34.9 kDa, which 
was suggested to bind to ribosomes in rough microsomes (Tazawa et al., 1991; Ichimura et al., 1993). 
p34 was shown to consist of 307 amino acids and contains a large cytosolic N-terminal domain followed 
by a single TMD and a short C-terminus facing the lumen of the ER (figure 7). It is a non-glycosylated 
type II signal-anchor membrane protein with a highly conserved sequence (Protein sequence BLAST 
tool of NCBI: at least 94% sequence identity of LRRC59 of Homo sapiens, Mus musculus, Rattus 
norvegicus and Bos taurus) and with a wide expression in different tissues (Skjerpen et al., 2002; 
Ohsumi et al., 1993). At the N-terminus, a leucine-rich repeat (LRR) domain with five repeats was 
identified (Ohsumi et al., 1993) (UniProt ID Q96AG4, Gene name: LRRC59, ORF name: PRO1855). 
Due to these repeats and the refutation of the potential function as a ribosome receptor (Ohsumi et al., 
1993; Kalies et al., 1994), p34 was termed LRRC59, leucine-rich repeat-containing protein 59. In 
general, leucine-rich repeats (LRR) are suggested to mediate reversible protein-protein interactions 
(Buchanan and Gay, 1996). LRRC59 was identified in some large-scale screens as a potential 
interaction partner of several proteins (interaction with human MT1 melatonin receptor (Daulat et al., 
2007); interaction with MPG (DNA-3-methyladenine glycosylase) and other proteins but with low 
confidence (Ewing et al., 2007); crosslinking to mitochondrial DNA (Bogenhagen et al., 2008); 
interaction with RRP1B (ribosomal RNA processing 1 homolog B) by tandem affinity purification analysis 
(Crawford et al., 2009)). However, these identifications were not further analyzed and do not indicate 
what the biological function of LRRC59 could be. In addition to the LRR domain, the cytosolic region 
contains a coiled-coil domain, which is in general known to assist in the assembly of dimers and higher 
multimers (Lupas, 1996). Later, the ability of LRRC59 to form dimers and trimers has been shown in 
crosslinking experiments (Skjerpen et al., 2002).  
 
 
Figure 7: The amino acid sequence of LRRC59, a single-pass type II membrane protein. 
(A) Scheme of full-length LRRC59 with the leucine rich repeat region (LRR, green) containing five 
repeats, the putative coiled-coil domain (blue) and the transmembrane domain (TMD, red). (B) Amino 
acid sequence of LRRC59 with the LRR region (green), the coiled-coil domain (blue) and the single 
TMD (red). See UniProt ID Q96AG4 and Zhen et al., 2012. 
 
Furthermore, LRRC59 was shown to interact with the ER-membrane protein UNC93B1 
(uncoordinated 93 homolog B1) upon stimulation of cells with certain nucleic acids independent of toll-
like receptors (TLRs). By direct interaction, UNC93B1 is involved in the trafficking of nucleic acid-sensing 
TLRs from the ER to the Golgi or endosomes. The endosomal localization of TLR3 was decreased upon 
LRRC59 depletion, suggesting that LRRC59 may be involved in the translocation of nucleic acid-sensing 
TLRs from the ER after infection by the interaction with UNC93B1 (Tatematsu et al., 2015). 
 
In a yeast two hybrid screen, LRRC59 was identified to interact with the oncoprotein CIP2A 
(cancerous inhibitor of PP2A), an inhibitor of the tumor suppressor PP2A (protein phosphatase 2A). 
CIP2A promotes mitotic progression and tumorigenesis after its nuclear translocation. LRRC59 was 
suggested to bind CIP2A during the G1/S phase of the cell cycle independent of PP2A and promotes 
nuclear import of CIP2A at G2/M of the cell cycle, as nuclear localization of CIP2A was decreased by 
80% upon knockdown of LRRC59 (Pallai et al., 2015).  
 
LRRC59 was demonstrated to localize to the ER-membrane and the NE. The luminal localization 
of the C-terminus was confirmed by the addition of a glycosylation site and SDS-PAGE analysis (Zhen 
et al., 2012; Skjerpen et al., 2002). LRRC59, was shown to interact with FGF1 (fibroblast growth factor 1) 
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via its coiled-coil domain (Skjerpen et al., 2002; Zhen et al., 2012). Fibroblast growth factors are involved 
in stimulation of cell proliferation after translocation into the nucleus (Maddaluno et al., 2017; Ornitz and 
Itoh, 2015). FGF1 and FGF2 do not diffuse freely into the nucleus, even though they have a low 
molecular mass. Two NLS have been identified within the amino acid sequence of FGF1, which are 
required for its nuclear import (Imamura et al., 1990; Wesche et al., 2005). Additionally, the nuclear 
import of exogenous FGF1, but not FGF2, was shown to be dependent on LRRC59. Depletion of 
LRRC59 blocked the transport of FGF1 into the nucleus but did not affect its translocation from 
endosomes into the cytosol. Also, the nuclear import of FGF1 was shown to be Ran-, importin - and 
importin -dependent. For LRRC59, the cytoplasmic region containing the coiled-coil domain in a 
soluble GFP-tagged version was located in the nucleus, indicating a potential NLS within the amino acid 
sequence. In U2OS cells, the knockdown of importin  resulted in a total loss of the NE localization of 
endogenous LRRC59. This suggests that the nuclear import of LRRC59 itself depends on importin . 
Together, exogenous FGF1 is supposed to bind to the coiled-coil domain of LRRC59 after uptake by 
the cell in endosomes and transfer into the cytosol. After binding of importin  and importin  to the 
coiled-coil domain of LRRC59, the complex was suggested to be targeted into the nucleus in a Ran-
dependent manner (Zhen et al., 2012).  
 
 
1.5 Aim of the study 
The nucleocytoplasmic transport of soluble cargo proteins is a well-studied research field. By 
contrast, there is not much known about the nuclear import of membrane proteins to the INM after their 
insertion into the ER-membrane. In this thesis, the INM targeting of membrane proteins is examined 
with special focus on LRRC59 as a model protein.  
 
First, the mechanism how LRRC59 is inserted into the ER-membrane will be studied. LRRC59 
contains a single TMD at its C-terminus followed by 40 amino acids facing the lumen of the ER. The 
TMD at the C-terminus suggests that LRRC59 is a potential TA protein (Kutay et al., 1993), which could 
be a substrate for post-translational membrane insertion via the TRC pathway. By in vitro microsome 
integration assays and cell-culture based experiments, the potential involvement of the TRC pathway in 
ER-membrane insertion of LRRC59 will be studied.  
In immunofluorescence experiments, LRRC59 was shown to localize mainly to the ER, but also 
to the NE, a localization which was suggested to be dependent on the transport factor importin  (Zhen 
et al., 2012). In this study, the mechanism of INM targeting of LRRC59 will be examined in more detail. 
Not much is known about the biological function of LRRC59. Therefore, the protein will be analyzed for 
potential interaction partners using proximity labeling.  
 
To get a more general impression of INM targeting of proteins containing a single TMD, seven 
additional proteins will be analyzed in terms of INM localization using rapamycin-induced dimerization 
assays and in terms of the mechanism in which some of them they are targeted into the nucleus.  
 
Overall, the aim of this thesis is to gain a deeper understanding in INM targeting of LRRC59 and 
other single TMD-containing proteins. This will potentially contribute to solve the question of how 
membrane proteins are targeted to the INM in general. 
 
Material and Methods 
 
 27 
2 Material and Methods 
For basic methods and buffer composition, see  Current Protocols in Molecular Biology, Luttmann 




Table 2: Software 
Software Company 
AxioVision (LE) Rel. 4.8.1 Carl Zeiss 
Gene 5 plate reader software BioTek 
EndNote X9 Clarivate Analytics 
Image Reader LAS-3000 Fujifilm 
ImageJ 1.52a NIH 
InkscapeTM Open Source Scalable Vector Graphics Editor 
ImageStudio, ImageStudio Lite 5.2.5 LI-COR 
LSM 510 Release Version 4.0 SP2 Zeiss 
LSM Image Browser Zeiss 
Microsoft Office Microsoft 
NanoDrop 2000 Software Thermo Fisher Scientific 
Perseus Software version 1.5.6.0 Max Planck Institute for Biochemistry, Martinsried, Germany 
Serial Cloner 2.6.1 SerialBasics 
 
 
2.1.2 Technical equipment 
Table 3: Technical equipment 
Equipment Company 
3 Channel Display Clock Timer WB388 Oregon Scientific 
Agarose gel documentation GelSTICK touch INTAS Science Imaging Instruments 
Agarose gel documentation printer P93D Mitsubishi 
Agarose gel running chamber Home-made, Workshop, UMG 
Airflow-Control EN14275 Weidner 
Autoclave Sterilizer DX-200 Systec 
BioPhotometer Eppendorf 
Cell culture hood HerasafeTM KS Thermo Fisher Scientific 
Cell culture incubator HeracellTM 150i Thermo Fisher Scientific 
Cell culture incubator Cytoperm 2 Heraeus Instruments 
Centrifuge 5414R Eppendorf 
Centrifuge 5424 Eppendorf 
Centrifuge Sigma Sigma-Aldrich 
Centrifuge Allegra® X-15R with rotor SX4750 Beckman Coulter 
Centrifuge Allegra® X-22 with rotor SX4250 Beckman Coulter 
Centrifuge AvantiTM J-30l with rotor JA30.50Ti Beckman Coulter 
Centrifuge J6-MI with rotor JS 4.2 Beckman Coulter 
Centrifuge Optima MAX-XP with rotor TLA 120.1 Beckman Coulter 
Compact disc Digital radio Player TCM 
Confocal microscope LSM 510 meta Zeiss 
Cryo System 750 MVE 
Developer machine CURIX60 Agfa 
Dual Gel Caster for Mini Vertical Units Hoefer 
Documentation system LAS-3000 Fujifilm 
DPU-414 Thermal Printer Seiko Instruments Inc. 
Electrophoresis Power Supply EPS 301 Amersham Bioscience 




Emulsiflex-C3 BD Bioscience 
Falcon tube roller Home-made, Workshop, UMG 
Fluorescence microscope Axioskop 2 Zeiss 
Hera freeze -80 °C Thermo Electron Corporation 
Heating plate Type 12801 MEDAX 
HP Laser Jet 1320n HP 
Ice machine Ziegra Eismaschinen GmbH 
iMac Apple 
Incubator Haraeus function line Haraeus 
Incubator Shaker INNOVA 4430 New Brunswick Scientific 
Incubation/Inactivation Water Bath Model 1003 GFL 
Isotherm liquid nitrogen storage KGW 
IMPRESSA J9.3 One Touch TFT Jura 
MacBook Pro Apple 
Magnetic stirrer H+P Variomag Power direct VWR 
Magnetic stirrer HR Hei-Mix L Heidolph 
Magnetic stirrer IKA – Combimag RCT Bachhofer 
Micro centrifuge model IR 220 VAC Roth 
Microwave oven Ciatronic 
Mini Trans-Blot® Cell Bio-Rad 
Milli-Q® Millipore 
Odyssey® Sa Infrared Imaging System LI-COR 
Odyssey® CLx Imaging System Li-COR 
Olympus CK40 Culture Microscope Olympus 
OptiPlex 7050 Dell 
pH 522 Bodo Schmidt 
Pipet 2.5 µl Eppendorf 
Pipet aid Drummond 
Pipetman 10, 20, 100, 200, 1000 µl Gilson 
Plate reader BioTek Synergy HT BioTek 
Premium No Frost Freezer Liebherr 
Profi Line Fridge Liebherr 
Pump KNF Lab Laboport 
Rocker Rocking Shaker ELMI 
Rocker Sky Sine Shaker DRS-12 ELMI 
Rocker Duomax 1030 Heidolph 
Scale Kern EW 
Scale PE 3600 Delta Range Mettler 
SE250 Mighty Small II Mini Vertical Electrophoresis Unit Hoefer 
Spectra/Por 1 Dialysis membrane Standard RC tubing 6-8 kDa Spectrum 
Spectrophotometer NanoDrop 2000c Thermo Fisher Scientific 
Spinning wheel LABINCO 
Standard Power Pack P25 Biometra 
Syntec DX-200 autoclave Syntec 
Thermocycler FlexCycler2 Analytik Jena AG 
Thermocycler T professional Biometra 
Thermomixer comfort Eppendorf 
Thermomixer compact Eppendorf 
UV (ultraviolet) sterilizer Biometra 
UV (ultraviolet) transilluminator Uvitec 
Vacuum sealer Vacupack Krups 
Vortexer MS2 Minishaker IKA 
VortexGenie2 Suedlabor 
 




Table 4: Consumables 
Consumable Company 
96 well micro test plate Sarstedt 
96 well micro test plate lid Sarstedt 
Amersham Hybond ECL Nitrocellulose Blotting Membrane GE Healthcare 
Amersham HyperfilmTM ECL GE Healthcare 
Amersham Protran 0.45 µm NC Nitrocellulose Blotting Membrane GE Healthcare 
Autoclave bag Sarstedt 
Beakers VWR, Labsolute 
Bottle Top Filter, 0,1 µm, 500 ml Sarstedt 
Bottle Top Filter,0,2 µm, 500 ml Sarstedt 
Cell culture dish 10 cm Sarstedt 
Cell scratcher 25 cm Sarstedt 
Centrifuge Bottle Assembly, Polycarbonate 50 ml Beckman Coulter 
Centrifuge tube, thick wall, Polycarbonate 500 µl Beckman Coulter 
Centrifuge tubes 500 ml Heinemann 
Cryotubes (Nunc) Thermo Fisher Scientific 
cuvette Sarstedt 
Disposable scalpel Bayha 
Erlenmeyer flask Schott 
Fabric tape Roth 
Falcon 15 ml Sarstedt 
Falcon 50 ml Sarstedt 
Filter tips 10, 20, 300, 1250 µl Greiner 
Glass bottles 50, 100, 250, 500, 1000, 2000 ml Schott 
Inoculation spreader Sarstedt 
Inoculation spreader glass beads Thermo Fisher Scientific 
Labeling tapes Pdc Precision dynamic corporation 
Magnetic stirrer VWR 
Measuring cup VWR 
Measuring cylinder VWR 
Medix XBU medical X-ray film FOMA Bohemia 
Microscope coverslips (12 mm ) Menzel-Glaeser 
Microscope slides Menzel-Glaeser 
Mini Protean TGX Precast gels (4-20%) Bio-Rad 
Minisart RC 15, single use syringe filters (0.45 µm, 0.20 µm) Sartorius 
Minisart single use filter units (0.45 µm) Sartorius   
Neubauer chamber advanced 0.100 mm Brand 
Parafilm “M” Bemis Company, Inc 
Pasteur pipets Brand 
PBS AppliChem 
PD-10 desalting columns GE Healthcare 
Petri dish 10 cm Sarstedt 
pH indicator strips Macherey-Nagel 
Plastic Pipet tips 5 ml, 10 ml, 25 ml Greiner 
Polystyrene Round-Bottom tubes 13 ml Sarstedt 
Reaction tubes (1.5 ml, 2 ml) Sarstedt 
Reaction tubes safe lock (0.2 ml, 0.5 ml) Eppendorf 
Reaction tubes safe lock (1.5 ml, 2 ml) Sarstedt 
Spray bottle VWR, Kautex 
Starlab comfort gloves S Starlab 
Storage box for reaction tubes Sarstedt 
Syringe filter 0,2 µm Th. Geyer 
Syringe filter 0,45 µm Th. Geyer 




Syringes and needles B. Braun, Servoprax 
TC-Plate 24 well standard F Sarstedt 
Tweezers LI-COR 
Weighing pan Th. Geyer 
Western blot incubation boxes LI-COR 




Table 5: Kits 
Kit Company 
NucleoBondTM Xtra Midi Macherey-Nagel 
NucleoSpin® PCR clean-up/Gel extraction Macherey-Nagel 
NucleoSpin® Plasmid Macherey-Nagel 
Pierce® BCA Protein Assay Kit Thermo Fisher Scientific 
RNeasy Mini Kit  Qiagen 
SuperScript III Reverse Transcriptase Thermo Fisher Scientific 
TnT® Quick Coupled Transcription/Translation System Promega 
 
 
2.1.5 Chemicals, reagents, enzymes 
All used chemicals and reagents were obtained from AppliChem GmbH (Darmstadt), Carl Roth 
GmbH + Co. KG (Karlsruhe), Serva Electrophoresis GmbH (Heidelberg), Sigma-Aldrich (Taufkirchen) 
or Merck (Darmstadt). 
 
Table 6: Chemicals and Reagents 
Reagent Company 
-Mercaptoethanol Roth 
Acetic acid Roth 
Acrylamide 4K Solution (30%) AppliChem 
Adenosine 5’-triphosphate disodium salt hydrate (A3377) Sigma-Aldrich 
Advanced protein assay reagent 5x Cytoskeleton Inc. 
Agarose PeqGold VWR 
Amylose Resin High Flow New England BioLabs 
Aluminum-sulfate-(14-18)-hydrate AppliChem 
Ampicillin Roth 
Ammonium persulfate Sigma-Aldrich 
Aprotinin Roth 
Biotinphenol Iris Biotech 
Bovine Serum Albumin (BSA) 20 mg/ml Thermo Fisher Scientific 
Bromophenol blue Serva 
BSA, fraction V AppliChem 
Calcium chloride (CaCl2) Sigma-Aldrich 
Chloramphenicol Sigma-Aldrich 
Coomassie Brilliant Blue (CBB)-G250 Serva 
DAPI (D9542) Sigma-Aldrich 
Desthiobiotin Sigma-Aldrich 
Dithiothreitol (DTT) AppliChem 
Dulbecco’s Modified Eagle Medium (DMEM), high glucose, pyruvate Thermo Fisher Scientific 
Dulbecco’s Modified Eagle Medium (DMEM), high glucose, no glutamine, 
no lysine, no arginine 
Thermo Fisher Scientific 
Digitonin Calbiochem 
Disodium hydrogen phosphate (Na2HPO4) Sigma-Aldrich 




dNTP Set, 100 mM solutions Thermo Fisher Scientific 
Ethanol (analytical grade) Roth 
Ethylenediaminetetraacetic acid (EDTA) AppliChem 
Ethyleneglycol-bis (-aminoethyl ether)-N,N,N’,N’-tetraacetic acid (EGTA) AppliChem 
Fetal bovine serum (FBS) Superior Biochrom 
Formaldehyde Solution min. 37% Millipore 
GeneRuler 100bp DNA Ladder Thermo Fisher Scientific 
GeneRuler 100bp DNA Ladder Plus Thermo Fisher Scientific 
GeneRuler 1kb DNA Ladder Thermo Fisher Scientific 
Gibco® Dulbecco’s Modified Eagle Medium (DMEM; 1x) Thermo Fisher Scientific 
Gibco® Penicillin Streptomycin Thermo Fisher Scientific 
Glycerol 87% AppliChem 
Glycine Roth 
Glutathione Sepharose 4 Fast Flow GE Healthcare 
Heavy 13C615N2-L-lysine Silantes 
Heavy 13C615N4-L-arginine Silantes 
HEPES AppliChem 
Hydrochloric acid (HCl) AppliChem 
Hydrogen peroxide (H2O2) Sigma-Aldrich 
Imidazole Roth 
ImmobilonTM Western Chemiluminescent HRP Substrate Millipore 
IPTG Thermo Fisher Scientific 
Kanamycin sulfate Roth 
LB medium AppliChem 
LB Agar AppliChem 
L-Glutamine 200 mM Roth 
Leupeptin Roth 
LiCl Merck 
Light 12C614N2-L-lysine  Sigma-Aldrich 
Light 12C614N4-L-arginine Sigma-Aldrich 
Magnesium acetate (Mg(OAc)2) Roth 
Magnesium Chloride (MgCl2) Roth 
Methanol (technical grade) Roth 
Mowiol ® 4-88 Calbiochem 
NeutrAvidin® Agarose Thermo Fisher Scientific 
Ni-NTA Agarose Qiagen 
Nonidet P-40 (NP-40) AppliChem 
Oligonucleotides Sigma-Aldrich 
Ortho-Phosphoric acid 85% p.A. AppliChem 
Ovalbumin AppliChem 
PageRuler Prestained Protein Ladder Thermo Fisher Scientific 
PageRuler Unstained Protein Ladder Thermo Fisher Scientific 
Pepstatin Roth 
Phenylmethane sulfonyl fluoride (PMSF) AppliChem 
Pierce Coomassie Plus Protein Assay Reagent Thermo Fisher Scientific 
Ponceau S Sigma-Aldrich 
Potassium acetate (KOAc) Roth 
Potassium chloride (KCl) AppliChem 
Potassium dihydrogen phosphate (KH2PO4) Roth 
Powdered milk Roth 
Protein-A-Sepharose 4 Fast Flow GE Healthcare 
Puromycin dihydrochloride from Streptomyces alboniger (P8833) Sigma-Aldrich 
Rapamycin Ready Made Solution, 2.5 mg/ml in DMSO (dimethyl 
sulfoxide) (2.74 mM), from Streptomyces hygroscopicus 
Sigma-Aldrich 




RNase free water Santa Cruz Biotechnology 
SafeViewTM Classic (DNA stain) Applied Biological Materials Inc. 
Sodium acetate (NaOAc) Roth 
Sodium ascorbate AppliChem 
Sodium azide (NaN3) Merck 
Sodium chloride (NaCl) Roth 
Sodium deoxycholate Merck 
Sodium dodecyl sulfate (SDS), powder Roth 
Sodium dodecyl sulfate (SDS), 20% liquid AppliChem 
Streptavidin HRP Jackson ImmunoResearch 
TEMED Roth 
Tris (buffer grade) AppliChem 
Triton-X100 Sigma-Aldrich 
Trolox Sigma-Aldrich 
Trypan blue solution 0.4% Sigma-Aldrich 
Tween Roth 
Xylene cyanole Abcam 
 
 
Table 7: Enzymes 
Enzyme Company 
Creatine phosphokinase, Rabbit Skeletal Muscle Calbiochem 
DNase I Roth 
Fast alkaline phosphatase (FastAP) Thermo Fisher Scientific 
Pfu Ultra II polymerase Agilent 
Phusion High-Fidelity DNA Polymerase Thermo Fisher Scientific 
Restriction enzymes Thermo Fisher Scientific 
T4 DNA ligase Thermo Fisher Scientific 
Gibco® Trypsin/EDTA 0.25% (1x) Thermo Fisher Scientific 
Peptide-N-Glycosidase F (PNGase F) New England BioLabs 
 
 
2.1.6 Buffers, stock solutions, media 
Table 8: Buffers and Solutions 
Buffer Composition 
Binding buffer 
50 mM Tris pH 7.4, 200 mM NaCl, 1 mM MgCl2, 5% (v/v) glycerol, 
1 mM DTT, 20 mg/ml ovalbumin 
CaCl2 buffer 250 mM in H2O 
Coomassie fixing solution 40% (v/v) ethanol, 10% (v/v) acetic acid 
Coomassie staining 
5% (w/v) aluminum sulfate-(14-18)-hydrate, 10% (v/v) ethanol, 2% (v/v) 
ortho-phosphoric acid, 0.02% (w/v) CBB-G250 
DNA loading buffer (6x) 
0.2% (w/v) bromophenol blue, 0.2% (w/v) xylene cyanole, 60% (v/v) 
glycerol, 60 mM EDTA 
G7 reaction buffer (10x) 0.5 M sodium phosphate pH 7.5 
Glycoprotein Denaturing buffer (10x) 5% SDS, 0.4 M DTT 
2x HEPES buffer 50 mM HEPES, 250 mM NaCl, 1.5 mM Na2HPO4, pH 6.94 
Laemmli running buffer (10x) 250 mM Tris, 1.92 M glycine, 0.5% (v/v) SDS 
Medium salt buffer 
50 mM HEPES, 300 mM KOAc, 10 mM Mg(OAc)2, 10% (v/v) glycerol, 
4 mM -mercaptoethanol, 1 µg/ml leupeptin, 1 µg/ml pepstatin, 1 µg/ml 
aprotinin 
Mowiol mounting medium 
13.3% (w/v) Mowiol 4-88, 33.3% (w/v) glycerol, 133 mM Tris-HCl, pH 
8.5, (1 µg/ml DAPI) 
PBS (10x) 1.37 M NaCl, 27 mM KCl, 100 mM Na2HPO4, 18 mM KH2PO4, pH 7.5 
Ponceau S staining solution 0.5% (w/v) Ponceau S in 1% (v/v) acetic acid 





50 mM Tris pH 7.4, 200 mM NaCl, 1 mM MgCl2, 5% (v/v) glycerol, 
1 mM DTT 
Quenching buffer 5 mM Trolox, 10 mM NaN3, 10 mM sodium ascorbate, in 1x PBS 
RIPA buffer 
50 mM Tris, (pH 7.4), 5 mM Trolox, 0.5% (w/v) sodium deoxycholate, 
150 mM NaCl, 0.1% (w/v) SDS, 1% (v/v) Triton X-100, 1 mM PMSF, 
10 mM NaN3, 10 mM sodium ascorbate, 1 µg/ml aprotinin, 1 µg/ml 
leupeptin and 1 µg/ml pepstatin 
SDS sample buffer (4x) 
125 mM Tris pH 6.8, 4% (v/v) SDS, 0.02% (w/v) Bromophenol blue, 
10% (v/v) glycerol 
TBST 50 mM Tris pH 7.5, 150 mM NaCl, 0.05% (v/v) Tween-20 
TAE buffer (50x) 2 M Tris, 0.05 M EDTA, 5.71% (v/v) acetic acid 
Transport buffer (10x) 200 mM HEPES, 1.1 M KOAc, 20 mM Mg(OAc)2, 10 mM EGTA, pH 7.3 
Washing buffer 1 
50 mM HEPES (pH 7.4), 0.1% (w/v) sodium deoxycholate, 1% (v/v) 
Triton X-100, 500 mM NaCl, 1 mM EDTA 
Washing buffer 2 
50 mM Tris (pH 8.0), 250 mM LiCl, 0.5% (v/v) NP-40, 0.5% (w/v) 
sodium deoxycholate, 1 mM EDTA 
Washing buffer 3 50 mM Tris (pH 7.4), 50 mM NaCl 
Western blot transfer buffer (10x) 250 mM Tris, 1.93 M glycerol, 0.2% (v/v) SDS 
Western blot transfer buffer 25 mM Tris, 193 mM glycine, 0.02% (v/v) SDS, 20% (v/v) methanol 
 
 
Table 9: Stock Solutions 
Solution Composition 
1,4-Dithiothreitol (DTT) 1 M in H2O 
4’,6-Diamidin-2-phenylindol (DAPI) 1 mg/ml in H2O 
Ammonium persulfate 10% ammonium persulfate in H2O 
Ampicillin 100 mg/ml in H2O 
Aprotinin 1 mg/ml in 20 mM HEPES pH 7.4 
Adenosine triphosphate (ATP) 100 mM ATP in 100 mM Mg(OAc)2, 20 mM HEPES (pH 7.4) 
Calcium Chloride (CaCl2) 1 M in H2O 
Chloramphenicol 30 mg/ml 
Creatine Phosphate 80 mg/ml in H2O 
Digitonin 10% (w/v) in DMSO (dimethyl sulfoxide) 
Ethylenediaminetetraacetic acid (EDTA) 0.5 M in H2O, pH 8 
Ethyleneglycol-bis (-aminoethyl ether)-
N,N,N’,N’-tetraacetic acid (EGTA) 
0.5 M in H2O, pH 8 
HEPES 1 M in H2O, pH 7.4 
Isopropyl -D-1-thiogalactopyranoside (IPTG) 10 M in H2O 
Kanamycin 60 mg/ml in H2O 
Leupeptin/Pepstatin 1 mg/ml each, in DMSO (dimethyl sulfoxide) 
Magnesium acetate (Mg(OAc)2) 1 M in H2O 
Magnesium chloride (MgCl2) 1 M in H2O 
Sodium chloride (NaCl) 5 M in H2O 
Phenylmethylsulfonyl fluoride (PMSF) 100 mM in 2-propanol 
Potassium acetate (KOAc) 1 M in H2O 
Potassium acetate (KOAc) 3 M in H2O 
Potassium chloride (KCl) 3 M in H2O 
Puromycin 10 mg/ml in H2O 
Sodium acetate  1 M in H2O 
Tris pH 6.8 1 M in H2O 
Tris pH 7.4 1 M in H2O 
Tris pH 8.8 2 M in H2O 
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Table 10: Bacterial media 
Medium Composition 
LB 1% (w/v) bacto-tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl, pH 7.0 
LB ampicillin LB medium supplemented with 100 mg/l Ampicillin 
LB kanamycin LB medium supplemented with 60 mg/l Kanamycin 
LB chloramphenicol LB medium supplemented with 30 mg/l Chloramphenicol 
LB agar plates LB supplemented with 1.5% (w/v) bacto-agar 
LB agar plates with ampicillin LB supplemented with 1.5% (w/v) bacto-agar, 80 mg/l Ampicillin 
LB agar plates with kanamycin LB supplemented with 1.5% (w/v) bacto-agar, 60 mg/l Kanamycin 
LB agar plates with chloramphenicol LB supplemented with 1.5% (w/v) bacto-agar, 1.5 mg/l Chloramphenicol 
SOC 
2% (w/v) tryptone, 0.5% (w/v) yeast extract, 10 mM NaCl, 2.5 mM KaCl, 
10 mM MgCl2, 10 mM MgSO4, 0.36% (w/v) glucose, pH 7.0  
 
 




Dulbecco´s Modified Eagle Medium (DMEM), 10% (v/v) FBS, 2 mM L-glutamine, 
100 U/ml penicillin, 100 µg/ml streptomycin 
Heavy isotopes 
labelling medium 
Dulbecco´s Modified Eagle Medium (high glucose, no glutamine, no lysine, no arginine), 
10% (v/v) dialyzed FBS, 6 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 
0.4 mM 13C615N2-L-lysine, 0.2 mM 13C615N4-L-arginine 
Light isotopes 
labelling medium 
Dulbecco´s Modified Eagle Medium (high glucose, no glutamine, no lysine, no arginine), 
10% (v/v) dialyzed FBS, 6 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 
0.4 mM 12C614N2-L-lysine, 0.2 mM 12C614N4-L-arginine 
 
 
2.1.7 Cell lines 
Table 12: Cell lines 
Cell line Specification Origin 
HeLa P4 
Human adenocarcinoma cell line; modified expressing CD4; 
adherent; derived from the cervix of a 31-year old woman 
NIH AIDS Reagent Program; 
Charneau et al. (1994)  
U2OS 
Human osteosarcoma cell line; adherent; derived from a 




2.1.8 Escherichia coli strains 
Table 13: E. coli strains 
E. coli strain Specification and genotype 
DH5 
F- 80lacZ M15 (lacZYA-argF) U169 recA1 endA1 hsdR17 (rK-, mK+) phoA supE44 - 
thi-1 gyrA96 relA1 




Table 14: Primary antibodies 
Name Species Origin Application* Dilution Number 
-alpha 
tubulin 
rabbit Proteintech, 11224-1-AP IF/WB 1:500/1:1000 Ab081 
-c-Myc mouse Santa Cruz Biotechnology, sc-40 IF 1:200 Ab191 
-calnexin rabbit Enzo, ADI-SPA-860 WB 1:1000 Ab220 
-CAML guinea pig Synaptic Systems, 359004 WB 1:1000 Ab0069** 
-emerin rabbit Proteintech, 10351-1-AP IF/WB 1:500/1:1000 Ab083 
-emerin mouse 
Santa Cruz Biotechnology, 
sc-81552 
IF/WB 1:200/1:1000 Ab301 
-FLAG mouse Sigma-Aldrich, F3165 IF 1:3000 Ab013 
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Name Species Origin Application* Dilution Number 
-GFP rat ChromoTek, 3h9-100 WB 1:1000 Ab015 
-GST goat Amersham, 27-4577-50 WB 1:2000 Ab127 
-HA mouse Covance, MMS-101P IF/WB 1:1000/1:1000 Ab186 
-His mouse Qiagen, 34660 WB 1:1000 Ab140 
-IgG rabbit Sigma Aldrich Depletion 
1.5 µg/20 µl Protein A 
Sepharose, 120 µl 
reticulocyte lysate 
Ab001 
-importin  rabbit Frohnert et al. (2014)  IF/WB 1:500/1:1000 Ab208b 
-importin  mouse 





-lamin A/C mouse Abcam, ab40567 IF/WB 1:250/1:1000 Ab095 
-lamin A/C rabbit Cell Signaling, #2032 IF/WB 1:100/1:1000 Ab089 
-LRRC59 rabbit Sigma-Aldrich, HPA030829 IF/WB 1:100/1:250 Ab090 
-MBP mouse New England BioLabs, E8032S IF/WB 1:500/1:1000 Ab214 
-opsin mouse Adamus et al. (1991)  WB 1:1000 Ab092 




WB 1:1000 Ab222 
-TRC40 rabbit Favaloro et al. (2010)  Depletion 
15 µl/20 µl Protein A 
Sepharose, 120 µl 
reticulocyte lysate 
Ab0405** 
*Abbreviation of application: WB: Western Blot, IF: immunofluorescence 
** Laboratory of Prof. Dr. Blanche Schwappach 
 
 
Table 15: Secondary antibodies 
Name Species Origin Application* Dilution 
IRDye 680 CW -mouse donkey LI-COR WB 1:10,000 
IRDye 800 CW -mouse donkey LI-COR WB 1:10,000 
IRDye 800 CW -mouse goat LI-COR WB 1:10,000 
IRDye 680 CW -rabbit donkey LI-COR WB 1:10,000 
IRDye 800 CW -rabbit donkey LI-COR WB 1:10,000 
IRDye 680 CW -goat donkey LI-COR WB 1:10,000 
IRDye 800 CW -goat donkey LI-COR WB 1:10,000 
IRDye 800 CW -guinea pig donkey LI-COR WB 1:10,000 
-mouse HRP goat Jackson ImmunoResearch WB 1:10,000 
-rabbit HRP goat Jackson ImmunoResearch WB 1:10,000 
-goat HRP donkey Jackson ImmunoResearch WB 1:10,000 
-rat HRP goat Jackson ImmunoResearch WB 1:10,000 
-mouse Alexa Fluor 488 conjugated donkey Molecular Probes IF 1:1000 
-mouse Alexa Fluor 594 conjugated donkey Molecular Probes IF 1:1000 
-mouse Alexa Fluor 647 conjugated goat Molecular Probes IF 1:1000 
-rabbit Alexa Fluor 488 conjugated donkey Molecular Probes IF 1:1000 
-rabbit Alexa Fluor 594 conjugated donkey Molecular Probes IF 1:1000 
-rabbit Alexa Fluor 647 conjugated donkey Molecular Probes IF 1:1000 




RNA interference (RNAi) or small interfering RNA (siRNA) was discovered by Fire et al. (1998). 
Further information can be found in Kim and Rossi (2008). Lyophilized siRNAs were diluted with RNase-
free water to a 100 µM stock solution for long time storage at -80°C. As working stock solution stored at 
-20°C, siRNAs were diluted further to 20 µM.  
Material and Methods 
 
 36 
Table 16: siRNA sequences and supplier 







Dharmacon, ON-TARGETplus Non-targeting 
siRNA #1, D-001810-01-50 




importin  Eurofins Genomics 










Dharmacon, siGENOME Lamin A/C Control 









All oligonucleotides were obtained from Sigma-Aldrich, a Merck subcompany, in a concentration 
of 100 µM in water solution. The synthesis scale was 0.025 µmol and the purification grade “desalted”. 
 
Design of oligonucleotides for PCR cloning 
For design of oligonucleotide primers for PCR, the software Serial Cloner 2.6.1 was used. 
According to cloning strategy, the sequence of the selected restriction enzyme was added to the 5’ end 
of the oligonucleotide together with 3 to 6 upstream base pairs facilitating cleavage close to the end of 
DNA fragments. The number of upstream base pairs was selected specifically for each restriction 
enzyme as recommended by the enzyme supplier Thermo Fisher Scientific. The primers were designed 
with a primer melting temperature of 56 °C to 62 °C. 
 
Table 17: Oligonucleotides for cloning 
Number Name Sequence (5`→ 3`) 
G1379 LRRC59 Forward XhoI TTTCTCGAGATGACCAAGGCCGGTAGC 
G1453 LRRC59 rev EcoRI TTTGAATTCTCACTGCTGAGAGTCGGTC 




G1560 LRRC59 AS1-137_SalI_His_rev 
TTTGTCGACTCAGTGATGGTGATGGTGATGACACTGCTT
CTCATCCAAGCAGT 







G1716 P_Rev_HA-LRRC59_XhoI AAAACTCGAGCTGCTGAGAGTCGGTCTG 





G1719 P_Rev_HA-LRRC59 AS1-267_XhoI AAAACTCGAGTCACCGACAAGCAACCAGCC 
G1720 P_Rev_HA-LRRC59 AS1-278_XhoI AAAACTCGAGTCAGGTGCAGAGGGGCTGC 
G1773 SND2 cDNA_fw_BamHI_with HA 
AAAAGGATCCATGTACCCATACGATGTTCCAGATTACGC
TATGGCGCCCAAGGGCAAA 
G1774 SND2 cDNA_rv_XhoI_wo HA AAAACTCGAGCTATAACCGCTTCATCTGCC 
G1775 SND2 cDNA_fw_BamHI_wo HA AAAAGGATCCAAATGGCGCCCAAGGGCAA 
G1776 SND2 cDNA_rv_XhoI_with HA 
AAAACTCGAGCTAAGCGTAATCTGGAACATCGTATGGGT
ATAACCGCTTCATCTGCCG 
G1777 MBP_fw_XhoI AAAACTCGAGATGAAAATCGAAGAAGGTAAACTG 
G1778 MBP_rv_XhoI AAAACTCGAGATTGTTATTGTTGTTGTTGTTCGAG 
G1779 LRRC59_fw_EcoRI AAAAAGAATTCAATGACCAAGGCCGGTAGC 
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Number Name Sequence (5`→ 3`) 
G1780 LRRC59dTM_rv_XbaI AAAATCTAGATTAGGAACGAGTGTGCTTCCG 
G1792 G1792_Emerin_BamHI_fw AAAAGGATCCATGGACAACTACGCAGATCTTT 
G1793 G1793_Emerin_XhoI_rv with HA 
AAAACTCGAGTCAAGCGTAATCTGGAACATCGTATGGGT
AGAAGGGGTTGCCTTCTTCA 





































G1808 G1808_AgeI-BFP_fw AAAACCGGTATGGTGTCTAAGGGCGAAGA 
G1809 G1809_BFP-XhoI_rv (BFP-MCS) AAAACTCGAGATTAAGCTTGTGCCCCAGTTT 
G1811 G1811_XhoI-LRRC59_fw AAAACTCGAGAAATGACCAAGGCCGGTAGC 





G1814 G1814_LRRC59 AA -137_EcoRI_rv AAAAAGAATTCTCAACACTGCTTCTCATCCAAGC 
G1815 G1815_LRRC59 AA -140-EcoRI_rv AAAAAGAATTCTCAACACTGCTTACACTGCTTCTC 
G1816 G1816_LRRC59 AA -235-EcoRI_rv AAAAAGAATTCTCACTTGCGGGGACGGGAG 







































G1903 G1903_Primer_Emerin-BamHI_rv AAAAGGATCCCTAGAAGGGGTTGCCTTCTTC 
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G1905 G1905_Primer_XhoI-ALG1_fw AAAACTCGAGATGGCGGCCTCATGCTTGGTC 
G1906 G1906_Primer_ALG1-SalI_rv AAAAGTCGACTTATGTGTCCATAACCAAAGGGAGCAC 
G1907 G1907_Primer_XhoI-ALG14_fw AAAACTCGAGATGGTGTGCGTTCTCGTTCTAGC 
G1909 G1909_Primer_XhoI-BET1_fw AAAACTCGAGATGAGGCGTGCAGGCCTGGG 
G1911 G1911_Primer_XhoI-LMAN2_fw AAAACTCGAGATGGCGGCGGAAGGCTGGATTTG 
G1912 G1912_Primer_LMAN2-SalI_rv AAAAGTCGACTCAGTAGAAGCGCTTGTTCCGCTCC 
G1913 G1913_Primer_XhoI-PIGK_fw AAAACTCGAGATGGCCGTCACCGACAGCC 
G1917 G1917_Primer_XhoI-TMED2_fw AAAACTCGAGATGGTGACGCTTGCTGAACTGC 
G1919 G1919_Primer_XhoI-TMED10_fw AAAACTCGAGATGTCTGGTTTGTCTGGCCCAC 
G1920 G1920_Primer_TMED10-SalI_rv AAAAGTCGACTTACTCAATCAATTTCTTGGCCTTGAAG 
G1923 G1923_Primer_HindIII-ALG5_fw AAAAAAGCTTATGGCTCCGCTTCTGTTGCAGC 
G1924 G1924_Primer_ALG5-SalI_rv AAAAGTCGACCTAATTCATTTTCCGAGTTTGCTCAAGC 
G1925 G1925_Primer_XhoI-BET1L_fw AAAACTCGAGATGGCGGACTGGGCTCGGG 
G1926 G1926_BET1L-SalI_rv AAAAGTCGACTCACGTCCTTGCCCTGGACAAG 
G1927 G1927_XhoI-SEC61B_fw AAAACTCGAGATGCCTGGTCCGACCCCCAG 
















G1969 G1969_Primer_BET1L-EcoRI_rv AAAAAGAATTCTCACGTCCTTGCCCTGGACAAG 
G1971 G1971_Primer_Sec61B-EcoRI_rv AAAAAGAATTCCTACGAACGAGTGTACTTGCCCCA 
G1975 G1975_Primer_Sec22B-EcoRI_rv AAAAAGAATTCTCACAGCCACCAGAATCGGACATACA 
G1977 G1977_Primer_SalI-FRB_fw AAAAGTCGACATGTGGCATGAAGGCCTGG 









































G2034 G2034_XhoI-Sec61B_AA1-70_fw AAAACTCGAGAAATGCCTGGTCCGACCCCC 
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G2078 G2078_Nup54*-XhoI_rv AAAACTCGAGTTAACTAAAGACACCACCTCTGATG 















G2108 G2108_Nup58_pre-PCR_rv TTATCTTTTTCCTCTTTTGTTTCCAGCTGGAGGTTTCTTC 
G2129 G2129_HindIII-MBP_fw AAAAAGCTTTAATGAAAATCGAAGAAGGTAAAC 
G2130 G2130_MBP-EcoRI_rv AAAAAGAATTCAAATTGTTATTGTTGTTGTTGTTCG 
G2131 G2131_MBP-HindIII_rv AAAAAGCTTTATTGTTATTGTTGTTGTTGTTCG 
G2132 G2132_HindIII-MBP_fw AAAAAGCTTATGAAAATCGAAGAAGGTAAAC 
G2133 G2133_MBP-HindIII_rv AAAAAGCTTATTGTTATTGTTGTTGTTGTTCG 
G2159 G2159_NcoI-Nup210AA1830-_fw AAACCATGGAAATGACTGTCTGCACGCCCCG 





G2176 G2176_XhoI-MBP_fw AAAAACTCGAGAAATGAAAATCGAAGAAGGTAAACTG 
G2177 G2177_MBP-HindIII_rv AAAAAGCTTATTGTTATTGTTGTTGTTGTTCGAG 
G2178 G2178_HindIII-M9_fw AAAAAGCTTATGGGGAATTACAACAATCAGTCTTC 
G2179 G2179_M9-EcoRI_rv AAAAAGAATTCATAGCCACCTTGGTTTCGTG 
G2180 G2180_EcoRI-FKBP12_fw AAAAAGAATTCATGGCTAGCGGAGTGCAGG 
G2181 G2181_FKBP12-BamHI_rv AAAGGATCCTCATTCCAGTTTTAGAAGCTCCACATC 
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G2183 G2183_BiMAX2-EcoRI_rv AAAAAGAATTCTCAGTCCAGCCTTCTCCGCTTC 
















G2195 G2195_XhoI-LRRC59_fw AAAACTCGAGATGACCAAGGCCGGTAGCAA 
G2196 G2196_LRRC59*-EcoRI_rv AAAAAGAATTCTCACTGCTGAGAGTCGGTCT 
















G2212 G2212_EcoRI-P2X2_fw AAAAAGAATTCATGGTCCGGCGCTTGGCCCG 
G2213 G2213_P2X2-HindIII*_rv AAAAAGCTTTCAAAGTTGGGCCAAACCTTTGGGGTC 
G2225 G2225_XhoI-GST_fw AAAACTCGAGATGTCCCCTATACTAGGTTATTG 
G2226 G2226_GST-XhoI_rv AAAACTCGAGTTTTGGAGGATGGTCGCCAC 
G2227 G2227_HindIII-GST_fw AAAAAGCTTATGTCCCCTATACTAGGTTATTG 
G2228 G2228_GST-HindIII_rv AAAAAGCTTTTTTGGAGGATGGTCGCCAC 
G2229 G2229_HindIII-GST+2bp_fw AAAAAGCTTATATGTCCCCTATACTAGGTTATTG 
G2230 G2230_GST-EcoRI+2bp_rv AAAAAGAATTCATTTTTGGAGGATGGTCGCCAC 
G2231 G2231_GST-HindIII+2bp_rv AAAAAGCTTTTTTTGGAGGATGGTCGCCAC 
* indicates a stop codon 
 
 
Design of oligonucleotides for mutagenesis PCR cloning 
Mutagenesis was performed using the site-directed mutagenesis method (Weiner et al., 1994) 
with primers containing the mutated sequence surrounded by 10-15 additional base pairs upstream and 
downstream of the mutation. The forward and reverse primer were designed with an identical sequence, 
but antiparallel, with a length up to 45 base pairs. Plasmid DNA sequence changes with the result of up 
to seven amino acids in the expressed protein were performed using one primer pair. 
 
Table 18: Oligonucleotides for mutagenesis 
Number Name Sequence (5`→ 3`) 
G1711 P_For_siRNA resistent Importin beta 
GTGAAAAACAGCGCCAAAGATTGCTATCCTG
CTGTCCAG 
G1712 P_Rev_siRNA resistent Importin beta 
CTGGACAGCAGGATAGCAATCTTTGGCGCTG
TTTTTCAC 
G1870 G1870_Primer_LRRC59 AA226 228 mut_fw CAGGCCCCGGCATCTGCGTCTGGCTC 
G1871 G1871_Primer_LRRC59 AA226 228 mut_rev GAGCCAGACGCAGATGCCGGGGCCTG 
G1872 
G1872_Primer_LRRC59 AA232 234 235 
mut_fw 
TGGCTCCGCTCCCGCCGCGCCACCA 
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G1873 






















G1878_Primer_LRRC59 mut 171 172 173 176 




G1879_Primer_LRRC59 mut 171 172 173 176 




G1880_Primer_LRRC59 mut 185 188 189 190 




G1881_Primer_LRRC59 mut 185 188 189 190 




G1882_Primer_LRRC59 mut 196 198 199 200 




G1883_Primer_LRRC59 mut 196 198 199 200 














G1955_Primer_fw_LRRC mut 207 210 211 215 




G1956_Primer_rv_LRRC mut 207 210 211 215 

























G2096 G2096_LRRC59 mut 239-243_-244-SalI_rv 
TTTGTCGACTCAGTGATGGTGATGGTGATGG
GAAGCAGTGTGCGCCGCGG 
G2172 G2172_LRRC59 S227A S229A S231A_fw 
CAGGCCCCGAAAGCTAAGGCTGGCGCCCGT
CCCCGCAAGC 
G2173 G2173_LRRC59 S227A S229A S231A_rv 
GCTTGCGGGGACGGGCGCCAGCCTTAGCTT
TCGGGGCCTG 
G2174 G2174_LRRC59 T242A S244A_fw 
CCACCCCGGAAGCACGCTCGTGCCTGGGCT
GTGCTGAAGC 
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Design of oligonucleotides for sequencing 
Sequencing primers were mainly used from the sequencing supplier GATC, a subcompany of 
Eurofins Genomics. If these primers were not sufficient for sequencing of long constructs, additional 
primers were sent in a concentration of 10 µM together with the sample. Individual primers were 
synthesized by Sigma-Aldrich and listed in the oligonucleotide list of the laboratory of Prof. Dr. Ralph H. 
Kehlenbach designed by different group members. 
 
Table 19: Oligonucleotides for sequencing 
Number Name Sequence (5→3`) 
G12 EF-For GAGTAGCACCCACCAAGGCA 
G13 EF-Rev CCCAAGAACCCAAGGAACAA 
G364 pEYFP-C1 5' CGAGAAGCGCGATCACAT 
G694 Syne1_aa355_NcoI_f TTTTCCATGGCCGCCTGGCTAGGAGAGACAG 
G695 Syne1_NotI_r TTTTGCGGCCGCGAGTGGAGGAGGACCGTT 
G718 Nup358_aa806_NotI_f TTTTGCGGCCGCGGATCAGAATTCTTTACTGAAAATG 
G719 Nup358_aa1306_SpeI_r TTTTACTAGTTTTTAAAATGCTCTGGGC 
G1440 Hzz_EcoRI_for  TTTGAATTCATGCACCACCATCACCATCAC 
G1453 LRRC59 rev EcoRI TTTGAATTCTCACTGCTGAGAGTCGGTC 
G1473 FRB NcoI fwd TTTCCATGGAAGAGATGTGGCATGAAGGC 
G1474 FRB EcoRI rev TTTGAATTCTGCTTTGAGATTCGTCGGAA 
G1487 pmCherry-C1_rev GCATTCATTTTATGTTTCAGGTTCAG 
G1622 FRB_forward_BglII GAAGATCTGAGATGTGGCATGAAGGCC 
G1716 P_Rev_HA-LRRC59_XhoI AAAACTCGAGCTGCTGAGAGTCGGTCTG 
G1724 Importin B Sequencing_Forward GTGTGCTGGGCTTTCTC 
G1905 G1905_Primer_XhoI-ALG1_fw AAAACTCGAGATGGCGGCCTCATGCTTGGTC 
G1913 G1913_Primer_XhoI-PIGK_fw AAAACTCGAGATGGCCGTCACCGACAGCC 
G1921 G1921_Primer_XhoI-TMEM214_fw AAAACTCGAGATGGCGACCAAGACGGCGG 
G1923 G1923_Primer_HindIII-ALG5_fw AAAAAAGCTTATGGCTCCGCTTCTGTTGCAGC 
G1929 G1929_Primer_XhoI-SORT1_fw AAAACTCGAGATGGAGCGGCCCTGGGGAG 
G1971 G1971_Primer_Sec61B-EcoRI_rv AAAAAGAATTCCTACGAACGAGTGTACTTGCCCCA 
G1975 G1975_Primer_Sec22B-EcoRI_rv AAAAAGAATTCTCACAGCCACCAGAATCGGACATACA 














G2043 G2043_Nup62*-XhoI_rv AAAACTCGAGTCAGTCAAAGGTGATCCGGA 
G2046 G2046_HindIII-Nup210_fw AAAAAGCTTATGGCGGCGCGGGGCCGGGG 
G2047 G2047_Nup210-EcoRI_rv AAAAAGAATTCGTGGGAGGCATAGGCTGGGCTCCAC 





G2109 G2109_Nup210-seq_bp800_fw CAGAAGATCAGGCAAGGG 
G2110 G2110_Nup210-seq_bp1600_fw GTATGTGATCGAGCCCC 
G2111 G2111_Nup210-seq_bp2400_fw GGTTCGACAACTTCAGCTC 
G2112 G2112_Nup210-seq_bp3200_fw GCTGGACAGAGAATCAAC 
G2113 G2113_Nup210-seq_bp4000_fw GTTCCAGTTGTGCATGTTG 
G2114 G2114_Nup210-seq_bp4800_fw GAAGTCATCCAGGCCTTG 
G2130 G2130_MBP-EcoRI_rv AAAAAGAATTCAAATTGTTATTGTTGTTGTTGTTCG 
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G2212 G2212_EcoRI-P2X2_fw AAAAAGAATTCATGGTCCGGCGCTTGGCCCG 
GATC BGH-Reverse TAGAAGGCACAGTCGAGG 
GATC CMV-F CGCAAATGGGCGGTAGGCGTG 
GATC EBV-RP GTGGTTTGTCCAAACTCATC 
GATC M13-RP CAGGAAACAGCTATGACC 
GATC pcDNA3.1-FP CTCTGGCTAACTAGAGAAC 
GATC pcDNA3.1-RP_1 CAAACAACAGATGGCTGGC 
GATC pEGFP_C2-FP GATCACATGGTCCTGCTG 
GATC pEGFP-FP TTTAGTGAACCGTCAGATC 
GATC pET-RP CTAGTTATTGCTCAGCGG 
GATC pGEX5-FP AACGTATTGAAGCTATCCC 
GATC pMalE TCAGACTGTCGATGAAGC 
GATC pRSET-RP ATGCTAGTTATTGCTCAGC 
GATC SP6 ATTTAGGTGACACTATAGAA 
GATC T7 TAATACGACTCACTATAGGG 
GATC pEGFP-RP AACAGCTCCTCGCCCTTG 
 
 
2.1.2 Synthesized Genes 
Synthesized genes were ordered at Thermo Fisher Scientific, cloned into pMA-RQ vector for 
GeneArtTM Gene Synthesis or sent as DNA fragments for further costumer cloning as GeneArtTM 
SringsTM Fragments. The sequence of the synthesized genes can be found in appendix A. 
 
Table 20: Overview of synthesized genes 
Name Type Company Product 
LRRC59_mut_210-243 Cloned into plasmid #2003 Thermo Fisher Scientific GeneArtTM Gene Synthesis 
Nup210_AA1830-1887 Cloned into vector #36 Thermo Fisher Scientific 
GeneArtTM StringsTM DNA 
Fragments 
EcoRI-P2X2-HindIII Cloned into plasmid #1239 Thermo Fisher Scientific 




Table 21: Available vectors 
Number Name Tag Resistance* Application Source 
3 pET-23b His (C-terminus) Amp Expression Novagen 
29 pMal-C2 MBP Amp Expression 
New England 
BioLabs 
30 pEGFP-C1 EGFP (N-terminus) Kana Transfection Clontech 
34 pcDNA3 untagged Amp Transfection Invitrogen 
36 pETM30 GST, His (N-terminus) Kana Expression EMBL 
37 pETM41 
His, MBP (N-terminus), 
His (C-terminus) 
Kana Expression EMBL 
65 pmCherry-N1 mCherry (C-terminus) Kana Transfection Clontech 
75 pMal-PreScission MBP (N-terminus) Amp Expression Sarah Port 
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*Abbreviation of resistance: Amp: ampicillin, Kana: kanamycin 
 
Table 22: Generated vectors 




PCR mTagBFP2 (AO2005, laboratory of Prof. Dr. Blanche 
Schwappach, G1808, G1809) cloned into vector #30 (AgeI, XhoI) 
 
pEGFP-(without EGFP)-mTagBFP2-MCS 
The EGFP-coding fragment of the vector pEGFP-C1 was replaced by mTagBFP2, which was 
PCR amplified using G1808 and G1809 as primers and AO2005 (laboratory of Prof. Dr. Blanche 
Schwappach) as template, via the restriction sites of AgeI and XhoI (figure 8). 
 
 
Figure 8: Multiple cloning site of pEGFP-(without GFP)-mTagBFP2-MCS 
 
 
2.1.4 Plasmids  
Table 23: Available plasmids 
Number Name Resistance* Application Source 
23 pRSETb-His-Importin alpha Amp Expression 
Laboratory of Ralph H. 
Kehlenbach 
26 pET30a-S-His-Importin beta Kana Expression 
Laboratory of Ralph H. 
Kehlenbach 
293 pdEGFP-GST Kana Transfection Christiane Spillner 
294 pdEGFP-C1 Kana Transfection 
Laboratory of Ralph H. 
Kehlenbach 
297 pdEGFP-GST-cNLS Kana Transfection Sonja Neimanis 
476 pEF-HA-Importin beta Amp Expression Hutten et al. (2008) 
552 pEF-myc-Importin beta Amp Expression Sarah Hutten 
762 
pCS2+MT-Syne1B aa1639-
1989 (mus musculus) 
Amp Transfection Dan Starr 
812 pCS2plus-Importin beta-FLAG Amp Expression Detlef Doenecke (pJK255) 
1052 pET328-HZZ-tev-emerin-opsin Amp Expression Ralph H. Kehlenbach 
1219 LRRC59-pcDNA3 Amp Transfection Antoni Wiedlocha 
1224 pET328-HZZ-tev-LRRC59-opsin Amp Expression Imke Baade 
1230 pdEGFP-GST-cNLS-FKBP12 Kana Transfection Janine Pfaff, Kalpana Rajanala 
1231 mCherry-FRB Kana Transfection Kalpana Rajanala 
1232 mCherry-FRB-Emerin Kana Transfection Kalpana Rajanala 
1239 pET328-His-ZZ-tev Amp Expression Fabio Vilardi 
1247 Sec61beta-opsin-pcDNA3.1 Amp Transfection Fabio Vilardi 
1424 mCherry-FRB-LRR59 Kana Transfection Kalpana Rajanala 
1425 WRB-FRB-HA Amp Transfection Kalpana Rajanala 
1458 pGEX-6P1-Nup62 Amp Expression Sarah Port, Sarina Norell 
1469 pdEGFP-GST-FKBP12 Kana Transfection Kalpana Rajanala 
1544 pMAL-PP-LRRC59 AA1-244-His Amp Expression Cara Jamieson 
1546 pmCherry-FRB-GST-LRRC59 Kana Transfection Cara Jamieson 
1580 pGEM3Z-emerin-opsin Amp Expression Fabio Vilardi 
1603 pdEGFP-GST-M9-FKBP12 Kana Transfection Janine Pfaff, Christiane Spillner 
1610 pcDNA3-FKBP12-EGFP-APEX2 Amp Transfection Marret Müller 
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Kana Transfection Marret Müller, Elif Günyüz 
1684 pEGFP-Bimax2 Kana Transfection 
Kosugi et al. (2008); Dorothee 
Dormann 
1720 pGEM3Z-Preprolactin-HA Amp Expression 
Fabio Vilardi, laboratory of Prof. 
Dr. Blanche Schwappach, AO2045 
1721 pGEM3Z-Preprolactin-myc Amp Expression 
Fabio Vilardi, laboratory of Prof. 
Dr. Blanche Schwappach, AO2026 








Amp Expression Favaloro et al. (2010)  
*Abbreviation of resistance: Amp: ampicillin, Kana: kanamycin 
 
 
Table 24: Generated plasmids 
Number Name Cloning 
1608 pMAL-PP-LRRC59 AA1-137-His 
PCR EcoRI-LRRC59 AA1-137-SalI (#1219, G1468, G1560) 
cloned into vector #75 (EcoRI, SalI) 
1609 PMAL-PP-LRRC59 AA138-244-His 
PCR EcoRI-LRRC59 AA138-244-SalI (#1219, G1469, 
G1561) cloned into vector #75 (EcoRI, SalI) 
1716 pET23b-HA-Emerin 
PCR BamHI-HA-Emerin-XhoI (#1232, G1713, G1717) cloned 
into vector #3 (BamHI, XhoI) 
1717 pET23b-HA-LRRC59 
PCR EcoRI-HA-LRRC59-XhoI (#1424, G1715, G1718) 
cloned into vector #3 (EcoRI, XhoI) 
1718 pET23b-HA-LRRC59 AA1-267 
PCR EcoRI-HA-LRRC59-XhoI AA1-267 (#1424, G1715, 
G1719) cloned into vector #3 (EcoRI, XhoI) 
1719 pET23b-HA-LRRC59 AA1-278 
PCR EcoRI-HA-LRRC59 AA1-278-XhoI (#1424, G1715, 
G1720) cloned into vector #3 (EcoRI, XhoI) 
1722 pEF-HA-Importin-β siRNA resistant mutagenesis (G1711, G1712) on plasmid #476 




mutagenesis (G1711, G1712) on plasmid #812 
1821 pET23b-Preprolactin-HA 
Fragment SacI-Preprolactin-HA-HindIII from plasmid #1720 
cloned into vector #3 (SacI, HindIII) 
1822 pET23b-Preprolactin-myc 
Fragment SacI-Preprolactin-myc-HindIII from plasmid #1721 
cloned into vector #3 (SacI, HindIII) 
1844 pcDNA3-HA-SND2 
PCR BamHI-HA-SND2-XhoI (HeLa P4 cDNA, G1773, 
G1774) cloned into vector #34 (BamHI, XhoI) 
1845 pcDNA3-SND2-HA 
PCR BamHI-SND2-HA-XhoI (HeLa P4 cDNA, G1775, 
G1776) cloned into vector #34 (BamHI, XhoI) 
1846 dEGFP-GST-LRRC59 AA1-244 
PCR EcoRI-LRRC59 AA1-244-XbaI (#1219, G1779, G1780) 
cloned into plasmid #1469 (EcoRI, XbaI) 
1848 pmCerry-FRB-MBP-LRRC59 
PCR XhoI-MBP-XhoI (vector #29, G1777, G1778) cloned into 
plasmid #1424 (XhoI) 
1863 pET23b-Emerin-HA 
PCR BamHI-Emerin-HA-XhoI (#1232, G1792, G1793) cloned 
into vector #3 (BamHI, XhoI) 
1864 pET23b-LRRC59-HA 
PCR EcoRI-LRRC59-HA-XhoI (#1424, G1794, G1795) 
cloned into vector #3 (EcoRI, XhoI) 
1865 pET23b-LRRC59 AA1-267-HA 
PCR EcoRI-LRRC59 AA1-267-HA-XhoI (#1424, G1794, 
G1796) cloned into vector #3 (EcoRI, XhoI) 
1866 pET23b-LRRC59 AA1-278-HA 
PCR EcoRI-LRRC59 AA1-278-HA-XhoI (#1424, G1794, 
G1797) cloned into vector #3 (EcoRI, XhoI) 
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PCR EcoRI-LRRC59 AA1-267-Emerin AA244-254-HA-XhoI 
(#1424, G1794, G1798) cloned into vector #3 (EcoRI, XhoI) 
1884 pEGFP-LRRC59 AA1-235 
PCR XhoI-LRRC59 AA1-235-EcoRI (#1219, G1813, G1816) 
cloned into vector #30 (XhoI, EcoRI) 
1885 pEGFP-LRRC59 AA1-244 
PCR XhoI-LRRC59 AA1-244-EcoRI (#1219, G1813, G1817) 
cloned into vector #30 (XhoI, EcoRI) 
1886 pEGFP-LRRC59 AA1-137 
PCR XhoI-LRRC59 AA1-137-EcoRI (#1219, G1813, G1814) 
cloned into vector #30 (XhoI, EcoRI) 
1887 pEGFP-LRRC59 AA1-140 
PCR XhoI-LRRC59 AA1-140-EcoRI (#1219, G1813, G1815) 
cloned into vector #30 (XhoI, EcoRI) 
1888 pEGFP-LRRC59 AA138-235 
PCR XhoI-LRRC59 AA138-235-EcoRI (#1219, G1816, 
G1818) cloned into vector #30 (XhoI, EcoRI) 
1889 pEGFP-LRRC59 AA138-244 
PCR XhoI-LRRC59 AA138-244-EcoRI (#1219, G1817, 
G1818) cloned into vector #30 (XhoI, EcoRI) 
1890 pEGFP-LRRC59 AA141-235 
PCR XhoI-LRRC59 AA141-235-EcoRI (#1219, G1816, 
G1819) cloned into vector #30 (XhoI, EcoRI) 
1891 pEGFP-LRRC59 AA141-244 
PCR XhoI-LRRC59 AA141-244-EcoRI (#1219, G1817, 
G1819) cloned into vector #30 (XhoI, EcoRI) 
1892 pcDNA3-NES-mTagBFP2 
PCR EcoRI-NES-mTagBFP2-XhoI (AO2005, laboratory of 
Prof. Dr. Blanche Schwappach, G1802, G1803) cloned into 
vector #34 (EcoRI, XhoI) 
1893 pcDNA3-NES-mTagBFP2-cNLS 
PCR EcoRI-NES-mTagBFP2-cNLS-XhoI (AO2005, laboratory 
of Prof. Dr. Blanche Schwappach, G1802, G1804) cloned into 
vector #34 (EcoRI, XhoI) 
1894 pcDNA3-NES-MBP 
PCR EcoRI-NES-MBP-XhoI (vector #29, G1805, G1806) 
cloned into vector #34 (EcoRI, XhoI) 
1895 pcDNA3-NES-MBP-cNLS 
PCR EcoRI-NES-MBP-cNLS-XhoI (vector #29, G1806, 




PCR XhoI-LRRC59-XbaI (#1219, G1811, G1812) cloned into 
plasmid #1648 (XhoI, XbaI) 
1923 pEGFP-LRRC59 AA138-216 
PCR EcoRI-LRRC59 AA138-216-XhoI (#1219, G1818, 
G1866) cloned into vector #30 (EcoRI, XhoI) 
1924 pEGFP-LRRC59 AA138-225 
PCR EcoRI-LRRC59 AA138-225-XhoI (#1219, G1818, 
G1867) cloned into vector #30 (EcoRI, XhoI) 
1925 pEGFP-LRRC59 AA138-231 
PCR EcoRI-LRRC59 AA138-231-XhoI (#1219, G1818, 
G1868) cloned into vector #30 (EcoRI, XhoI) 
1926 pEGFP-LRRC59 AA 217-244 
PCR EcoRI-LRRC59 AA217-244-XhoI (#1219, G1817, 
G1869) cloned into vector #30 (EcoRI, XhoI) 
1927 
pEGFP-LRRC59 AA138-244 K226A 
K228A 
Mutagenesis (G1870, G1871) on plasmid #1889 
1928 
pEGFP-LRRC59 AA138-244 R232A 
R234A K235A 
Mutagenesis (G1872, G1873) on plasmid #1889 
1929 pcDNA3-HA-LRRC59 
Fragment EcoRI-HA-LRRC59-XhoI from plasmid #1717 
cloned into vector #34 (EcoRI, XhoI) 
1930 
pEGFP-LRRC59 AA138-244 R239A 
K240A R243A 
Mutagenesis (G1874, G1875) on plasmid #1889 
1932 
pEGFP-LRRC59 AA138-244 R157A 
R159A R161A R162A 
Mutagenesis (G1876, G1877) on plasmid #1889 
1933 
pEGFP-LRRC59 AA138-244 K171A 
K172A R173A K176A R178A 
Mutagenesis (G1878, G1879) on plasmid #1889  
1934 
pEGFP-LRRC59 AA138-244 R185A 
R188A K189A R190A K192A 
Mutagenesis (G1880, G1881) on plasmid #1889 
1935 
pEGFP-LRRC59 AA138-244 K196A 
R198A R199A R200A K201A 
Mutagenesis (G1882, G1883) on plasmid #1889  
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1936 
pEGFP-LRRC59 AA138-244 K210A 
R211A K215A K216A 
Mutagenesis (G1884, G1885) on plasmid #1889  
1946 pcDNA3-HA-Emerin 
PCR HindIII-HA-Emerin-BamHI (#1232, G1902, G1903) 
cloned into vector #34 (HindIII, BamHI) 
1947 pcDNA3-HA-Emerin AA1-222 
PCR HindIII-HA-Emerin AA1-222-BamHI (#1232, G1902, 
G1904) cloned into vector #34, (HindIII, BamHI) 
1948 pMAL-PP-Emerin AA1-222-His 
PCR BamHI-Emerin AA1-222-His-HindIII (#1232, G1900, 
G1901) cloned into vector #75 (BamHI, HindIII) 
1968 pcDNA3-HA-LRRC59 AA1-244 
PCR EcoRI-HA-LRRC59 AA1-244-EcoRI (#1219, G1715, 
G1817) cloned into vector #34 (EcoRI) 
1974 
pEGFP-LRRC59 AA 138-244 K207A 
K210A R211A K215A K216A K218A 
K219A 
Mutagenesis (G1955, G1956) on plasmid #1936  
1975 
pEGFP-LRRC59 AA 138-244 K210A 
R211A K215A K216A K218A K219A 
Mutagenesis (G1957, G1958) on plasmid #1936 
1976 
pEGFP-LRRC59 AA 138-225 K210A 
R211A K215A K216A K218A K219A 
Mutagenesis (G1957, G1958) on plasmid #1924  
1977 pmCherry-FRB-ALG5 
PCR HindIII-ALG5-SalI (HeLa P4 cDNA, G1923, G1924) 
cloned into plasmid #1231 (HindIII, SalI) 
1982 
pEGFP-LRRC59 AA138-225 K207A 
K210A R211A K215A K216A K218A 
K219A 
Mutagenesis (G1955, G1956) on plasmid #1976  
1983 pmCherry-FRB-ALG1 
PCR XhoI-ALG1-SalI (HeLa P4 cDNA, G1905, G1906) 
cloned into plasmid #1231 (XhoI, SalI) 
1984 pmCherry-FRB-LMAN2 
PCR XhoI-LMAN2-SalI (HeLa P4 cDNA, G1911, G1912) 
cloned into plasmid #1231 (XhoI, SalI) 
1985 pmCherry-FRB-TMED10 
PCR XhoI-TMED10-SalI (HeLa P4 cDNA, G1919, G1920) 
cloned into plasmid #1231 (XhoI, SalI) 
1986 pET23b-Emerin AA1-222-His 
PCR BamHI-Emerin AA1-222-His-HindIII (#1948, G1900, 
G1901) cloned into vector #3 (BamHI, HindIII) 
1987 pcDNA3-mTagBFP2-cNLS 
PCR EcoRI-mTag-BFP2-cNLS-XhoI (#1893, G1804, G1961) 




PCR XhoI-SYNE1B AA1639-1989-HindIII (#762, G1962, 
G1963) cloned into plasmid #1231 (XhoI, HindIII) 
1995 
pEGFP-LRRC59 AA138-244 K210A 
R211A K215A K216A K218A K219A 
R239A K240A R243A 
Mutagenesis (G1874, G1875) on plasmid #1975 
1996 pFRB-mCherry 
PCR AgeI-FRB-SalI (#1424, G1977, G1978) cloned into 
vector #65 (AgeI, SalI) 
1997 
pEGFP-LRRC59 AA138-244 K207A 
K210A R211A K215A K216A K218A 
K219A R239A K240A R243A 
Mutagenesis (G1955, G1956) on plasmid #1995 
1998 pmCherry-FRB-BET1 
PCR XhoI-BET1-EcoRI (HeLa P4 cDNA, G1909, G1968) 
cloned into plasmid #1424 (XhoI, EcoRI) 
1999 pmCherry-FRB-BET1L 
PCR XhoI-BET1L-EcoRI (HeLa P4 cDNA, G1925, G1969) 
cloned into plasmid #1424 (XhoI, EcoRI) 
2000 pmCherry-FRB-SEC61B 
PCR XhoI-SEC61B-EcoRI (#1247, G1927, G1971) cloned 
into plasmid #1424 (XhoI, EcoRI) 
2001 pTMED2-FRB-mCherry 
PCR XhoI-TMED2-EcoRI (HeLa P4 cDNA, G1917, G1998) 
cloned into plasmid #1996 (XhoI, EcoRI) 
2002 pTMED10-FRB-mCherry 
PCR XhoI-TMED10-EcoRI (#1985, G1919, G1999) cloned 
into plasmid #1996 (XhoI, EcoRI) 
2003 pmCherry-FRB-SEC22B 
PCR XhoI-SEC22-EcoRI (HeLa P4 cDNA, G1959, G1975) 
cloned into plasmid #1424 (XhoI, EcoRI) 
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2004 ALG14-FRB-mCherry 
PCR XhoI-ALG14-HindIII (HeLa P4 cDNA, G1907, G1991) 
cloned into plasmid #1996 (XhoI, HindIII) 
2005 LMAN2-FRB-mCherry 
PCR XhoI-LMAN2-HindIII (#1984, G1911, G1992) cloned 
into plasmid #1996 (XhoI, HindIII) 
2006 PIGK-FRB-mCherry 
PCR XhoI-PIGK-HindIII (HeLa P4 cDNA, G1913, G1993) 
cloned into plasmid #1996 (XhoI, HindIII) 
2007 DDOST-FRB-mCherry 
PCR XhoI-DDOST-HindIII (HeLa P4 cDNA, G2002, G2003) 
cloned into plasmid #1996 (XhoI, HindIII) 
2008 mCherry-FRB-UBE2J1 
PCR XhoI-UBE2J1-SalI (HeLa P4 cDNA, G2004, G2005) 
cloned into plasmid #1424 (XhoI, SalI) 
2009 mCherry-FRB-UBE2J2 
PCR HindIII-UBE2J2-EcoRI (HeLa P4 cDNA, G2006, G2007) 
cloned into plasmid #1424 (HindIII, EcoRI) 
2017 
DDOST K450A K452A K454A - 
FRB-mCherry 
Mutagenesis (G2028, G2029) on plasmid #2007 
2018 
LMAN2 K347A R348A R351A 
K353A R354A -FRB-mCherry 
Mutagenesis (G2030, G2031) on plasmid #2005 
2019 pEGFP-SEC22B AA1-194 
PCR XhoI-SEC22B AA1-194-EcoRI (#2003, G2032, G2033) 
cloned into vector #30 (XhoI, EcoRI) 
2020 pEGFP-SEC61B AA1-70 
PCR XhoI-SEC61B AA1-70-EcoRI (#2000, G2034, G2035) 
cloned into vector #30 (XhoI, EcoRI) 
2021 pEGFP-UBE2J1 AA1-285 
PCR XhoI-UBE2J1 AA1-285-BamHI (#2008, G2036, G2037) 
cloned into vector #30 (XhoI, BamHI) 
2022 pEGFP-UBE2J2 AA1-226 
PCR EcoRI-UBE2J2 AA1-226-BamHI (#2009, G2038, 
G2039) cloned into vector #30 (EcoRI, BamHI) 
2023 pcDNA3-HA-FKBP12 
PCR HindIII-HA-FKBP12-EcoRV (#1603, G2040, G2041) 
cloned into vector #34 (HindIII, EcoRV) 
2024 pcDNA3-FKBP12-HA 
PCR EcoRV-FKBP12-HA-EcoRI (#1603, G2044, G2045) 
cloned into vector #34 (EcoRV, EcoRI) 
2025 
pmCherry-FRB-LRRC59 K210A 
R211A K215A K216A K218A K219A 
R239A K240A R243A 
PCR XhoI-LRRC59 K210A R211A K215A K216A K218A 
K219A R239A K240A R243A-EcoRI (GeneArtTM Gene 
Synthesis LRRC59_mut_210-243, G1379, G1453) cloned into 
#2003 (XhoI, EcoRI) 
2026 pET328-HZZ-tev-SUN1 
PCR EcoRI-SUN1-HindIII (HeLa P4 cDNA, G2056, G2057) 
cloned into plasmid #1239 (EcoRI, HindIII) 
2030 
pMAL-PP-LRRC59 AA138-244 
K210A R211A K215A K216A K218A 
K219A R239A K240A R243A 
PCR EcoRI-LRRC59 AA138-244 K210A R211A K215A 
K216A K218A K219A R239A K240A R243A-SalI (#2025, 
G1561, G2096) cloned into plasmid #1544 (EcoRI, SalI) 
2031 
pMAL-PP-LRRC59 AA1-244 K210A 
R211A K215A K216A K218A K219A 
R239A K240A R243A 
PCR EcoRI-LRRC59 AA1-244 K210A R211A K215A K216A 
K218A K219A R239A K240A R243A-SalI (#2025, G1468, 
G2096) cloned into plasmid #1608 (EcoRI, SalI) 
2042 pcDNA3-HA-FKBP12-Nup62 
PCR EcoRV-Nup62-XhoI (#1458, G2042, G2043) cloned into 
plasmid #2023 (EcoRV, XhoI) 
2045 pcDNA3-NEGFP-FLAG 
PCR HindIII-NEGFP-FLAG-BamHI (vector #30, G2089, 
G2090) cloned into vector #34 (HindIII, BamHI) 
2046 pcDNA3-HA-FKBP12-Nup54 
Pre-PCR Nup54 (HeLa P4 cDNA, G2105, G2106), PCR on 
Pre-PCR NotI-Nup54-XhoI (G2077, G2078) cloned into 
plasmid #2023 (NotI, XhoI) 
2047 pcDNA3-Nup58-HA-FKBP12 
Pre-PCR Nup54 (HeLa P4 cDNA, G2107, G2108), PCR on 
Pre-PCR HindIII-Nup54-BamHI (G2083, G2084) cloned into 
plasmid #2024 (HindIII, BamHI) 
2090 pETM30-Nup210 AA1830-1887 
PCR NcoI-Nup210 AA1830-1887-EcoRI (GeneArtTM Gene 
Synthesis Nup210_AA1830-1887) cloned into vector #36 
(NcoI, EcoRI) 
2091 pET328-HZZ-SUN1-opsin 
PCR EcoRI-SUN1-opsin-HindIII (plasmid #2026, G2056, 
G2161) cloned into plasmid #2026 (EcoRI, HindIII) 
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2092 pdEGFP-MBP-M9-FKBP12 
PCR 1 XhoI-MBP-HindIII (plasmid #1848, G2176, G2177), 
PCR 2 HindIII-M9-EcoRI (plasmid #1603, G2178, G2179), 
PCR 3 EcoRI-FKBP12-BamHI (plasmid #1603, G2180, 
G2181) cloned into plasmid #294 (XhoI, BamHI) 
2093 pcDNA3-FLAG-BiMAX2 
PCR BamHI-FLAG-BiMAX2-EcoRI (plasmid #1684, G2182, 








PCR 1 BspOI-mCherry-AgeI (plasmid #1424, G2197, 
G2200), PCR 2 AgeI-FRB-XhoI (plasmid #1424, G2191, 
G2199), PCR 3 XhoI-LRRC59-EcoRI (plasmid #1424, G2195, 
G2196) cloned into plasmid #1424 (BspOI, EcoRI) 
2103 
pmCherry-FRB-MBP-LRRC59 
(containing GGGGS linker) 
PCR 1 BspOI-mCherry-AgeI (plasmid #1424, G2197, 
G2200), PCR 2 AgeI-FRB-HindIII (plasmid #1424, G2191, 
G2192), PCR 3 HindIII-MBP-XhoI (plasmid #1848, G2193, 
G2194), PCR 4 XhoI-LRRC59-EcoRI (plasmid #1424, G2195, 
G2196) cloned into plasmid #1424 (BspOI, EcoRI) 
2104 
pmCherry-FRB-LRRC59 S227A 
S229A S231A T242A S244A 
Mutagenesis (G2174, G2175) on plasmid #2094 
2107 
pmCherry-mCherry-FRB-LRRC59 
(containing GGGGS linker) 
PCR 1 BspOI-mCherry-EcoRV (plasmid #1424, G2197, 
G2198), PCR 2 EcoRV-mCherry-AgeI (plasmid #1424, 
G2189, G2190), PCR3 AgeI-FRB-XhoI (plasmid #1424, 
G2191, G2199), PCR4 XhoI-LRRC59-EcoRI (plasmid #1424, 
G2195, G2196) cloned into plasmid #1424 (BspOI, EcoRI) 
2108 
pmCherry-mCherry-FRB-MBP-
LRRC59 (containing GGGGS linker) 
PCR1 BspOI-mCherry-EcoRV (plasmid #1424, G2197, 
G2198), PCR2 EcoRV-mCherry-AgeI (plasmid #1424, 
G2189, G2190), PCR3 AgeI-FRB-HindIII (plasmid #1424, 
G2191, G2192), PCR4 HindIII-MBP-XhoI (plasmid #1848, 
G2193, G2194), PCR5 XhoI-LRRC59-EcoRI (plasmid #1424, 




(containing GGGGS linker) 
PCR1 BspOI-MBP-EcoRV (plasmid #1848, G2187, G2188), 
PCR2 EcoRV-mCherry-AgeI (plasmid #1424, G2189, 
G2190), PCR3 AgeI-FRB-HindIII (plasmid #1424, G2191, 
G2192), PCR4 HindIII-MBP-XhoI (plasmid #1848, G2193, 
G2194), PCR5 XhoI-LRRC59-EcoRI (plasmid #1424, G2195, 
G2196) cloned into plasmid #1424 (BspOI, EcoRI) 
2110 pET328-HZZ-tev-P2X2 
PCR EcoRI-P2X2-HindIII (GeneArtTM Gene Synthesis EcoRI-
P2X2-HindIII, G2212, G2213) cloned into plasmid #1239 
(EcoRI, HindIII) 
2111 pET328-HZZ-tev-Preprolactin-HA 
Fragment SacI-Preprolactin-HA-HindIII from plasmid #1821 
cloned into vector #1239 (SacI, HindIII) 
2112 pET328-HZZ-tev-Preprolactin-myc 
Fragment SacI-Preprolactin-myc-HindIII from plasmid #1822 
cloned into vector #1239 (SacI, HindIII) 
2119 mCherry-FRB-MBP-Sec61ß 
PCR XhoI-MBP-XhoI (plasmid #1848, G1777, G1778) cloned 
into plasmid #2000 via XhoI 
2120 LMAN2-MBP-FRB-mCherry 
PCR HindIII-MBP-EcoRI (plasmid #1848, G2129, G2130) 
cloned into plasmid #2005 via HindIII, EcoRI 
2121 DDOST-MBP-FRB-mCherry 
PCR HindIII-MBP-HindIII (plasmid #1848, G2129, G2131) 
cloned into plasmid #2007 via HindIII 
2122 mCherry-FRB-MBP-UBE2J2 
PCR HindIII-MBP-HindIII (plasmid #1848, G2132, G2133) 
cloned into plasmid #2009 via HindIII 
2123 mCherry-FRB-MBP-Sec22ß 
PCR XhoI-MBP-XhoI (plasmid #1848, G1777, G1778) cloned 
into plasmid #2003 via XhoI 
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2124 mCherry-FRB-MBP-UBE2J1 
PCR XhoI-GST-XhoI (plasmid #1848, G1777, G1778) cloned 
into plasmid #2008 via XhoI 
2125 mCherry-FRB-GST-Sec61ß 
PCR XhoI-GST-XhoI (plasmid #1546, G2225, G2226) cloned 
into plasmid #2000 via XhoI 
2126 mCherry-FRB-GST-Sec22ß 
PCR XhoI-GST-XhoI (plasmid #1546, G2225, G2226) cloned 
into plasmid #2003 via XhoI 
2127 LMAN2-GST-FRB-mCherry 
PCR HindIII-GST-EcoRI (plasmid #1546, G2229, G2230) 
cloned into plasmid #2005 via HindIII, EcoRI 
2128 DDOST-GST-FRB-mCherry 
PCR HindIII-GST-HindIII (plasmid #1546, G2229, 2231) 
cloned into plasmid #2007 via HindIII 
2129 mCherry-FRB-GST-UBE2J1 
PCR XhoI-GST-XhoI (plasmid #1546, G2225, G2226) cloned 
into plasmid #2008 via XhoI 
2130 mCherry-FRB-GST-UBE2J2 
PCR HindIII-GST-HindIII (plasmid #1546, G2227, G2228) 
cloned into plasmid #2009 via HindIII 
 
 
2.2 Molecular Biology Methods 
2.2.1 RNA Isolation from Cellular Extracts 
Total RNA was isolated from HeLa P4 cells, growing on a 10 cm cell culture dish with a density 
of 1x107 cells, using the RNeasy Mini Kit (Qiagen). The protocol “Purification of Total RNA from Animal 
Cells using Spin Technology” was performed according to the instructions of the manufacturer. For RNA 
elution, two times 30 µl RNase-free water was used. Before storage at -20 °C, RNA purity was 
determined by measurement of the A260/A280 ratio with the spectrophotometer NanoDrop 2000c. 
Samples with an A260/A280 ratio of 1.8-2.0 were considered as pure RNA.  
 
2.2.2 cDNA synthesis 
Complementary DNA (cDNA) is an artificially synthesized DNA from mRNA as template using the 
enzyme reverse transcriptase. For cDNA synthesis from isolated RNA, the SuperScirpt III reverse 
transcriptase of Thermo Fisher Scientific was used according to manufacturer’s recommendation. 2 µg 
of RNA was mixed with 1 µl of 100 µM oligo(dT)-primer, 1 µl of 10 mM dNTPs and an appropriate 
volume of RNAse-free water for a final volume of 13 µl. After 5 minutes of incubation at 65 °C, the 
solution was cooled on ice for 1 minute. For synthesis of cDNA, 4 µl of 5x First-Strand buffer, 1 µl of 
0.1 M DTT (dithiothreitol), 1 µl of RiboLock RNase Inhibitor (40 U/µl) and 1 µl of SuperScript III reverse 
transcriptase (100 U/µl) were added to the reaction. Reactions were performed after careful mixing of 
all components at 50 °C for 60 minutes before enzyme inactivation at 70 °C for 15 minutes. cDNA was 
stored at -20 °C. 
 
2.2.3 Polymerase Chain Reaction (PCR) 
Polymerase chain reaction is an in vitro method for amplification of a selected, specific DNA 
sequence using a DNA template, two oligonucleotide primers, dNTPs and a thermostable DNA 
polymerase under different temperature phases (Mullis and Faloona, 1987; Saiki et al., 1988). For 
amplification of specific DNA segments, the Phusion High-Fidelity DNA Polymerase (Thermo Fisher 
Scientific) was used according to manufacturer’s instructions. The amplification was performed using 
1-2 µl of cDNA or 100 ng of plasmid DNA as template. For a 50 µl reaction, the template was mixed with 
high-fidelity buffer, 0.2 µM of forward and reverse primer, respectively, 0.2 mM of dNTPs, 1 U of proof-
reading Phusion polymerase and an appropriate volume of ddH2O. The amplification was performed in 
a three-temperature step reaction using a thermocycler. For the denaturation of complexes of DNA and 
primers, the mixture was heated to 98 °C for 10 seconds, followed by an annealing phase for 15 seconds 
at 56-62 °C according to the melting temperature of the primers, and an elongation step at 72 °C 
adjusted to the number of base pairs of the amplified DNA segment with 30 seconds/1000 base pairs. 
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This cycle was repeated 35 times. The PCR product was mixed with 6x DNA loading buffer and analyzed 
by preparative agarose gel-electrophoresis (see section 2.2.5) 
 
2.2.4 Site-directed mutagenesis 
Site-directed mutagenesis is a PCR-based method to change single base pairs of a DNA 
sequence introducing the sequence change via primers. The used protocol is based on the publication 
of Weiner et al. (1994). For the mutagenesis PCR of 50 µl volume, 1 µg of plasmid DNA was added to 
Pfu buffer, 0.2 µM for forward and reverse primers, 0.2 mM dNTPs, 2.5 U Pfu Ultra II DNA polymerase 
(Agilent) and filled up with ddH2O. For the denaturation step of the PCR, a temperature of 98 °C for 
30 seconds was chosen, followed by annealing of primers and single strand DNA at 60 °C for 
30 seconds and an elongation phase at 72 °C for a time adjusted to the number of base pairs of the 
plasmid DNA by 1000 base pairs/minute. This amplification cycle was repeated 35 times. Afterwards, 
the template plasmid DNA was digested by the addition of 2 µl of DpnI (Thermo Fisher Scientific) at 
37 °C for 3 h, as this restriction enzyme cleaves only the methylated template DNA. 25 µl of the digested 
PCR product was then transformed into chemically competent E. coli DH5 (see section 2.2.10). The 
bacteria were plated onto LB agar plates containing appropriate antibiotics and incubated at 37 °C over 
night. At least three colonies were picked for inoculation of 6 ml of LB media supplemented with 
antibiotics at 37 °C over night. Plasmid DNA was isolated from 5 ml of the culture using NucleoSpin® 
Plasmid Isolation Kit of Macherey-Nagel (see section 2.2.11).  
 
2.2.5 Agarose gel electrophoresis 
Agarose gel electrophoresis is a method for DNA fragment separation using an electric field to 
move the charged molecules through an agarose matrix. The used protocol is based on the publication 
of Lee et al. (2012), with adjustments in buffer compositions and usage of a non-toxic nucleic acid stain 
instead of ethidium bromide. For visualization of the DNA fragments, the 1-2% agarose gels were 
supplemented with SafeViewTM Classic DNA stain (Applied Biological Materials Inc.) according to the 
instructions of the manufacturer. Agarose was dissolved in 1x TAE (Tris/Acetate/EDTA) buffer by boiling 
in a microwave oven. After the solution was cooled down to 60 °C, SafeViewTM Classic DNA stain was 
added (7.5 µl/100 ml agarose gel solution) prior to casting of the gel. DNA samples were supplemented 
with 6x DNA loading buffer and loaded onto the gel next to a DNA standard for size comparison 
(GeneRuler 100bp DNA Ladder, GeneRuler 100bp DNA Ladder Plus, GeneRuler 1kb DNA Ladder, 
Thermo Fisher Scientific). The gel run in 1x TAE buffer at 100 V for 20 to 40 minutes depending on the 
size of the DNA fragments to be separated and the gel size. DNA fragments determined for further 
cloning were identified and cut out on a UV (ultraviolet) transilluminator using a scalpel, followed by 
purification using the NucleoSpin® PCR clean-up/Gel extraction kit (Macherey-Nagel) according to the 
recommendation of the manufacturer. For analytical agarose gel electrophoresis of DNA fragments 
resulting from plasmid DNA digestion, size separation was documented using Agarose gel 
documentation GelSTICK touch.  
 
2.2.6 Quantification of double stranded DNA 
Concentration and purity of DNA was determined using the NanoDrop 2000c (Thermo Fisher 
Scientific) by measurement of the UV absorbance at 260 nm and 280 nm. Samples with an A260/A280 
ratio of 1.7 to 2 were considered as double stranded DNA and further processed. 
 
2.2.7 Restriction enzyme digest 
Restriction digestion is a technique for cleavage of DNA at specific sites of the sequence using 
restriction endonucleases. With this tool, DNA fragments can be removed from a plasmid and further 
inserted into another linearized plasmid, cut with the same enzymes. For planning of the cloning 
strategy, the enzyme ratio and the best buffer conditions of the digest, the Double Digest Calculator 
from Thermo Fisher Scientific was used.  
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Preparative digest of PCR products and plasmids 
For plasmid DNA digestion, 3 µg of plasmid was cut using 2 U of restriction enzyme in a total 
reaction volume of 40 µl, supplemented with 1x buffer, suitable for the enzyme combination, and ddH2O. 
PCR products were extracted from agarose gels using PCR clean-up/Gel extraction Kit and eluted in 
25 µl of buffer NE. For a digestion reaction volume of 40 µl, 1 U of restriction enzyme each, ddH2O and 
recommended 1x buffer was added. The reactions were incubated at 37 °C for 2 h. Digested plasmid 
DNA was supplemented with 6x DNA loading buffer after dephosphorylation (see section 2.2.8) and 
analyzed by agarose gel electrophoresis followed by isolation, while digested PCR products were 
purified using the PCR clean-up protocol of PCR clean-up/gel extraction Kit of Macherey-Nagel.  
 
Analytical digest of isolated plasmid DNA 
For the analysis of cloning success, 300-500 ng of plasmid DNA were digested in a total reaction 
volume of 20 µl, 0.5 U of each restriction enzyme and 1x buffer, suitable for the enzyme combination. 
DNA was digested at 37 °C for 2 hours prior to analytic agarose gel electrophoresis.  
 
2.2.8 Dephosphorylation of vectors 
After restriction digest, the phosphate groups of the 5’-ends of the cleaved DNA-strands were 
removed using Fast alkaline phosphatase to avoid recirculation during ligation of the plasmid cut by just 
one enzyme. 1 U of FastAP (Thermo Fisher Scientific) was added to 40 µl of the digestion reaction and 
incubated at 37 °C for 10 minutes. Afterwards, plasmid DNA was analyzed in a preparative way by 
agarose gel electrophoresis. 
 
2.2.9 Ligation of DNA Fragments 
To ligate DNA fragments cut with one or two identical restriction enzymes, T4 DNA ligase (Thermo 
Fisher Scientific) was used, which joins the DNA fragment ends by the formation of two covalent 
phosphodiester bonds between the 3’-hydroxyl end of one with the 5’-phosphate end of another DNA 
terminus. In a reaction volume of 10 µl, 100 ng of digested, dephosphorylated and purified plasmid was 
mixed with 5x molar excess of the DNA fragment to be inserted, 1 µl of 100 mM ATP, 1 µl of 10x 
T4 ligase buffer, 0.2 µl of T4 DNA ligase (1 U/µl) and ddH2O. The reaction solution was incubated at 
room temperature for 1-2 hour(s) and partially transformed into E. coli DH5 (see section 2.2.10). 
 
2.2.10 Transformation of plasmid DNA into E. coli DH5 
Bacterial transformation is a method to introduce foreign plasmid DNA into a bacterium (modified 
from Seidman and Struhl (2001), Froger and Hall (2007)). Chemically competent E. coli DH5 cells 
were thawed on ice for 10 minutes, before 5 µl of ligation reaction, 0.3 µg of plasmid DNA or 25 µl of 
mutagenesis-PCR was added for 30 minutes. Cells were heat shocked at 42 °C for 90 seconds prior to 
2 minutes incubation on ice followed by addition of 500 µl SOC-medium and soft shaking of 400 rpm in 
a Thermomixer at 37°C for 60 minutes. Afterwards, cells were spun down at 300 xg for 3 minutes, 450 µl 
of the supernatant was removed, the pellet was resuspended in the remaining media and plated on LB 
agar plates containing the appropriate antibiotic using 10-20 glass beads. The bacteria were incubated 
at 37 °C over night.  
 
2.2.11 Small Scale Plasmid DNA Isolation 
For the isolation of the plasmid DNA, the NucleoSpin® Plasmid Miniprep Kit according to 
Macherey-Nagel’s instruction was used which is based on the protocol of Birnboim and Doly (1979). 
Individual bacteria colonies were picked using a pipet tip and used for inoculation of 6 ml of LB-medium 
supplemented with appropriate antibiotics. After growing at 37 °C at 150 rpm for 16 h, 5 ml of the 
bacteria solution was pelleted in several steps in a 2 ml reaction tube at 11,000 xg for 1 minute. From 
this bacteria pellet, the plasmid DNA was isolated following the protocol “Isolation of high-copy plasmid 
DNA from E. coli” or “Isolation of low-copy plasmid DNA from E. coli” of the kit. 
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2.2.12 Large Scale Plasmid DNA Isolation 
After successful DNA-sequencing (see section 2.2.13) of a newly cloned plasmid, plasmid DNA 
was isolated from E. coli DH5 in a large scale using NucleoBondTM Xtra Midi Kit (Macherey-Nagel, 
based on Birnboim and Doly (1979)) according to instructions of the manufacturer. For the protocol 
“High-copy plasmid purification” 200 ml of LB-medium supplemented with antibiotic was inoculated with 
1 ml of bacteria culture containing the sequenced plasmid, while 400 ml of LB-medium was used for the 
protocol “Low-copy plasmid purification”. The bacteria culture was incubated at 37 °C at 150 rpm over 
night and pelleted at 5250 xg at 4 °C for 20 minutes. After the purification, the DNA-concentration was 
adjusted to 1 mg/ml with ddH2O. 
 
2.2.13 Sequencing 
All newly cloned plasmids were sequenced by GATC Biotech, a subcompany of Eurofins 
Genomics. Either GATC-standard primers were selected for sequencing or costumer specific primers 
(table 19) at a concentration of 10 pmol/µl in 20 µl volume were sent together with the samples to be 
analyzed. The company performs sequencing based on Sanger et al. (1977). 
 
 
2.3 Biochemical Methods 
2.3.1 SDS-PAGE 
Sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) is a method for 
separation of charged molecules by their molecular mass in an electric field, described first by Laemmli 
(1970), performed here with modifications according to Harlow and Lane (1988) and Sambrook and 
Russell (2006). Two-parted gels consisting of a resolving gel containing 10-15% acrylamide and a 
stacking gel with 5% acrylamide were prepared in the Dual Gel Caster for Mini Vertical Units of Hoefer. 
Protein samples or cell lysate were supplemented with SDS sample buffer, boiled at 95 °C for 5 minutes 
and centrifuged at 15,000 xg for 5 minutes prior to loading of the gel. For protein molecular mass 
comparison, the protein standard PageRuler Prestained Protein Ladder or PageRuler Unstained Protein 
Ladder (Thermo Scientific Fisher) was loaded next to the samples. Gel running was performed in the 
SE250 Mighty Small II Mini Vertical Electrophoresis Unit of Hoefer using 1x Laemmli running buffer at 
20-25 mA per gel until the required separation was reached. For better visualization of protein samples 
of small and large molecular mass, Mini Protean TGX Precast gels (4-20%, Bio-Rad) were used for 
SDS-PAGE of RAPIDS experiments (see section 2.6.4). Gels were either used for visualization of 
proteins with Coomassie staining or for immunodetection after Western blotting. 
 
2.3.2 Coomassie staining of SDS-PAGE gels 
Proteins of pulldown experiments or purifications separated via SDS-PAGE were visualized using 
Coomassie staining, as Coomassie dye interacts with amino and carboxyl groups of proteins. The gel 
was incubated in ddH2O for 10 minutes prior to fixation using Coomassie fixing solution for 5-60 minutes 
and staining with Coomassie staining solution over night. Gels were rinsed with ddH2O shortly before 
documentation with LAS3000 (Fujifilm) followed by image analysis using ImageJ. The Coomassie 
staining protocol was modified from Neuhoff et al. (1988) and Kang et al. (2002). 
 
2.3.3 Western Blotting 
For the immunodetection of proteins, the proteins separated by SDS-PAGE were blotted under 
wet conditions onto an Amersham Protran 0.45 µm NC Nitrocellulose Blotting Membrane (GE 
Healthcare). For blotting, the Mini Trans-Blot® Cell of Bio-Rad filled with cold 1x Western blot transfer 
buffer and a cooling pack was used. The SDS-gel was placed without air bubbles onto the nitrocellulose 
membrane surrounded by Whatman gel blotting paper and fiber pads to both sides in a gel holder 
cassette. The transfer was performed at 100 V for 1.5 h. Blotting onto nitrocellulose membrane was first 
described by Towbin et al. (1979). 
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2.3.4 Ponceau S staining 
After blotting of proteins onto nitrocellulose membrane, they were optionally stained by incubation 
with Ponceau S staining solution for 1 minute (Salinovich and Montelaro, 1986). Excess of staining 
solution was removed by several washing steps with 0.1% acetic acid. For documentation of the stained 
proteins, LAS-3000 (Fujifilm) was used, followed by image processing in ImageJ.  
 
2.3.5 Immunodetection of proteins 
The immunodetection of proteins is based on the method described by Gallagher et al. (2004) 
and the recommendation of LI-COR, the developer company of the Odyssey System. The nitrocellulose 
membrane was incubated with 5% milk powder dissolved in 1x TBST buffer for 30 minutes at room 
temperature on a rocking plate after blotting was completed. The membrane was cut into smaller pieces 
using the PageRuler prestained protein Ladder for orientation. Each piece was incubated with 
appropriate antibodies diluted in 5% TBST-milk at 4 °C over night. Unbound antibodies were removed 
by three washing steps with 1x TBST at room temperature on the rocker plate for 10 minutes each. After 
that, the membrane was incubated with appropriate fluorescence- or HRP- (Schneppenheim et al., 
1991) coupled secondary antibodies (1:10,000 in 1x TBST-milk) for at least 1 hour at room temperature. 
After three washing steps with 1x TBST for 10 minutes on a rocker plate, the fluorescence-coupled 
antibodies were visualized using the Odyssey® Sa Infrared Imaging System or Odyssey® CLx Imaging 
System of LI-COR. For HRP-coupled secondary antibody detection, the membrane was incubated with 
ImmobilonTM Western Chemiluminescent HRP Substrate (Millipore) for 1 minute, before the emitted 
luminescence light was detected using the LAS3000 (Fujifilm) or by putting the membrane into a light-
protected cassette and exposing it to Medix XBU medical X-ray film (FOMA Bohemia), followed by film 
development in the developer machine CURIX60 (Agfa).  
 
2.3.6 Protein purification 
Purified GST (glutathione S-transferase) was available in the common laboratory stock. 
For in vitro binding assays, recombinant proteins were expressed in E. coli Rosetta 2. For the 
cultivation of E. coli Rosetta 2, 30 mg/l chloramphenicol and, according to transformed plasmid for 
protein expression, 100 mg/l ampicillin or 60 mg/l kanamycin were added to the LB medium. After 
transformation of 0.2 µg of plasmid DNA (pETM41 for expression of His-MBP-His, pMAL-PP-LRRC59 
aa1-244 for expression of MBP-LRRC59 aa1-244-His and pETM30-Nup210 aa1830-1887 for 
expression of His-GST-Nup210 aa1830-1887) into bacteria, cells were distributed using glass beads 
onto LB agar plates with appropriate antibiotics and 1.5 µg of chloramphenicol per plate and incubated 
at 37 °C over night. On the next day, 6 ml LB medium containing antibiotics was inoculated with 25 
colonies picked from the LB agar plate. This preculture was cultivated at 37 °C for 4 hours prior to 
inoculation of an overnight preculture of 250 ml LB medium supplemented with appropriate antibiotics. 
The overnight preculture was used on the next morning to inoculate 3 to 9 l of LB medium supplemented 
with appropriate antibiotics starting with an OD600 of 0.03-0.06 (optical density at a wavelength of 
600 nm). The culture was incubated at 37 °C with 120 rpm until reaching an OD600 of 0.6. Prior to the 
addition of 0.3 mM IPTG to start overexpression of proteins, a 30 µl sample (“before induction”) was 
taken and supplemented with 30 µl of SDS sample buffer. For protein expression, cultures were 
incubated for 4 hours at 25 °C. 30 µl of bacteria culture was supplemented with 30 µl of SDS sample 
buffer referred to as “after induction”. For cell harvest, cells were centrifuged at 4200 rpm (Beckman 
Coulter, centrifuge J6-MI with rotor JS 4.2) and 4 °C for 30 minutes. The cell pellet was resuspended in 
25 ml of cold PBS and transferred into 50 ml Falcon tubes. Cells were centrifuged at 4750 xg and 4 °C 
for 15 minutes before the supernatant was removed and the pellet was frozen in liquid nitrogen for 
storage at -80 °C.  
 
For purification, a pellet from 2 l of bacteria culture, was resuspended in 35 ml medium salt buffer 
prior to cell lysis using an EmulsiFlex-C3 (BD Bioscience). A sample of 30 µl referred to as “EmulsiFlex 
homogenate” was supplemented with 30 µl of SDS sample buffer. For clearing, the lysate was 
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centrifuged at 100,000 xg and 4 °C for 30-60 minutes. 30 µl of the cleared lysate was mixed with SDS 
sample buffer for workflow control and referred to as “total fraction”. For 35 ml of cleared lysate, 700 µl 
of NI-NTA Agarose (Qiagen) was equilibrated in 50 ml medium salt buffer and spun down at 800 xg and 
4 °C for 3 minutes. The supernatant was removed and the cleared cell lysate was added to the beads 
and incubated at 4 °C for 2 hours on a spinning wheel. After binding of proteins to the beads, the mixture 
was centrifuged at 800 xg, 4 °C for 3 minutes (sample “unbound”) before three or four washing steps 
using 50 ml of medium salt buffer supplemented with 20 mM imidazole. After each centrifugation step, 
a sample of the supernatant was taken referred to as “washing 1-4”. The beads were transferred into 
an empty column and proteins were eluted from the beads using medium salt buffer supplemented with 
300 mM imidazole (“non-dialyzed eluate”). To remove imidazole from the eluate, the eluted sample was 
desalted with medium salt buffer using PD-10 Desalting Columns (GE Healthcare). Fractions containing 
the highest amount of protein were identified using Pierce Coomassie Plus Protein Assay Reagent 
(Thermo Fisher Scientific) and pooled. After dialysis, the eluate was aliquoted and frozen in liquid 
nitrogen for storage at -80 °C (dialyzed eluate). For protein concentration determination, SDS-PAGE 
followed by Coomassie staining was performed with increasing amounts of purified proteins. The 
concentration was calculated relative to a BSA-standard using an LAS3000-picture of the Coomassie 
stained gel, lane scanning with ImageJ and analysis by Microsoft Excel. 
 
2.3.7 Binding assay 
For analysis of protein binding of LRRC59 aa1-244 and Nup210 aa1830-1887, pulldown 
experiments were performed immobilizing either MBP-LRRC59 aa1-244-His and His-MBP-His as 
control on amylose beads or His-GST-Nup210 aa1830-1887 or GST as control on glutathione beads. 
75 µl of Amylose Resin High Flow (BioLabs) or Glutathione Sepharose High Performance (GE 
Healthcare) was equilibrated in pulldown buffer (Port et al., 2016) in 500 µl reaction tubes. Beads were 
centrifuged at 500 xg, 4 °C for 3 minutes followed by removal of the supernatant. For each immobilized 
protein, 200 pmol was added to the beads together with 500 µl of pulldown buffer prior to incubation at 
4 °C on a spinning wheel for 60 minutes. After immobilization of the proteins, beads were washed twice 
with binding buffer. After washing, 500 µl of binding buffer was added to the beads followed by 5 minutes 
of incubation on ice and addition of 600 pmol of MBP-LRRC59 aa1-244 to the immobilized GST or His-
GST-Nup210 aa1830-1887 and 600 pmol of His-GST-Nup210 aa1830-1887 to the immobilized His-
MBP-His or MBP-LRRC59 aa1-244-His, respectively. After 60 minutes of incubation at 4 °C on a 
spinning wheel, beads were washed four times using pulldown buffer. After total removal of the 
supernatant of the last washing step, beads were mixed with 50 µl of SDS sample buffer, vortexed, 
boiled at 95 °C for 5 minutes and spun down at 15,000 xg for 5 minutes. The binding was analyzed by 
12% SDS-PAGE followed by Coomassie staining or Western blotting and immunodetection. For 
Coomassie staining, 10% of the used input of immobilized and added protein was separated by SDS-
PAGE, while for Western Blot analysis 1% of the used protein amounts was analyzed. 
 
2.3.8 Microsome integration assay 
The microsome integration assay is a method to observe the membrane insertion of an in vitro 
transcribed and translated integral membrane protein. The terminus of the membrane protein which is 
facing the lumen is tagged with a 13 amino acid long opsin-tag, which is glycosylated upon membrane 
insertion of the integral membrane protein. This glycosylation can be observed by SDS-PAGE and 
immunoblotting. 
For the insertion of proteins into rough microsomes, the protein of interest was cloned into a T7-
promotor containing plasmid (pET328-HZZ or pGEM3) with a C-terminal opsin tag. These constructs 
were used for a coupled in vitro transcription and translation reaction using the TnT Quick Coupled 
Transcription/Translation system (Promega) (Pelham and Jackson, 1976; Jagus and Beckler, 2003; 
Favaloro et al., 2010; Vilardi et al., 2011) according to the protocol of the manufacturer. For the reaction, 
1 µl of 200 ng/µl plasmid DNA was mixed with 8.8 µl of rabbit reticulocyte lysate and 0.2 µl methionine 
(1 mM stock solution). As transcription/translation control for specific protein expression, the translation 
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inhibitor puromycin at a final concentration of 2.5 mM was added to the mixture at time point 0 minutes. 
The reaction was taking place at 30 °C in a Thermomixer for 90 minutes until the addition of puromycin 
at a final concentration of 2.5 mM for 10 minutes (Favaloro et al., 2010). After 10 minutes of incubation 
with puromycin, 1 µl of dog pancreas rough microsomes (Walter and Blobel, 1983) were added to the 
reaction for 60 minutes at 30 °C. Reactions were stopped by addition of 50 µl SDS sample buffer, 
heating at 95 °C for 5 minutes and centrifugation at 15,000 xg for 5 minutes. Protein expression and 
membrane insertion monitored by the N-glycosylation of the opsin-tag (Adamus et al., 1991) was 
analyzed by loading 10-25% of the samples onto 12% SDS-PAGE followed by Western blotting and 
immunodetection. For quantification, lane scans were performed using ImageJ. The membrane insertion 
efficiencies were calculated as the percentage of the glycosylated protein compared to the sum of the 
glycosylated and the non-glycosylated form. Values were normalized to the control reaction for the 
transcribed and translated protein for rough microsome treatment. The mean and the standard deviation 
for each treatment condition were calculated from five or six individual experiments. 
 
PNGase F treatment 
For confirmation of specific N-glycosylation of the inserted opsin-tag, a deglycosylation reaction 
after the microsome integration assay was performed. The protocol was modified from Pfaff et al. (2016). 
25% of the insertion reaction was mixed with 1 µl glycoprotein denaturing buffer and filled up with ddH2O 
to a final volume of 13 µl. The proteins were denatured at 100 °C for 10 minutes. Afterwards, the solution 
was chilled on ice for 1 minute and centrifuged for 10 seconds. For the specific cleavage of N-linked 
oligosaccharides from glycoproteins, either 500 U of peptide-N-Glycosidase F (PNGase F, New 
England BioLabs) or ddH2O as a control was added to the reaction supplemented with 1% NP-40 
(Nonidet P-40), 1x G7 reaction buffer and ddH2O added to a final volume of 20 µl. After the 
deglycosylation reaction at 37 °C for 60 minutes, 12 µl of 4x SDS sample buffer was added and 50% of 
the reaction was analyzed by SDS-PAGE and immunoblotting. 
 
Microsome integration assay using trypsin-treated rough microsomes 
The microsome integration assay was performed as described above with addition of 1 µl of 
trypsin- (Favaloro et al., 2010) or EDTA and high salt-treated microsomes instead of rough microsomes. 
The treatment of rough microsomes with trypsin leads to the removal of receptor proteins of the 
membranes while preparation of microsomes with washing steps using EDTA and high salt leads to 
removal of peripheral attached proteins to the membrane serving as control treatment. For proof of 
receptor removal, 1 µl of trypsin- and EDTA/high salt-treated microsomes were supplemented with SDS 
sample buffer followed by analysis using SDS-PAGE and immunoblotting. 
 
Microsome integration assay with addition of MBP-WRBcc or GST-CAML-N 
For proof of membrane insertion of examined protein via the TRC pathway receptors WRB and 
CAML, the microsome integration assay was performed as described above with the addition of the 
dominant negative inhibitory fragments MBP-WRBcc (Vilardi et al., 2011; Pfaff et al., 2016) or GST-
CAML-N (Yamamoto and Sakisaka, 2012; Pfaff et al., 2016). Instead of puromycin addition after 
90 minutes of transcription and translation reaction, 5 or 10 µM of purified MBP-WRBcc or GST-CAML-N 
was added 10 minutes prior to supplemental of 1 µl rough microsomes. After additional 60 minutes of 
reaction, 50 µl of SDS sample buffer was added and the samples were analyzed using 12% SDS-PAGE 
and immunoblotting. Purified MBP-WRBcc and GST-CAML-N was a kind gift of Dr. Jhon Rivera-Monroy, 
member of the laboratory of Prof. Dr. Blanche Schwappach.  
 
Immunodepletion of rabbit reticulocyte lysate 
The immunodepletion of TRC40 from rabbit reticulocyte lysate was described previously by 
Leznicki et al. (2010). Shortly, rabbit reticulocyte lysate was immunodepleted using anti-TRC40 
antibodies (laboratory of Prof. Dr. Blanche Schwappach, Ab0405) (Favaloro et al., 2010) in 1.5 ml 
reaction tubes. 20 µl of Protein A Sepharose 4 Fast Flow (GE Healthcare) were washed in 1 ml cold 1x 
PBS buffer followed by a centrifugation step at 500 xg, 4 °C for 2 minutes and removal of the 
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supernatant. After that, 15 µl of rabbit anti-TRC40 (Favaloro et al. (2010); TRC40 depletion) or 1.5 µg 
of rabbit IgG (Sigma-Aldrich; mock depletion) was added and the tube was filled up with 500 µl of cold 
1x PBS. For binding of the antibody or IgG to the Protein A Sepharose, the reaction tubes were put onto 
a spinning wheel at 4 °C for 60 minutes. After a washing step with cold 1x PBS and centrifugation at 
500 xg, 4 °C for 2 minutes, 120 µl of rabbit reticulocyte lysate was added to the immobilized antibodies. 
The immunodepletion was performed in the reaction tubes put into a 50 ml Falcon tube, rotating at 4 °C 
for 60 minutes. The solution was spun down at 13,000 xg, 4 °C for 1 minute, the supernatant was 
transferred into a new reaction tube and used for the microsome integration assay as described above. 
To check for the efficiency of the immunodepletion of TRC40, 2 µl of anti-TRC40 or the IgG-treated 
rabbit reticulocyte lysate was analyzed using 12% SDS-PAGE, Western blotting, Ponceau S staining 
and immunodetection after mixing with SDS sample buffer.  
 
 
2.4 Cell Biology Methods 
2.4.1 Cultivation of adherent cells 
The adherent cell lines HeLa P4 (Charneau et al., 1994) and U2OS (ATCC® HTB96) were 
cultivated in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% (v/v) fetal bovine 
serum (FBS) Superior (Biochrom) (v/v), 2 mM L-glutamine (Roth), 100 U/ml penicillin and 100 µg/ml 
streptomycin (Thermo Fisher Scientific). Cells were grown in 10 cm cell culture dishes at 37 °C and 5% 
CO2 in a humid atmosphere. Cells were checked for contamination with mycoplasma on a regular basis. 
When cells reached a density of 80%, the cells were passaged and diluted for further growing. Medium 
was removed and the cells were washed with 1x PBS. Cells were supplemented with 1 ml of Gibco® 
Trypsin/EDTA 0.25% and placed onto a heating plate (Type 12801, MEDAX) at 37 °C. By addition of 
9 ml of FBS containing DMEM growth medium, the digestion was inhibited and the cells were separated 
from each other by pipetting using a 1 ml pipet. For HeLa P4, 750 µl of cells suspension was added to 
9.25 ml of cell culture medium in a new 10 cm cell culture dish (splitting 1:15). U2OS cells were split in 
a ratio 1:7 (1.5 ml of cell suspension mixed with 8.5 ml of cell culture medium). Both cell lines were split 
twice a week. All cell culture work was performed under a tissue culture hood. 
 
2.4.2 Determination of cell concentration 
For the determination of the number of cells growing in a 10 cm dish, the hemocytometer 
Neubauer chamber advanced 0.1 mm (Brand) was used. 25 µl of cell suspension was mixed with 75 µl 
of 0.4% Trypan blue solution (Sigma-Aldrich) and added to both counting grids of the Neubauer 
chamber. In each counting grid, cells in the four corner quadrates of the 3x3 counting quadrates of 1 mm 
edge length were counted. The mean of the cell number of these eight counted quadrates was 
calculated and multiplied by four to consider the dilution with Trypan blue solution. The received value 
multiplied by 10,000 corresponded to the number of cells in 1 ml cell culture medium. 
 
2.4.3 Seeded cell number for different experiments 
For transient transfection of HeLa P4 cells, 24 well cell culture plates were equipped with 12 mm 
coverslips and a 120,000 cells/ml cell suspension was prepared. In each well, 500 µl of cell suspension 
was added (60,000 cells/well). The next morning, cells were transfected using the calcium-phosphate 
method (see section 2.4.4). For the transfection of U2OS cells with siRNAs, 30,000 cells were seeded 
per well (500 µl cell suspension) in a 24 well cell culture plate. For immunostaining of endogenous 
proteins without transfection, HeLa P4 cells were seeded in a 24 well cell culture plate with a number of 
120,000 cells/well and stained the next day. For RAPIDS experiments (see section 2.6), 1,650,000 
cells/10 ml were seeded onto 10 cm cell culture dishes containing one coverslip per plate for 
immunofluorescence analysis. For selective permeabilization of cells in solution using digitonin, 
5,000,000 cells were seeded onto a 10 cm cell culture dish containing 10 ml of cell culture medium, 
while several coverslips were distributed over the plate for immunofluorescence staining. 
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2.4.4 Transient transfection of mammalian cells with DNA and siRNAs using 
calcium-phosphate 
For transient transfection of HeLa P4 or U2OS cells with plasmid DNA and/or siRNAs, the 
calcium-phosphate method (Chen and Okayama, 1987) was modified and used for cells seeded one 
day before treatment. For microscopy-based cell assays (24 well cell culture plates), 20 µl of CaCl2 
(250 mM) was added to a final concentration of 0.2-1.5 µg of plasmid DNA and/or 100 nM siRNAs per 
well provided in a 1.5 ml reaction tube before the mixture was vortexed at full power for 5 seconds. 
Afterwards, 20 µl of 2x HEPES were added prior to 10 second vortexing and 25 minutes of incubation 
time at room temperature. As a master mix, transfection reactions for up to six wells were performed in 
one tube. After 40 µl of the mixture was added to the cells in one well drop by drop, cells were incubated 
at 3% CO2 for 6 hours. The next day, the media was replaced after two washing steps with 1x PBS. 
For the transfection of HeLa P4 cells with plasmid DNA used for RAPIDS experiments (10 cm 
dishes), 500 µl of CaCl2 (250 mM) was added to 10 µg of plasmid pmCherry-FRB-LRRC59 and 7 µg of 
plasmid pcDNA3-FKBP12-EGFP-APEX2 for each plate followed by 5 seconds of full speed vortexing. 
After the addition of 500 µl of 2x HEPES, the mixture was vortexed with full speed for 10 seconds. After 
25 minutes at room temperature, the reaction mixtures (one per 10 cm dish) were united and 1 ml was 
added to the cells of each dish. Cells were incubated at 3% CO2 for 6 hours. After two washing steps 
with 1x PBS, the medium was replaced by medium containing the appropriate isotopes on the next day. 
 
2.4.5 Differential permeabilization of cells 
Semi-permeabilization of the plasma membrane was first described by Adam et al. (1990) using 
the glycoside digitonin. Digitonin selectively permeabilizes the plasma membrane due to its high 
concentration of cholesterol, but the intracellular membranes stay intact (Adam, 2016). For microscopy-
based experiments, HeLa P4 cells were grown on coverslips in a 10 cm cell culture dish with 5,000,000 
cells seeded the day before. For permeabilization of attached cells using digitonin, cells were washed 
twice with 1x PBS and coverslips were moved onto a parafilm positioned on a metal block on ice. Cells 
were washed twice with transport buffer supplemented with 1 µg/ml leupeptin and pepstatin, 1 µg/ml 
aprotinin and 0.1 mM PMSF (phenylmethane sulfonyl fluoride) followed by digitonin permeabilization 
using 60 µl of 0.001% digitonin diluted in transport buffer for 5 minutes. After removal of the 
permeabilization solution, cells were washed three times (2x shortly, 1x for 2 minutes) using transport 
buffer. After a washing step with 1x PBS on the ice block, the wet coverslips were transferred quickly 
into a humidity/dark chamber on top of a parafilm positioned on a wet tissue paper. After an additional 
washing step with 1x PBS, the cells were fixed with 3.7% formaldehyde diluted in 1x PBS. If necessary, 
cells were subjected to indirect immunofluorescence staining for protein detection (see section 2.4.6). 
For permeabilization of HeLa P4 cells in solution, 5,000,000 cells were seeded on a 10 cm dish 
for 24 hours before washing with 1x PBS. Coverslips for immunostaining of proteins were removed 
before further procedure. Cells were detached using 1 ml of Gibco® Trypsin/EDTA 0.25% for enzymatic 
digest of cell attaching proteins. After detachment of the cells, 9 ml of cell culture medium was added. 
Cells were pelleted with 300 xg at room temperature for 3 minutes prior to washing with 2 ml of 1x PBS. 
Cell number was determined using the Neubauer chamber. The volume containing 1,000,000 cells was 
transferred into a new tube, cells were pelleted with 300 xg at room temperature for 3 minutes. PBS was 
removed and cells were resuspended in 2 ml of transport buffer. From this cell suspension, 1 ml was 
transferred into a new tube supplemented with SDS sample buffer (input) while the other 1 ml was mixed 
with 12 µl of 1% digitonin incubated for 5 minutes on ice. Permeabilized cells were centrifuged at 
16,000 xg and 4 °C for 30 minutes. The supernatant was transferred into a new tube and mixed with 
SDS sample buffer while the pellet remained in the tube for mixing with SDS sample buffer. All samples 
were boiled at 95 °C for 10 minutes and centrifuged at 15,000 xg for 5 minutes prior to analysis by SDS-
PAGE, Western blotting and immunodetection. 
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2.4.6 Indirect immunofluorescence for protein detection 
For the detection of endogenous or HA-, FLAG- or c-Myc-tagged proteins, cells were subjected 
to indirect immunofluorescence staining. Cells were grown on coverslips and, if necessary, transiently 
transfected with plasmid DNA or siRNAs. After 48 hours of knockdown and/or overexpression, cells 
were washed twice with 1x PBS and the coverslips were transferred into a humidity/dark chamber using 
tweezers. In the chamber, the coverslips were positioned onto a parafilm on top of a wet tissue paper. 
Whenever possible, the humidity/dark chamber was closed to protect fluorescently labeled proteins from 
light exposure. Cells were fixed with 3.7% formaldehyde diluted in 1x PBS at room temperature for 
15 minutes. After two washing steps with 1x PBS, the cells were permeabilized using 0,5% Triton X-100 
for 5 minutes (Koley and Bard, 2010) followed by three washing steps with 1x PBS. For reduction of 
unspecific antibody binding, cells were incubated with blocking solution (3% BSA diluted in 1x PBS) for 
20 minutes. After removal of the blocking solution, primary antibody appropriately diluted in blocking 
solution was added to the cells (50 µl/coverslip) for 1-1.5 hours. For endogenous staining of LRRC59, 
primary antibody incubation time was extended to 2.5 hours and the blocking solution was 
supplemented with Triton X-100 in a final concentration of 0.05%. Cells were washed three times with 
1x PBS prior to addition of secondary antibody diluted in blocking solution for 1 hour. For LRRC59 
staining, the blocking solution was supplemented with 0.05% Triton X-100 and the incubation time 
extended to 1.5 hours. After two washing steps with 1x PBS and one with H2O, coverslips were 
transferred onto a Whatman paper for drying and protected from light. The coverslips were placed onto 
Mowiol mounting medium, if necessary supplemented with 1 µg/ml DAPI (Sigma-Aldrich) on microscopy 
slides prior to microscopy analysis. A list of primary and secondary antibodies used in this work can be 
found in table 14 and 15. 
 
2.4.7 Confocal microscopy 
For the analysis of directly or indirectly fluorescent labeled proteins, the Zeiss LSM 510 meta 
confocal microscope base on the Axiovert 200M was used. Images were taken with the 63x Plan-
Neofluar 1.3 NA water-corrected objective with appropriate filter settings. For detection of DAPI or NES-
mTagBFP2-cNLS at 405 nm, a Diode-laser was used. For detection of EGFP-tagged or Alexa Fluor 488 
conjugated secondary antibody stained proteins, an Argon488 laser was used. For detection of 
mCherry-tagged or Alexa Fluor 594 stained proteins, a HeNe543 or HeNe594 laser was used, while 
Alexa Fluor 633 and 647 was detected with a HeNe633 laser. For reduction of bleaching time, scanning 
with Diode-laser and HeNe543 or Argon488 and HeNe633 were performed in one scanning process. 
Dependent on the fluorescence signal, laser power was adjusted for signal detection. The pinhole was 
set to a diameter of 0.8 airy units for all used channels. Background level was controlled by Amplifier 
Offset adjustment. All settings were controlled with the help of the range indicator function in the palette 
tool. Generally, four images were averaged at a data depth of 8 bit. For processing of microscopy 
images in ImageJ 1.52a, channels were separated followed by brightness and contrast adjustment. The 
image type was changed to RGB color prior to saving as tiff file. 
 
Note: Where indicated, the Zeiss microscope Axioskop2 mot plus, an upright, non-confocal light 
microscope was used as an alternative. For images, the AxioVision 4.8.1 software was used with the 
AxioCam MRm TV2/3”C 0,63x with the objective Plan-Neofluar 100x/1,30 Oil. The exposure time for 
each channel was appropriately adjusted and kept for all taken images of an experiment.  
 
 
2.5 Rapamycin-induced dimerization assay 
For the verification of INM localization of a membrane protein, a rapamycin-based dimerization 
assay, was used (Pfaff et al., 2016; Ohba et al., 2004; Haruki et al., 2008). Detailed information about 
the dimerization mechanism can be found in section 3.2.2.  
Cells were transiently transfected with the plasmid coding for the nuclear reporter EGFP2-GST-
M9-FKBP12 or EGFP2-MBP-M9-FKBP12 and the protein of interest. This protein contains a membrane 
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domain and is tagged with a FRB domain and a HA- or mCherry-tag on its cytoplasmic localizing 
terminus. An overview of all used constructs and plasmid DNA concentrations for transient transfection 
used in the rapamycin-based dimerization assay can be found in table 25. After 48 hours of 
overexpression, cells were washed twice with 1x PBS. The coverslips were transferred into the 
humidity/dark chamber using tweezers onto a parafilm on top of a wet tissue paper. Cells were treated 
with 200 nM rapamycin diluted in 1x PBS at room temperature for 1-30 minutes to allow the dimerization 
between the FKBP12- and the FRB-domain mediated by rapamycin. When the incubation time was 
over, rapamycin-PBS was removed and cells were immediately fixed with 3.7% formaldehyde diluted in 
PBS. If necessary, immunofluorescence staining was performed prior to fluorescence microscopy.  
 
The rapamycin-induced dimerization assay was performed with simultaneous knockdown of 
importin . Cells were transfected with 100 nM control siRNA or 50 nM importin  siRNA 1 + 50 nM 
importin  siRNA 2 and 0.3 µg EGFP2-GST-M9-FKBP12, 0.5 µg mCherry-FRB-LRRC59 and, optionally, 
0.7 µg NES-mTagBFP2-cNLS (per well). For rapamycin-induced dimerization assay with simultaneous 
expression of Bimax2 or a control, the cells were transfected with 0.3 µg EGFP2-GST-M9-FKBP12, 
0.5 µg mCherry-FRB-LRRC59, 1 µg NES-mTagBFP2-cNLS and 1 µg FLAG-Bimax2 or the vector 
pcDNA3 (per well). 
For the analysis of rapamycin induced reporter response, at least 100 cells were counted per 
condition and experiment and categorized as “responding” or “not responding”. A “responding” cell was 
defined as a cell which showed a reporter recruitment to the NE indicated as a green rim, while the 
reporter of a “not responding” cell was distributed all over the nucleus without aggregation at the NE.  
 
Table 25: Plasmids used for transfection of HeLa P4 cells in a 24 well cell culture plate 
Rapamycin assay constructs with FRB domain Reporter with FKBP12 domain 
Number Name [µg/well] Number Reporter [µg/well] 
1232 mCherry-FRB-emerin 0.5 1603 EGFP2-GST-M9-FKBP12 0.3 
1424 mCherry-FRB-LRRC59 0.4/0.5 1603 EGFP2-GST-M9-FKBP12 0.3 
1424 mCherry-FRB-LRRC59 0.4/0.5 2092 EGFP2-MBP-M9-FKBP12 0.2 
1425 WRB-FRB-HA 0.5 1603 EGFP2-GST-M9-FKBP12 0.3 
1546 mCherry-FRB-GST-LRRC59 1 2092 EGFP2-MBP-M9-FKBP12 0.2 
1848 mCherry-FRB-MBP-LRRC59 1 1603 EGFP2-GST-M9-FKBP12 0.3 
1848 mCherry-FRB-MBP-LRRC59 1 2092 EGFP2-MBP-M9-FKBP12 0.2 
1905 HA-FRB-LRRC59 1 1603 EGFP2-GST-M9-FKBP12 0.3 
2000 mCherry-FRB-Sec61 0.5 1603 EGFP2-GST-M9-FKBP12 0.3 
2000 mCherry-FRB-Sec61 1.5 2092 EGFP2-MBP-M9-FKBP12 0.166 
2003 mCherry-FRB-Sec22 0.5 1603 EGFP2-GST-M9-FKBP12 0.3 
2005 LMAN2-FRB-mCherry 0.5 1603 EGFP2-GST-M9-FKBP12 0.3 
2007 DDOST-FRB-mCherry 0.5 1603 EGFP2-GST-M9-FKBP12 0.3 
2007 DDOST-FRB-mCherry 1.5 2092 EGFP2-MBP-M9-FKBP12 0.166 
2008 mCherry-FRB-UBE2J1 1 1603 EGFP2-GST-M9-FKBP12 0.3 
2008 mCherry-FRB-UBE2J1 1.5 2092 EGFP2-MBP-M9-FKBP12 0.166 
2009 mCherry-FRB-UBE2J2 1 1603 EGFP2-GST-M9-FKBP12 0.3 
2102 
mCherry-FRB-LRRC59 
(containing GGGGS linker) 
0.7 1603 EGFP2-GST-M9-FKBP12 0.3 
2103 
mCherry-FRB-MBP-LRRC59 
(containing GGGGS linker) 
0.7 1603 EGFP2-GST-M9-FKBP12 0.3 
2119 mCherry-FRB-MBP-Sec61 1.5 2092 EGFP2-MBP-M9-FKBP12 0.166 
2121 DDOST-MBP-FRB-mCherry 1.5 2092 EGFP2-MBP-M9-FKBP12 0.166 
2124 mCherry-FRB-MBP-UBE2J1 1.5 2092 EGFP2-MBP-M9-FKBP12 0.166 
2125 mCherry-FRB-GST-Sec61 1.5 2092 EGFP2-MBP-M9-FKBP12 0.166 
2128 DDOST-GST-FRB-mCherry 1.5 2092 EGFP2-MBP-M9-FKBP12 0.166 
2129 mCherry-FRB-GST-UBE2J1 1.5 2092 EGFP2-MBP-M9-FKBP12 0.166 
 
Material and Methods 
 
 61 
2.6 Rapamycin- and APEX-dependent identification of proteins by SILAC (RAPIDS) 
The rapamycin- and APEX-dependent identification of proteins by SILAC (RAPIDS) is an 
experimental approach to identify proteins in close proximity to a membrane protein. The experimental 
protocol was established by Dr. Marret Müller in the laboratory of Prof. Dr. Ralph H. Kehlenbach, and 
performed with adjustments for the protein LRRC59 in plasmid DNA concentration usage and 
overexpression time of 52 hours instead of 24 hours. 
 
2.6.1 Dialyzing FBS 
FBS (100 ml) was dialyzed against PBS using a dialysis membrane with a molecular mass cut-
off of 6-8 kDa (Spectra/Por 1 Dialysis membrane Standard RC tubing 6-8 kDa, Spectrum) while stirring 
at 4 °C. PBS (2 l) was exchanged after 1 hour before dialysis over night. On the next day, 1x PBS was 
again exchanged followed by 1 hour dialysis and transfer of the FBS into two 50 ml Falcon tubes. 
Dialyzed FBS was stored at -20 °C until usage. 50 µl of the dialyzed FBS was added to 2 ml of DMEM 
medium in a 2 cm cell culture dish and observed for bacterial contamination. 
 
2.6.2 SILAC labeling 
For SILAC (stable isotope labeling of amino acids in cell culture) experiments (Ong et al., 2002), 
HeLa P4 cells were grown in medium containing heavy or light isotopes of arginine and lysine. Cells 
were cultivated in high glucose DMEM lacking glutamine, lysine and arginine (Thermo Fisher Scientific) 
supplemented with 10% (v/v) dialyzed FBS, 6 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml 
streptomycin and either heavy or light labeled isotopes. For “heavy media” 0.4 mM 13C615N2-L-lysine 
and 0.2 mM 13C615N4-L-arginine, for “light media” 0.4 mM 12C614N2-L-lysine and 0.2 mM 12C614N4-L-
arginine were added. To ensure a sufficient incorporation of heavy amino acids of  97%, cells were 
passaged five to seven times in SILAC medium before the biotinylation experiment. The incorporation 
rate was analyzed by mass spectrometry analysis and was higher than 98% for all performed 
experiments. Cells were grown at 37 °C and 5% CO2 and passaged when reaching 80% confluency.  
 
2.6.3 Rapamycin-dependent biotinylation assay 
After cultivation of HeLa P4 cells in either heavy or light isotope labeled medium for five to seven 
passages, 1,650,000 cells/10 cm dish, seeded the day before, were transiently transfected with 
plasmids coding for mCherry-FRB-LRRC59 and FKBP12-EGFP-APEX2. For cells grown in light 
medium, six 10 cm dishes were prepared, while for cells of heavy medium seven 10 cm dishes were 
used, as one plate was for incorporation analysis. For microscopic analysis of the cells, one coverslip 
per plate was added. 24 hours after transfection, cells were washed using 1x PBS prior to medium 
replacement. After 52 hours of overexpression, the biotinylation experiment was performed. Cells for 
incorporation analysis were only harvested in RIPA buffer as described below prior to determination of 
the protein concentration. In the forward experiment, medium of cells cultivated in light medium was 
replaced with light medium supplemented with 500 µM biotinphenol (Iris Biotech) and 200 nM 
rapamycin, while cells grown in heavy medium were incubated with heavy medium containing 500 µM 
biotinphenol lacking rapamycin. For the reverse experiment, rapamycin addition to the cells in 
appropriate medium was switched. Incubation of the cells with biotinphenol with or without rapamycin 
was performed at 37 °C, 5% CO2 for 30 minutes. Subsequently, 1 mM H2O2 was added to each 10 cm 
dish at room temperature for 1 minute. The medium was immediately removed and cells were 
supplemented with 10 ml of quenching buffer. After an additional washing step with 10 ml quenching 
buffer, cells were washed with 1x PBS. The coverslip of each plate was taken out with tweezers and 
placed into a humidity/dark chamber for fixation of the cells with 3.7% formaldehyde in PBS for 
15 minutes. Coverslips were placed onto microscopy slides with Mowiol mounting medium containing 
DAPI for microscopy analysis. The PBS in the cell culture dishes was removed and 1,4 ml of RIPA buffer 
was added prior to cell harvest using a cell scraper. The cell suspension was transferred into 2 ml 
reaction tubes and kept on ice until all plates were processed. The cell lysate was centrifuged at 
16,000 xg, 4 °C for 10 minutes.  
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The protein concentrations of cell lysates coming from heavy or light isotope labeled medium 
were determined using Pierce 660 nm Protein Assay (Thermo Fisher Scientific) analyzed with the plate 
reader BioTek Synergy HT and a BSA dilution series for comparison and adjusted to each other. 40 µl 
of both cell lysates were mixed with 40 µl of SDS sample buffer (“total lysate”). For Western blot analysis, 
2.8 ml of each cell lysate was transferred into two 1.5 ml reaction tubes. For mass spectrometry analysis, 
equal protein amounts of cell lysates cultivated in heavy or light medium, were mixed in a ratio 1:1 (total 
volume: 11.2 ml) and transferred into eight 1.5 ml reaction tubes. Each reaction tube contained 130 µl 
of NeutrAvidin Agarose Resin (Thermo Fisher Scientific), equilibrated in RIPA buffer. For protein binding 
to the NeutrAvidin beads, the mixtures were incubated on a rotation wheel at 4 °C over night. The 
mixtures were centrifuged at 800 xg, 4 °C for 1 minute and the supernatant was removed. Beads were 
washed once using washing buffer 1 on a spinning wheel at 4 °C for 8 minutes followed by one additional 
washing step using washing buffer 2 and two washing steps with washing buffer 3. After the last 
washing, supernatant was removed and beads were dried using a compressed loading tip to avoid 
sucking off of beads. Proteins bound to the beads from different tubes were eluted by incubation with in 
total 110 µl (mass spectrometry samples) or 80 µl (Western blot samples) SDS sample buffer 
supplemented with 5 mM desthiobiotin (Sigma Aldrich) at 95 °C for 5 minutes. The RAPIDS experiment 
was performed twice to have four independent replicates. 
 
2.6.4 Protein analysis using SDS-PAGE and Western blotting 
The biotinylated proteins of samples of RAPIDS experiments prepared for SDS-PAGE and 
Western blotting were analyzed using Mini Protean TGX Precast gels, 4-20% (BioRad) in Laemmli 
running buffer prior to transfer onto Nitrocellulose Blotting Membrane. Biotinylated proteins were 
detected using HRP-coupled streptavidin (1:20,000 in 3% BSA in 1x TBST). 
 
2.6.5 Mass spectrometry analysis 
The mass spectrometry analysis for the samples of RAPIDS experiments was performed by 
Thierry Wasselin, Dr. Christof Lenz and Dr. Henning Urlaub (Core Facility Proteomics, University 
Medical Center Göttingen). The submitted samples were separated using 4-12% NuPAGE Novex Bis-
Tris Minigels (Invitrogen) followed by Coomassie Blue staining. Each lane was sliced into 11-12 pieces, 
all equal in size, washed and reduced with DTT. Afterwards, proteins in gel pieces were alkylated with 
2-iodoacetaminde and digested with trypsin overnight followed by peptide extraction and drying in a 
SpeedVac. Afterwards, the peptides were reconstituted in 2% acetonitrile and 0.1 formic acid (v/v) and 
analyzed as described in Atanassov and Urlaub (2013) using a nanoLC-MS/MS on a hybrid 
quadrupole/orbitrap mass spectrometer (Q Exactive, Thermo Fisher Scientific). The raw data processing 
was performed using MaxQuant Software version 1.5.7.4 (Max Planck Institute for Biochemistry, 
Martinsried, Germany). For analysis of proteins, peptides were identified by comparison to the human 
reference proteome (v2017.02) considering a set of common laboratory contaminations. For the relative 
protein quantification, Arginine R10 and Lysine K8 labels including the “Re-quantify” option were used.  
For the statistic evaluation, Perseus Software version 1.5.6.0 (Max Planck Institute for 
Biochemistry, Martinsried, Germany), was used. For information about the Matrix workflow see table 
S 8. The results of two forward and two reverse RAPIDS experiments were analyzed together for 
statistical evaluation of relative protein quantification values and a two-sided Significance B test (Cox 
and Mann, 2008) using normalized log2 ratios. In Significance B testing, Benjamini Hochberg False 





In this study, the ER- and NE-localizing protein LRRC59 was examined with respect to its 
ER-membrane insertion mechanism using microsome integration and cell culture-based assays (see 
section 3.1). Detailed information about LRRC59 can be found in section 1.4. Additionally, the INM 
targeting of LRRC59 using cell culture-based techniques and rapamycin-induced dimerization assays 
was studied (see section 3.2). By the performance of RAPIDS (rapamycin- and APEX-dependent 
identification of proteins by SILAC) experiments, proteins in close proximity to LRRC59 were identified 
and further analyzed. RAPIDS experiments combine biotinylation of proteins by the rapamycin-
dependent targeting of APEX2 with stable isotope labeling of amino acids in cell culture (SILAC) (see 
section 3.3). Beyond this, further ER- and NE-localizing proteins were identified as INM proteins and 
examined for their INM targeting by rapamycin-induced dimerization assays (see section 3.4). 
 
3.1 Membrane insertion of LRRC59 
LRRC59 is a protein of 34.9 kDa (UniProt ID Q96AG4) and has a single TMD at its C-terminus 
followed by additional 40 amino acids. Its N-terminus is oriented towards the cytoplasm, while the 
C-terminus is facing the lumen of the ER. LRRC59 has no signal sequence, but a hydrophobic segment 
(signal anchor) near the C-terminus. These properties classify LRRC59 as a potential tail-anchored (TA) 
protein (Kutay et al., 1993), which could be post-translationally inserted into ER-membranes using the 
classical insertion mechanism for TA proteins, the TRC pathway (Stefanovic and Hegde, 2007). To 
examine the membrane insertion mechanism of LRRC59, in vitro microsome integration assays were 
performed (Favaloro et al., 2010; Vilardi et al., 2011). In these assays, the well analyzed TA protein 
emerin, which is inserted via the TRC pathway into the microsomal membranes, served as control (Pfaff 
et al., 2016). 
 
 
3.1.1 Post-translational membrane insertion of LRRC59 
For microsome integration assays, an in vitro transcription and translation reaction is coupled with 
a membrane insertion reaction using purified dog pancreas rough microsomes (Walter and Blobel, 1983; 
Favaloro et al., 2010; Vilardi et al., 2011). For this, the cDNA sequences of LRRC59 and emerin were 
cloned into the T7-promotor containing plasmids pET328-HZZ or pGEM3. An additional 13 amino acid 
long opsin-tag (Adamus et al., 1991) was added to the C-terminus of LRRC59. This opsin-tag is 
N-glycosylated when it is inside the microsomal lumen. The insertion of the transcribed and translated 
products into rough microsomes were observed by detection of the glycosylation of the opsin-tag by 
SDS-PAGE, Western blot and immunodetection using a specific opsin-antibody (Adamus et al., 1991). 
 
Microsome integration assay using puromycin 
First, LRRC50-opsin or emerin-opsin were produced in rabbit reticulocyte lysate supplemented 
with the plasmids pET328-HZZ-LRRC59-opsin or pET328-HZZ-emerin-opsin (figure 9A). This 
transcription/translation reaction was highly specific, as no product could be detected if no DNA was 
added to the reaction. Upon the addition of rough microsomes (RM), an additional slower migrating band 
could be observed for LRRC59-opsin and emerin-opsin in the immunoblotting. This slower migrating 
protein represents the N-linked glycosylated form of opsin-tagged LRRC59 or emerin after insertion into 
microsomes, as the opsin-tag is specifically modified in the microsomal lumen. To confirm that the 
additional band is a result of glycosylation of the opsin-tag, 25% of an insertion reaction of LRRC59-
opsin was treated with the deglycosylation enzyme PNGase F. This treatment resulted in the loss of the 
additional band, showing the specific glycosylation of the opsin tag upon membrane insertion (figure 
9C). When puromycin, a translation-inhibitor, was added to the transcription/translation reaction before 
addition of rough microsomes, LRRC59-opsin and emerin-opsin could still be inserted (figure 9A and 
B). This indicates that both proteins insert post-translationally into microsomal membranes. As a positive 
control for the inhibitory effect of puromycin, the experiment was carried out with addition of the drug to 
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the transcription/translation reaction of LRRC59-opsin and emerin-opsin at time point 0 minutes. In 
these reactions, no production of LRRC59-opsin or emerin-opsin could be observed, showing the 
efficiency of the drug.  
 
 
Figure 9: LRRC59 is post-translationally inserted into rough microsomes. 
(A) LRRC59 and emerin tagged by opsin (HZZ-LRRC59-op, HZZ-emerin-op) were produced in vitro 
by coupled transcription/translation reactions. As indicated in the figure, the reaction took place in the 
presence (+) or absence (-) of rough microsomes (RM) and the translation inhibitor puromycin. After 
SDS-PAGE and Western blotting, the glycosylation of the opsin-tag was analyzed by immunoblotting 
using antibodies against opsin and calnexin as loading control. HZZ-LRRC59/emerin-op G indicates 
the glycosylated forms of the proteins. (B) Quantification of the experimental results of (A). The mean 
and the standard deviation were calculated from six individual experiments. (C) Test for N-linked 
glycosylation of HZZ-LRRC59-op G. Treatment with PNGase F or buffer of in vitro produced protein 
as described in (A) prior to SDS-PAGE, Western blot and immunodetection analysis using antibodies 
against opsin and calnexin as loading control. See also Blenski and Kehlenbach, 2019. 
 
 
Microsome integration assay using trypsin-treated microsomes 
Some proteins, such as cytochrome b5, can insert spontaneously into membranes without the 
involvement of a receptor (Favaloro et al., 2008; Stefanovic and Hegde, 2007; Colombo et al., 2009; 
Rabu et al., 2009). To examine this possibility for LRRC59, the microsome integration assay was 
performed as described above but with trypsin- (T-RM) (Favaloro et al., 2010) or high salt/EDTA- (EK-
RM) treated microsomes (figure 10). The treatment of rough microsomes with trypsin removes receptor 
proteins inserted in the membrane, while the control treatment with high salt/EDTA leads to the removal 
of peripherally attached proteins. As shown in figure 10B, the receptor protein CAML was removed upon 
the treatment of rough microsomes with trypsin. For both, LRRC59-opsin and emerin-opsin, no 
membrane insertion was observed with trypsin-treated microsomes (figure 10A), while 
cytochrome b5-opsin was still able to insert (figure 10C). This result indicates that LRRC59 cannot insert 
into membranes independently of a receptor protein. Emerin, which is known to insert into the 
ER-membrane via the TRC pathway using the receptors WRB and CAML (Pfaff et al., 2016), served as 




Figure 10: LRRC59 is inserted in a receptor-dependent manner. 
(A) The in vitro produced HZZ-LRRC59-op or HZZ-emerin-op were tested for membrane insertion 
into EDTA/high-salt (EK-RM) or trypsin-treated (T-RM) rough microsomes in the presence (+) or 
absence (-) of puromycin. After separation in SDS-PAGE, the proteins were analyzed by 
immunoblotting with opsin- and PDI- (loading control) antibodies. HZZ-LRRC59/emerin-op G 
represents the glycosylated forms of the proteins. (B) For comparison, EK-RM or T-RM were mixed 
with SDS sample buffer and analyzed by SDS-PAGE, Western blotting and immunodetection using 
antibodies against CAML or PDI as loading control. (C) After production in an in vitro 
transcription/translation reaction, HZZ-cytochrome b5-opsin was incubated with EK-RM or T-RM in 
the presence (+) or absence (-) of puromycin. HZZ-cytochrome b5-op G indicates the glycosylated 
form of the protein. Protein analysis was performed by SDS-PAGE prior to Western blotting and 
immunodetection with antibodies against the opsin-tag and PDI as loading control. See also Blenski 
and Kehlenbach, 2019. 
 
 
3.1.2 Examination of involvement of the TRC pathway in LRRC59 ER-membrane 
insertion 
As LRRC59 was shown to insert into membranes post-translationally in a receptor-dependent 
manner, the potential involvement of the TRC pathway for LRRC59 membrane insertion was further 
examined.  
 
Microsome integration assays using dominant negative inhibitory fragments of WRB and CAML 
First, the dependency of membrane insertion of LRRC59 on the heteromultimeric receptors WRB 
and CAML of the TRC pathway was studied.  
Pfaff et al. (2016) showed an inhibitory effect for membrane insertion for emerin upon the addition 
of the dominant negative inhibitory fragments GST-CAML-N or MBP-WRBcc in microsome integration 
assays. To study the effect on LRRC59, 5 µM or 10 µM of GST-CAML-N (figure 11A) or MBP-WRBcc 
(figure 11B) were added after 90 minutes of in vitro transcription and translation reaction prior to the 
addition of rough microsomes. For emerin, already the presence of 5 µM of the dominant negative 
inhibitory fragments resulted in a total loss of membrane insertion. Further experiments showed that the 
addition of only 1 µM or 3 µM of GST-CAML-N or MBP-WRBcc affected emerin membrane insertion 
(data not shown). The insertion of LRRC59 into rough microsomes was not affected at all by the addition 
of the dominant negative inhibitory fragments, not even with 10 µM of receptor fragments. This result 





Figure 11: WRB and CAML, the TRC pathway receptors, are not required for LRRC59 
microsome insertion. 
(A) HZZ-LRRC59-op or emerin-op were produced in an in vitro transcription/translation reaction 
followed by incubation with rough microsomes (RM) without (-) or with 5 or 10 µM of GST-CAML-N. 
Proteins were analyzed by SDS-PAGE, Western blotting and immunodetection using antibodies 
against the opsin-tag and calnexin as loading control. In this experiment, the emerin-construct lacks 
the HZZ-tag at the N-terminus. HZZ-LRRC59-op G and emerin-op G mark the glycosylated form of 
the proteins. (B) Experimental implementation as (A) using MBP-WRBcc instead of GST-CAML-N. 




Microsome integration assay using TRC40-immunodepleted lysate 
The involvement of TRC40 itself in the membrane insertion mechanism of LRRC59 was studied 
by the performance of microsome integration assays using TRC40 immunodepleted rabbit reticulocyte 
lysate (figure 12). The reticulocyte lysate was depleted using an antibody against TRC40 (Favaloro et 
al., 2010) while rabbit IgG served as a control in mock-depletion. The extent of the depletion was 
controlled with reticulocyte lysate mixed with SDS sample buffer and analyzed by SDS-PAGE and 
immunoblotting using an alternative TRC40 antibody. Indeed, no TRC40 protein could be detected in 
the TRC40-depleted lysate, while a Ponceau S staining of the lysate showed equal loading and transfer 
of the proteins (figure 12C). Using this TRC40-immunodepleted reticulocyte lysate in the microsome 
integration assay, the membrane insertion of emerin was strongly inhibited to 11.5% ± 12.7 of the value 
obtained in the mock depleted reaction. For LRRC59, by contrast, only a modest inhibition to 80.9% ± 
11.5 was observed (figure 12A and B). This result of the microsome integration assay shows a clear 





Figure 12: TRC40 is not required for membrane insertion of LRRC59. 
(A) HZZ-LRRC59/emerin-op were produced by TRC40- or mock-depleted rabbit reticulocyte lysate 
and incubated with rough microsomes (RM). Proteins were analyzed with SDS-PAGE prior to 
Western blotting and immunodetection using antibodies against the opsin-tag and PDI, which served 
as a loading control. HZZ-LRRC59/emerin-op G indicates the glycosylated proteins. (B) 
Quantification of five individual experiments as described in (A). Individual values of the reactions 
with TRC40-depleted lysate were normalized to the reaction with mock-depleted lysate for each 
experiment. The diagram shows mean and standard deviation of these values. (C) Immunodepletion 
of the lysate using antibodies against TRC40 (+) or IgG (-) as control used in (A) was analyzed by 
SDS-PAGE and immunoblotting with antibodies against TRC40 (top) and Ponceau S staining 
(bottom). See also Blenski and Kehlenbach, 2019. 
 
 
Subcellular localization of emerin and LRRC59 in TRC40 D74E overexpressing cells 
TRC40 is the mammalian homolog of the S. cerevisiae ATPase Get3, which has an aspartic acid 
active site in position 57 (Mateja et al., 2009). In its TA protein bound form, Get3 is recruited to the 
membrane via its interaction with Get2 (the yeast homolog of CAML). Upon ATP hydrolysis and release 
of ADP, the TA protein is released from Get3 and is inserted into the ER-membrane by Get2 and Get1 
(the yeast homolog of WRB) (Shao and Hegde, 2011b; Yamamoto and Sakisaka, 2012; Hegde and 
Keenan, 2011). Mariappan and colleagues showed that Get3 is ATPase deficient upon the mutation of 
aspartic acid in position 57 to asparagine (Get3 D57N). This mutant was able to interact with the TA 
protein, but the release of the TA protein upon interaction with Get1/2 was not possible (Mariappan et 
al., 2011). When the aspartic acid was changed to glutamic acid (Get3 D57E), Get3 was also inhibited 
in its ATPase activity but bound to the TMD of TA proteins (Powis et al., 2013). TRC40 has its aspartic 
acid active site in amino acid position 74. It was shown, that the mutant TRC40 D74E is still able to bind 
to different TA proteins, but cannot release them due to its ATPase deficiency. This dominant negative 
mutant was used to trap TA proteins and analyze them by mass spectrometry to identify substrates 
which can use the TRC pathway for membrane insertion (Coy-Vergara et al., 2019). 
HeLa cells were transfected with plasmids coding for c-Myc-TRC40 WT and c-Myc-TRC40 D74E 
and immunostained for endogenous LRRC59 and emerin (figure 13). For LRRC59 and emerin, no 
difference in localization was observed in cells overexpressing c-Myc-TRC40 WT compared to non-
transfected cells. In both cases, LRRC59 localized to the ER and NE, while emerin mainly localized to 
the NE. In contrast to cells overexpressing c-Myc-TRC40 D74E, emerin showed a weaker NE-
localization but a diffuse staining in the cytoplasm. This result suggests that TRC40 D74E bound emerin, 
but could not release it for membrane insertion via the WRB and CAML receptors (also showed by Coy-
Vergara et al. (2019)). However, for LRRC59 no difference in localization could be observed in non-




Figure 13: TRC40 D74E inhibits the ER-membrane insertion of emerin but does not seem to 
affect LRRC59. 
HeLa cells were transfected with 1.5 µg of plasmids coding for c-Myc-TRC40 WT or c-Myc-
TRC40 D74E. After 48 hours, cells were fixed and immunostained using antibodies against c-Myc 
and LRRC59 or emerin for confocal microscopy analysis. DAPI marked the nucleic acids in 
fluorescence microscopy. 
 
The results of the microsome integration assay using TRC40 immunodepleted rabbit reticulocyte 
lysate and the overexpression of the TRC40 ATPase deficient mutant showing no effect for LRRC59 
but for emerin indicate differences in the insertion mechanism of both TA proteins. Further examination 




3.2 Inner nuclear membrane targeting of LRRC59 
The mammalian protein LRRC59 was suggested to dependent on importin  for its NE localization 
(Zhen et al., 2012). The treatment of U2OS cells with importin  siRNAs resulted in a loss of NE 
localization of endogenous LRRC59. As a dependency on transport factors and the Ran GTPase cycle 
for INM targeting could - so far - just be shown for the S. cerevisiae proteins Heh1 and Heh2 (King et 
al., 2006), the INM targeting of LRRC59 was studied in detail.  
 
3.2.1 Subcellular localization of endogenous and overexpressed LRRC59 
LRRC59 has previously been shown to localize to the ER-membrane and the NE (Zhen et al., 
2012). First, the localization of endogenous LRRC59 in HeLa cells was examined by immunostaining 
(figure 14A). The specificity of the LRRC59-antibody was confirmed in HeLa cells treated with LRRC59 
siRNAs, resulting in a reduction of the signal for LRRC59 in comparison to control knockdown cells 
(figure S 1). Endogenous LRRC59 localized to the ER and the NE. The NE localization of LRRC59 was 
indicated by a rim around the nucleus, similar to the localization of lamin A/C, which are proteins 
peripherally attached to the INM (figure 14A). To examine, whether LRRC59 is mainly membrane-
inserted, HeLa cells were semi-permeabilized using digitonin, which permeabilizes the plasma 
membrane but leaves intracellular membranes intact. Due to digitonin treatment, soluble proteins of the 
cytoplasm can be washed out of the cell by several washing steps. The digitonin treatment was done 
for HeLa cells growing on coverslips, followed by immunostaining of LRRC59 (figure S 2A). No 
difference in LRRC59 staining could be observed between cells treated with digitonin or buffer as a 
control. Importin  was located in the cytoplasm and at the nuclear membrane in cells incubated with 
buffer. The localization to the NE is due to the interaction of importin  with the NPC. Upon the treatment 
with digitonin, however, cytoplasmic importin  is washed out, serving as the control for permeabilization 
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of cells. Additionally, HeLa cells detached from the cell culture dish were permeabilized using digitonin 
(figure S 2B). The cells were collected by centrifugation to separate soluble cytoplasmic proteins in the 
supernatant from membranes and membrane-inserted proteins in the pellet. The supernatant and the 
pellet were analyzed for LRRC59 by SDS-PAGE and Western blotting. In the insoluble fraction, LRRC59 
and the ER-membrane protein calnexin could be detected. LRRC59 could not be detected in the 
supernatant, which contained soluble proteins of the cytoplasm like alpha-tubulin. This suggests that 
the major proportion of LRRC59 in HeLa cells was membrane bound and not soluble. 
The localization of overexpressed LRRC59 tagged with HA, mCherry or mCherry-FRB was 
analyzed in HeLa cells. All three, HA-LRRC59, mCherry-LRRC59 and mCherry-FRB-LRRC59 showed 
a similar localization to the ER and the NE as endogenous LRRC59 (figure 14B). 
 
 
Figure 14: Endogenous or overexpressed LRRC59 localizes to the NE. 
(A) For immunofluorescence staining, HeLa cells were grown on coverslips and analyzed with 
LRRC59- and lamin A/C-antibodies. (B) HeLa cells were transiently transfected for 48 hours with 
0.7 µg of plasmids coding for HA-LRRC59, mCherry-LRRC59 and mCherry-FRB-LRRC59. After 
fixation, the cells were analyzed directly for mCherry-tagged LRRC59 by confocal microscopy or after 
immunofluorescence staining using antibodies against HA. DAPI marked the nucleic acids in 
fluorescence microscopy. See also Blenski and Kehlenbach, 2019. 
 
Endogenous LRRC59 was shown to localize to the ER and the NE and is associated with the 
membrane. The overexpressed protein of differently tagged LRRC59 showed identical localization. 
 
3.2.2 Analysis of inner nuclear membrane localization of LRRC59 
With endogenous staining or overexpressed LRRC59, a NE localization could be seen with 
confocal microscopy. This experimental setup does not discriminate between the localization to the 
ONM and/or INM. By using a combination of single-point illumination with single-molecule fluorescence 
recovery after photobleaching (smFRAP), Mudumbi and colleagues could show the localization of 
nuclear membrane proteins to the INM or ONM with a resolution of <10 nm (Mudumbi et al., 2016). 
Metal-induced energy transfer (MIET) examined the axial distance between the ONM and INM using 
the INM protein LAP2 (lamina-associated polypeptide 2) and the NPC protein Nup358, which faces 
the cytoplasm (Chizhik et al., 2017). By immunoelectron microscopy, localization of a protein to the INM 
or ONM is possible, but requires specific antibodies and complex fixation protocols (Yokoyama et al., 
1995; Cordes et al., 1997). In general, these super-resolution methods are complex in experimental 
implementation and technical equipment. Therefore, a fluorescence microscopy based experimental 
approach was established by Dr. Janine Pfaff in the laboratory of Prof. Dr. Ralph H. Kehlenbach (Pfaff 
et al., 2016) to indicate the localization of a membrane protein to the INM. The presence in the INM of 
the protein of interest is shown by a clear change in the subcellular localization of a nuclear reporter 
upon addition of rapamycin. 
 
Rapamycin, discovered first in 1975 by Vézina C. (1975) and further analyzed by Singh et al. 
(1979), is a cell permeable antifungal antibiotic produced by Streptomyces hygroscopicus. Rapamycin 
inhibits the lymphokine-dependent proliferation in a moderate way by inhibition of the G1 progression in 
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the cell cycle and binds with a high affinity (dissociation constant Kd = 0.2 nM) to FK506 binding protein 
FKBP (Bierer et al., 1990), later named FKBP12 (12 kDa FK506/rapamycin-binding protein). This 
interaction became interesting for several groups trying to identify rapamycin binding proteins. In yeast-
two-hybrid screens, the kinase mTOR or FRAP (FKBP12-rapamycin associated protein) could be 
identified as a binding partner of FKBP12/rapamycin (Chiu et al., 1994; Brown et al., 1994; Sabatini et 
al., 1994; Stan et al., 1994). Within FRAP, a 11 kDa FKBP12-rapamycin binding domain could be 
identified (Chen et al., 1995). This binding domain, later referred to as the FRB (FKBP12-rapamycin-
binding) domain, was further characterized by crystal structure analysis. Rapamycin was shown to bind 
FRB and FKBP12 at the same time via two different hydrophobic pockets, while FRB and FKBP12 are 
not able to interact among themselves in the absence of rapamycin (Choi et al., 1996). Furthermore, it 
was shown that FKBP12 binds to rapamycin first due to their high binding affinity, followed by the binding 
to FRB (Liang et al., 1999; Banaszynski et al., 2005). 
 
The rapamycin-induced dimerization assay 
As the dimerization of FRB and FKBP12 in the presence of rapamycin was well established and 
the binding reaction is specific, the inducible interaction has been used for several experimental 
approaches addressing localization and targeting questions within the cell. Klemm et al. (1997), for 
instance, identified an NES within NF-ATc by the localization change of a nuclear reporter to the 
cytoplasm. Upon the addition of rapamycin, the nuclear reporter Gal4-NLS-FKBP123 was bound to the 
potential FRB-tagged NF-ATc NES, resulting in the export of the whole complex from the nucleus into 
the cytoplasm. Later, Ohba and colleagues used the dimerization of FRB with FKBP12 in the presence 
of rapamycin to analyze the movement of some membrane proteins from the ONM to the INM in a live 
cell-based assay. Therefore, they established several FRB and GFP tagged reporters, which 
accumulate upon the addition of rapamycin within the INM due to binding to a nuclear protein trap tagged 
with FKBP12. With this approach, they could show a size-dependency in INM targeting for the 
cytoplasmic domains of their artificial reporters (Ohba et al., 2004). In their “anchor-away technique”, 
Haruki and colleagues used the rapamycin-based dimerization of FRB and FKBP12 to establish a 
depletion system in S. cerevisiae to deplete proteins from the nucleus (Haruki et al., 2008). Lastly, Pfaff 
et al. (2016) established a rapamycin-based dimerization assay for the identification of INM proteins, 
which is used with adaptions in this thesis. 
 
To observe INM localization of a TMD-containing protein by usage of the rapamycin-induced 
dimerization assay, HeLa cells were transiently transfected with plasmids coding for the reporter EGFP2-
GST-M9-FKBP12 and the membrane protein of interest, LRRC59, tagged with mCherry-FRB at its 
N-terminus (figure 15A). Both proteins were overexpressed for 48 hours. The soluble reporter EGFP2-
GST-M9-FKBP12 localized in the nucleus due to nuclear import of the M9 sequence by transportin 
(Pollard et al., 1996). The reporter contained the FKBP12 domain, which made the dimerization with 
FRB upon rapamycin addition possible. Additionally, it contained two EGFP- and a GST-tag(s) resulting 
in a total molecular mass of 99 kDa. As GST is known to dimerize (Bell et al., 2013), EGFP2-GST-M9-
FKBP12 probably assembles into dimers of 198 kDa, which should be trapped in the nucleus. The 
membrane protein of interest, LRRC59, was N-terminally tagged with the FRB domain and the 
fluorescent tag mCherry. As shown before, mCherry-FRB-LRRC59 is located at the ER-membrane and 
at the NE (figure 14B, and 15B). If mCherry-FRB-LRRC59 is located at the INM, the soluble reporter 
EGFP2-GST-M9-FKBP12 will be recruited from its localization all over the nucleus to the NE in the 
presence of rapamycin (figure 15A). The reporter EGFP2-GST-M9-FKBP12 was located in the nucleus 
in the rapamycin-induced dimerization assay in the absence of rapamycin. In mCherry-FRB-LRRC59 
overexpressing cells incubated with 200 nM rapamycin for 10 minutes, a recruitment of the reporter to 
the NE resulting in a green rim was observable, while the reporter did not localize to the center of the 
nucleus (figure 15B). This result indicates that mCherry-FRB-LRRC59 is located in the INM. For emerin, 
a well-studied INM protein, the reporter was also recruited to the NE upon the addition of rapamycin, 
confirming the INM localization of emerin (figure 15B). Additionally, WRB, one of the two membrane 
receptors of the TRC pathway, was examined for INM localization with this approach. As the C-terminus 
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of WRB is facing the cytoplasm, the protein was tagged C-terminally with FRB and HA. WRB-FRB-HA 
was localized to the ER and in a rim at the NE, but the localization of the nuclear reporter was not 
changed by the addition of rapamycin (figure 15B). When the incubation time with rapamycin was 
increased to 30 minutes, the reporter did still not show any recruitment to the NE in WRB-FRB-HA 
overexpressing cells (figure S 3). This indicates that WRB-FRB-HA is a protein of the ER and ONM and 
is not located in the INM. Therefore, this protein serves as a negative control for this assay (figure 15B).  
For mCherry-FRB-LRRC59 expressing cells, the reporter recruitment to the NE was comparable 
for 10 and 30 minutes of rapamycin treatment. Also, for the increased incubation time, when mCherry-
FRB-LRRC59 reached the INM, it was bound by rapamycin/EGFP2-GST-M9-FKBP12 and the complex 
got trapped in the nucleus. It can be excluded that the complex left the nucleus as the reporter retained 
in the nucleus and was not distributed in the cytoplasm (figure S 3). 
 
 
Figure 15: Rapamycin-induced dimerization assay confirms the INM localization of LRRC59. 
(A) The scheme gives an overview of the rapamycin-induced dimerization assay. Cells are transiently 
transfected with plasmids coding for the protein of interest tagged with mCherry and FRB (red) and 
the nuclear reporter EGFP2-GST-M9-FKBP12 (green). Upon the addition of rapamycin (orange 
hexagon) the FRB- and FKBP12-domains dimerize which leads to a recruitment of the reporter to the 
NE, if the protein of interest locates to the INM. (B) HeLa cells were transiently transfected with 
constructs coding for the proteins mCherry-FRB-LRRC59, mCherry-FRB-emerin and WRB-FRB-HA, 
respectively, and EGFP2-GST-M9-FKBP12. After the treatment of the cells with (+) or without (-) 
rapamycin for 10 minutes, the cells were fixed and analyzed directly for mCherry-tagged proteins or 
after immunofluorescence using antibodies against HA (WRB-FRB-HA). DAPI marked the nucleic 
acids in fluorescence microscopy. For analysis, confocal microscopy was performed. See also 
Blenski and Kehlenbach, 2019. 
 
The rapamycin-induced dimerization assay identified LRRC59 as a protein of the INM and is a 
robust and reliable approach to examine the INM localization of LRRC59 and other membrane proteins 







Analysis of binding of INM-localized LRRC59 to lamin A/C 
The localization of emerin to the INM was shown to depend on its binding partner lamin A/C 
(Vaughan et al., 2001). As LRRC59 was identified as an INM protein by the rapamycin-induced 
dimerization assay, it is unclear whether LRRC59 located at the INM is also bound by lamin A/C. HeLa 
cells were transfected with siRNAs targeting lamin A/C, fixed and immunostained using antibodies 
against lamin A/C, LRRC59 or emerin. The efficiency of the knockdown was assessed by microscopic 
(figure 16A) and Western blot analysis (figure 16B). In control depletion cells, emerin was mainly located 
at the NE, while a knockdown of lamin A/C resulted in a diffuser localization of emerin to the ER with a 
signal decrease at the NE. This indicates a loss of INM localization of emerin, as it could not bind to 
lamin A/C for anchoring. LRRC59 localized in control knockdown cells to the ER and the NE. This 
localization pattern was not changed upon siRNA mediated knockdown of lamin A/C (figure 16A). This 
result suggests that LRRC59 does not require lamin A/C-binding for its INM localization. 
 
 
Figure 16: Knockdown of lamin A/C does not affect the NE localization of LRRC59. 
(A) HeLa cells were treated with control siRNAs or siRNAs against lamin A/C, fixed after 48 hours 
and analyzed by indirect immunofluorescence detecting lamin A/C and LRRC59 (left) or emerin 
(right). DAPI marked the nucleic acids in fluorescence microscopy. Cells were analyzed by confocal 
microscopy. (B) Cells were treated as in (A) and analyzed by SDS-PAGE followed by Western blotting 
and immunodetection of lamin A/C and alpha tubulin. The mean and the standard deviation of 
normalized lamin A/C levels of seven experiments are indicated. For values see table S 1. 
 
3.2.3 Importin  is not required for inner nuclear membrane targeting of LRRC59 
It has previously been suggested that the INM targeting of LRRC59 depends on the transport 
factor importin . This was based on the observation that the NE localization of endogenous LRRC59 
was lost in U2OS cells treated with siRNAs against importin  (Zhen et al., 2012). In this thesis, this 
observation was re-examined.  
 
NE localization of LRRC59 in importin  knockdown U2OS cells  
First, U2OS cells were transiently transfected with two siRNAs against importin  for 48 hours. 
The cells were fixed and immunostained with an antibody against LRRC59. Cells grown on different 
coverslips, but treated with the identical transfection solution, were fixed and immunostained with an 
antibody against importin . As the LRRC59- and the importin -antibodies were both raised in rabbits, 
the staining could not be performed in the same cells. As shown in figure 17, importin  knockdown was 
successful. The efficiency of the knockdown was also confirmed by Western blot analysis of cell lysate 
(figure S 4A, table S 2). In control knockdown cells, LRRC59 was located mainly to the ER and to a rim 
at the NE, as shown in HeLa cells before (figure 14A). In importin  knockdown cells, no difference in 
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the localization of LRRC59 could be observed (figure 17). This result does not suggest an importin -
dependent NE localization of LRRC59. 
 
 
Figure 17: Knockdown of importin  has no effect on NE localization of LRRC59 in U2OS cells. 
U2OS cells were treated with control or importin  siRNAs. After 48 hours, cells were analyzed by 
indirect immunofluorescence using antibodies against LRRC59 or, on separate coverslips, 
importin . See also Blenski and Kehlenbach, 2019. 
 
Rapamycin-induced dimerization assay in importin  siRNA treated cells 
Next, the rapamycin-induced dimerization assay was performed to clarify whether the INM 
targeting of LRRC59 is affected by an importin  knockdown. 
HeLa cells were transiently transfected with siRNAs against importin  and the plasmids coding 
for EGFP2-GST-M9-FKBP12, mCherry-FRB-LRRC59 and NES-mTagBFP2-cNLS. The protein NES-
mTagBFP2-cNLS is a blue fluorescent protein with an N-terminal nuclear export signal (NES) and a 
C-terminal classical nuclear localization signal (cNLS). A soluble protein containing a cNLS is 
transported into the nucleus by the importin /importin  pathway. In control siRNA treated cells, NES-
mTagBFP2-cNLS was located in the nucleus while its localization was shifted to the cytoplasm in 
importin  knockdown cells (figure 18A). The transfection of cells for the rapamycin-induced dimerization 
assay with the additional construct coding for NES-mTagBFP2-cNLS has two advantages. First, the 
efficiency of the importin  knockdown could not only be observed by an importin  immunostaining 
(figure 18A), but also by a shift of NES-mTagBFP2-cNLS from the nucleus to the cytoplasm. Second, 
importin  was rate limiting for nucleocytoplasmic transport in importin  knockdown cells. The 
remaining importin  targeted the in excess available cNLS-containing protein to the nucleus. 
Additionally, the efficiency of the importin  knockdown was controlled by immunostaining of importin  
(figure 18A) and Western blot analysis of the cell lysate (figure S 4B). 
The reporter EGFP2-GST-M9-FKBP12 used in the rapamycin-induced dimerization assay 
contained the nuclear localization signal M9. Proteins containing a M9 sequence are targeted to the 
nucleus by the transport factor transportin (Pollard et al., 1996). Therefore, the nuclear localization of 
the reporter was not affected by the importin  knockdown (figure 18A). The original used reporter 
EGFP2-GST-cNLS-FKBP12 of Pfaff et al. (2016) is dependent on the importin /importin  pathway and 
therefore could not be used in importin  knockdown cells.  
The protein mCherry-FRB-LRRC59 was located to the ER and NE in control and importin  siRNA 
treated cells (figure 18A). After 10 minutes of rapamycin treatment, the reporter was recruited to the NE 
in cells of control knockdown, as well as importin  siRNA treated cells (figure 18A). After 10 minutes of 
drug incubation, no dependency of INM localization of LRRC59 on importin  could be observed. As 
differences might only be observable in cells with a shorter incubation time with rapamycin, the 
rapamycin-induced dimerization assay was performed with drug treatment for 1, 1.5, 2, 2.5, 3, 4 and 
10 minutes. At least 100 cells per condition and experiment were analyzed with respect to the reporter 
response. The mean of the responding cells in percent and the standard deviation of 500 (incubation 
time 1-4 minutes) and 1850 (10 minutes) analyzed cells were plotted against the incubation time (figure 
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18B, table S 4). After 1 minute of rapamycin treatment, the reporter of 63% ± 5.7 of control siRNA treated 
cells was recruited to the NE. With the extension of rapamycin addition, more cells responded with a 
reporter recruitment to the NE until a plateau of 91.2% ± 4.4 responding cells was reached after 
3 minutes. For cells treated with siRNA against importin , the values of rapamycin responding cells 
were nearly identical to those of cells treated with control siRNA. This result shows that there is no 
difference in INM targeting of LRRC59 in importin  knockdown cells compared to control siRNA 
treatment. LRRC59 reaches the INM independently of importin . Nuclear import of NES-mTagBFP2-
cNLS by contrast was clearly affected by the importin  depletion.  
 
 
Figure 18: The INM-targeting of LRRC59 is not dependent on importin . 
(A) HeLa cells were transfected with control or importin  siRNAs and plasmids coding for mCherry-
FRB-LRRC59, EGFP2-GST-M9-FKBP12 and NES-mTagBFP2-cNLS. After 48 hours, cells were 
incubated with rapamycin at room temperature for 10 minutes and fixed. After immunostaining using 
antibodies against importin , the cells were analyzed by confocal microscopy. DAPI marked the 
nucleic acids in fluorescence microscopy. (B) Quantification of experiments as in (A) with rapamycin 








Rapamycin-induced dimerization assay in cells expressing Bimax2 
To validate this result in a different experimental setup, the rapamycin-induced dimerization assay 
was performed by simultaneously overexpression of the plasmid pcDNA3-FLAG-Bimax2 (figure 19A) 
and the constructs used for the assay before. Bimax2 is a peptide sequence, which inhibits the 
importin /importin  nuclear import pathway (Kosugi et al., 2008). This peptide inhibitor binds with a 
very high affinity to importin . As importin  bound to Bimax2 can still assemble a complex together 
with importin , this complex is imported into the nucleus. Due to the tight binding of Bimax2 to 
importin , however, the cargo Bimax2 cannot be released from importin . As importin  is only 
exported from the nucleus in a cargo-unbound from, Bimax2-importin  accumulates in the nucleus and 
cannot be recycled for its contribution to the importin /importin  import machinery (Kosugi et al., 2008). 
As shown in figure 19A, NES-mTagBFP2-cNLS was shifted from the nucleus to the cytoplasm in cells 
expressing FLAG-Bimax2 compared to cells transfected with the control plasmid pcDNA3. This indicates 
the inhibition of the importin /importin  import pathway by Bimax2. For the quantification of the 
rapamycin-induced dimerization assay, cells showing a shift of NES-mTagBFP2-cNLS to the cytoplasm 
were analyzed for NE recruitment of the reporter EGFP2-GST-M9-FKBP12 after 10 minutes of 
rapamycin treatment. No difference in rapamycin-response of FLAG-Bimax2-expressing cells could be 
observed compared to cells transfected with the control plasmid pcDNA3 (figure 19A and B). This result 




Figure 19: Overexpression of Bimax2 does not influence the nuclear localization of LRRC59. 
(A) HeLa cells were transiently transfected with plasmids coding for mCherry-FRB-LRRC59, EGFP2-
GST-M9-FKBP12, NES-mTagBFP2-cNLS and FLAG-Bimax2 or with the plasmid pcDNA3 as control, 
respectively. Cells were incubated with rapamycin for 10 minutes prior to fixation and 
immunofluorescence staining using antibodies against the FLAG-tag. Cells were analyzed by 
confocal microscopy. DAPI marked the nucleic acids in fluorescence microscopy. (B) Quantification 
of the rapamycin-induced dimerization assay as described in (B). Diagram contains the mean of the 
percentage of rapamycin responding cells and the standard deviation of three individual experiments, 






Analysis of nuclear targeting of LRRC59 lacking the TMD 
The nuclear transport of a protein mediated by the importin /importin  pathway requires a 
targeting sequence. If LRRC59 is targeted to the INM in an importin  dependent manner as claimed by 
Zhen et al. (2012), the cytoplasmic domain of LRRC59 should have a targeting sequence for nuclear 
import. To examine the cytoplasmic part of LRRC59 for a potential NLS, the amino acids 1-244 before 
the TMD were cloned into an EGFP containing plasmid resulting in the plasmid pEGFP-LRRC59 
aa1-244. The protein EGFP-LRRC59 aa1-244 was overexpressed in cells treated with control or 
importin  siRNAs. The efficiency of the importin  knockdown was controlled by immunostaining (figure 
20A) or immunoblotting of cell lysate (figure 20B). In control knockdown cells, EGFP-LRRC59 aa1-244 
localized to the nucleus but not in the cytoplasm. The same localization pattern was observed in cells 
treated with importin  siRNAs. This result points to an importin -independent localization of soluble 
EGFP-LRRC59 aa1-244 to the nucleus. To distinguish between active, transport factor-mediated 
transport and nuclear retention after passive diffusion, the molecular mass of LRRC59 aa1-244 was 
increased by a second EGFP and a GST-tag in the construct pEGFP2-GST-LRRC59 aa1-244. With 
these additional tags, the molecular mass of the overexpressed protein was increased from 55.5 kDa 
(EGFP-LRRC59 aa1-244) to 109.3 kDa of EGFP2-GST-LRRC59 aa1-244. In addition, the GST-tag 
leads to dimerization (Bell et al., 2013) of EGFP2-GST-LRRC59 resulting in dimers of 218.6 kDa. If a 
soluble protein containing an NLS is targeted to the nucleus by the importin /importin  pathway, the 
size of the protein should – to a certain degree – not matter for the import machinery. However, EGFP2-
GST-LRRC59 aa1-244 was exclusively localized to the cytoplasm (figure 20C), excluding an active 
transport mechanism. This indicates that EGFP-LRRC59 aa1-244 reached the nucleus by diffusion 
because of its small molecular mass. To exclude that the localization of EGFP2-GST-LRRC59 aa1-244 
could be caused by the EGFP2-GST tag itself, the localization of EGFP2-GST-cNLS was analyzed 
compared to EGFP-cNLS (figure S 5). EGFP-cNLS localized exclusively to the nucleus, comparable to 
EGFP-LRRC59 aa1-244. While EGFP2-GST-LRRC59 aa1-244 was not targeted to the nucleus at all 
and localized only in the cytoplasm, EGFP2-GST-cNLS was mainly found in the nucleus with a weak 
signal in the cytoplasm. This indicates that the tag EGFP2-GST influenced the localization of cNLS in a 
weak manner, but was not the reason for the exclusive cytoplasmic localization of EGFP2-GST-LRRC59 
aa1-244. The size of this LRRC59 protein seems to be too large to diffuse into the nucleus compared 
to EGFP-LRRC59 aa1-244. These results show that the cytoplasmic domain of LRRC59 does not 
contain a nuclear targeting sequence, which could be bound and imported by the importin /importin  
pathway or by any other transport factor. 
 
 
Figure 20: Importin  does not mediate active nuclear import of LRRC59 lacking the TMD. 
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(A) HeLa cells were transiently transfected with 0.7 µg of plasmid coding for EGFP-LRRC59 aa1-244 
and control or importin  siRNAs. After 48 hours, cells were fixed, indirectly immunostained using 
antibodies against importin  and analyzed by confocal microscopy. (B) Cell lysate of (A) was 
analyzed by SDS-PAGE and immunoblotting using antibodies against importin  and alpha tubulin. 
The signal of alpha tubulin served for the normalization of the importin  level. (C) HeLa cells 
overexpressed 0.7 µg of the plasmid coding for EGFP2-GST-LRRC59 aa1-244 for 48 hours prior to 
fixation and analysis by confocal microscopy. DAPI marked the nucleic acids in fluorescence 
microscopy. See also Blenski and Kehlenbach, 2019. 
 
Together, no active transport of LRRC59 to the INM via importin  could be shown. In addition, 
no importin /importin - or importin -dependent NLS could be found in the cytoplasmic domain of 
LRRC59. All these results do not point to an importin /importin  mediated INM targeting of LRRC59. 
 
 
3.2.4 Size dependency of inner nuclear membrane targeting of LRRC59 on the 
extraluminal domain 
In the literature, two main models for membrane protein targeting to the INM are discussed. In 
addition to the model of INM targeting of membrane proteins by transport factors, a mechanism by 
diffusion to and retention at the INM is suggested. In this model, a membrane protein is supposed to 
diffuse freely from the ER-membrane to the ONM and then to the INM by passing though the NPC via 
peripheral channels. The NPC seems to have a size limitation for the passage of cytoplasmic domains 
of membrane proteins dictated by the peripheral channel width. After the INM has been reached, the 
INM protein could bind to lamins or chromatin using a binding domain in order to remain in the INM, 
which could lead to a concentration difference between the INM and the ONM (Katta et al., 2014). 
 
For LRRC59, an active transport mechanism using an importin /importin - or importin -
dependent pathway could not be shown. To examine whether a diffusion-dependent INM targeting 
mechanism could apply to LRRC59, the size of the cytoplasmic domain of the proteins used in the 
rapamycin-induced dimerization assay was changed. The cytoplasmic/nucleoplasmic domain of 
endogenous LRRC59 has a molecular mass of 27.8 kDa. As the FRB domain is necessary for the 
rapamycin-induced dimerization assay, this tag had to be cloned into all used constructs for this 
experimental approach. In addition, the 1.08 kDa small human influenza hemagglutinin (HA)-tag was 
added to FRB-LRRC59 at the N-terminus to create a protein with a small cytoplasmic domain of 
40.8 kDa (HA-FRB-LRRC59). Furthermore, the extraluminal domain was increased in size by adding 
an MBP-tag between the FRB-tag and the LRRC59 sequence of the pmCherry-FRB-LRRC59 construct 
creating a plasmid coding for mCherry-FRB-MBP-LRRC59 (cytoplasmic domain: 107.5 kDa, figure 
21A). These three constructs were used for a rapamycin-induced dimerization assay with rapamycin 
incubation times of 1, 1.5, 2, 2.5, 3, 4 and 10 minutes. mCherry-FRB-LRRC59, HA-FRB-LRRC59 and 
mCherry-FRB-MBP-LRRC59 similarly located to the ER and the NE (figure 21B). The reporter EGFP2-
GST-M9-FKBP12 was recruited to the NE upon rapamycin treatment in the majority of cells 
overexpressing mCherry-FRB-LRRC59 and HA-FRB-LRRC59, respectively. After 3 minutes of 
rapamycin incubation, a plateau of approximately 92% of rapamycin-responding cells was reached for 
these two proteins. The values of rapamycin-responding cells of mCherry-FRB-LRRC59 and HA-FRB-
LRRC59 overexpressing cells were almost identical for the examined rapamycin incubation times. For 
mCherry-FRB-MBP-LRRC59, however, only 52.3% ± 6.3 of the cells responded with a reporter 
recruitment to the NE after 10 minutes of rapamycin treatment. For rapamycin incubation times of 1-
10 minutes, a reduction of around 40% for the number of rapamycin-responding cells was observed for 
cells overexpressing mCherry-FRB-MBP-LRRC59 compared to the proteins with smaller cytoplasmic 
domains (figure 21C). 
The reduction of the cytoplasmic domain from 65.8 kDa of mCherry-FRB-LRRC59 to 40.8 kDa of 
HA-FRB-LRRC59 did not influence the fast recruitment of the reporter to the NE, confirming the INM 
localization of both proteins. The increase of the cytoplasmic domain by 41.7 kDa (mCherry-FRB-
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LRRC59 compared to mCherry-FRB-MBP-LRRC59), however, reduced the INM localization by 
approximately 40%.  
 
For the plasmid coding for mCherry-FRB-MBP-LRRC59, the MBP-tag was inserted without 
additional amino acids into pmCherry-FRB-LRRC59. This insertion could influence the agility of the tags 
to each other or the accessibility of FKBP12/rapamycin to the FRB-tag. This possibility was excluded 
by performing a rapamycin-induced dimerization assay with mCherry-FRB-MBP-LRRC59 containing 
flexible GGGGS-linker (Chen et al., 2013) between each tag and LRRC59. Cells overexpressing the 
linker-containing protein mCherry-FRB-MBP-LRRC59 showed an identical reduction in rapamycin-
responding cells as demonstrated in figure 21 (figure S6). This control experiment demonstrated that 
the reduction of the reporter recruitment to the NE in rapamycin-responding cells for mCherry-FRB-
MBP-LRRC59 was caused by the increase in the cytoplasmic domain. The dependency of INM targeting 
on the cytoplasmic size points to a diffusion mechanism for nuclear import of LRRC59. 
 
 
Figure 21: The size of the extraluminal region of LRRC59 affects targeting to the INM. 
(A) Schematic overview of LRRC59 proteins with different sizes of the cytoplasmic/nucleoplasmic 
region used together with the reporter EGFP2-GST-M9-FKBP12 in the rapamycin-induced 
dimerization assay. (B). The proteins mCherry-FRB-LRRC59, mCherry-FRB-MBP-LRRC59 and HA-
FRB-LRRC59, respectively, were expressed in HeLa cells together with EGFP2-GST-M9-FKBP12. 
For similar expression levels, the plasmid DNA concentrations were adjusted for the different proteins 
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of LRRC59. Cells were incubated without (-) or with (+) rapamycin for 1, 1.5, 2, 2.5, 3, 4, and 
10 minutes. After fixation, the cells were analyzed by confocal microscopy. The images represent the 
rapamycin incubation time of 10 minutes. DAPI marked the nucleic acids in fluorescence microscopy. 
(C) Quantification of the experiment as described in (B). The mean of the percentage of cells 
responding to rapamycin treatment was plotted against the rapamycin incubation time. The standard 
deviation of the mean of at least four individual experiments (100 cells analyzed each time point) is 
indicated by error bars. For values, see table S 5, for overview of counted cell numbers see table S 6. 
Also see Blenski and Kehlenbach, 2019. 
 
 
Next, the cytoplasmic domain was further increased in size by inserting a GST-tag into pmCherry-
FRB-LRRC59 resulting in a plasmid coding for mCherry-FRB-GST-LRRC59. This protein had a 
cytoplasmic size of 91.4 kDa, but as GST is known to dimerize (Bell et al., 2013), expression of mCherry-
FRB-GST-LRRC59 resulted in expected dimers with an extraluminal domain of 182.8 kDa (figure 22A). 
Due to the dimerization property of GST, the reporter EGFP2-GST-M9-FKBP12 had to be exchanged 
into a reporter lacking the GST-tag. Therefore, a plasmid coding for EGFP2-MBP-M9-FKBP12 was 
created, which located to the nucleus (figure 22B). In the rapamycin-induced dimerization assay, the 
proteins mCherry-FRB-LRRC59, mCherry-FRB-MBP-LRRC59 and mCherry-FRB-GST-LRRC59 
located similar to the ER and in a rim at the NE (figure 22B). Cells overexpressing these proteins were 
examined in a rapamycin-induced dimerization assay with rapamycin-incubation times of 1, 1.5, 2, 2.5, 
3, 4, and 10 minutes. For cells overexpressing mCherry-FRB-LRRC59 and mCherry-FRB-MBP-
LRRC59, a similar percentage of rapamycin-responding cells was observed for the reporter EGFP2-
MBP-M9-FKBP12 as for EGFP2-GST-M9-FKBP12 (compare figure 21C and 22C). The increase of the 
cytoplasmic domain by the insertion of the MBP-tag reduced the rapamycin-responding cells by 
approximately 40% (figure 22C). For mCherry-FRB-GST-LRRC59 expressing cells, the reporter EGFP2-
MBP-M9-FKBP12 was almost not recruited to the NE (figure 22B and C). On average for all tested 
rapamycin incubation times for mCherry-FRB-GST-LRRC59, approximately 92% of the cells did not 
show a reporter-recruitment to the NE. This result indicates that the further increase of the cytoplasmic 
domain to 182.8 kDa almost completely blocked INM targeting of mCherry-FRB-GST-LRRC59 in the 




Figure 22: Increase of the size of the cytoplasmic domain of LRRC59 inhibits its INM targeting. 
(A) Schematic overview of LRRC59 constructs of different extraluminal regions used together with 
the reporter EGFP2-MBP-M9-FKBP12. (B) HeLa cells were transiently transfected with plasmids 
coding for EGFP2-MBP-M9-FKBP12 and mCherry-FRB-LRRC59, mCherry-FRB-MBP-LRRC59 and 
mCherry-FRB-GST-LRRC59, respectively. For similar expression levels of the LRRC59-proteins, the 
plasmid DNA concentrations were adjusted. Cells were treated without (-) or with (+) rapamycin for 
1, 1.5, 2, 2.5, 3, 4, and 10 minutes, fixed and analyzed by fluorescence microscopy. The microscopic 
images represent cells of 10 minutes rapamycin incubation time. (C) Quantification of the experiment 
as described in (B). The graph plots the percentage of cells responding to rapamycin against the drug 
incubation time. The error bars indicate the standard deviation from the mean of five independent 
experiments, counting 100 cells per time point and condition. For values see table S 7. See also 
Blenski and Kehlenbach, 2019. 
 
Taken together, these results indicate a dependency of INM targeting on the size of the 
extraluminal domain of LRRC59. The exchange of mCherry in mCherry-FRB-LRRC59 to the smaller 
HA-tag did not change the number of rapamycin-responding cells in the rapamycin-induced dimerization 
assay. However, the increase of the cytoplasmic domain to 107.5 kDa of mCherry-FRB-MBP-LRRC59 
reduced the recruitment of both used reporters to the NE by approximately 40%. By further increase of 
the cytoplasmic domain to 182.8 kDa of the dimerizing protein mCherry-FRB-GST-LRRC59, the reporter 
was almost not recruited to the NE. This indicates that the protein mCherry-FRB-GST-LRRC59 was 
inhibited in its INM targeting by the increase of the extraluminal domain. This size-dependency in INM-
targeting suggests that LRRC59 reaches the INM by diffusion, not by active transport. 
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3.3 Rapamycin- and APEX-dependent identification of proteins by SILAC (RAPIDS): 
analysis of LRRC59 by proximity 
3.3.1 Experimental procedure 
Very little is known about the biological function of LRRC59 (see section 1.4). A method for the 
identification of binding and/or proximity partners of membrane proteins was established by Dr. Marret 
Müller in the laboratory of Prof. Dr. Ralph H. Kehlenbach, Göttingen. For the analysis of LRRC59 by 
proximity, the original assay was applied to LRRC59 with some experimental modifications. 
To identify proteins in close proximity of a protein of interest, three experimental components 
were combined in one approach (figure 23). First, the rapamycin-induced dimerization assay using cells 
expressing the membrane protein of interest tagged with FRB and the reporter FKBP12-EGFP-APEX2 
was applied. Second, a biotinylation assay followed by enrichment of biotinylated proteins was 
performed, and third, mass spectrometry was done to analyze the biotinylated proteins in the context of 
a SILAC (stable isotope labeling by amino acids in cell culture) approach. This assay was called 
rapamycin- and APEX-dependent identification of proteins by SILAC (RAPIDS).  
The rapamycin-induced dimerization assay was performed with HeLa cells expressing mCherry-
FRB-LRRC59 and the soluble reporter FKBP12-EGFP-APEX2, which localized all over the cell. Upon 
the addition of rapamycin, the soluble reporter is recruited to mCherry-FRB-LRRC59 due to the 
dimerization of FKBP12/rapamycin with FRB. For further and general information about the rapamycin-
induced dimerization assay, see section 3.2.2 and 2.5. 
The biotinylation of proteins in the RAPIDS experiments is mediated by APEX2, an engineered 
ascorbate peroxidase, which is part of the reporter used for the rapamycin-induced dimerization assay. 
APEX2 oxidizes biotinphenol into phenoxyl radicals in the presence of H2O2. These biotin-phenoxyl 
radicals covalently react with electron-rich amino acids of proteins in close proximity to APEX2 (<20 nm), 
resulting in biotinylation of endogenous proteins, which can be enriched by NeutrAvidin beads (Martell 
et al., 2012; Lam et al., 2015).  
Mass spectrometry analysis was performed to identify biotinylated, endogenous proteins in close 
proximity to mCherry-FRB-LRRC59. Transfected cells were incubated with medium supplemented with 
rapamycin and biotinphenol, followed by treatment with H2O2 for the biotinylation reaction. Upon the 
addition of rapamycin, the APEX2-containing reporter was recruited to mCherry-FRB-LRRC59. Because 
of the recruitment, the biotinylation of proteins close to mCherry-FRB-LRRC59 by APEX2 increases 
upon H2O2 treatment. In the absence of rapamycin, APEX2 located all over the cell and biotinylates 
random proteins in close proximity to itself upon H2O2 treatment. To distinguish between these two 
conditions in mass spectrometry, cells were cultivated in medium containing heavy or light isotopes of 
arginine and lysine (SILAC: Ong et al. (2002)). In a forward experiment, cells grown in light isotope 
labeled medium were treated with rapamycin and biotinphenol, resulting in an increased biotinylation of 
proteins close to mCherry-FRB-LRRC59. Cells grown in heavy isotope labeled medium were only 
incubated with biotinphenol. After the biotinylation reaction, cells were lysed, the protein concentrations 
were determined and adjusted. For mass spectrometry analysis, the lysates of cells coming from heavy 
or light isotope labeled medium were mixed in a protein concentration ratio of 1:1. Biotinylated proteins 
were enriched with NeutrAvidin beads. The eluted proteins were sent for mass spectrometry analysis 
or analyzed by Western blot (figure 23). 
To exclude the possible influence of the isotope labeling itself on the experimental setup, RAPIDS 
experiments were performed in a forward and a reverse experiment switching the rapamycin-treatment 
depending on the isotope labeled medium. In the forward experiments, cells grown in light isotope 
labeled medium were supplemented with rapamycin, while in the reverse experiments the rapamycin 
treatment was performed with cells of heavy isotope labeled medium. In total, two forward and two 
reverse experiments were performed and the results of mass spectrometry analysis were united for 




Figure 23: Workflow of RAPIDS experiments for identification of proteins in close proximity 
to mCherry-FRB-LRRC59. 
For forward experiments, HeLa cells were grown in heavy or light isotope labeled medium and 
transfected with plasmids coding for mCherry-FRB-LRRC59 and FKBP12-EGFP-APEX2. Cells 
cultivated in light isotope labeled medium (blue box) were incubated with biotinphenol and rapamycin, 
increasing the biotinylation of proteins in close proximity to mCherry-FRB-LRRC59 by the recruitment 
of the FKBP12-tagged APEX2. Cells grown in heavy isotope labeled medium (red box) were not 
treated with rapamycin. For the biotinylation reaction of endogenous proteins by APEX2, H2O2 was 
added. After cell lysis, the lysates were mixed in a 1:1 protein concentration ratio and biotinylated 
proteins were enriched by incubation with NeutrAvidin beads. For mass spectrometry analysis, the 
eluate was separated by SDS-PAGE and proteins were digested by trypsin. The increase of 
biotinylation of proteins in close proximity to mCherry-FRB-LRRC59 due to rapamycin treatment in 
cells grown in light isotope labeled medium led to an increase in their relative intensity (blue peak). 
Biotinylated proteins of cells cultivated in heavy isotope labeled medium showed an increase in the 
mass to charge ratio of 10 Da (red peak). The 10 Da shift enables a discrimination of proteins being 
biotinylated in the presence or absence of rapamycin. The reverse experiments were performed in 
an identical workflow with rapamycin treatment for cells grown in heavy isotope labeled medium. 
 
 
Microscopic analysis of RAPIDS experiments 
In RAPIDS experiments, the recruitment of FKBP12-EGFP-APEX2 to mCherry-FRB-LRRC59 
upon rapamycin treatment was controlled by microscopic analysis. For cells grown in heavy or light 
isotope labeled medium, mCherry-FRB-LRRC59 localized to the ER and the NE. In the absence of 
rapamycin, the reporter FKBP12-EGFP-APEX2 was observed all over the cell (figure 24). In cells treated 
with rapamycin, the reporter was targeted to mCherry-FRB-LRRC59 due to the dimerization of FRB and 
FKBP12. Both overexpressed proteins colocalized at the ER and in a rim at the NE (figure 24). The 
cultivation in differently isotope labeled medium had no observable influence on the localization of the 





Figure 24: The reporter FKBP12-EGFP-APEX2 is recruited to mCherry-FRB-LRRC59 in 
RAPIDS experiments upon the addition of rapamycin. 
HeLa cells for RAPIDS experiments were cultivated in heavy or light isotope labeled medium prior to 
seeding into 10 cm cell culture dishes for RAPIDS experiments containing a coverslip for 
fluorescence microscopy. Cells were transfected with plasmids coding for mCherry-FRB-LRRC59 
and FKBP12-EGFP-APEX2 for 52 hours and incubated with biotinphenol in the presence (+) or 
absence (-) of rapamycin for 30 minutes. After the treatment of the cells with H2O2 but before cell 
lysis, the coverslips were removed. Cells were fixed and directly analyzed by confocal microscopy. 
DAPI marked the nucleic acids in fluorescence microscopy. For forward experiments (left panel), 
rapamycin was added to cells cultivated in light isotope labeled medium, while in reverse 




Western blot analysis of RAPIDS experiments 
In addition to microscopic analysis, Western blot analysis was performed to monitor the 
enrichment of biotinylated proteins using NeutrAvidin beads and to compare the transfection efficiency 
of cells grown in heavy or light isotope labeled medium.  
For the analysis of enrichment of biotinylated proteins with NeutrAvidin beads, total cell lysate 
and eluate coming from forward and reverse experiments, respectively, were separated by SDS-PAGE 
prior to Western blotting and detection using HRP-coupled Streptavidin. It was shown that biotinylated 
proteins could be isolated from the total lysate and eluted from the beads for the forward and reverse 
experiments (figure 25A).  
Next, it was examined whether the rapamycin addition led to an increase in biotinylation of 
mCherry-FRB-LRRC59, as the APEX2-containing reporter was recruited to FRB upon drug treatment. 
As seen in figure 25B, a weak increase in biotinylation of mCherry-FRB-LRRC59 could be shown in the 
presence of rapamycin for both forward and reverse experiments. Interestingly, endogenous LRRC59 
was also biotinylated in the presence of rapamycin, indicating a potential dimer assembly between 
endogenous LRRC59 and mCherry-FRB-LRRC59.  
Comparable signals for FKBP12-EGFP-APEX2 could be detected in lysates of cells cultivated in 
heavy or light isotope labeled medium for forward and reverse experiments. This result indicates a 




Figure 25: Western blot analysis of forward and reverse experiments of RAPIDS approach. 
Cell lysates from cells cultivated in heavy or light isotope labeled medium were adjusted to each other 
in protein concentration (total). Biotinylated proteins were enriched by usage of NeutrAvidin beads. 
After elution (eluate), biotinylated proteins were analyzed by SDS-PAGE and Western blotting in 
comparison to the total cell lysate. (A) Detection of biotinylated proteins using HRP-coupled 
Streptavidin for forward and reverse experiments. (B) Immunodetection of LRRC59 using a LRRC59-
antibody for forward and reverse experiments. (C) Immunodetection of FKBP12-EGFP-APEX2 using 
an antibody against GFP. The signal of the antibody against alpha-tubulin served as a loading control.  
 
The microscopy analysis showed a recruitment of FKBP12-EGFP-APEX2 to mCherry-FRB-
LRRC59 in the presence of rapamycin. In the Western blot analysis, the successful enrichment of 
biotinylated proteins could be confirmed. In addition, an increase in biotinylation of mCherry-FRB-
LRRC59 in presence of rapamycin could be demonstrated, as well as a comparable transfection 
efficiency for the reporter FKBP12-EGFP-APEX2. Based on these results, the samples were subjected 
to mass spectrometry analysis. 
 
3.3.2 Mass spectrometry 
The enriched biotinylated proteins of the RAPIDS experiments were analyzed by mass 
spectrometry. The results were processed in a significance analysis resulting in a Scatter plot containing 
all identified proteins (figure S 7). In the Scatter plot, the logarithmic values of the heavy/light normalized 
LRRC59 of the forward experiments were plotted on the x-axis against the values of the reverse 
experiments on the y-axis. Proteins identified as significantly enriched were marked within the Scatter 
plot. In the forward experiments, cells grown in light isotope labeled medium were treated with 
rapamycin. APEX2 was recruited to mCherry-FRB-LRRC59 in these cells leading to an increase in the 
biotinylation of proteins in close proximity to mCherry-FRB-LRRC59. The values of relative intensity of 
increased biotinylated proteins grown in light isotope labeled medium is therefore expected to be higher 
than the values of the same proteins of cells grown in heavy isotope labeled medium. As the values are 
given in a ratio of heavy to light, a smaller value is divided by a bigger value leading to a negative value 
in the logarithmic calculation. Proteins which were not affected by the rapamycin treatment would not 
cause a difference between the heavy or light normalized LRRC59 values resulting in a log2-ratio around 
zero. For the reverse experiments, an enrichment of biotinylation of proteins in close proximity to 
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mCherry-FRB-LRRC59 was expected in cells cultivated in heavy isotope labeled medium, as these cells 
were treated with rapamycin. This led to an increase of the relative intensity of proteins of cells of heavy 
isotope medium. Therefore, a high value was divided by a smaller value in the ratio of heavy to light, 
yielding a positive value for the log2. Within the Scatter plot, the interesting candidates expected to be 
in close proximity to mCherry-FRB-LRRC59 are located in the fourth quadrant (negative value for 
forward and positive value for reverse experiments of ratio log2 heavy/light normalized LRRC59). In this 
quadrant, 13 candidates were identified as significantly enriched in the forward and the reverse 
experiments as well as LRRC59 itself (figure 26, red font color). By rapamycin treatment, 6 proteins 
were significantly enriched in the forward experiments (figure 26, blue font color), while 10 (figure 26, 
green font color) were identified as significantly enriched in the reverse experiments. The significantly 
enriched proteins of quadrant IV are listed with the gene and protein names, information of localization 
within the cell and function assigned to UniProt in table 26. The majority of proteins were not identified 
as significant. Proteins not affected by the rapamycin treatment clustered around zero for the ratio log2 
heavy/light normalized LRRC59 for forward and reverse experiments (figure 26, gray dots). The proteins 
MCCC2, MCCC1, ACABA, ACACA, PCCA and PCCB are endogenously biotinylated and served as 
internal controls, as their biotinylation should not be changed by rapamycin treatment. This was true for 
five of the six proteins. MCCC1 was identified as significantly enriched by rapamycin treatment in the 
forward experiments, but with a positive ratio log2 heavy/light normalized LRRC59 value. For further 
details of values see table S 9 and S 10.  
 
 
Figure 26: Mass spectrometry analysis of four RAPIDS experiments identifies significantly 
enriched candidates in close proximity to mCherry-FRB-LRRC59. 
Data of mass spectrometry was analyzed using Perseus Software and a matrix resulting in a two-
sided Significance B test with Benjamini Hochberg False Discovery Rate and a Scatter plot scaling 
the ratio log2 heavy/light normalized LRRC59 of the forward experiments on the x-axis and this ratio 
for the reverse experiments on the y-axis. The fourth quadrant (IV) contains proteins enriched upon 
the addition of rapamycin. Significantly enriched proteins in forward and reverse experiments are 
highlighted with red gene names. Proteins identified as significantly enriched in the forward 
experiments are highlighted with blue gene names, while green font indicates significant enrichment 
in the reverse experiments. For details see table S 9. For all quadrants of the Scatter plot see 








Table 26: Overview of the significantly enriched proteins of quadrant IV with localization and 







Protein function and further 
information 
APOL2 Apolipoprotein L2 Q9BQE5 cytoplasm 
potential role in lipid movement 
and lipid binding to organelles 
CLCC1 
Chloride channel 





three TMDs, Potential function as 
chloride ion channel 
LRRC59 
Leucine-rich repeat-










three TMDs, potential function as 
tumor suppressor 
EMD Emerin P50402 ONM and INM 
single C-terminal TMD, several 






two TMDs, involvement in ER-





Q8TEM1 nuclear membrane 
has one TMD and is important for 
NPC assembly and anchoring to 





one TMD, function in electron 







one TMD, component of the SRP 







one TMD, involvement in the 
vesicle transport between ER 








component of the SRP complex. 







two TMDs, potential involvement 






P49792 nucleus, NPC 
involvement in nuclear transport 
mediated by interaction of the 
transport factors with the 
FG-repeat containing domain of 




containing protein 1 
Q7KZF4 nucleus involvement in miRNA decay 
FNDC3A 
Fibronectin type III 
domain-containing 
protein 3A 
Q9Y2H6 Golgi apparatus 







binding to DNA and activity 



















one TMD, involvement in nuclear 
lamina assembly contributing to 
the maintain of the structural NE 
organization 
KTN1 Kinectin Q86UP2 ER-membrane 
one TMD, receptor for kinesin, 










one TMD, involvement in the 












involvement in the regulation of 
cellular metabolism, hormone 
response and other cellular 
processes. The FRB domain of 
mTOR is bound by rapamycin-









one TMD, involvement in lipid 









one TMD, involvement in protein 
folding and trafficking as co-
chaperone with Hsc70 
FNDC3B 




one TMD, potential positive 







region (isoform 1) 
one TMD (isoform 1), function as 
signal-transducing molecule 
GDI1 





involvement in the GDP/GTP 
exchange of most Rab proteins 
by inhibiting the dissociation of 




MTMR6 NE phosphatase acting on lipids 
USP33 
Ubiquitin carboxyl-




deubiquitinase, involvement in 





Q9Y624 plasma membrane 
one TMD, potential involvement 




associated factor 8 
Q5TAQ9 nucleus, cytoplasm 
potential substrate receptor for 
the E3 ubiquitin ligase complex 
CUL4-DDB1 
NUP107 





part of the NPC, involvement in 
NPC assembly and maintenance. 
See section 1.1 
* for further information about INM localization, see section 3.4 
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3.3.3 Analysis of potential interaction of LRRC59 with Nup210 
In the RAPIDS experiments, Nup210 was identified as a significantly enriched protein in close 
proximity to mCherry-FRB-LRRC59. Nup210 is a nucleoporin, a protein of the NPC. It has 1887 amino 
acids with a single TMD close to its C-terminus (TMD: 1809-1829 aa (Greber et al., 1990; Wozniak et 
al., 1989)). Nup210, also known as gp210, is one of three TMD-containing proteins assembled in the 
NPC. In metazoan, Nup210 and the other two TMD-containing proteins POM121 and NDC1 are 
suggested to anchor the NPC in the pore membrane (Weberruss and Antonin, 2016). It was suggested 
that TMD-containing proteins reaching the INM by diffusion, overcome the NPC by using peripheral 
channels. These are inner lateral channels adjacent to the pore membrane (Maimon et al., 2012). Due 
to the proximity of Nup210 to these peripheral channels, this protein is the focus of further analysis.  
A pulldown experiment was performed with the protein corresponding to the region of LRRC59 
facing the cytoplasm (aa1-244) and the short C-terminal domain of Nup210 after the TMD (aa1830-
1887) located in the cytoplasm. The recombinant expressed proteins MBP-LRRC59 aa1-244-His, His-
GST-Nup210 aa1830-1887 and His-MBP-His were purified for this pulldown assay (figure S 8). As 
shown in figure 27, His-GST-Nup210 aa1830-1887 and GST could be immobilized on glutathione 
beads, while MBP-LRRC59 aa1-244-His and His-MBP-His were immobilized on amylose beads. No 
binding of His-GST-Nup210 aa1830-1889 to MBP-LRRC59 aa1-244-His could be detected. Weak 
binding of MBP-LRRC59 aa1-244-His could be shown with immobilized His-GST-Nup210 aa1830-1887, 
but also with the immobilized GST-tag itself. This shows that the binding between LRRC59 aa1-244 and 
Nup210 aa1830-1887 was not specific because it was mediated by the GST-tag (figure 27). 
 
Figure 27: LRRC59 aa1-244 does not bind to Nup210 aa1830-1887. 
For the binding assay, MBP-LRRC59 aa1-244-His or His-MBP-His were immobilized using Amylose 
Resin High Flow and His-GST-Nup210 aa1830-1887 or GST using Glutathione Sepharose High 
Performance for 60 minutes, respectively. After washing, His-GST-Nup210 aa1830-1887 was added 
to the immobilized His-MBP-His or MBP-LRRC59 aa1-244-His, while MBP-LRRC59 aa1-244-His 
was added to the immobilized GST or His-GST-Nup210 aa1830-1887 for 60 minutes. After washing, 
the binding was analyzed by SDS-PAGE followed by Coomassie staining (upper panel, 60% loading 
of the reaction) or immunodetection after Western blotting using antibodies against His- and GST-
tags (lower panel, 20% loading of the reaction). For Coomassie staining, 10% of immobilized or 
added protein was loaded as an input, while 1% of used protein was loaded onto SDS-PAGE used 
for Western blotting. Asterisks indicate the protein immobilized onto the beads in the corresponding 
binding reaction.  
 
The regions of LRRC59 and Nup210 facing the cytoplasm were analyzed for binding using the 
pulldown experiment. Even though Nup210 was identified as protein in close proximity to mCherry-FRB-




3.4 Analysis of inner nuclear membrane localization of classical ER proteins 
In 2016, Smoyer and colleagues established a split-GFP microscopy-based live cell assay in 
S. cerevisiae to identify unknown membrane proteins of the INM. More than 400 membrane proteins 
able to reach the INM were found with this approach. 230 of these proteins have a human ortholog 
(Smoyer et al., 2016). From these, five single TMD-containing proteins Sec61, DDOST, LMAN2, 
Ube2j1, Ube2j2 and the protein Sec22b identified by RAPIDS experiments (as well as LMAN2) were 
chosen for further analysis of INM localization using the rapamycin-induced dimerization assay. 
 
3.4.1 Overview of the examined single transmembrane domain containing proteins 
The N-terminus of Sec61 (Protein transport protein Sec61 subunit beta, yeast ortholog is SBH2, 
figure 28A) faces the cytoplasm. The C-terminus contains a TMD followed by a five amino acid short tail 
in the ER-lumen (Hartmann et al., 1994) (UniProt ID P60468). Sec61 is one of three transmembrane 
proteins (with Sec61 and Sec61) forming the Sec61 translocon which localizes in the ER-membrane 
(Osborne et al., 2005). It can, however, also occur as a stable protein on its own (Panzner et al., 1995; 
Esnault et al., 1994). The translocon is known to insert proteins containing a TMD into the ER-membrane 
as well as to import proteins for the secretory pathway into the ER-lumen, but can also export misfolded 
proteins from the ER into the cytoplasm (Osborne et al., 2005; Tsai et al., 2002). For the export, the 
translocon is part of the endoplasmic reticulum-associated degradation (ERAD) pathway, in which 
misfolded proteins are exported from the ER, marked with ubiquitin-chains and targeted for degradation 
to the proteasome (Schnell and Hebert, 2003; Romisch, 2005). Sec61 was shown to associate with 
the epidermal growth factor (EGF) receptor and retro-translocate it from the ER to the cytoplasm (Liao 
and Carpenter, 2007). Later it was found that the cytoplasmic, but membrane associated EGF receptor 
is imported into the nucleus by importin . Surprisingly, Sec61 was also identified to locate to the INM, 
where it associates with the EGF receptor to release it from the INM into the nucleus (Wang et al., 2010). 
This gave a first hint for a potential INM function of Sec61. 
 
Sec22b, also called vesicle-trafficking protein SEC22B (figure 28B), has a single TMD at its very 
C-terminus. The N-terminus of the protein faces the cytoplasm and contains a longin domain followed 
by a v-SNARE coiled-coil homology domain (Mancias and Goldberg, 2007) (UniProt ID O75396). 
Sec22b is involved in the vesicle transport between the ER-membrane and the Golgi apparatus. The 
vesicular transport mechanism can be divided into three different steps. First, the vesicle forms at a 
donor compartment to pack the cargo proteins. This step is mediated by coat proteins, e.g. COPI and 
COPII, together with GTPases. Second, the vesicle has to be transported from its place of origin to its 
destination by movement via the cytoskeleton. This step is mediated by motor proteins. Third, the vesicle 
has to fuse to the membrane meant for destination mediated by the SNARE (Soluble N-ethylmaleimide-
sensitive-factor Attachment Protein Receptor) complex. For this complex assembly, one v-SNARE 
protein pairs with three t-SNARE proteins. Proteins of v-SNARE come from the vesicular membrane, 
while t-SNARE stands for proteins of the SNARE complex present in the target membrane. The 
membrane and the vesicle are fused by the formation of these four SNARE proteins. So far, 38 members 
of the SNARE protein family have been identified. This protein variability controls the fusion of vesicles 
with the membrane of destination in a variety of membranes (Wang et al., 2017). Sec22b shuttles 
integrated into the vesicle membrane and is involved in fusion events at the Golgi and the ER-membrane 
in anterograde and retrograde transport (Liu and Barlowe, 2002; Spang and Schekman, 1998). 
 
Ube2j1 and Ube2j2 (UniProt IDs Q9Y385 and Q8N2K1, figure 28C and D), also called Ubiquitin-
conjugating enzyme E2 J1 and J2, respectively, are TA proteins of the ER-membrane (figure 28C and 
D). Both proteins are involved in the endoplasmic reticulum-associated protein degradation (ERAD) 
pathway. Proteins, which are not correctly folded, are marked by ubiquitin for degradation via the 
proteasome. For the transfer of ubiquitin to these proteins, an enzymatic cascade is necessary. A 
ubiquitin-activating enzyme E1 activates ubiquitin in an ATP-dependent manner, then the activated 
ubiquitin is transferred from E1 to the ubiquitin-conjugating enzyme E2 and finally, ubiquitin is 
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transferred onto the substrate, which is bound by the ubiquitin ligase E3. The E3 ligase binds to E2 and 
the substrate protein at the same time and mediates the ubiquitin transfer onto the target protein 
(Glickman and Ciechanover, 2002; Pickart, 2004). Ube2j1 and Ube2j2 are ubiquitin-conjugating E2 
enzymes, which are located in the ER-membrane. It has been shown that Ube2j1, but not Ube2j2 is 
involved in the cell recovery from ER-stress (Lester et al., 2000; Elangovan et al., 2017). The yeast 
ortholog of Ube2j1 is Ubc6. 
 
LMAN2, also called vesicular integral-membrane protein VIP36, has a C-terminal TMD with a 
short tail facing the cytoplasm. It has an N-terminal signal peptide, which is cleaved after ER-membrane 
insertion (UniProt ID Q12907, figure 28E). LMAN2 localizes to the ER-membrane and the Golgi 
apparatus (Fullekrug et al., 1999). This protein is a mannose-binding lectin protein with a specificity for 
high-mannose-type glycans and is involved in export of glycoproteins from the ER (Vagin et al., 2009). 
Its yeast ortholog is EMP47. 
 
DDOST (synonym OST48, figure 28F) has a C-terminal short tail in the cytoplasm after its TMD. 
The protein is inserted in the ER-membrane via a signal peptide, which is located at the N-terminus 
(UniProt ID P39656). DDOST, also called Dolichyl-diphosphooligosaccharide-protein 
glycosyltransferase 48 kDa subunit, is an oligosaccharyltransferase (Yamagata et al., 1997). Most 
proteins, which are targeted by the secretory pathway, are modified by N-linked glycosylation, the 
addition of oligosaccharides to asparagine residues. This N-linked glycosylation marks proteins for the 
secretory pathway. The glycosylation reaction is catalyzed by an oligosaccharyltransferase, a protein 
complex of several subunits. The proteins STT3A or STT3B are the active catalytic subunit of the OST 
complex, while several non-catalytic proteins contribute to the complex, one of them being DDOST 
(Roboti and High, 2012; Aebi et al., 2010). The yeast ortholog of DDOST is WBP1. 
 
 
Figure 28: Schemes and amino acid sequences of the proteins tested for INM localization 
using the rapamycin-induced dimerization assay. 
Results 
 91 
Sec61, Sec22b, Ube2j1 and Ube2j2 have a C-terminus facing the lumen of the ER, while the 
C-terminus of LMAN2 and DDOST is located in the cytoplasm. The transmembrane domain (TMD) 
is indicated in red. (A) For Sec61 (protein transport protein Sec61 subunit beta), no domains or 
regions are identified except for the TMD. (B) The vesicle-trafficking protein SEC22B (Sec22b) has 
a longin domain (green) followed by a v-SNARE coiled-coil homology domain (blue) before the TMD. 
For Ube2j1 (C), ubiquitin-conjugating enzyme E2 J1 and Ube2j2 (D), ubiquitin-conjugating enzyme 
E2 J2, a single TMD is identified. (E) In addition to the signal peptide (purple) and the TMD, LMAN2 
(vesicular integral-membrane protein VIP36) has a L-type lectin-like domain (brown). (F) Dolichyl-
diphosphooligosaccharide-protein glycosyltransferase 48 kDa subunit (DDOST) has a signal peptide 
at its N-terminus. 
 
 
3.4.2 Rapamycin-induced dimerization assay of potential inner nuclear membrane 
candidates 
In order to examine the INM localization of Sec61, Sec22b, Ube2j1, Ube2j2, LMAN2 and 
DDOST, mRNA was isolated from HeLa cells and reverse transcribed into cDNA. Specific cDNAs were 
cloned into an mCherry- and FRB-containing vector. As the N-terminus of Sec61, Sec22b, Ube2j1 and 
Ube2j2 is located in the cytoplasm, mCherry-FRB was added to the N-terminus, resulting in mCherry-
FRB-Sec61, mCherry-FRB-Sec22b, mCherry-FRB-Ube2j1 and mCherry-FRB-Ube2j2. For LMNA2 
and DDOST, the cytoplasmic C-terminus was tagged with FRB-mCherry: LMAN2-FRB-mCherry and 
DDOST-FRB-mCherry. In the rapamycin-induced dimerization assay, the protein of interest was 
overexpressed together with the nuclear reporter EGFP2-GST-M9-FKBP12 in HeLa cells and analyzed 
by fluorescence microscopy. 
 
For mCherry-FRB-Sec61, an ER- and NE-localization of the overexpressed protein could be 
observed (figure 29A). Already after one minute of rapamycin incubation, more than 70% of the 
overexpressing cells showed a reporter recruitment to the NE. After 2 minutes, a plateau in rapamycin-
responding cells of approximately 97% was reached (figure 29B). This strong response of the 
overexpressing cells to rapamycin-treatment could confirm the already published INM localization of 
Sec61. This also confirms the result of Smoyer et al. (2016) for the yeast ortholog SBH2, which was 
identified as an INM protein.  
 
The protein mCherry-FRB-Sec22b localized to the ER and the NE, but for some cells, a 
punctuated pattern at the ER could be observed (figure 29C). Upon rapamycin-addition, the reporter 
was recruited to the NE. By increasing the time of rapamycin-treatment, an increasing number of cells 
responding to rapamycin was observed until a plateau of approximately 70-80% was reached after 
3 minutes of incubation (figure 29D). This experiment confirms Sec22b as a protein of the INM. 
 
mCherry-FRB-Ube2j1 localized to the ER and the NE. Upon the addition of rapamycin, the 
reporter was targeted to the NE, indicating an INM localization of Ube2j1 (figure 29E). The maximum of 
rapamycin-responding cells was approximately 70% and was reached after 5 minutes of rapamycin 
treatment (figure 29F). Ube2j1 seems to be able to reach the INM, but not in every cell examined in the 
rapamycin-induced dimerization assay. 
 
Next, the INM localization of mCherry-FRB-Ube2j2 was tested in the rapamycin-induced 
dimerization assay. mCherry-FRB-Ube2j2 localized at the ER and the NE. Upon rapamycin-addition, 
the nuclear reporter was targeted to the NE, indicating the INM localization of mCherry-FRB-Ube2j2 
(figure 29G). A plateau of 60% rapamycin-responding cells was reached after 4 minutes of rapamycin 
treatment (figure 29H). This shows that Ube2j2 could localize to the INM, however, this was not 
observed in every cell analyzed in the rapamycin-induced dimerization assay. 
 
The signal of overexpressed LMAN2-FRB-mCherry indicated a localization of this protein to the 
ER. In addition, a rim at the NE was observed, pointing to a potential ONM and INM localization of 
LMAN2 (figure 29I). Indeed, the INM localization of LMAN2-FRB-mCherry could be confirmed by the 
recruitment of EGFP2-GST-M9-FKBP12 from the nucleoplasm to the NE upon rapamycin treatment. 
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The number of cells responding to rapamycin slowly increased with incubation time (figure 29J). 
Approximately 70% of the cells expressing both constructs showed a reporter recruitment to the NE 
after 6 minutes of rapamycin treatment. This result shows that LMAN2 can locate to the INM, but this 
did not happen in all cells.  
 
The last tested potential INM candidate was DDOST. The overexpressed protein DDOST-FRB-
mCherry was located at the ER-membrane and the NE. Upon rapamycin-treatment, the reporter 
EGFP2-GST-M9-FKBP12 was targeted to the NE, showing an INM localization of DDOST-FRB-mCherry 
(figure 29K). By increasing the incubation time of rapamycin treatment, more and more cells showed 
this reporter recruitment to the NE until a plateau of approximately 98% rapamycin-responding cells was 







Figure 29: Sec61, Sec22b, Ube2j1, Ube2j2, LMAN2 and DDOST are located in the INM. 
For the rapamycin-induced dimerization assay, HeLa cells were transfected with the reporter EGFP2-
GST-M9-FKBP12 and the mCherry- and FRB-tagged protein of interest. After 48 hours, the cells 
were treated with rapamycin for 1-10 minutes, fixed and directly analyzed by confocal microscopy. 
DAPI marked the nucleic acids in fluorescence microscopy. (A) Representative microscopic image 
of mCherry-FRB-Sec61. (B) Quantification of (A) shows mean and standard deviation for each 
incubation time with rapamycin of three individual experiments counting 100 cells each. (C) 
Representative microscopic image of mCherry-FRB-Sec22b. (D) As (B) for mCherry-FRB-Sec22b. 
(E) Representative microscopic image of mCherry-FRB-Ube2j1. (F) As (B) for mCherry-FRB-Ube2j1. 
(G) Representative microscopic image of mCherry-FRB-Ube2j2. (H) As (B) for mCherry-FRB-Ube2j2. 
(I) Representative microscopic image of LMAN2-FRB-mCherry. (J) As (B) for LMAN2-FRB-mCherry. 
(K) Representative microscopic image of DDOST-FRB-mCherry. (L) As (B) for DDOST-FRB-
mCherry. For values see table S 11. 
 
For the six tested potential INM proteins Sec61, Sec22b, Ube2j1, Ube2j2, LMAN2 and DDOST, 
a localization to the INM could be shown by the rapamycin-induced dimerization assays. 
 
3.4.3 Size dependency of inner nuclear membrane targeting of candidates on the 
extraluminal domain 
For further examination of INM targeting, Sec61, Ube2j1 and DDOST became the focus of 
interest. These three proteins in their mCherry- and FRB-tagged form localized to the ER and NE without 
punctuated pattern. By the increase of the size of their cytoplasmic domains, the INM targeting of these 
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proteins was analyzed, as it was performed for LRRC59 (see section 3.2.4). New constructs with tags 
of MBP and GST, respectively, in addition to the mCherry- and the FRB-tags for the three proteins were 
cloned.  
For the endogenous Sec61 protein, the cytoplasmic domain has a molecular mass of 7 kDa. 
This domain was already increased in the rapamycin-induced dimerization assay for validation of INM 
localization to 44.9 kDa for mCherry-FRB-Sec61. To further increase the cytoplasmic domain size, a 
GST- or an MBP-tag was inserted into the mCherry-FRB-Sec61 construct between FRB and Sec61. 
The cytoplasmic domain of the new protein mCherry-FRB-MBP-Sec61 is 86.6 kDa from the starter 
methionine of mCherry until the last amino acid before the TMD. By the insertion of a GST-tag, the 
cytoplasmic domain increased to 70.6 kDa in mCherry-FRB-GST-Sec61. GST is known to assemble 
into dimers (Bell et al., 2013), so that mCherry-FRB-GST-Sec61 should have a cytoplasmic domain of 
141.2 kDa (figure 30A). 
Figure 30B gives an overview of the sizes of the cytoplasmic domains of the new constructs of 
Ube2j1 for the rapamycin-induced dimerization assay. The addition of mCherry-FRB to Ube2j1 
increased the cytoplasmic domain by 38 kDa. mCherry-FRB-MBP-Ube2J1 further increased the 
extraluminal region to 110.8 kDa, while the dimerizing protein mCherry-FRB-GST-Ube2j1 has a 
cytoplasmic domain of 189.6 kDa. 
For endogenous DDOST, its very short C-terminus of 1.1 kDa is facing the cytoplasm. This was 
increased by the addition of FRB-mCherry to 39.6 kDa. The additional MBP-tag increased the 
cytoplasmic facing C-terminus by 80.3 kDa compared to endogenous DDOST. In DDOST-GST-FRB-
mCherry, the size of the extraluminal region in the dimerized form was 130.8 kDa (figure 30C).  
 
 
Figure 30: Overview of constructs of Sec61, Ube2j1 and DDOST with increasing size of the 
extraluminal domains by addition of different tags. 
Scheme of the size of the cytoplasmic domain of Sec61 (A) and Ube2j1 (B), for which the tags 
mCherry, FRB, GST and MBP are added to the N-terminus of the protein. For DDOST (C), the tags 
were added to the C-terminus, facing the cytoplasm and/or nucleus. 
 
 
For the different Sec61-proteins, a localization to the ER and the NE could be observed without 
any obvious differences (figure 31A-C). For the rapamycin-induced dimerization assay using the 
reporter EGFP2-GST-M9-FKBP12 (figure 29A and B) described above, 97% of the cells expressing 
mCherry-FRB-Sec61 showed a reporter response upon rapamycin-treatment for 10 minutes. This was 
also true for the same Sec61-construct tested in the experiment with the reporter EGFP2-MBP-M9-
FKBP12 (figure 31D). With the increase of the size of the cytoplasmic domain to 86.6 kDa, 55.7% ± 7.2 
of the cells responded with a reporter recruitment to the NE due to rapamycin treatment. For mCherry-
FRB-GST-Sec61 (141.2 kDa for cytoplasmic domain), 44.7% ± 11.4 showed a reporter response upon 
the addition of rapamycin. This indicates that by increase of the cytoplasmic domain of Sec61 by 




Figure 31: Size-dependency of INM targeting of Sec61 on the extraluminal region. 
(A) HeLa cells were transfected with plasmids coding for mCherry-FRB-Sec61 and EGFP2-MBP-
M9-FKBP12 for 48 hours followed by an incubation with rapamycin for 10 minutes, fixation and direct 
analysis using the Axioskop2 mot plus. DAPI marked the nucleic acids in fluorescence microscopy. 
(B) As (A) with mCherry-FRB-MBP-Sec61 and EGFP2-MBP-M9-FKBP12. (C) As (A) with mCherry-
FRB-GST-Sec61 and EGFP2-MBP-M9-FKBP12. (D) Quantification (A-C) shows the mean and the 
standard deviation of three individual experiments with two replicates each, counting 600 cells of 
every condition in total.  
 
The overexpression of the three differently tagged Ube2j1-proteins resulted in a similar 
distribution over the cell. The proteins localized to the ER and the NE (figure 32A-C). After 10 minutes 
of rapamycin-treatment, 68% ± 5.7 of the cells showed a recruitment of the reporter EGFP2-MBP-M9-
FKBP12 to the NE. This result was comparable to the rapamycin-induced dimerization assay using the 
reporter EGFP2-GST-M9-FKBP12 (74.6% ± 9.9 responding cells, figure 29E and F). When the protein 
mCherry-FRB-MBP-Ube2j1 was analyzed in the rapamycin-induced dimerization assay, the number of 
rapamycin-responding cells massively decreased: 23% ± 4.7 showed a reporter targeting to the NE 
when the cytoplasmic size was increased from 44.9 kDa (mCherry-FRB-Ube2j1) to 86.6 kDa (mCherry-
FRB-MBP-Ube2j1). This effect was even more dramatic for cells overexpressing the GST-tagged 
protein: only 3.3% ± 0.5 of the cells responded to the rapamycin treatment (figure 32D). These results 
demonstrate that the increase of the size of the cytoplasmic domain of Ube2j1 had an inhibiting effect 
on its INM targeting. The increase of the size of the cytoplasmic domain by 120.5 kDa decreased the 




Figure 32: Size-dependency of INM targeting of Ube2j1 on the extraluminal region. 
(A) Rapamycin-induced dimerization assay for HeLa cells overexpressing mCherry-FRB-Ube2j1 and 
EGFP2-MBP-M9-FKBP12 for 48 hours. After 10 minutes of rapamycin addition, cells were fixed and 
directly analyzed using the Axioskop2 mot plus. DAPI marked the nucleic acids in fluorescence 
microscopy. (B) As (A) with HeLa cells expressing mCherry-FRB-MBP-Ube2j1 and EGFP2-MBP-M9-
FKBP12. (C) As (A) with proteins mCherry-FRB-GST-Ube2j1 and EGFP2-MBP-M9-FKBP12. (D) 
Quantification of (A-C) shows the mean and standard deviation of three independent experiments 
with two replicates each, counting 600 cells of every condition in total.  
 
 
The differently tagged proteins of DDOST located to the ER and the NE in a similar way (figure 
33A-C). The testing of DDOST-FRB-mCherry in the rapamycin-induced dimerization assay for 
10 minutes of treatment showed comparable results in the number of rapamycin-responding cells for 
the reporters EGFP2-GST-M9-FKBP12 (figure 29K and L; 98% ± 1) and EGFP2-MBP-M9-FKBP12 
(figure 33D; 96.8% ± 1.5). Interestingly, when the domain facing the cytoplasm was increased from 
39.6 kDa (DDOST-FRB-mCherry) to 81.4 kDa by an additional MBP-tag, the number of rapamycin-
responding cells was reduced to 23.7% ± 5.9. For DDOST-GST-FRB-mCherry, 15.8% ± 6.9 of the cells 
showed a reporter recruitment to the NE. These results show that the increase of the size of the 
cytoplasmic domain from 39.6 kDa (DDOST-FRB-mCherry) to 81.4 kDa (DDOST-MBP-FRB-mCherry) 




Figure 33: Size-dependency of INM targeting of DDOST on the extraluminal region. 
(A) HeLa cells overexpressing DDOST-FRB-mCherry and EGFP2-MBP-M9-FKBP12 for 48 hours 
prior to rapamycin treatment for 10 minutes, fixation and direct analysis using the Axioskop2 mot 
plus. DAPI marked the nucleic acids in fluorescence microscopy. (B) As (A) with plasmids coding for 
DDOST-MBP-FRB-mCherry and EGFP2-MBP-M9-FKBP12. (C) As (A) with plasmids coding for 
DDOST-GST-FRB-mCherry and EGFP2-MBP-M9-FKBP12. (D) Quantification shows the mean and 
standard deviation of rapamycin-responding cells for differently tagged DDOST-constructs (A-C) for 
three individual experiments with two replicates each, counting 600 cells of every condition in total.  
 
 
The diffusion of proteins to the INM is supposed to be size-dependent. The increase of the size 
of the extraluminal domains of Sec61, Ube2j1 and DDOST had an inhibitory effect for their INM 





The localization of integral membrane proteins at the INM still raises many questions: First, it is 
not completely clear, why some membrane proteins reach the INM while others are excluded. How are 
proteins sorted or which protein properties are required for this restricted access? Further, is there an 
active transport involving transport factors for some membrane proteins? And if so, how can a transport 
factor pass the central channel of the NPC while it is bound by a protein which is embedded into the 
membrane? Does this way of trafficking disrupt the structure of the NPC? If membrane proteins reach 
the INM by passive diffusion, are the peripheral channels the route into the nucleus to pass the NPC? 
How flexible are peripheral channels or do they act as bottle neck for diffusion? When membrane 
proteins reach the INM, are all of these proteins retained by binding events or do some proteins diffuse 
back into the ER-membrane if they are not retained in the INM? Do all proteins which reach the INM 
fulfill a function in the nucleus? Do the ONM/ER-membrane and the INM share all membrane proteins 
containing extraluminal regions which are small enough to pass the peripheral channels by diffusion?  
As a contribution solving some of these questions, the protein LRRC59 was chosen as a model 
protein. LRRC59 is a protein containing a single TMD, which makes the investigation less complex than 
the analysis of a multi-spanning membrane protein containing several TMDs and intermembrane 
regions. Furthermore, LRRC59 was suggested to reach the INM in an importin -dependent manner 
(Zhen et al., 2012), making LRRC59 an interesting model protein to analyze its INM targeting in more 
detail.  
First, the mechanism of membrane insertion of LRRC59 was investigated by in vitro microsome 
integration assays and cell-based experiments. Then, targeting to the INM of the membrane-embedded, 
overexpressed mCherry-FRB-LRRC59 protein was studied in rapamycin-induced dimerization assays. 
Additionally, the extraluminal amino acid sequence of LRRC59 was analyzed with respect to a potential 
NLS, which could be crucial for the nuclear import of the full-length protein. Not much is known about 
the biological function of LRRC59. Therefore, LRRC59 was examined by the identification of binding 
and/or proximity partners by RAPIDS experiments.  
In addition to LRRC59, seven proteins, Sec61, Sec22b, Ube2j1, Ube2j2, LMAN2, DDOST and 
WRB, were investigated with respect to a potential INM localization. Similar to LRRC59, these proteins, 
which contain one TMD (except of WRB) and are mainly localized to the ER-membrane, were analyzed 
for localization of a subpopulation to the INM. 
 
4.1 Membrane insertion of LRRC59 
Newly synthesized TMD-containing proteins are inserted into the lipid bilayer of the 
ER-membrane via co- or post-translational integration mechanisms. After insertion and folding, they are 
targeted to their final destination (Rapoport, 1992; Kutay et al., 1993).  
It was shown that LRRC59 contains a single TMD and a 40 amino acid long C-terminus facing 
the lumen of the ER (Zhen et al., 2012). As the ribosomal tunnel houses around 40 amino acids during 
translation (Hegde and Keenan, 2011), this tail could be long enough to enable a co-translational 
insertion mechanism for LRRC59 using the SRP-dependent pathway. Proteins with shorter luminal 
C-termini had been shown to be targeted to the ER-membrane by a post-translational insertion 
mechanism. For instance, the TRC pathway substrate emerin contains 11 amino acids (Pfaff et al., 
2016), Sec61 five amino acids (Stefanovic and Hegde, 2007; Favaloro et al., 2008) and syntaxin 5 only 
one amino acid (Rivera-Monroy et al., 2016) at their C-termini following the TMD.  
For the analysis of the insertion mechanism for LRRC59, in vitro microsome integration assays 
were performed (Favaloro et al., 2008; Favaloro et al., 2010; Vilardi et al., 2011; Pfaff et al., 2016; 
Rivera-Monroy et al., 2016). In the presence of the translation inhibitor puromycin, LRRC59 was still 
able to insert into rough microsomes when the co-translational insertion mechanism was blocked. This 
result indicates that LRRC59 can be post-translationally inserted and is therefore classified as a TA 
protein (figure 9). This post-translational insertion was possible even though the C-terminus of LRRC59 
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was extended by 13 amino acids by the addition of the opsin-tag. However, with this experimental 
approach, it cannot formally be excluded that LRRC59 is able to use alternatively a co-translational 
insertion mechanism, if the post-translational route is blocked.  
Further, it was demonstrated that the insertion of LRRC59 cannot happen spontaneously but 
depends on a receptor (figure 10). Consequently, the involvement of the TRC pathway receptors WRB 
and CAML for insertion of LRRC59 was further investigated, as the TRC pathway is the main route of 
post-translational membrane insertion for TA proteins (Vilardi et al., 2011; Yamamoto and Sakisaka, 
2012; Vilardi et al., 2014; Borgese and Fasana, 2011). In the presence of dominant negative inhibitory 
fragments of WRB and CAML (Vilardi et al., 2011; Yamamoto and Sakisaka, 2012; Pfaff et al., 2016), 
the membrane insertion of LRRC59 was not inhibited at all, while emerin, a TRC pathway-dependent 
TA protein (Pfaff et al., 2016), could not be inserted (figure 11). Further, the depletion of TRC40 itself 
did not affect the membrane insertion of LRRC59 in contrast to emerin (figure 12).  
When the ATPase-deficient mutant TRC40 D74E (Coy-Vergara et al., 2019), the equivalent of 
yeast Get3 D57E (Powis et al., 2013), was overexpressed (figure 13), endogenous emerin showed a 
weaker NE-localization but a diffuse staining in the cytoplasm compared to TRC40 WT expressing or 
non-transfected cells which both showed a strong NE staining of emerin. This result suggests that 
emerin was bound by TRC40 D74E but could not be passed on to the receptors WRB and CAML for 
membrane insertion and further targeting to the NE. Interestingly, Bag6, a component of the pre-
targeting complex of the TRC pathway, was not only shown to recruit TRC40 to its substrate, but also 
to be able to recruit the ubiquitination machinery (Hessa et al., 2011). Proteins which have to be 
degraded can be marked by polyubiquitin chains resulting in the degradation of the protein by the 
proteasome (Glickman and Ciechanover, 2002). Therefore, it is possible that emerin bound by 
TRC40 D74E is degraded by the proteasome which could be tested by the determination and 
comparison of the signal of emerin in cells overexpressing TRC40 WT or TRC40 D74E.  
In contrast to emerin, which needs a functional TRC40 protein for membrane insertion, the 
localization of endogenous LRRC59 was comparable between TRC40 WT and TRC40 D74E 
overexpressing and non-transfected cells. This indicates that LRRC59 is either not a substrate of TRC40 




Conclusion and perspectives 
In summary, LRRC59 was demonstrated to be a TA protein, which can be inserted post-
translationally into rough microsomes. A dependency for membrane insertion of LRRC59 on the 
TRC pathway, the best described route of post-translational membrane insertion of TA proteins, could 
not be shown. The open question is, which alternative pathway could mediate LRRC59 insertion, as an 
unassisted mechanism was excluded. 
Alternatively, LRRC59 could be a substrate of the chaperones Hsp40 and Hsc70, which have 
been shown to directly interact with the TMD of TA proteins (Abell et al., 2007; Rabu et al., 2008). This 
possibility could be tested by microsome integration assays using Hsp40 and Hsc70 immunodepleted 
rabbit reticulocyte lysate similar to the performed TRC40 depletion experiment.  
The SND pathway was shown to be an alternative route of TA proteins to the ER-membrane in 
S. cerevisiae if the SRP and GET pathways were not functional (Aviram et al., 2016). So far, only one 
protein, hSnd2, was identified to be part of the human SND pathway. Interestingly, LRRC59 was co-
immunoprecipitated with hSnd2 and identified by mass spectrometry (Hassdenteufel et al., 2017). To 
further test for an interaction of hSnd2 with LRRC59, chemical crosslinking experiments (Favaloro et 
al., 2008; Stefanovic and Hegde, 2007) with in rabbit reticulocyte lysate in vitro transcribed/translated 
LRRC59 could be performed. 
Another alternative would be membrane targeting in a post-translational manner by SRP, which 
was shown to bind TA proteins after termination of translation in crosslinking experiments (Abell et al., 
2004). As the usage of puromycin in the microsome integration assay only blocks translation itself, it 
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cannot be excluded that SRP is able to bind and target LRRC59 for membrane insertion after translation 
termination. Interestingly, RAPIDS experiments identified the SRP receptor subunit alpha and beta 
(SRPRB, SRPR, figure 26, table 26) to be in close proximity to mCherry-FRB-LRRC59. Ideally, SRP 
could be blocked by a specific inhibitor as for instance eeyarestatin I (Van Puyenbroeck and Vermeire, 
2018). This drug blocks specifically the SRP-dependent pathway by inhibition of the transfer of the signal 
peptide from SRP to the Sec61 translocon (Cross et al., 2009; Van Puyenbroeck and Vermeire, 2018). 
However, in this work the efficiency of the drug could not be confirmed with several control proteins 
(data not shown), even though they were shown or predicted to be eeyarestatin I sensitive (confirmed: 
preprolactin, P2X2 (Cross et al., 2009); suggested: SUN1 (Laba et al., 2014)).  
 
The experiments performed in this thesis could show that LRRC59 can be inserted post-
translationally if the co-translational mechanism is blocked. However, the possibility that LRRC59 is able 
to insert co-translationally, when this route is not blocked, cannot be excluded by the experimental 
approach. LRRC59 could be inserted by several mechanism, shifting to an alternative route if one 
pathway is blocked. To finally answer which route(s) could be used by LRRC59, blocking of several 
pathways at the same time would be necessary until a total inhibition of membrane insertion in the 
microsome integration assays is observed. Additionally, chemical crosslinking experiments with the in 
vitro transcribed/translated LRRC59 would be possible (Favaloro et al., 2008; Stefanovic and Hegde, 
2007). The performance of siRNA mediated knockdowns of SRP, TRC40 and hSnd2 alone or in 
combination coupled with the analysis of subcellular localization of endogenous LRRC59 could also be 
conceivable experiments if compatible with cell survival. In general, further studies are necessary to 
determine the insertion mechanism of LRRC59 into the ER-membrane. 
 
 
4.2 Targeting of LRRC59 to the inner nuclear membrane 
4.2.1 The rapamycin-induced dimerization assay as a tool for examination of inner 
nuclear membrane localization 
The INM localization of mCherry-FRB-LRRC59 was demonstrated by the rapamycin-induced 
dimerization assay. In this approach, the presence of an integral membrane protein in the INM is 
indicated by the recruitment of a soluble nuclear reporter to the NE due to the dimerization of the 
FKBP12-tagged reporter with the FRB-tagged membrane protein of interest upon rapamycin treatment. 
As this complex formation was shown to be very stable (Hosoi et al., 1999), it can be excluded that the 
complex disassembles in the presence of rapamycin. Therefore, mCherry-FRB-LRRC59, which reached 
the INM, got trapped in the nucleus upon dimerization with rapamycin/EGFP2-GST/MBP-M9-FKBP12. 
This was indicated by the reporter, which remained in the nucleus and was not distributed to the 
cytoplasm.  
The dimerization of FRB and FKBP12 by rapamycin happens via two hydrophobic pockets (Choi 
et al., 1996), suggesting a 1:1:1 ratio of dimerization on molecular level. With increasing rapamycin 
incubation time, the number of cells responding to rapamycin, as indicated by reporter recruitment to 
the NE, increased for mCherry-FRB-(MBP)-LRRC59. Furthermore, it could be observed that high 
expression levels of mCherry-FRB-LRRC59 lead to complete reporter recruitment to the NE in less 
rapamycin incubation time than in cells overexpressing the protein at moderate or low levels. Also, the 
ratio of overexpression between reporter and protein of interest is important for the reporter recruitment 
to the NE: when the reporter is highly overexpressed, only a proportion of the reporter could be targeted 
to the NE. For a complete recruitment of a highly expressed reporter, more plasmid DNA coding for 
mCherry-FRB-LRRC59 has to be used for transfection (data not shown). The ratio between the 
concentrations of plasmid DNA coding for reporter and protein of interest is crucial and had to be 
adjusted for all tested membrane proteins and reporters. This suggests that a targeting process of 
mCherry-FRB-(MBP)-LRRC59 from the ER-membrane/ONM to the INM can happen during the 
treatment of the cells with rapamycin. However, the NE recruitment kinetic of the reporter is only an 
indicator for the amount of integral membrane protein which reaches the INM. The rapamycin-induced 
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dimerization assay does not reflect the kinetic of movement of the membrane protein of interest to the 
INM. For kinetic studies of LRRC59 itself, FLIP (Shimi et al., 2004) or FRAP (Zuleger et al., 2011; Wu 
et al., 2002) experiments could be performed. Furthermore, the kinetic of INM targeting of LRRC59 
could be examined by the performance of an established FRAP assay. In this experiment, the 
extraluminal domain of the membrane protein of interest is tagged with several RFP-tags followed by a 
tobacco etch virus (TEV) protease site, while the luminal region of the membrane protein is fused to a 
GFP-tag. Before cleavage, the membrane protein of interest localizes to the ER-membrane as the large 
extraluminal domain inhibits its diffusion to the INM. Upon the TEV-induced cleavage of the RFP-tags, 
the membrane protein reaches the INM, which can be observed by the movement of the GFP-tag from 
the ER to the NE. To analyze the mobility of the membrane protein in the ER before cleavage and at 
the NE after cleavage of the RFP-tags, FRAP can be performed (Ungricht et al., 2015). With this 
approach, the kinetic of INM targeting of LRRC59 could be directly observed in contrast to the reporter 
kinetic of the rapamycin-induced dimerization assay, which indicates the amounts of mCherry-FRB-
(MBP)-LRRC59 reaching the INM. 
Alternatively, Boni and colleagues used a reporter protein containing a self-cleavage retention 
system to examine the NE targeting of the N-terminus and the first TMD of LBR in living cells. At the 
N-terminus of LBR, a NS3 protease, a CMPK domain and a NS3 cleavage site was placed. LBR was 
tagged with GFP at the C-terminus after the TMD to observe the movement of the protein. The protease 
cleavage activity is inhibited by the presence of the inhibitor BILN2061 resulting in an ER-membrane 
localization of the protein. When the inhibitor was washed out, the CMPK domain, which is sufficient to 
inhibit INM targeting of LBR, was cleaved off and LBR was targeted to the NE. This approach was 
combined with an RNA interference screen and showed that the depletion of most transport receptors 
had no effect on the NE targeting of LBR, supporting a diffusion and retention model (Boni et al., 2015). 
This inducible cleavage could be combined with the rapamycin-induced dimerization assay to examine 
not only NE targeting and retention but to confirm localization to the INM. For instance, mCherry-FRB-
LRRC59 could be N-terminally tagged with the NS3 protease, a GST-tag and the NS3 cleavage site. In 
the presence of the protease inhibitor, this protein will probably locate to the ER-membrane as it is too 
big to pass the peripheral channels. Consequently, the nuclear reporter will not be recruited to the NE if 
the cells are incubated with rapamycin. However, when the protease inhibitor BILN2061 is washed out 
and rapamycin is added, the INM targeting and retention in the nucleus of the cleaved mCherry-FRB-
LRRC59 could be observed in real time by the recruitment of the reporter to the NE. In this thesis, the 
rapamycin-induced dimerization assay was performed with different incubation times prior to fixation 
and microscopic analysis of the cells. However, this assay can also be performed in living cells. 
Therefore, the combination of the inducible cleavage and the rapamycin-induced dimerization assay 
could be an approach to observe not only NE targeting but confirm INM localization of an integral 
membrane protein.  
The rapamycin-induced dimerization assay could also exclude the possibility that a proportion of 
mCherry-FRB-LRRC59 was transported into the nucleus as soluble protein and integrated into the INM 
by a not yet described insertion mechanism within the nucleus. If mCherry-FRB-LRRC59 was 
transported into the nucleus as a soluble protein, rapamycin/EGFP2-GST/MBP-M9-FKBP12 would 
probably bind to FRB immediately after the import event, resulting in a complex of two soluble proteins 
located all over the nucleus. As mCherry-FRB-LRRC59 was at the NE and the reporter was recruited to 
the NE upon rapamycin treatment, it was assumed that the further analysis observes the INM targeting 




The rapamycin-induced dimerization assay is a strong tool to analyze the localization of a 
membrane-embedded protein to the INM. The presence of the membrane protein of interest is indicated 
by the reporter recruitment to the NE. The kinetic of reporter recruitment is an indicator for the amounts 
of FRB-tagged membrane proteins that reach the INM.  
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4.2.2 Importin  is not required for localization of LRRC59 to the inner nuclear 
membrane 
The S. cerevisiae integral membrane proteins Heh1 and Heh2 were suggested to be targeted to 
the INM dependent on the karyopherin Kap95 (yeast homolog of human importin ), the adaptor protein 
Kap60 (yeast homolog of human importin ) and the activity of Ran (King et al., 2006). So far, no active 
transport factor-dependent mechanism could be shown for the nuclear import of a mammalian 
membrane protein. The human protein LRRC59, however, was suggested to localize to the NE in an 
importin -dependent manner (Zhen et al., 2012). In that study, endogenous LRRC59 was shown to 
lose its NE localization in U2OS cells if the cells were treated with importin  siRNAs (Zhen et al., 2012). 
However, when this experiment was repeated with the same specific LRRC59-antibody, LRRC59 
localized to the ER-membrane and NE similar in control or importin  knockdown cells (figure 17). 
Experiments with a very high depletion of importin  (14% remaining importin  in Western blot analysis) 
showed no difference in the localization of endogenous LRRC59 compared to control knockdown cells. 
As importin  is a crucial component of a functional nucleocytoplasmic transport, which is essential for 
cell viability (Chook and Suel, 2011), it is likely that in the former study (Zhen et al., 2012) importin  
was not depleted in total. Perhaps the loss of the NE localization of LRRC59 was rather caused by off-
target effects of the siRNA treatment than by a total importin  knockdown. In the previous study, the 
importin  knockdown was not controlled by immunofluorescence staining or Western blotting, in 
contrast to the performed experiments of this thesis. At present, the reason for the conflicting results 
cannot be easily explained. 
To examine the localization of LRRC59 specifically in the INM, the rapamycin-induced 
dimerization assay was performed in importin  siRNA treated cells. Here, the efficiency of the importin  
knockdown was controlled by Western blot with immunodetection and the transfection of the cells with 
an additional plasmid coding for NES-mTagBFP2-cNLS, which is a substrate of importin . This protein 
was shifted from the nucleus to the cytoplasm in importin  siRNA treated cells, indicating that importin  
became rate-limiting for nuclear transport. However, in these cells, the recruitment of the reporter to the 
NE upon rapamycin treatment was not affected in cells overexpressing mCherry-FRB-LRRC59 even in 
experiments with the highest depletion of importin  (figure 18). The INM localization of mCherry-FRB-
LRRC59 was also not affected in the rapamycin-induced dimerization assay when FLAG-Bimax2, a 
peptide sequence which was shown to block specifically the importin /importin  pathway (Kosugi et 
al., 2008), was overexpressed. In contrast, the localization of the importin /importin  pathway 
dependent protein NES-mTagBFP2-cNLS was affected (figure 19).  
Further, the amino acid sequence of the extraluminal domain of LRRC59 was analyzed for a 
potential NLS. The soluble protein EGFP-LRRC59 aa1-244 was found exclusively in the nucleus as it 
was shown before with a similar construct (Zhen et al., 2012). However, this localization was not affected 
by an importin  knockdown. When the protein was enlarged by an additional EGFP- and a GST-tag, 
the dimerized protein of 218.6 kDa was found in the cytoplasm (figure 20). The import of a soluble 
protein containing an NLS would not be limited by this molecular mass, as the NPC is able to transport 
soluble proteins up to a few megadaltons (Grossman et al., 2012). It is more likely that EGFP-LRRC59 
aa1-244 reaches the nucleus by diffusion. The accumulation in the nucleus could be due to unspecific 
binding to chromatin, which might be mediated by the very basic amino acid sequence of LRRC59 aa1-
244 with an isoelectric point of 8.8 (Protein isoelectric point calculator, testing of LRRC59 aa1-244 at 
isoelectric.org). Importantly, when EGFP-LRRC59 aa1-244 was increased in size by the additional 
EGFP- and GST-tags, the passive diffusion was inhibited. Consequently, the existence of an NLS within 
the extraluminal domain of LRRC59 as well as an active nuclear import by importin  or any other 
transport factor can be excluded for the soluble protein. 
 
Conclusion 
In this study, it could be ruled out that LRRC59 is targeted to the INM by an active transport 
mechanism. The extraluminal domain of LRRC59 does not contain an NLS. In addition, the depletion of 
Discussion 
 103 
importin  by siRNAs or the inhibition of the importin /importin  pathway did not affect the localization 
of LRRC59 to the INM.  
 
 
4.2.3 LRRC59 reaches the inner nuclear membrane by passive diffusion 
For the yeast integral membrane protein Heh2 an active import mechanism into the INM was 
suggested. However, this finding is still debated as yeast cells lack lamins, which could retain Heh2 in 
the INM. The observed effect of inhibition in INM targeting of Heh2 by depletion of Kap95 and Kap60 
could be the result of blocking the nuclear transport of a soluble binding partner, which retains Heh2 at 
the INM (Ungricht and Kutay, 2015). The main route to the INM is supposed to be mediated by passive 
diffusion and retention (Ungricht et al., 2015; Boni et al., 2015; Ungricht and Kutay, 2015). The diffusion 
to the INM is suggested to occur via peripheral channels of the NPC. These lateral openings are 
approximately 10 nm in width and restrict the diffusion of membrane proteins with an extraluminal 
domain of about 60 kDa. As an active transport mechanism depending on importin  could be ruled out 
for LRRC59, the possibility of free diffusion to the INM was examined. Therefore, the extraluminal 
domain of LRRC59 was changed for the proteins used in the rapamycin-induced dimerization assay.  
The protein mCherry-FRB-LRRC59 has an extraluminal domain of 65.8 kDa and was shown to 
reach the INM in more than 90% of the cells. When this domain was reduced in size to 40.8 kDa with 
the exchange of the mCherry- to a HA-tag, the percentage of rapamycin-responding cells was similar 
over time. However, when the cytoplasmic/nucleoplasmic region was increased to 107.5 kDa with the 
insertion of an MBP-tag, the percentage of rapamycin responding cells was decreased by approximately 
40% for each tested rapamycin incubation time (figure 21, 22). Strikingly, when the extraluminal domain 
was further increased to 182.8 kDa in the dimerizing protein mCherry-FRB-GST-LRRC59, the INM 
targeting was almost totally blocked (figure 22). As the size of the extraluminal domain was important 
for INM localization, these results indicate that LRRC59 reaches the INM by diffusion.  
Do these findings fit with the suggested size limit of approximately 60 kDa of diffusing INM 
proteins (Soullam and Worman, 1993, 1995; Wu et al., 2002; Ohba et al., 2004; Zuleger et al., 2011; 
Antonin et al., 2011; Katta et al., 2014; Ungricht and Kutay, 2015)? The extraluminal domain of mCherry- 
and HA-tagged FRB-LRRC59 differ by 25 kDa, but do not show differences in INM targeting of the 
overexpressed proteins. It was suggested that not only the size of the cytoplasmic/nucleoplasmic 
domain but also the structure is important for INM targeting of a membrane protein (Soullam and 
Worman, 1995). Here, a size limit of around 60 kDa for the extraluminal domain is probably not a fixed 
value, but maybe considered as flexible depending on the geometry of the protein. The 28.8 kDa 
mCherry -barrel has a width of approximately 3 nm and a height of about 4 nm (Day and Davidson, 
2009). FRB, which is necessary for the experimental approach of the rapamycin-induced dimerization 
assay, is a helix bundle of four helices with short connections with dimensions of approximately 3 nm x 
4.5 nm x 3 nm (Choi et al., 1996). These dimensions are smaller than the suggested width of 10 nm of 
the peripheral channels. Therefore, it is not surprising that mCherry-FRB-tagged LRRC59 reached the 
INM even if the considered reference value in INM diffusion of 60 kDa is exceeded by 5.8 kDa.  
When the extraluminal domain was further increased by the insertion of an MBP-tag, the INM 
targeting of LRRC59 was reduced but not blocked. As targeting of proteins occurs during the 
performance of the rapamycin-induced dimerization assay and rapamycin/reporter-bound FRB-tagged 
LRRC59 cannot leave the nucleus (discussed in section 4.2.1), more and more mCherry-FRB-MBP-
LRRC59 proteins accumulated in the INM over time as indicated by the recruitment of the reporter to 
the NE. However, the INM targeting of mCherry-FRB-MBP-LRRC59 was delayed compared to INM 
targeting of mCherry/HA-FRB-tagged LRRC59. It seems that the 42 kDa MBP-tag slowed down the 
diffusion via the peripheral channels. The MBP-tag has dimensions of approximately 3 nm x 4 nm x 
6.5 nm (Spurlino et al., 1991), which should fit into the 10 nm wide peripheral channels. For integral 
membrane proteins, an inhibition in INM targeting was observed, when the extraluminal domains were 
increased in size (Boni et al., 2015; Ungricht et al., 2015). It was suggested that the extraluminal 
domains have to funnel into lateral channels for the diffusion of integral membrane proteins to the INM. 
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This step seems to be more time-consuming when the cytoplasmic/nucleoplasmic domain is increased 
in size (Ungricht and Kutay, 2015). Therefore, the MBP-tag slowed down but did not block the INM 
targeting of LRRC59, as an additional tag had to threat into the lateral channels. However, for defined 
statements about fast or slow diffusion to the INM, kinetic studies are needed, as the kinetic of the 
reporter in the rapamycin-induced dimerization assay is only an indicator for the amount of FRB-tagged 
membrane protein, which reaches the INM. 
When the MBP-tag was exchanged for a GST-tag, which is known to assemble into dimers (Bell 
et al., 2013), the INM targeting of LRRC59 was almost completely inhibited (figure 22). The used GST-
tag, which contains several -sheets and -helices, has a geometry of approximately 10 nm x 10 nm x 
6 nm for the monomer (Lim et al., 1994). When GST assembles in dimers yielding an extraluminal 
domain of 182.8 kDa for mCherry-FRB-GST-LRRC59, the geometry of GST is suggested to block INM 
targeting as the protein is too big in dimension to fit into peripheral channels of the NPC. Therefore, 
mCherry-FRB-GST-LRRC59 was hardly targeted to the INM to mediate a reporter recruitment to the 
NE, as no differences in the percentage of rapamycin-responding cells over time could be observed 
(figure 22). For all tested rapamycin incubation times, in average around eight percent of the cells 
showed a moderate reporter recruitment to the NE. This recruitment could potentially be explained by 
mCherry-FRB-GST-LRRC59 reaching the INM rather during NE reassembly in mitosis than by passive 
diffusion during interphase.  
For a schematic overview of the results of the rapamycin-induced dimerization assay for LRRC59 
see figure 34.  
 
 
Figure 34: The size and the geometry of the extraluminal domain control the localization of 
LRRC59 indicating an INM targeting by passive diffusion. 
Schematic overview of the results of the rapamycin-induced dimerization assays: mCherry-FRB-
LRRC59 (red protein) and mCherry-FRB-MBP-LRRC59 (blue protein) reach the INM by passive 
diffusion. However, the kinetic of the recruitment of the reporter to the NE (reporter not illustrated in 
scheme) is much slower for mCherry-FRB-MBP-LRRC59 compared to the protein lacking the MBP-
tag. As the reporter kinetic is an indicator for the amounts of proteins, which reach the INM, less 
mCherry-FRB-MBP-LRRC59 diffuses into the INM compared to mCherry-FRB-LRRC59 for similar 
incubation times with the drug in the rapamycin-induced dimerization assay. This could be explained 
by threading into the peripheral channels of the nuclear pore complex (NPC), which could require 
more time for larger cytoplasmic/nucleoplasmic regions. It is speculated that both proteins are also 
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able to leave the INM to the ONM/ER-membrane by diffusion. The protein mCherry-FRB-GST-
LRRC59 (green protein), which is assembled in dimers, is not able to reach the INM due to the large 
extraluminal domain and the geometry of the GST-tag. 
 
Endogenous emerin lost its NE localization upon the knockdown of lamin A/C. However, when 
endogenous LRRC59 reaches the INM, it seems that it is not retained in the nucleus by binding to 
lamin A/C (figure 16). The absence of an effect of the localization of LRRC59 in lamin A/C siRNA treated 
cells could be due to two reasons: first, as LRRC59 mainly localizes to the ER-membrane, the loss of 
the retaining protein in the nucleus would not cause an observable shift to the ER-membrane compared 
to emerin, which is mainly in the INM in control knockdown cells. The second explanation could be that 
LRRC59, in contrast to emerin, is not a binding partner of lamin A/C and therefore the knockdown has 
no effect for the INM localization. 
Previously, the nuclear targeting mechanism has been mainly studied by the examination of 
proteins primarily localizing to the INM as for instance emerin (Manilal et al., 1996), LBR (Worman et 
al., 1990) or LAP2 (Furukawa et al., 1995). For integral membrane proteins diffusing to the INM, a 
retention mechanism is suggested, which mediates the accumulation of these proteins in the nucleus. 
Many INM protein have been shown to bind lamins or chromatin for their INM retention (Katta et al., 
2014; Ungricht and Kutay, 2015). In contrast, the majority of the model protein LRRC59 is located in the 
ER-membrane, whereas only a small subpopulation reaches the INM. The question arises whether 
LRRC59 is retained in the INM or rather diffuse into and out of the nucleus as its small extraluminal 
domain does not inhibit passage through peripheral channels. To solve this question, further studies are 
needed to assign a biological function to LRRC59, which might explain its INM localization, and to rule 
out that the subpopulation could be retained in the INM by binding to other proteins than lamin A/C. As 
only a small subpopulation of LRRC59 reaches the INM, this thesis rather suggests that LRRC59 is an 
ER-membrane protein, which can diffuse into the nucleus via peripheral channels due to its small 




In this thesis, it could be shown that LRRC59 is targeted to the INM independent of the 
importin /importin  pathway (see section 4.2.2). In contrast, by the increase of the size of the 
extraluminal domain, it could be demonstrated that LRRC59 diffuses into the INM. For the passage of 
the peripheral channel of the NPC, not only the size of the cytoplasmic/nucleoplasmic domain was 
important for INM targeting of LRRC59, but also the geometry and dimensions of the used tags, as the 
107.5 kDa MBP-tagged LRRC59 protein was able to reach the INM over time, an extraluminal domain 
size which is much bigger than the suggested limit for passage of peripheral channels of approximately 
60 kDa (Ungricht and Kutay, 2015). In the INM, LRRC59 does not seem to get retained by binding to 




4.3 Protein interaction partners of LRRC59 
Proteins in close proximity to LRRC59 
Nup210 was identified in RAPIDS experiments as a protein in close proximity to mCherry-FRB-
LRRC59. Nup210 is a protein of the NPC that contains a TMD at its C-terminus and anchors the NPC 
together with the TMD-containing nucleoporins Pom121 and NDC1 to the NE (Weberruss and Antonin, 
2016; Grossman et al., 2012). These proteins are suggested to be adjacent to peripheral channels 
(Knockenhauer and Schwartz, 2016). LRRC59 diffuses into the INM, which is in general suggested to 
occur via peripheral channels of the NPC (Katta et al., 2014; Ungricht and Kutay, 2015). Therefore, it is 
not surprising that Nup210 was identified in RAPIDS experiments to be in close proximity to LRRC59 
(figure 26, table 26). A direct interaction between the extraluminal domains of LRRC59 (N-terminus) and 
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Nup210 (C-terminus) could not be identified by pulldown experiments (figure 27). This is in line with the 
suggestion that passage of LRRC59 by peripheral channels does not require binding to the NPC when 
LRRC59 is targeted to the INM. The second nucleoporin identified by RAPIDS was RANBP2, also called 
Nup358. This protein assembles the cytoplasmic filaments together with Nup214 and Nlp1.These 
filaments extend into the cytoplasm and interact with transport complexes (Beck and Hurt, 2017; Marelli 
et al., 2001; Suntharalingam and Wente, 2003). As LRRC59 is not actively transported into the INM by 
a transport factor, which could interact with Nup358, it is likely that the extraluminal domain of LRRC59 
extended by mCherry-FRB is adjacent to Nup358, when the protein is on its way to the INM. However, 
it cannot be easily explained why RAPIDS experiments did not identify further proteins of the NPC 
except of Nup210, Nup358 and Nup107 to be in close proximity to LRRC59.  
In other large-scale studies and yeast two-hybrid screens, LRRC59 was identified as a binding 
partner for human MT1 melatonin receptor (Daulat et al., 2007), MPG (DNA-3-methyladenine 
glycosylase) (Ewing et al., 2007), RRP1B (ribosomal RNA processing 1 homolog B) (Crawford et al., 
2009), CIP2A (Pallai et al., 2015) or FGF1 (Skjerpen et al., 2002; Zhen et al., 2012). However, none of 
these binding partners could be identified by the RAPIDS experiments. Several ER-membrane resident 
proteins, for instance Sec22b or LMAN2, could be identified, which could be explained by their proximity 
to LRRC59. Nevertheless, further experiments are needed to analyze a potential direct interaction or 
proximity between LRRC59 and the remaining identified proteins of the RAPIDS experiments. 
 
The interaction of LRRC59 with FGF1 and CIP2A 
In previous studies, it was proposed that the nuclear localization of CIP2A (Pallai et al., 2015) and 
FGF1 (Zhen et al., 2012) depends on LRRC59. In fractionation studies, exogenous FGF1 was 
suggested to be imported into the nucleus by the interaction with LRRC59. The INM targeting of LRRC59 
was suggested to be importin -dependent in importin  siRNA treated U2OS cells (Zhen et al., 2012). 
However, these cells were not controlled for the efficiency of the importin  knockdown as discussed 
above. As LRRC59 was shown to diffuse into the INM and its nuclear targeting is importin -
independent, the question arises, how the findings of this thesis fit together with the LRRC59-
dependency of nuclear localization of CIP2A and FGF1. 
CIP2A, an inhibitor of PP2A (Protein phosphatase 2A, involved in tumor suppression), has in total 
905 amino acids and contains a single TMD (amino acids 192-212; UniProt ID Q8TCG1). Its N-terminus 
(amino acids 1-583) was shown to bind to LRRC59 in a yeast two-hybrid screen, an interaction which 
was validated by immunoprecipitation experiments in prostate cancer cells. CIP2A translocates into the 
nucleus at G2/M due to the interaction with LRRC59 (Pallai et al., 2015). However, it was not shown 
whether the N-terminus of CIP2A is oriented to the cytoplasm or the lumen of the ER. In this thesis, it is 
suspected that the interacting part of CIP2A faces the cytoplasm, as the interaction probably occurs with 
the N-terminal LRR or the coiled-coil domain of LRRC59 rather than with its short C-terminus in the 
lumen. For CIP2A, this could either be amino acids 1-192, which is the N-terminal region before the 
TMD, or amino acids 213-583 after the TMD. If the binding to LRRC59 occurs via amino acids 1-192 of 
CIP2A, 21.3 kDa of the extraluminal domain of CIP2A would bind to 27.8 kDa of the 
cytoplasmic/nucleoplasmic region of LRRC59. The molecular mass of both interacting cytoplasmic 
regions could be small enough to pass the peripheral channels by diffusion. If amino acids 213-583 of 
CIP2A bind to the N-terminal region of LRRC59, the C-terminus of CIP2A, which has a molecular mass 
of 78.7 kDa (amino acid 213-905), would probably face the cytoplasm. Therefore, the extraluminal 
domain of LRRC59 would be increased by binding to CIP2A to a total of 106.5 kDa. As the protein 
mCherry-FRB-MBP-LRRC59 with its extraluminal domain of 107.5 kDa is able to reach the INM, 
LRRC59 bound by the C-terminus of CIP2A could probably also reach the INM. However, as mentioned 
above, the shape and dimension of the extraluminal domains of proteins play a role in the passage of 
the peripheral channels. Consequently, these speculations have to be proofed by further studies.  
FGF1 is a soluble protein of only 17.5 kDa (UniProt ID P05230) which was shown to interact with 
the coiled-coil domain of LRRC59 (Skjerpen et al., 2002; Zhen et al., 2012). Despite its small molecular 
mass, exogenous FGF1 is not able to freely diffuse into the nucleus (Imamura et al., 1990; Zhan et al., 
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1992; Wesche et al., 2005) but its nuclear localization depends on LRRC59 (Zhen et al., 2012). The 
suggested import of LRRC59 by importin  could be ruled out in this thesis. It could be possible that 
FGF1 binds to LRRC59 in the cytoplasm and diffuses together with LRRC59 into the nucleus. However, 
this targeting would not explain why the knockdown of importin  inhibits the nuclear import of FGF1 
(Zhen et al., 2012). If FGF1 is bound by importin  in the cytoplasm and additionally interacts with 
LRRC59, the targeting via a peripheral channel would probably not be possible. A collective diffusion of 
FGF1 and LRRC59 to the INM would only be possible, if the transport factor is striped off from FGF1 
before entering the peripheral channel (Ungricht and Kutay, 2015).  
 
LRRC59 was shown to be overexpressed in some metastasizing cell lines (Terp et al., 2012) and 
to interact with FGF1 (Skjerpen et al., 2002; Zhen et al., 2012), an inhibitor of p53-dependent apoptosis 
and cell growth arrest (Rodriguez-Enfedaque et al., 2009; Bouleau et al., 2005), and CIP2A (Pallai et 
al., 2015), an inhibitor of a phosphatase involved in tumor suppression (Eichhorn et al., 2009; Junttila et 
al., 2007). In the rapamycin-induced dimerization assay, it was observed that a higher percentage of 
cells respond to the rapamycin treatment in a shorter period of time, if the cells were transfected with an 
increased amount of plasmid DNA coding for mCherry-FRB-LRRC59 (data not shown). This indicates 
that more LRRC59 diffuses into the INM if the cell expresses more LRRC59 in general. If the expression 
of endogenous LRRC59 is increased in metastasizing cell lines, it can be speculated that more FGF1 
and/or CIP2A could reach the nucleus. This increase in the nucleus could contribute to metastatic 
potential of a cell and cancer formation.  
 
 
Conclusion and perspectives 
Not much is known about the biological function of LRRC59. In this thesis, several proteins have 
been shown to be in close proximity to LRRC59. Interestingly, the TMD-containing nucleoporin Nup210, 
which is adjacent to peripheral channels of the pore, was significantly enriched in RAPIDS experiments 
indicating a close proximity to LRRC59. Here, it was shown that the N-terminus of LRRC59 cannot 
interact with the extraluminal region of Nup210. This is in line with the suggestion that LRRC59 passes 
the peripheral channels on its way to the INM and that a direct binding would not fit to the theory of free 
diffusion in and out of the nucleus of the mainly ER-membrane localized membrane protein. However, 
to exclude that LRRC59 is able to bind to Nup210 directly, the luminal domains of both proteins have to 
be recombinantly purified and tested for binding in pulldown experiments, comparable to the performed 
testing of the extraluminal regions. The pulldown experiments could also be used to examine further 
identified proteins in close proximity to mCherry-FRB-LRRC59 of the RAPIDS experiment for direct 
binding events. In general, to identify additional proteins which directly interact with the extraluminal 
domain of LRRC59, the purified MBP-tagged LRRC59 aa1-244 could be immobilized on beads and 
incubated with cell lysate. If interacting proteins can be pulled out of the cell lysate indicated by 
Coomassie staining after SDS-PAGE, samples could be analyzed by mass spectrometry. To assign a 
biological function to LRRC59, further studies have to be performed, which can, for instance, start with 
the analysis of binding partners.  
 
 
4.4 The analysis of inner nuclear membrane targeting of further membrane proteins 
In addition to LRRC59 and emerin, seven more membrane proteins were analyzed in this thesis 
with respect to an INM localization.  
First, WRB was examined, a small protein of around 19 kDa, which contains 3 TMDs (UniProt ID 
O00258). Its N-terminus is luminal while the 4 amino acid short C-terminus faces the cytoplasm. The 
intermembrane region of 69 amino acids following the N-terminal TMD contains a coiled-coil domain 
(Vilardi et al., 2011; Anghel et al., 2017). In theory, by the addition of the 11 kDa FRB-tag and the 
1.1 kDa small HA-tag, the extraluminal region of the C-terminus of WRB should be small enough to 
reach the INM, resulting in a recruitment of the reporter to the NE in the presence of rapamycin. 
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However, even after 30 minutes of rapamycin treatment, no reporter recruitment could be observed 
(figure S 3 and 15B) indicating that WRB-FRB-HA is unable to reach the INM. Therefore, it served as a 
negative control for the rapamycin-induced dimerization assay. Nevertheless, the question arises, why 
WRB was not identified as an INM protein. One explanation could be that WRB exists in a large complex 
together with CAML. It was shown that the overexpression of both TRC pathway receptor subunits, 
WRB and CAML, did not inhibit the membrane insertion of Sec61, while the overexpression of one 
subunit alone lead to membrane insertion inhibition (Yamamoto and Sakisaka, 2012). Later, it was 
shown that CAML can be found in 4-fold excess in rat liver microsomes or 7-fold excess in 
neuroblastoma or human primary fibroblast cell lines compared to WRB. The stoichiometric analysis of 
the complex indicated that the expression levels of WRB and CAML critically depend on the presence 
of the other protein. The depletion of CAML, for instance, reduced the WRB levels in HeLa cells 
(Colombo et al., 2016). However, in this study the stoichiometric imbalance of WRB and CAML was not 
examined in cells overexpressing one of the receptor subunits. The overexpression of WRB-FRB-HA 
could therefore lead to two scenarios: as a result, expression levels of CAML could also be changed, 
probably upregulated, or CAML is not affected in its expression levels as it was shown to be available 
in excess compared to WRB. In the rapamycin-induced dimerization assay, it is possible that WRB-
FRB-HA assembles a complex in the ER-membrane with CAML. The N-terminus of CAML (amino acid 
1-189), which faces the cytoplasm, has a molecular mass of 20.8 kDa. If WRB and CAML assemble in 
a complex, each of the extraluminal domains should be small enough to pass peripheral channels. 
However, when WRB is tagged with FRB-HA and both extraluminal domains are not in close proximity 
to each other, the shape and structures of the cytoplasmic regions could inhibit INM targeting. 
Furthermore, the absence of WRB-FRB-HA in the INM could also be explained by the coiled-coil domain 
of the cytoplasmic intermembrane region. Even though this region has only a molecular mass of 8.3 kDa, 
the shape and dimensions of this domain could inhibit INM targeting of WRB via peripheral channels 
especially when the C-terminus of the protein is tagged by FRB-HA. These hypotheses again suggest 
an importance not only of the molecular mass but also of the geometry of extraluminal domains in 
context of INM targeting events via peripheral channels. To confirm this idea, further analyses have to 
be performed to see whether endogenous WRB would be able to reach the INM alone or in a complex 
with CAML.  
 
 
Six additional proteins were analyzed for localization to the INM in the rapamycin-induced 
dimerization assay. These single TMD-containing candidates were either picked because they were 
identified ER-membrane proteins in close proximity to mCherry-FRB-LRRC59 in RAPIDS experiments 
(Sec22b, LMAN2) or they were human orthologs of identified S. cerevisiae INM proteins of a systematic 
split-GFP microscopy-based live cell assay (Smoyer et al., 2016) (HCOP: Orthology Prediction Search: 
www.genenames.org/tools/hcop; LMAN2: human ortholog of EMP47; SEC61: human ortholog of 
SBH2; DDOST: human ortholog of WBP1; Ube2j1: human ortholog of Ubc6; Ube2j2: similar function 
and 43% sequence identity to Ube2j1 (Protein sequence BLAST tool of NCBI)). 
The mCherry- and FRB-tagged proteins Sec22b, LMAN2 and Ube2j2 were shown to localize to 
the ER-membrane and the NE. In the rapamycin-induced dimerization assay, an INM localization could 
be demonstrated for these proteins (figure 29). This result does not explain, why these proteins locate 
to the INM or whether they fulfill a function in the nucleus. However, it is interesting that proteins, which 
localized similar to LRRC59 mainly in the ER-membrane and contain a small extraluminal domain, are 
able to reach the INM. It could be that these proteins reach the nucleus by diffusion as their extraluminal 
domains could be small enough to pass the peripheral channels. In the INM, it is not obvious that they 
are bound or retained by nuclear proteins as they mainly locate to the ER-membrane as overexpressed 






For the candidates DDOST, Ube2j1 and Sec61 an INM localization could be shown. To analyze 
their targeting mechanism to the INM, the extraluminal domains of these proteins were also enlarged, 
similar to the analysis of LRRC59.  
 
DDOST has a very short C-terminal extraluminal domain of 9 amino acids. When DDOST was 
C-terminally tagged with FRB-mCherry, it located to the ER-membrane and at the NE. An INM 
localization could be confirmed in the rapamycin-induced dimerization assay (figure 29). When the 
extraluminal domain of DDOST was increased in size by the insertion of MBP or GST into the FRB-
mCherry-tagged protein, the INM targeting was inhibited, indicating that DDOST reaches the INM by 
diffusion. However, the insertion of an MBP- or a GST-tag reduced the INM targeting in similar way: 
DDOST-MBP-FRB-mCherry could recruit the reporter to the NE in around 23% of the examined cells, 
while around 16% of the cells respond to rapamycin for DDOST-GST-FRB-mCherry (figure 33). The 
extraluminal domain of the GST-tagged DDOST protein has a molecular mass of 130.8 kDa, which is 
much more than the cytoplasmic/nucleoplasmic region of MBP-tagged DDOST (81.4 kDa). Due to the 
enlarged size of the extraluminal domain and the geometry of the GST-tag, the diffusion of DDOST-
GST-FRB-mCherry to the INM was expected to be more drastically inhibited. This finding cannot be 
explained easily, however, the INM targeting of DDOST is reduced with the extension of its extraluminal 
domain. Further experiments, for instance rapamycin-induced dimerization assays with a shorter drug 
incubation time than 10 minutes, are needed to explain the small difference in INM targeting inhibition 
between MBP- and GST-tagged DDOST-FRB-mCherry. 
 
 
The 283 amino acid long N-terminus (31.1 kDa) of Ube2j1 faces the cytoplasm/nucleoplasm. 
When the mCherry-FRB-tagged protein was enlarged by the addition of an MBP-tag, the percentage of 
rapamycin-responding cells was reduced from around 70% to 23% (figure 32). This result indicates that 
Ube2j1 diffuses to the INM comparable to LRRC59. The extraluminal domain of mCherry-FRB-MBP-
Ube2j1 (110.8 kDa) was similar in size to mCherry-FRB-MBP-LRRC59 (107.5 kDa). As mCherry-FRB-
MBP-Ube2j1 could still reach the INM, it is possible that with increasing drug treatment time, more and 
more of this protein accumulates in the INM mediating an NE recruitment of the reporter. It is conceivable 
that this larger extraluminal domain needs more time to funnel into the peripheral channels, resulting in 
a delay of the rapamycin response of the reporter, similar as it was discussed for mCherry-FRB-MBP-
LRRC59. With the further increase of the extraluminal domain by the exchange of the MBP-tag to the 
dimerizing GST-tag, the INM localization of Ube2j1 got almost completely lost. Here, the dimer of GST 
could also be too big in dimension to fit into the peripheral channels inhibiting the INM targeting of 
mCherry-FRB-GST-Ube2j1. In general, these results are very similar to the rapamycin-induced 
dimerization assay with respect to the increase of the size of the extraluminal domain of LRRC59.  
Interestingly, an ortholog of human Ube2j1, the S. cerevisiae ubiquitin conjugating enzyme Ubc6 
was shown to function together with the E3 ubiquitin ligase complex Asi (Asi1, Asi2, and Asi3) at the 
INM to degrade soluble and integral membrane proteins. This special quality control at the INM differs 
from but is complementary to the endoplasmic reticulum-associated degradation (ERAD). In ERAD, 
misfolded proteins are exported from the ER, marked with ubiquitin-chains by a reaction cascade and 
targeted to the proteasome for degradation (Schnell and Hebert, 2003; Romisch, 2005). For the 
modification of a protein with ubiquitin, ubiquitin is transferred from the ubiquitin-activating protein E1 to 
the ubiquitin-conjugating enzyme E2. The E3 ubiquitin ligase binds to E2 and the substrate protein at 
the same time and mediates the ubiquitin transfer onto the substrate (Glickman and Ciechanover, 2002; 
Pickart, 2004). It had been shown that the Asi complex acts as an E3 ubiquitin ligase at the INM together 
with the ubiquitin-conjugating enzyme E2 Ubc6 or Ubc7 and is involved in the degradation of a distinct 
set of INM proteins (Foresti et al., 2014; Khmelinskii et al., 2014). However, not much is known so far 
about the degradation of INM proteins but it was suggested that the Asi complex together with Ubc6 is 
part of an INM-associated degradation (INMAD) pathway which controls the quality of INM proteins 
(Foresti et al., 2014; Khmelinskii et al., 2014; Smoyer et al., 2019). For the Asi complex subcomponents, 
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sequence homologs have been found in fungi but not in higher eukaryotes. However, a functional 
homolog of the Asi complex might be important for the INM quality control in post-mitotic cells, which do 
not undergo frequent NE breakdown (Foresti et al., 2014). If Ube2j1 is part of an INMAD pathway in 
human cells similar to Ubc6 in yeast, it has to reach the INM. The possibility of Ube2j1 to reach the INM 
was demonstrated in this thesis and the protein was shown to reach the INM by diffusion. 
 
Sec61 was examined with an N-terminal mCherry-FRB-tag in the rapamycin-induced 
dimerization assay. This protein localized at in the ER-membrane and in a rim around the NE. The 
recruitment of the reporter to the NE confirmed an INM localization of mCherry-FRB-Sec61. When the 
extraluminal domain of this protein was increased by the insertion of an MBP-tag, the percentage of 
rapamycin-responding cells was reduced by around 40% suggesting an INM localization of Sec61 
mediated by diffusion. Similar to LRRC59, the insertion of the GST-tag was expected to block the 
diffusion of Sec61 to the INM. However, when the cytoplasmic/nucleoplasmic domain was increased 
from 86.6 kDa of the MBP-tagged protein to 141.2 kDa of the GST-tagged protein, the percentage of 
rapamycin responding cells was only reduced to around 45% (figure 31). This result cannot be easily 
explained.  
Sec61, which is a subunit of the Sec61 translocon, was supposed to fulfill a function in the INM. 
Cell surface located EGFR (epidermal growth factor receptor) was suggested to reach the INM in a 
membrane-embedded manner dependent on importin  after EGF (epidermal growth factor) stimulation. 
In the INM, Sec61 associates with EGFR. When Sec61 was knocked down, EGFR accumulated in 
the INM. Sec61 was supposed to mediate the release of EGFR from the INM to the nucleoplasm (Wang 
et al., 2010), as the translocon mediates import of proteins in the ER-lumen but also retro-translocation 
of misfolded proteins from the ER to the cytoplasm for degradation (part of the ERAD process) (Schnell 
and Hebert, 2003; Romisch, 2005). As Sec61 was shown to associate with EGFR also in the 
ER-membrane in cell fractionation experiments, it was suspected that Sec61 is targeted together with 
EGFR in an importin -dependent manner to the INM. However, this theory was not proven 
experimentally (Wang et al., 2010).  
The reduction of INM localization of mCherry-FRB-MBP-Sec61 in the rapamycin-induced 
dimerization assay points to a diffusion of Sec61 into the nucleus. However, an active transport 
mechanism cannot be excluded completely, as the exchange of the MBP- to a GST-tag did not result in 
a full inhibition of INM targeting of Sec61. So far, an active transport mechanism to the INM dependent 
on karyopherin Kap95 (yeast homolog of human importin ), the adaptor protein Kap60 (yeast homolog 
of human importin ) and the activity of Ran was suggested for Heh1 and Heh2 in yeast (King et al., 
2006). The fragment of Heh2 containing the bipartite NLS (Lokareddy et al., 2015; Kralt et al., 2015), 
the first TMD and the linker between these regions, was shown to localize to the NE. This localization 
was lost, if the region containing the NLSs was removed (Meinema et al., 2011). When the identical 
fragment containing the NLSs (GFP-Heh2-NLS-linker-TMD) was expressed in leaf epidermal cells of 
the plant Nicotiana benthamiana, a stronger accumulation at the NE was observed compared to the 
fragment missing the NLSs (GFP-Heh2-linker-TMD) or the full-length protein (Groves et al., 2019). 
However, when the cNLS of SV40 was N-terminally added in front of the Heh2 sequence (GFP-cNLS-
Heh2-linker-TMD), the protein accumulated at the NE. This increase in NE targeting could also be 
observed when the cNLS in GFP-cNLS-Heh2-linker-TMD was replaced by different monopartite or 
bipartite NLS compared to the protein missing an NLS. When the linker between cNLS and TMD was 
reduced from 145 to 10 amino acids, the localization to the NE increased for this fragment of Heh2 
compared to GFP-Heh2-linker-TMD. Also, when the linker was increased to 60 kDa, an increase in NE 
targeting of the protein was observed (Groves et al., 2019). By the performance of Airyscan sub-
diffraction limited imaging, which reaches a resolution of 140 nm (Weisshart, 2014; Huff, 2015; 
Korobchevskaya et al., 2017), it could be demonstrated that the N-terminal fusion of GFP-cNLS enabled 
the access to the INM of the plant ER-membrane TA protein PICL. Also, the fusion of a GFP-tagged 
monopartite or a bipartite NLS to the N-terminus of Heh2-linker-TMD was sufficient to mediate INM 
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localization of the protein as shown by Airyscan sub-diffraction limited imaging (Groves et al., 2019). 
Not much is known about the INM targeting of membrane proteins in plants. However, the findings in 
plants that the NE accumulation and the INM targeting of an integral membrane protein can be mediated 
by monopartite or bipartite NLSs of different species gives a first hint about a potential active transport 
mechanism to the INM. It is possible that the INM targeting of membrane proteins in yeast and plants 
differs from mammals. However, further studies are necessary to analyze whether some membrane 
proteins are also targeted to the INM by an active transport mechanism in mammals, in contrast to the 
so far examined proteins whose INM localization is mainly explained by passive diffusion. One potential 
candidate for further analysis could be Sec61, because the results in the rapamycin-induced 
dimerization assay cannot be explained only by passive diffusion.  
 
 
Conclusion and perspectives 
In this thesis, by rapamycin-induced dimerization assays, an INM localization of the single TMD-
containing proteins Sec22b, LMAN2, Ube2j2, Sec61, DDOST and Ube2j1 could be shown. By an 
increase of the extraluminal domains, DDOST and Ube2j1 could be shown to diffuse to the INM. For 
Sec61, the results do not give a clear answer for an INM targeting mechanism. The three proteins 
Sec22b, LMAN2 and Ube2j2 remain for analysis of their INM targeting mechanism in an identical 
experimental approach. Similar to LRRC59, Sec61, DDOST and Ube2j1 are mainly ER-located 
proteins which are able to reach the INM. For Sec61 and Ube2j1, a potential function in the INM has 
been suggested. However, if the main function of the proteins is fulfilled in the INM, a retention 
mechanism would be expected to keep this protein in the nucleus, comparable to emerin. However, 
these two overexpressed proteins did not accumulate at the NE. Immunofluorescence or electron 
microscopy studies are needed to analyze the localization of endogenous Sec61, DDOST and Ube2j1. 
A similar localization of overexpressed and endogenous proteins could suggest a function rather in the 
ER-membrane than in the INM. Sec61 is part of the ER-membrane embedded translocon, while Ube2j1 
is required for ERAD, the degradation pathway at the ER-membrane. Therefore, it is suggested that 
Sec61, DDOST and Ube2j1 diffuse into the INM but also leave the nucleus, similar to LRRC59. 
However, the subpopulation of Ube2j1 and Sec61 in the INM could be constantly exchanged due to 
the diffusion process, but could be large enough to fulfill their function in the nucleus. To prove this 





















4.5 Summary and Outlook 
The aim of this thesis was to gain a deeper understanding for the INM targeting mechanism of 
LRRC59 and other single TMD-containing proteins. 
First, the insertion of LRRC59 into rough microsomes was examined showing that the TA protein 
LRRC59 can insert via a post-translational integration mechanism. However, the post-translational 
TRC pathway was not required for insertion of LRRC59. This makes LRRC59 an interesting TA protein 
to be studied further. It could be possible that LRRC59 can switch from one insertion pathway to another, 
if a pathway is not functional. In addition to the TRC pathway, several recently described ways into the 
ER-membrane have been shown to enable a post-translational insertion of TA proteins. As both subunits 
of the SRP receptor were shown to be in close proximity to LRRC59 in RAPIDS experiments, the 
possibility of a post-translational insertion via SRP should be further analyzed.  
In addition to these studies, an examination of the insertion mechanism of the five tested INM 
proteins Sec22b, Ube2j1, Ube2j2, DDOST and LMAN2 would be interesting. Membrane insertion of 
Sec61 has already been shown to depend on the TRC pathway (Stefanovic and Hegde, 2007). The 
yeast protein Sec22, the orthologue of human Sec22b, was shown to interact with Get3 in a yeast two-
hybrid screen (Schuldiner et al., 2008) and structural analysis (Yamagata et al., 2010). This interaction 
could be examined for the human homolog. Sec22b has its TMD at the very C-terminus, while Ube2j1 
and Ube2j2 have 15 and 12 amino acids, respectively, following the TMD. Therefore, these proteins 
could be membrane inserted in a post-translational manner as termination of translation probably occurs 
before the TMD emerges from the ribosome. The proteins DDOST and LMAN2 each contain a signal 
peptide at their N-terminus, which could be co-translationally targeted by SRP for membrane insertion. 
Microsome integration assays with SRP-immunodepleted rabbit reticulocyte lysate could be used to 
confirm this.  
 
Further, the INM targeting mechanism of LRRC59 is independent of the importin /importin  
pathway and the extraluminal region of LRRC59 does not contain an NLS. However, by the increase of 
the size of the extraluminal domain in rapamycin-induced dimerization assays, it could be shown that 
LRRC59 reaches the INM by passive diffusion. It was suggested that not only the molecular mass of 
the cytoplasmic/nucleoplasmic region is crucial for the passage of the peripheral channels but also the 
geometry of the domains. Additionally, it was proposed that the mainly ER-membrane located protein 
LRRC59 diffuses into the INM by peripheral channels, but might not be retained in the nucleus and 
subsequently leaves the nucleus by a diffusion process. To confirm this theory, kinetic studies need to 
focus not only on the INM targeting mechanism but also on the way of the protein back to the 
ER-membrane.  
For DDOST, Ube2j1 and Sec61, it could be shown that the majority of the proteins resides in 
the ER-membrane, while a subpopulation is able to reach the INM. The INM localization of DDOST and 
Ube2j1 was shown to depend on the size of the extraluminal domains suggesting a diffusion into the 
nucleus. However, the INM localization of Sec61 did not depend on the size of the extraluminal region 
to the same extent as it does for LRRC59, DDOST and Ube2j1. Further studies are needed to analyze 
whether Sec61 reaches the INM only by diffusion. 
The ER-membrane/ONM and the INM could in principle share all proteins with an extraluminal 
domain able to pass the peripheral channels by diffusion. Only proteins with binding sites would 
consequently be retained and accumulated in the INM (Ungricht and Kutay, 2017; Zuleger et al., 2011). 
In yeast, around 35% of the proteins able to reach the INM are proteins of the ER-membrane with small 
extraluminal regions (Smoyer et al., 2016). This thesis contributes to the understanding of the INM 
targeting in mammals of the mainly ER located integral membrane proteins LRRC59, Sec61, DDOST 
and Ube2j1, which might or might not have a function in the nucleus. The proteins LRRC59, DDOST 
and Ube2j1 seem to reach the INM by diffusion but are probably not retained in the INM in contrast to 
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B. Supplemental figures 
 
Figure S 1: The LRRC59 antibody is specific. 
HeLa cells were transfected with control or LRRC59 siRNAs for 48 hours, fixed and analyzed by 
indirect immunofluorescence using the LRRC59-antibody (A) or by SDS-PAGE and immunoblotting 
using antibodies against LRRC59 and alpha tubulin (B). (A) DAPI marked the nucleic acids in 
fluorescence microscopy. Analysis by confocal microscopy. (B) Levels of LRRC59 were normalized 






Figure S 2: LRRC59 is a membrane-bound protein. 
(A) For the examination of soluble LRRC59, 5x106 HeLa cells were seeded onto a 10 cm cell culture 
dish containing several coverslips. Cells were treated with (+) or without (-) digitonin. After fixation, 
cells were immunostained using antibodies against LRRC59 and as permeabilization control 
importin-. DAPI marked the nucleic acids in fluorescence confocal microscopy. (B) HeLa cells were 
detached from the 10 cm cell culture dish. 1x106 cells were resuspended in transport buffer. For the 
input, 5x105 cells were mixed with SDS sample buffer. The remaining 5x105 cells were permeabilized 
with digitonin for 5 minutes. After centrifugation, the supernatant was transferred into a new tube and 
supplemented with SDS sample buffer. The pellet was resuspended in SDS sample buffer. For 
analysis, proteins of 2,4% of input, supernatant and pellet were analyzed by SDS-PAGE, Western 
blotting and immunodetection using antibodies against LRRC59, alpha tubulin as control for the 




Figure S 3: Upon addition of rapamycin, EGFP2-GST-M9-FKBP12 bound by mCherry-FRB-
LRRC59 does not diffuse out of the nucleus. 
HeLa cells were seeded on coverslips and co-transfected with plasmids coding for EGFP2-GST-M9-
FKBP12 together with mCherry-FRB-LRRC59 or WRB-FRB-HA. After 48 hours, cells were treated 
with (+) or without (-) rapamycin for 30 minutes. For immunodetection of WRB-FRB-HA, indirect 
immunostaining using antibodies against HA was performed, while mCherry-FRB-LRRC59 was 






Figure S 4: Knockdown of importin . 
U2OS cells (A) or HeLa P4 cells (B) were treated with control or importin  siRNAs prior to analysis 
by SDS-PAGE, Western-blotting and detection of importin  and alpha tubulin. The mean and the 
standard deviations of the importin  levels of four (A) or nine (B) experiments, normalized to alpha 




Figure S 5: Comparison of size-dependent localization of LRRC59 lacking a TMD and cNLS. 
HeLa cells were transfected with 1 µg plasmids coding for EGFP-LRRC59 aa1-244, EGFP2-GST-
LRRC59 aa1-244, EGFP-cNLS or EGFP2-GST-cNLS. After 48 hours, cells were fixed and directly 
analyzed by fluorescence microscopy using the Axioskop2 mot plus. DAPI marked the nucleic acids 




Figure S 6: Additional GGGGS-linker in the construct mCherry-FRB-MBP-LRRC59 do not 
change the number of rapamycin-responding cells. 
HeLa cells were transfected with plasmids coding for EGFP2-GST-M9-FKBP12 and mCherry-FRB-
LRRC59 or mCherry-FRB-MBP-LRRC59 without linker between the domains (A) or with additional 
GGGGS-linker between all domains (B). After 48 hours, the cells were incubated with rapamycin for 
10 minutes followed by fixation of the cells and direct analysis using the Zeiss microscope Axioskop2 
mot plus. DAPI marked the nucleic acids in fluorescence microscopy. (C) Quantification of mean and 
the standard deviation of rapamycin-responding cells of (A) and (B) for three independent 




Figure S 7: Overview of all four quadrants of the Scatter plot of the analysis of RAPIDS 
experiments. 
Data of mass spectrometry was analyzed using Perseus Software with matrix indicated in table S 8. 
The Scatter plot shows the ratio log2 heavy/light normalized LRRC59 of forward experiments on the 
x-axis and of reverse experiments on the y-axis. Using Significance B test, significant enriched 
candidates were identified. Double significant enriched candidates are indicated in red, significantly 
enriched candidates of the forward experiments in blue and significantly enriched candidates of the 

























Figure S 8: Protein purification of His-GST-Nup210 aa1830-1887, MBP-LRRC59 aa1-244-His 
and His-MBP-His from E. coli Rosetta 2. 
The appropriate plasmid was transformed into E. coli Rosetta 2 for expression. His-tagged proteins 
were purified using Ni-NTA. Purification steps and protein concentration by comparison to a BSA 
standard (asterisks) were analyzed by SDS-PAGE and Coomassie staining for (A) His-GST-Nup210 
aa1830-1887, (B) MBP-LRRC59 aa1-244-His and (C) His-MBP-His. 
 
 
C. Supplemental data corresponding to section 3.2 








Ratio lamin A/C 
/alpha tubulin 
Normalized 
lamin A/C level 
20160307 0008750_01 800 control lamin A/C 310000 
0.04 100.00 
20160307 0008750_01 800 control alpha tubulin 7660000 
20160307 0008750_01 800 lamin A/C lamin A/C 32800 
0.00 9.36 
20160307 0008750_01 800 lamin A/C alpha tubulin 8660000 
20160315 0013778_01 800 control lamin A/C 158000 
2.60 100.00 
20160315 0013778_01 800 control alpha tubulin 60700 










Ratio lamin A/C 
/alpha tubulin 
Normalized 
lamin A/C level 
20160315 0013778_01 800 lamin A/C alpha tubulin 42100 
20160315 0013778_01 800 control lamin A/C 430000 
3.91 100.00 
20160315 0013778_01 800 control alpha tubulin 110000 
20160315 0013778_01 800 lamin A/C lamin A/C 62000 
0.65 16.68 
20160315 0013778_01 800 lamin A/C alpha tubulin 95100 
20161212 0013149_01 800 control lamin A/C 208000 
0.10 100.00 
20161212 0013149_01 800 control alpha tubulin 2020000 
20161212 0013149_01 800 lamin A/C lamin A/C 18300 
0.01 11.18 
20161212 0013149_01 800 lamin A/C alpha tubulin 1590000 
20161212 0013149_01 800 control lamin A/C 235000 
0.19 100.00 
20161212 0013149_01 800 control alpha tubulin 1230000 
20161212 0013149_01 800 lamin A/C lamin A/C 26800 
0.01 6.84 
20161212 0013149_01 800 lamin A/C alpha tubulin 2050000 
20170130 0013149_01 800 control lamin A/C 57500 
0.04 100.00 
20170130 0013149_01 800 control alpha tubulin 1480000 
20170130 0013149_01 800 lamin A/C lamin A/C 15100 
0.01 27.96 
20170130 0013149_01 800 lamin A/C alpha tubulin 1390000 
20171009 0011725_01 700 control lamin A/C 144000 
0.32 100.00 
20171009 0011725_01 800 control alpha tubulin 449000 
20171009 0011725_01 700 lamin A/C lamin A/C 7860 
0.02 5.48 
20171009 0011725_01 800 lamin A/C alpha tubulin 447000 
20181022 0000864_02 800 control lamin A/C 2320 
1.58 100.00 
20181022 0000864_02 800 control alpha tubulin 1470 
20181022 0000864_02 800 lamin A/C lamin A/C 188 
0.19 11.79 
20181022 0000864_02 800 lamin A/C alpha tubulin 1010 
20181105 0000951_02 800 control lamin A/C 72.3 
0.01 100.00 
20181105 0000951_02 800 control alpha tubulin 6800 
20181105 0000951_02 800 lamin A/C lamin A/C -18.5 
0.00 1.00* 
20181105 0000951_02 800 lamin A/C alpha tubulin 4520 
* value of lamin A/C signal was negative, so put to 1 
 









β /alpha tubulin 
Normalized 
importin β level 
20180709 0017393_01 800 control importin β 207000 
1.13 100.00 
20180709 0017393_01 800 control alpha tubulin 183000 
20180709 0017393_01 800 importin β importin β 30600 
0.16 14.02 
20180709 0017393_01 800 importin β alpha tubulin 193000 
20180709 0017393_01 800 control importin β 243000 
1.96 100.00 
20180709 0017393_01 800 control alpha tubulin 124000 
20180709 0017393_01 800 importin β importin β 45900 
0.38 19.36 
20180709 0017393_01 800 importin β alpha tubulin 121000 
20180806 0000122_02 800 control importin β 1830 
0.50 100.00 
20180806 0000122_02 800 control alpha tubulin 3670 
20180806 0000122_02 800 importin β importin β 295 
0.14 28.72 
20180806 0000122_02 800 importin β alpha tubulin 2060 
20180813 0000260_02 800 control importin β 336 
0.37 100.00 
20180813 0000260_02 800 control alpha tubulin 906 
20180813 0000260_02 800 importin β importin β 124 
0.11 30.67 
20180813 0000260_02 800 importin β alpha tubulin 1090 
20180820 0000260_02 800 control importin β 600 
0.30 100.00 
20180820 0000260_02 800 control alpha tubulin 1970 
20180820 0000260_02 800 importin β importin β 120 
0.14 44.82 
20180820 0000260_02 800 importin β alpha tubulin 879 
 









β /alpha tubulin 
Normalized 
importin β level 
20180312 0016521_01 800 control importin β 123000 
0.14 100.00 
20180312 0016521_01 800 control alpha tubulin 860000 
20180312 0016521_01 800 importin β importin β 37600 
0.05 37.40 
20180312 0016521_01 800 importin β alpha tubulin 703000 
20180319 0016521_01 800 control importin β 261000 
0.25 100.00 
20180319 0016521_01 800 control alpha tubulin 1030000 
20180319 0016521_01 800 importin β importin β 86300 
0.07 29.36 
20180319 0016521_01 800 importin β alpha tubulin 1160000 
20180430 0016806_01 800 control importin β 370000 
0.97 100.00 
20180430 0016806_01 800 control alpha tubulin 382000 
20180430 0016806_01 800 importin β importin β 125000 
0.20 20.29 











β /alpha tubulin 
Normalized 
importin β level 
20180430 0016806_01 800 control importin β 761000 
1.18 100.00 
20180430 0016806_01 800 control alpha tubulin 647000 
20180430 0016806_01 800 importin β importin β 389000 
0.29 25.06 
20180430 0016806_01 800 importin β alpha tubulin 1320000 
20180924 0000654_02 800 control importin β 2040 
0.08 100.00 
20180924 0000654_02 800 control alpha tubulin 24200 
20180924 0000654_02 800 importin β importin β 753 
0.02 26.43 
20180924 0000654_02 800 importin β alpha tubulin 33800 
20180924 0000654_02 800 control importin β 3830 
0.10 100.00 
20180924 0000654_02 800 control alpha tubulin 36700 
20180924 0000654_02 800 importin β importin β 503 
0.02 21.05 
20180924 0000654_02 800 importin β alpha tubulin 22900 
20180522 0017108_01 800 control importin β 592000 
4.11 100.00 
20180522 0017108_01 800 control alpha tubulin 144000 
20180522 0017108_01 800 importin β importin β 250000 
0.59 14.41 
20180522 0017108_01 800 importin β alpha tubulin 422000 
20180528 0017109_01 800 control importin β 589000 
5.61 100.00 
20180528 0017109_01 800 control alpha tubulin 105000 
20180528 0017109_01 800 importin β importin β 280000 
1.26 22.38 
20180528 0017109_01 800 importin β alpha tubulin 223000 
20180604 0017110_01 800 control importin β 420000 
2.64 100.00 
20180604 0017110_01 800 control alpha tubulin 159000 
20180604 0017110_01 800 importin β importin β 328000 
0.51 19.37 
20180604 0017110_01 800 importin β alpha tubulin 641000 
20181015 0000831_02 800 control importin β 2170 
0.58 100.00 
20181015 0000831_02 800 control alpha tubulin 3710 
20181015 0000831_02 800 importin β importin β 748 
0.13 21.42 
20181015 0000831_02 800 importin β alpha tubulin 5970 
20181105 0000951_02 800 control importin β 1930 
1.12 100.00 
20181105 0000951_02 800 control alpha tubulin 1720 
20181105 0000951_02 800 importin β importin β 599 
0.18 16.23 
20181105 0000951_02 800 importin β alpha tubulin 3290 
20181105 0000951_02 800 control importin β 2440 
0.79 100.00 
20181105 0000951_02 800 control alpha tubulin 3070 
20181105 0000951_02 800 importin β importin β 857 
0.16 19.93 
20181105 0000951_02 800 importin β alpha tubulin 5410 
 












20180522 control 1 minute 55 55 
63.00 5.74 
20180528 control 1 minute 60 60 
20180604 control 1 minute 70 70 
20181015 control 1 minute 64 64 
20181105 control 1 minute 66 66 
20180522 control 1.5 minutes 66 66 
76.20 6.91 
20180528 control 1.5 minutes 85 85 
20180604 control 1.5 minutes 75 75 
20181015 control 1.5 minutes 79 79 
20181105 control 1.5 minutes 76 76 
20180522 control 2 minutes 76 76 
83.80 8.73 
20180528 control 2 minutes 78 78 
20180604 control 2 minutes 96 96 
20181015 control 2 minutes 90 90 
20181105 control 2 minutes 79 79 
20180522 control 2.5 minutes 85 85 
86.80 6.26 
20180528 control 2.5 minutes 79 79 
20180604 control 2.5 minutes 95 95 
20181015 control 2.5 minutes 91 91 
20181105 control 2.5 minutes 84 84 
20180522 control 3 minutes 86 86 
91.20 4.44 
20180528 control 3 minutes 96 96 
20180604 control 3 minutes 94 94 
20181015 control 3 minutes 93 93 
20181105 control 3 minutes 87 87 
20180522 control 4 minutes 94 94 
92.60 1.95 
20180528 control 4 minutes 91 91 
20180604 control 4 minutes 94 94 













20181105 control 4 minutes 90 90 
20181015 control 10 minutes 98 98 
92.83 3.84 
20180312 control 10 minutes 46 92 
20180312 control 10 minutes 46 92 
20180312 control 10 minutes 45 90 
20180312 control 10 minutes 44 88 
20180312 control 10 minutes 45 90 
20180319 control 10 minutes 47 94 
20180319 control 10 minutes 48 96 
20180319 control 10 minutes 43 86 
20180319 control 10 minutes 44 88 
20180319 control 10 minutes 45 90 
20180430 control 10 minutes 45 90 
20180430 control 10 minutes 48 96 
20180430 control 10 minutes 47 94 
20180430 control 10 minutes 49 98 
20180430 control 10 minutes 47 94 
20180430 control 10 minutes 50 100 
20180430 control 10 minutes 44 88 
20180430 control 10 minutes 47 94 
20180430 control 10 minutes 50 100 
20180430 control 10 minutes 47 94 
20180430 control 10 minutes 47 94 
20180430 control 10 minutes 46 92 
20180430 control 10 minutes 48 96 
20180430 control 10 minutes 48 96 
20180430 control 10 minutes 44 88 
20180924 control 10 minutes 43 86 
20180924 control 10 minutes 45 90 
20180924 control 10 minutes 48 96 
20180924 control 10 minutes 44 88 
20180924 control 10 minutes 47 94 
20180924 control 10 minutes 46 92 
20180924 control 10 minutes 47 94 
20180924 control 10 minutes 49 98 
20180924 control 10 minutes 48 96 
20180924 control 10 minutes 45 90 
20180522 importin β 1 minute 47 47 
62.80 11.82 
20180528 importin β 1 minute 78 78 
20180604 importin β 1 minute 56 56 
20181015 importin β 1 minute 65 65 
20181105 importin β 1 minute 68 68 
20180522 importin β 1.5 minutes 75 75 
75.00 3.32 
20180528 importin β 1.5 minutes 70 70 
20180604 importin β 1.5 minutes 74 74 
20181015 importin β 1.5 minutes 78 78 
20181105 importin β 1.5 minutes 78 78 
20180522 importin β 2 minutes 83 83 
83.80 5.63 
20180528 importin β 2 minutes 87 87 
20180604 importin β 2 minutes 76 76 
20181015 importin β 2 minutes 91 91 
20181105 importin β 2 minutes 82 82 
20180522 importin β 2.5 minutes 81 81 
83.60 3.58 
20180528 importin β 2.5 minutes 83 83 
20180604 importin β 2.5 minutes 80 80 
20181015 importin β 2.5 minutes 89 89 
20181105 importin β 2.5 minutes 85 85 
20180522 importin β 3 minutes 87 87 
86.80 5.07 
20180528 importin β 3 minutes 78 78 
20180604 importin β 3 minutes 89 89 
20181015 importin β 3 minutes 90 90 
20181105 importin β 3 minutes 90 90 
20180522 importin β 4 minutes 91 91 
92.80 2.39 
20180528 importin β 4 minutes 96 96 
20180604 importin β 4 minutes 90 90 
20181015 importin β 4 minutes 93 93 
20181105 importin β 4 minutes 94 94 
20181015 importin β 10 minutes 97 97 
90.64 7.38 
20180312 importin β 10 minutes 39 78 
20180312 importin β 10 minutes 41 82 













20180312 importin β 10 minutes 44 88 
20180312 importin β 10 minutes 36 72 
20180319 importin β 10 minutes 47 94 
20180319 importin β 10 minutes 48 96 
20180319 importin β 10 minutes 45 90 
20180319 importin β 10 minutes 45 90 
20180319 importin β 10 minutes 40 80 
20180430 importin β 10 minutes 44 88 
20180430 importin β 10 minutes 44 88 
20180430 importin β 10 minutes 50 100 
20180430 importin β 10 minutes 45 90 
20180430 importin β 10 minutes 49 98 
20180430 importin β 10 minutes 45 90 
20180430 importin β 10 minutes 50 100 
20180430 importin β 10 minutes 48 96 
20180430 importin β 10 minutes 49 98 
20180430 importin β 10 minutes 50 100 
20180430 importin β 10 minutes 45 90 
20180430 importin β 10 minutes 48 96 
20180430 importin β 10 minutes 48 96 
20180430 importin β 10 minutes 46 92 
20180430 importin β 10 minutes 47 94 
20180924 importin β 10 minutes 43 86 
20180924 importin β 10 minutes 40 80 
20180924 importin β 10 minutes 47 94 
20180924 importin β 10 minutes 45 90 
20180924 importin β 10 minutes 47 94 
20180924 importin β 10 minutes 48 96 
20180924 importin β 10 minutes 45 90 
20180924 importin β 10 minutes 47 94 
20180924 importin β 10 minutes 47 94 
20180924 importin β 10 minutes 46 92 
Constructs: pmCherry-FRB-LRRC59, pEGFP2-GST-M9-FKBP12 
 
Table S 5: Raw data of rapamycin-induced dimerization assay using reporter EGFP2-GST-M9-
















20180625 0.4 mCherry-FRB-LRRC59 1 minute 58 58 
60.43 6.63 
20180702 0.4 mCherry-FRB-LRRC59 1 minute 63 63 
20180702 0.4 mCherry-FRB-LRRC59 1 minute 50 50 
20180702 0.4 mCherry-FRB-LRRC59 1 minute 58 58 
20180806 0.4 mCherry-FRB-LRRC59 1 minute 72 72 
20180813 0.4 mCherry-FRB-LRRC59 1 minute 62 62 
20180820 0.4 mCherry-FRB-LRRC59 1 minute 60 60 
20180625 0.4 mCherry-FRB-LRRC59 1.5 minutes 85 85 
81.00 7.53 
20180702 0.4 mCherry-FRB-LRRC59 1.5 minutes 75 75 
20180702 0.4 mCherry-FRB-LRRC59 1.5 minutes 74 74 
20180702 0.4 mCherry-FRB-LRRC59 1.5 minutes 84 84 
20180806 0.4 mCherry-FRB-LRRC59 1.5 minutes 88 88 
20180813 0.4 mCherry-FRB-LRRC59 1.5 minutes 90 90 
20180820 0.4 mCherry-FRB-LRRC59 1.5 minutes 71 71 
20180625 0.4 mCherry-FRB-LRRC59 2 minutes 80 80 
86.88 4.67 
20180702 0.4 mCherry-FRB-LRRC59 2 minutes 83 83 
20180702 0.4 mCherry-FRB-LRRC59 2 minutes 90 90 
20180702 0.4 mCherry-FRB-LRRC59 2 minutes 90 90 
20180806 0.4 mCherry-FRB-LRRC59 2 minutes 90 90 
20180813 0.4 mCherry-FRB-LRRC59 2 minutes 91 91 
20180820 0.4 mCherry-FRB-LRRC59 2 minutes 81 81 
20181015 0.4 mCherry-FRB-LRRC59 2 minutes 90 90 
20180625 0.4 mCherry-FRB-LRRC59 2.5 minutes 86 86 
88.71 5.41 
20180702 0.4 mCherry-FRB-LRRC59 2.5 minutes 83 83 
20180702 0.4 mCherry-FRB-LRRC59 2.5 minutes 95 95 
20180702 0.4 mCherry-FRB-LRRC59 2.5 minutes 88 88 
20180806 0.4 mCherry-FRB-LRRC59 2.5 minutes 92 92 
20180813 0.4 mCherry-FRB-LRRC59 2.5 minutes 95 95 
20180820 0.4 mCherry-FRB-LRRC59 2.5 minutes 82 82 
20180625 0.4 mCherry-FRB-LRRC59 3 minutes 88 88 
92.43 5.16 


















20180702 0.4 mCherry-FRB-LRRC59 3 minutes 96 96 
20180702 0.4 mCherry-FRB-LRRC59 3 minutes 95 95 
20180806 0.4 mCherry-FRB-LRRC59 3 minutes 90 90 
20180813 0.4 mCherry-FRB-LRRC59 3 minutes 98 98 
20180820 0.4 mCherry-FRB-LRRC59 3 minutes 84 84 
20180625 0.4 mCherry-FRB-LRRC59 4 minutes 90 90 
92.33 4.23 
20180702 0.4 mCherry-FRB-LRRC59 4 minutes 95 95 
20180702 0.4 mCherry-FRB-LRRC59 4 minutes 91 91 
20180806 0.4 mCherry-FRB-LRRC59 4 minutes 94 94 
20180813 0.4 mCherry-FRB-LRRC59 4 minutes 98 98 
20180820 0.4 mCherry-FRB-LRRC59 4 minutes 86 86 
20181015 0.4 mCherry-FRB-LRRC59 10 minutes 95 95 
95.25 1.71 
20181015 0.4 mCherry-FRB-LRRC59 10 minutes 96 96 
20181015 0.4 mCherry-FRB-LRRC59 10 minutes 97 97 
20181015 0.4 mCherry-FRB-LRRC59 10 minutes 93 93 
20180625 1 mCherry-FRB-MBP-LRRC59 1 minute 28 28 
22.86 4.45 
20180702 1 mCherry-FRB-MBP-LRRC59 1 minute 22 22 
20180702 1 mCherry-FRB-MBP-LRRC59 1 minute 18 18 
20180702 1 mCherry-FRB-MBP-LRRC59 1 minute 30 30 
20180806 1 mCherry-FRB-MBP-LRRC59 1 minute 20 20 
20180813 1 mCherry-FRB-MBP-LRRC59 1 minute 20 20 
20180820 1 mCherry-FRB-MBP-LRRC59 1 minute 22 22 
20180625 1 mCherry-FRB-MBP-LRRC59 1.5 minutes 32 32 
29.57 7.21 
20180702 1 mCherry-FRB-MBP-LRRC59 1.5 minutes 31 31 
20180702 1 mCherry-FRB-MBP-LRRC59 1.5 minutes 34 34 
20180702 1 mCherry-FRB-MBP-LRRC59 1.5 minutes 41 41 
20180806 1 mCherry-FRB-MBP-LRRC59 1.5 minutes 19 19 
20180813 1 mCherry-FRB-MBP-LRRC59 1.5 minutes 25 25 
20180820 1 mCherry-FRB-MBP-LRRC59 1.5 minutes 25 25 
20180625 1 mCherry-FRB-MBP-LRRC59 2 minutes 34 34 
37.00 3.21 
20180702 1 mCherry-FRB-MBP-LRRC59 2 minutes 35 35 
20180702 1 mCherry-FRB-MBP-LRRC59 2 minutes 38 38 
20180702 1 mCherry-FRB-MBP-LRRC59 2 minutes 43 43 
20180806 1 mCherry-FRB-MBP-LRRC59 2 minutes 40 40 
20180813 1 mCherry-FRB-MBP-LRRC59 2 minutes 35 35 
20180820 1 mCherry-FRB-MBP-LRRC59 2 minutes 37 37 
20181015 1 mCherry-FRB-MBP-LRRC59 2 minutes 34 34 
20180625 1 mCherry-FRB-MBP-LRRC59 2.5 minutes 43 43 
41.71 6.16 
20180702 1 mCherry-FRB-MBP-LRRC59 2.5 minutes 40 40 
20180702 1 mCherry-FRB-MBP-LRRC59 2.5 minutes 30 30 
20180702 1 mCherry-FRB-MBP-LRRC59 2.5 minutes 39 39 
20180806 1 mCherry-FRB-MBP-LRRC59 2.5 minutes 47 47 
20180813 1 mCherry-FRB-MBP-LRRC59 2.5 minutes 48 48 
20180820 1 mCherry-FRB-MBP-LRRC59 2.5 minutes 45 45 
20180625 1 mCherry-FRB-MBP-LRRC59 3 minutes 40 40 
45.43 6.43 
20180702 1 mCherry-FRB-MBP-LRRC59 3 minutes 39 39 
20180702 1 mCherry-FRB-MBP-LRRC59 3 minutes 40 40 
20180702 1 mCherry-FRB-MBP-LRRC59 3 minutes 44 44 
20180806 1 mCherry-FRB-MBP-LRRC59 3 minutes 50 50 
20180813 1 mCherry-FRB-MBP-LRRC59 3 minutes 49 49 
20180820 1 mCherry-FRB-MBP-LRRC59 3 minutes 56 56 
20180625 1 mCherry-FRB-MBP-LRRC59 4 minutes 70 70 
51.50 9.67 
20180702 1 mCherry-FRB-MBP-LRRC59 4 minutes 42 42 
20180702 1 mCherry-FRB-MBP-LRRC59 4 minutes 46 46 
20180806 1 mCherry-FRB-MBP-LRRC59 4 minutes 50 50 
20180813 1 mCherry-FRB-MBP-LRRC59 4 minutes 51 51 
20180820 1 mCherry-FRB-MBP-LRRC59 4 minutes 50 50 
20181015 1 mCherry-FRB-MBP-LRRC59 10 minutes 54 54 
52.25 6.34 
20181015 1 mCherry-FRB-MBP-LRRC59 10 minutes 50 50 
20181015 1 mCherry-FRB-MBP-LRRC59 10 minutes 60 60 
20181015 1 mCherry-FRB-MBP-LRRC59 10 minutes 45 45 
20180716 0.5 HA-FRB-LRRC59 1 minute 75 75 
61.30 8.74 
20180716 0.5 HA-FRB-LRRC59 1 minute 70 70 
20180716 0.5 HA-FRB-LRRC59 1 minute 64 64 
20180716 0.5 HA-FRB-LRRC59 1 minute 60 60 
20180813 0.5 HA-FRB-LRRC59 1 minute 55 55 
20180813 0.5 HA-FRB-LRRC59 1 minute 54 54 
20180813 0.5 HA-FRB-LRRC59 1 minute 55 55 
20180820 0.5 HA-FRB-LRRC59 1 minute 63 63 


















20180820 0.5 HA-FRB-LRRC59 1 minute 47 47 
20180716 0.5 HA-FRB-LRRC59 1.5 minutes 75 75 
77.00 8.55 
20180716 0.5 HA-FRB-LRRC59 1.5 minutes 90 90 
20180716 0.5 HA-FRB-LRRC59 1.5 minutes 85 85 
20180716 0.5 HA-FRB-LRRC59 1.5 minutes 83 83 
20180813 0.5 HA-FRB-LRRC59 1.5 minutes 78 78 
20180813 0.5 HA-FRB-LRRC59 1.5 minutes 75 75 
20180813 0.5 HA-FRB-LRRC59 1.5 minutes 76 76 
20180820 0.5 HA-FRB-LRRC59 1.5 minutes 80 80 
20180820 0.5 HA-FRB-LRRC59 1.5 minutes 60 60 
20180820 0.5 HA-FRB-LRRC59 1.5 minutes 68 68 
20180716 0.5 HA-FRB-LRRC59 2 minutes 87 87 
82.64 6.14 
20180716 0.5 HA-FRB-LRRC59 2 minutes 81 81 
20180716 0.5 HA-FRB-LRRC59 2 minutes 89 89 
20180716 0.5 HA-FRB-LRRC59 2 minutes 79 79 
20180813 0.5 HA-FRB-LRRC59 2 minutes 82 82 
20180813 0.5 HA-FRB-LRRC59 2 minutes 80 80 
20180813 0.5 HA-FRB-LRRC59 2 minutes 78 78 
20180820 0.5 HA-FRB-LRRC59 2 minutes 76 76 
20180820 0.5 HA-FRB-LRRC59 2 minutes 76 76 
20180820 0.5 HA-FRB-LRRC59 2 minutes 85 85 
20181015 0.5 HA-FRB-LRRC59 2 minutes 96 96 
20180716 0.5 HA-FRB-LRRC59 2.5 minutes 95 95 
89.70 5.83 
20180716 0.5 HA-FRB-LRRC59 2.5 minutes 90 90 
20180716 0.5 HA-FRB-LRRC59 2.5 minutes 98 98 
20180716 0.5 HA-FRB-LRRC59 2.5 minutes 96 96 
20180813 0.5 HA-FRB-LRRC59 2.5 minutes 85 85 
20180813 0.5 HA-FRB-LRRC59 2.5 minutes 78 78 
20180813 0.5 HA-FRB-LRRC59 2.5 minutes 90 90 
20180820 0.5 HA-FRB-LRRC59 2.5 minutes 88 88 
20180820 0.5 HA-FRB-LRRC59 2.5 minutes 87 87 
20180820 0.5 HA-FRB-LRRC59 2.5 minutes 90 90 
20180716 0.5 HA-FRB-LRRC59 3 minutes 95 95 
92.80 3.99 
20180716 0.5 HA-FRB-LRRC59 3 minutes 98 98 
20180716 0.5 HA-FRB-LRRC59 3 minutes 93 93 
20180716 0.5 HA-FRB-LRRC59 3 minutes 97 97 
20180813 0.5 HA-FRB-LRRC59 3 minutes 95 95 
20180813 0.5 HA-FRB-LRRC59 3 minutes 90 90 
20180813 0.5 HA-FRB-LRRC59 3 minutes 95 95 
20180820 0.5 HA-FRB-LRRC59 3 minutes 90 90 
20180820 0.5 HA-FRB-LRRC59 3 minutes 85 85 
20180820 0.5 HA-FRB-LRRC59 3 minutes 90 90 
20180716 0.5 HA-FRB-LRRC59 4 minutes 98 98 
90.62 6.19 
20180716 0.5 HA-FRB-LRRC59 4 minutes 97 97 
20180716 0.5 HA-FRB-LRRC59 4 minutes 94 94 
20180813 0.5 HA-FRB-LRRC59 4 minutes 90 90 
20180813 0.5 HA-FRB-LRRC59 4 minutes 80 80 
20180813 0.5 HA-FRB-LRRC59 4 minutes 95 95 
20180813 0.5 HA-FRB-LRRC59 4 minutes 80 80 
20180813 0.5 HA-FRB-LRRC59 4 minutes 91 91 
20180820 0.5 HA-FRB-LRRC59 4 minutes 89 89 
20180820 0.5 HA-FRB-LRRC59 4 minutes 85 85 
20180820 0.5 HA-FRB-LRRC59 4 minutes 87 87 
20180820 0.5 HA-FRB-LRRC59 4 minutes 97 97 
20180820 0.5 HA-FRB-LRRC59 4 minutes 95 95 
20181015 0.5 HA-FRB-LRRC59 10 minutes 96 96 
96.00 1.41 
20181015 0.5 HA-FRB-LRRC59 10 minutes 94 94 
20181015 0.5 HA-FRB-LRRC59 10 minutes 97 97 
20181015 0.5 HA-FRB-LRRC59 10 minutes 97 97 
 
Table S 6: Overview of counted cell number for rapamycin-induced dimerization assay using 
reporter EGFP2-GST-M9-FKBP12 (figure 21) 
Rapamycin treatment mCherry-FRB-LRRC59 mCherry-FRB-MBP-LRRC59 HA-FRB-LRRC59 
1 minute 700 700 1000 
1.5 minutes 700 700 1000 
2 minutes 800 800 1100 
2.5 minutes 700 700 1000 
3 minutes 700 700 1000 
4 minutes 600 600 1300 
10 minutes 400 400 400 
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Table S 7: Raw data of rapamycin-induced dimerization assay using reporter EGFP2-MBP-M9-















standard    
deviation 
20181008 0.4 mCherry-FRB-LRRC59 1 minute 61 61 
65.00 4.74 
20181015 0.4 mCherry-FRB-LRRC59 1 minute 68 68 
20181022 0.4 mCherry-FRB-LRRC59 1 minute 70 70 
20181022 0.4 mCherry-FRB-LRRC59 1 minute 67 67 
20181029 0.4 mCherry-FRB-LRRC59 1 minute 59 59 
20181008 0.4 mCherry-FRB-LRRC59 1.5 minutes 64 64 
71.40 4.39 
20181015 0.4 mCherry-FRB-LRRC59 1.5 minutes 73 73 
20181022 0.4 mCherry-FRB-LRRC59 1.5 minutes 75 75 
20181022 0.4 mCherry-FRB-LRRC59 1.5 minutes 74 74 
20181029 0.4 mCherry-FRB-LRRC59 1.5 minutes 71 71 
20181008 0.4 mCherry-FRB-LRRC59 2 minutes 73 73 
79.80 6.30 
20181015 0.4 mCherry-FRB-LRRC59 2 minutes 90 90 
20181022 0.4 mCherry-FRB-LRRC59 2 minutes 80 80 
20181022 0.4 mCherry-FRB-LRRC59 2 minutes 77 77 
20181029 0.4 mCherry-FRB-LRRC59 2 minutes 79 79 
20181008 0.4 mCherry-FRB-LRRC59 2.5 minutes 74 74 
84.00 6.78 
20181015 0.4 mCherry-FRB-LRRC59 2.5 minutes 91 91 
20181022 0.4 mCherry-FRB-LRRC59 2.5 minutes 89 89 
20181022 0.4 mCherry-FRB-LRRC59 2.5 minutes 81 81 
20181029 0.4 mCherry-FRB-LRRC59 2.5 minutes 85 85 
20181008 0.4 mCherry-FRB-LRRC59 3 minutes 85 85 
89.40 3.65 
20181015 0.4 mCherry-FRB-LRRC59 3 minutes 95 95 
20181022 0.4 mCherry-FRB-LRRC59 3 minutes 90 90 
20181022 0.4 mCherry-FRB-LRRC59 3 minutes 88 88 
20181029 0.4 mCherry-FRB-LRRC59 3 minutes 89 89 
20181008 0.4 mCherry-FRB-LRRC59 4 minutes 93 93 
93.00 1.58 
20181015 0.4 mCherry-FRB-LRRC59 4 minutes 94 94 
20181022 0.4 mCherry-FRB-LRRC59 4 minutes 95 95 
20181022 0.4 mCherry-FRB-LRRC59 4 minutes 92 92 
20181029 0.4 mCherry-FRB-LRRC59 4 minutes 91 91 
20181008 0.4 mCherry-FRB-LRRC59 10 minutes 94 94 
95.00 0.71 
20181015 0.4 mCherry-FRB-LRRC59 10 minutes 96 96 
20181022 0.4 mCherry-FRB-LRRC59 10 minutes 95 95 
20181022 0.4 mCherry-FRB-LRRC59 10 minutes 95 95 
20181029 0.4 mCherry-FRB-LRRC59 10 minutes 95 95 
20181008 1 mCherry-FRB-MBP-LRRC59 1 minute 25 25 
23.40 2.19 
20181015 1 mCherry-FRB-MBP-LRRC59 1 minute 25 25 
20181022 1 mCherry-FRB-MBP-LRRC59 1 minute 25 25 
20181022 1 mCherry-FRB-MBP-LRRC59 1 minute 21 21 
20181029 1 mCherry-FRB-MBP-LRRC59 1 minute 21 21 
20181008 1 mCherry-FRB-MBP-LRRC59 1.5 minutes 26 26 
28.20 2.28 
20181015 1 mCherry-FRB-MBP-LRRC59 1.5 minutes 30 30 
20181022 1 mCherry-FRB-MBP-LRRC59 1.5 minutes 31 31 
20181022 1 mCherry-FRB-MBP-LRRC59 1.5 minutes 26 26 
20181029 1 mCherry-FRB-MBP-LRRC59 1.5 minutes 28 28 
20181008 1 mCherry-FRB-MBP-LRRC59 2 minutes 27 27 
33.20 5.22 
20181015 1 mCherry-FRB-MBP-LRRC59 2 minutes 35 35 
20181022 1 mCherry-FRB-MBP-LRRC59 2 minutes 41 41 
20181022 1 mCherry-FRB-MBP-LRRC59 2 minutes 31 31 
20181029 1 mCherry-FRB-MBP-LRRC59 2 minutes 32 32 
20181008 1 mCherry-FRB-MBP-LRRC59 2.5 minutes 42 42 
40.20 5.81 
20181015 1 mCherry-FRB-MBP-LRRC59 2.5 minutes 40 40 
20181022 1 mCherry-FRB-MBP-LRRC59 2.5 minutes 49 49 
20181022 1 mCherry-FRB-MBP-LRRC59 2.5 minutes 35 35 
20181029 1 mCherry-FRB-MBP-LRRC59 2.5 minutes 35 35 
20181008 1 mCherry-FRB-MBP-LRRC59 3 minutes 53 53 
45.60 4.67 
20181015 1 mCherry-FRB-MBP-LRRC59 3 minutes 44 44 
20181022 1 mCherry-FRB-MBP-LRRC59 3 minutes 47 47 
20181022 1 mCherry-FRB-MBP-LRRC59 3 minutes 43 43 
20181029 1 mCherry-FRB-MBP-LRRC59 3 minutes 41 41 
20181008 1 mCherry-FRB-MBP-LRRC59 4 minutes 46 46 
48.20 3.50 
20181015 1 mCherry-FRB-MBP-LRRC59 4 minutes 48 48 
20181022 1 mCherry-FRB-MBP-LRRC59 4 minutes 54 54 
20181022 1 mCherry-FRB-MBP-LRRC59 4 minutes 48 48 
20181029 1 mCherry-FRB-MBP-LRRC59 4 minutes 45 45 
20181008 1 mCherry-FRB-MBP-LRRC59 10 minutes 55 55 
55.40 4.04 20181015 1 mCherry-FRB-MBP-LRRC59 10 minutes 52 52 

















standard    
deviation 
20181022 1 mCherry-FRB-MBP-LRRC59 10 minutes 59 59 
20181029 1 mCherry-FRB-MBP-LRRC59 10 minutes 51 51 
20181008 1 mCherry-FRB-GST-LRRC59 1 minute 8 8 
6.20 2.59 
20181015 1 mCherry-FRB-GST-LRRC59 1 minute 4 4 
20181022 1 mCherry-FRB-GST-LRRC59 1 minute 9 9 
20181022 1 mCherry-FRB-GST-LRRC59 1 minute 7 7 
20181029 1 mCherry-FRB-GST-LRRC59 1 minute 3 3 
20181008 1 mCherry-FRB-GST-LRRC59 1.5 minutes 8 8 
7.20 2.59 
20181015 1 mCherry-FRB-GST-LRRC59 1.5 minutes 5 5 
20181022 1 mCherry-FRB-GST-LRRC59 1.5 minutes 10 10 
20181022 1 mCherry-FRB-GST-LRRC59 1.5 minutes 9 9 
20181029 1 mCherry-FRB-GST-LRRC59 1.5 minutes 4 4 
20181008 1 mCherry-FRB-GST-LRRC59 2 minutes 10 10 
7.80 2.59 
20181015 1 mCherry-FRB-GST-LRRC59 2 minutes 5 5 
20181022 1 mCherry-FRB-GST-LRRC59 2 minutes 11 11 
20181022 1 mCherry-FRB-GST-LRRC59 2 minutes 6 6 
20181029 1 mCherry-FRB-GST-LRRC59 2 minutes 7 7 
20181008 1 mCherry-FRB-GST-LRRC59 2.5 minutes 4 4 
6.60 3.21 
20181015 1 mCherry-FRB-GST-LRRC59 2.5 minutes 5 5 
20181022 1 mCherry-FRB-GST-LRRC59 2.5 minutes 7 7 
20181022 1 mCherry-FRB-GST-LRRC59 2.5 minutes 12 12 
20181029 1 mCherry-FRB-GST-LRRC59 2.5 minutes 5 5 
20181008 1 mCherry-FRB-GST-LRRC59 3 minutes 8 8 
7.60 4.04 
20181015 1 mCherry-FRB-GST-LRRC59 3 minutes 3 3 
20181022 1 mCherry-FRB-GST-LRRC59 3 minutes 12 12 
20181022 1 mCherry-FRB-GST-LRRC59 3 minutes 11 11 
20181029 1 mCherry-FRB-GST-LRRC59 3 minutes 4 4 
20181008 1 mCherry-FRB-GST-LRRC59 4 minutes 11 11 
10.00 2.12 
20181015 1 mCherry-FRB-GST-LRRC59 4 minutes 8 8 
20181022 1 mCherry-FRB-GST-LRRC59 4 minutes 13 13 
20181022 1 mCherry-FRB-GST-LRRC59 4 minutes 8 8 
20181029 1 mCherry-FRB-GST-LRRC59 4 minutes 10 10 
20181008 1 mCherry-FRB-GST-LRRC59 10 minutes 18 18 
11.20 4.21 
20181015 1 mCherry-FRB-GST-LRRC59 10 minutes 10 10 
20181022 1 mCherry-FRB-GST-LRRC59 10 minutes 12 12 
20181022 1 mCherry-FRB-GST-LRRC59 10 minutes 7 7 
20181029 1 mCherry-FRB-GST-LRRC59 10 minutes 9 9 
 
 
D. Supplemental data corresponding to section 3.3 
Table S 8: Perseus workflow for the identification of proteins in close proximity to mCherry-FRB-
LRRC59 
Matrix Processing Settings Description 
Matrix 1 Generic matrix upload 
Main columns 
Ratio H/L LRRC59-fwd 
Ratio H/L LRRC59-rev 
Ratio H/L normalized LRRC59-fwd 





Ratio H/L count LRRC59-fwd 
Ratio H/L count LRRC59-rev 
Peptides 
Razor + unique peptides 
Sequence coverage [%] 
Mol. weight [kDa] 
Categorical columns 





Majority protein IDs 
Protein names 
Gene names 
Upload of by mass spectrometry 
identified protein groups with file 
“proteinGroups – LRRC59.txt” 
Matrix 2 
Filter rows based on 
categorical column 
Column: Only identified by site, Values: + 
Mode: Remove matching rows 
Filter mode: Reduce matrix 
Remove proteins only identified by 
peptides carrying a modified residue 
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Matrix Processing Settings Description 
Matrix 3 
Filter rows based on 
categorical column 
Column: Reverse; Values: + 
Mode: Remove matching rows 
Filter mode: Reduce matrix 
Remove hits that match against a 
nonsense database 
Matrix 4 
Filter rows based on 
categorical column 
Column: Potential contaminant, Values: + 
Mode: Remove matching rows 
Filter mode: Reduce matrix 




 Remove empty columns 
Matrix 6 Transform 
Transformation: log2(x) 
Columns:  
Ratio H/L LRRC59-fwd 
Ratio H/L LRRC59-rev 
Ratio H/L normalized LRRC59-fwd 
Ratio H/L normalized LRRC59-rev 
Intensity LRRC59-fwd 
Intensity LRRC59-rev 





Ratio H/L LRRC59-fwd 
Ratio H/L LRRC59-rev 
Ratio H/L normalized LRRC59-fwd 




Ratio H/L count LRRC59-fwd 
Ratio H/L count LRRC59-rev 
Peptides 
Razor + unique peptides 
Sequence coverage [%] 
Creating Venn diagram with Matrix 6 
Matrix 8 Significance B 
Ratio columns: 
Ratio H/L LRRC59-fwd 
Ratio H/L LRRC59-rev 
Ratio H/L normalized LRRC59-fwd 
Ratio H/L normalized LRRC59-rev 
Intensity columns:  
Ratio H/L LRRC59-fwd 
Ratio H/L LRRC59-rev 
Ratio H/L normalized LRRC59-fwd 




Ratio H/L count LRRC59-fwd 
Ratio H/L count LRRC59-rev 
Peptides 
Razor + unique peptides 
Sequence coverage [%] 
Mol. Weight [kDa] 
Q-value 
Score 
Ratio H/L normalized LRRC59-fwd 
Significance B 
Ratio H/L normalized LRRC59-rev 
Significance B 
Side: both 
Use for truncation: Benjamini-Hochberg 
FDR 
Threshold value: 0.05 
Performance of Significance B test with 
data of Venn diagram 
Matrix 9 Result of Matrix 8 
Main columns 
Ratio H/L LRRC59-fwd 
Ratio H/L LRRC59-rev 
Ratio H/L normalized LRRC59-fwd 
Ratio H/L normalized LRRC59-rev 
Categorical columns 
Ratio H/L normalized LRRC59-fwd B 
significant: + 










Export: Generic matrix export 
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Matrix Processing Settings Description 
Intensity 
Ratio H/L count LRRC59-fwd 
Ratio H/L count LRRC59-rev 
Peptides 
Razor + unique peptides 
Sequence coverage [%] 
Mol. Weight [kDa] 
Q-value 
Score 
Ratio H/L normalized LRRC59-fwd 
Significance B 
Ratio H/L normalized LRRC59-rev 
Matrix 10 Scatter plot Matrix access: Columns 
Creating Scatter plot with data of Matrix 
9 
Matrix 11 Data for export 
Main columns 
Ratio H/L LRRC59-fwd 
Ratio H/L LRRC59-rev 
Ratio H/L normalized LRRC59-fwd 
Ratio H/L normalized LRRC59-rev 
Categorical columns 
Ratio H/L normalized LRRC59-fwd B 
significant 











Ratio H/L count LRRC59-fwd 
Ratio H/L count LRRC59-rev 
Peptides 
Razor + unique peptides 
Sequence coverage [%] 
Mol. Weight [kDa] 
Q-value 
Score 
Ratio H/L normalized LRRC59-fwd 
Significance B 
Ratio H/L normalized LRRC59-rev 
Export: Generic matrix export 
Abbreviations: fwd: forward, rev: reverse, Mol. weight: molecular weight, ratio H/L: ratio heavy/light, 
IDs: identifications 
 
Table S 9: Overview of the significant candidates identified in RAPIDS experiments in close 
proximity to mCherry-FRB-LRRC59 (Scatter plot quadrant IV) 
Gene 
names 
Ratio H/L normalized 
LRRC59-forward 
































































Ratio H/L normalized 
LRRC59-forward 











































SND1 -0.3976952 + 0.50853008 + 44 102 Q7KZF4; H7C597 Q7KZF4 





LRRC59 -0.9017692 + 0.89971703 + 21 34.93 Q96AG4; I3L223 Q96AG4 


























ARID4A -1.0110935 + 0.3329657  2 134.95 
P29374-3; P29374-
2; P29374; H7C485 
P29374-3; P29374-
2; P29374; H7C485 
TMPO -0.5500425 + 0.29748487  17 50.67 P42167; G5E972 P42167; G5E972 
MTOR -0.4019016 + 0.16748644  12 288.89 P42345; B1AKP8 P42345; B1AKP8 

























GDI1 -0.4588619  1.14802301 + 12 50.58 P31150; G5E9U5 P31150; G5E9U5 










FNDC3B -0.5491979  0.89001858 + 5 132.89 Q53EP0; Q53EP0-2 Q53EP0; Q53EP0-2 














DNAJB12 -0.5971469  0.95546162 + 4 41.82 
Q9NXW2; Q9NXW2-




MTMR6 -0.3672664  1.18618357 + 3 71.97 Q9Y217; Q9Y217-2 Q9Y217; Q9Y217-2 


























Ratio H/L normalized 
LRRC59-fwd B 
significant 
Ratio H/L  
normalized LRRC59-
rev B significant 
MCCC2 
Methylcrotonoyl-CoA carboxylase 
beta chain, mitochondrial 
0.43935713 -0.0723917   
MCCC1 
Methylcrotonoyl-CoA carboxylase 
subunit alpha, mitochondrial 
0.57734424 -0.131013 +  
ACACB 
Acetyl-CoA carboxylase 2; Biotin 
carboxylase 
-0.0735602 -0.3954162   
ACACA 
Acetyl-CoA carboxylase 1; Biotin 
carboxylase 
-0.1019233 -0.0510554   
PCCA 
Propionyl-CoA carboxylase alpha 
chain, mitochondrial 
0.37417707 -0.128803   
PCCB 
Propionyl-CoA carboxylase beta 
chain, mitochondrial 
0.18256515 -0.1416211   
Abbreviations: fwd: forward, rev: reverse, ratio H/L: ratio heavy/light 
 
 
E. Supplemental data corresponding to section 3.4 
Table S 11: Raw data of rapamycin-induced dimerization assay using reporter EGFP2-GST-M9-















20180416 0.5 mCherry-FRB-Sec61β 1 minute 67 67 
76.00 7.81 20180423 0.5 mCherry-FRB-Sec61β 1 minute 80 80 
20180420 0.5 mCherry-FRB-Sec61β 1 minute 81 81 
20180416 0.5 mCherry-FRB-Sec61β 2 minutes 91 91 
95.67 4.16 20180423 0.5 mCherry-FRB-Sec61β 2 minutes 97 97 
20180420 0.5 mCherry-FRB-Sec61β 2 minutes 99 99 
20180416 0.5 mCherry-FRB-Sec61β 3 minutes 98 98 
99.00 1.00 20180423 0.5 mCherry-FRB-Sec61β 3 minutes 99 99 
20180420 0.5 mCherry-FRB-Sec61β 3 minutes 100 100 
20180416 0.5 mCherry-FRB-Sec61β 4 minutes 93 93 
97.00 3.61 20180423 0.5 mCherry-FRB-Sec61β 4 minutes 98 98 
20180420 0.5 mCherry-FRB-Sec61β 4 minutes 100 100 
20180416 0.5 mCherry-FRB-Sec61β 5 minutes 96 96 
98.33 2.08 20180423 0.5 mCherry-FRB-Sec61β 5 minutes 100 100 
20180420 0.5 mCherry-FRB-Sec61β 5 minutes 99 99 
20180416 0.5 mCherry-FRB-Sec61β 6 minutes 97 97 
97.67 0.58 20180423 0.5 mCherry-FRB-Sec61β 6 minutes 98 98 
20180420 0.5 mCherry-FRB-Sec61β 6 minutes 98 98 
20180416 0.5 mCherry-FRB-Sec61β 7 minutes 99 99 
99.00 0.00 20180423 0.5 mCherry-FRB-Sec61β 7 minutes 99 99 
20180420 0.5 mCherry-FRB-Sec61β 7 minutes 99 99 
20180416 0.5 mCherry-FRB-Sec61β 8 minutes 94 94 
97.33 3.06 20180423 0.5 mCherry-FRB-Sec61β 8 minutes 98 98 
20180420 0.5 mCherry-FRB-Sec61β 8 minutes 100 100 
20180416 0.5 mCherry-FRB-Sec61β 9 minutes 98 98 
98.67 1.15 20180423 0.5 mCherry-FRB-Sec61β 9 minutes 100 100 
20180420 0.5 mCherry-FRB-Sec61β 9 minutes 98 98 
20180416 0.5 mCherry-FRB-Sec61β 10 minutes 97 97 
98.67 1.53 20180423 0.5 mCherry-FRB-Sec61β 10 minutes 99 99 
20180420 0.5 mCherry-FRB-Sec61β 10 minutes 100 100 
20180416 0.5 mCherry-FRB-Sec22b 1 minute 47 47 
39.33 11.59 20180423 0.5 mCherry-FRB-Sec22b 1 minute 45 45 
20180420 0.5 mCherry-FRB-Sec22b 1 minute 26 26 
20180416 0.5 mCherry-FRB-Sec22b 2 minutes 56 56 
65.00 9.54 20180423 0.5 mCherry-FRB-Sec22b 2 minutes 64 64 
20180420 0.5 mCherry-FRB-Sec22b 2 minutes 75 75 
20180416 0.5 mCherry-FRB-Sec22b 3 minutes 80 80 
75.67 5.13 20180423 0.5 mCherry-FRB-Sec22b 3 minutes 70 70 
20180420 0.5 mCherry-FRB-Sec22b 3 minutes 77 77 
20180416 0.5 mCherry-FRB-Sec22b 4 minutes 80 80 
78.67 2.31 20180423 0.5 mCherry-FRB-Sec22b 4 minutes 76 76 
20180420 0.5 mCherry-FRB-Sec22b 4 minutes 80 80 
20180416 0.5 mCherry-FRB-Sec22b 5 minutes 75 75 
79.00 3.46 20180423 0.5 mCherry-FRB-Sec22b 5 minutes 81 81 
20180420 0.5 mCherry-FRB-Sec22b 5 minutes 81 81 
20180416 0.5 mCherry-FRB-Sec22b 6 minutes 69 69 
74.33 7.57 

















20180420 0.5 mCherry-FRB-Sec22b 6 minutes 71 71 
20180416 0.5 mCherry-FRB-Sec22b 7 minutes 79 79 
77.33 5.69 20180423 0.5 mCherry-FRB-Sec22b 7 minutes 82 82 
20180420 0.5 mCherry-FRB-Sec22b 7 minutes 71 71 
20180416 0.5 mCherry-FRB-Sec22b 8 minutes 80 80 
80.67 2.08 20180423 0.5 mCherry-FRB-Sec22b 8 minutes 83 83 
20180420 0.5 mCherry-FRB-Sec22b 8 minutes 79 79 
20180416 0.5 mCherry-FRB-Sec22b 9 minutes 69 69 
74.33 5.03 20180423 0.5 mCherry-FRB-Sec22b 9 minutes 79 79 
20180420 0.5 mCherry-FRB-Sec22b 9 minutes 75 75 
20180416 0.5 mCherry-FRB-Sec22b 10 minutes 70 70 
77.67 7.51 20180423 0.5 mCherry-FRB-Sec22b 10 minutes 85 85 
20180420 0.5 mCherry-FRB-Sec22b 10 minutes 78 78 
20180416 0.5 LMAN2-FRB-mCherry 1 minute 15 15 
22.00 6.24 20180423 0.5 LMAN2-FRB-mCherry 1 minute 27 27 
20180420 0.5 LMAN2-FRB-mCherry 1 minute 24 24 
20180416 0.5 LMAN2-FRB-mCherry 2 minutes 20 20 
40.67 17.93 20180423 0.5 LMAN2-FRB-mCherry 2 minutes 52 52 
20180420 0.5 LMAN2-FRB-mCherry 2 minutes 50 50 
20180416 0.5 LMAN2-FRB-mCherry 3 minutes 28 28 
46.67 16.29 20180423 0.5 LMAN2-FRB-mCherry 3 minutes 58 58 
20180420 0.5 LMAN2-FRB-mCherry 3 minutes 54 54 
20180416 0.5 LMAN2-FRB-mCherry 4 minutes 51 51 
57.00 6.00 20180423 0.5 LMAN2-FRB-mCherry 4 minutes 63 63 
20180420 0.5 LMAN2-FRB-mCherry 4 minutes 57 57 
20180416 0.5 LMAN2-FRB-mCherry 5 minutes 42 42 
56.33 12.66 20180423 0.5 LMAN2-FRB-mCherry 5 minutes 66 66 
20180420 0.5 LMAN2-FRB-mCherry 5 minutes 61 61 
20180416 0.5 LMAN2-FRB-mCherry 6 minutes 63 63 
68.67 4.93 20180423 0.5 LMAN2-FRB-mCherry 6 minutes 71 71 
20180420 0.5 LMAN2-FRB-mCherry 6 minutes 72 72 
20180416 0.5 LMAN2-FRB-mCherry 7 minutes 65 65 
74.67 10.60 20180423 0.5 LMAN2-FRB-mCherry 7 minutes 86 86 
20180420 0.5 LMAN2-FRB-mCherry 7 minutes 73 73 
20180416 0.5 LMAN2-FRB-mCherry 8 minutes 59 59 
66.67 8.02 20180423 0.5 LMAN2-FRB-mCherry 8 minutes 75 75 
20180420 0.5 LMAN2-FRB-mCherry 8 minutes 66 66 
20180416 0.5 LMAN2-FRB-mCherry 9 minutes 65 65 
68.33 4.16 20180423 0.5 LMAN2-FRB-mCherry 9 minutes 73 73 
20180420 0.5 LMAN2-FRB-mCherry 9 minutes 67 67 
20180416 0.5 LMAN2-FRB-mCherry 10 minutes 57 57 
66.00 9.00 20180423 0.5 LMAN2-FRB-mCherry 10 minutes 75 75 
20180420 0.5 LMAN2-FRB-mCherry 10 minutes 66 66 
20180416 0.5 DDOST-FRB-mCherry 1 minute 44 44 
58.67 14.50 20180423 0.5 DDOST-FRB-mCherry 1 minute 59 59 
20180420 0.5 DDOST-FRB-mCherry 1 minute 73 73 
20180416 0.5 DDOST-FRB-mCherry 2 minutes 55 55 
77.33 19.40 20180423 0.5 DDOST-FRB-mCherry 2 minutes 90 90 
20180420 0.5 DDOST-FRB-mCherry 2 minutes 87 87 
20180416 0.5 DDOST-FRB-mCherry 3 minutes 90 90 
95.33 5.03 20180423 0.5 DDOST-FRB-mCherry 3 minutes 100 100 
20180420 0.5 DDOST-FRB-mCherry 3 minutes 96 96 
20180416 0.5 DDOST-FRB-mCherry 4 minutes 93 93 
97.33 3.79 20180423 0.5 DDOST-FRB-mCherry 4 minutes 100 100 
20180420 0.5 DDOST-FRB-mCherry 4 minutes 99 99 
20180416 0.5 DDOST-FRB-mCherry 5 minutes 96 96 
97.00 1.00 20180423 0.5 DDOST-FRB-mCherry 5 minutes 97 97 
20180420 0.5 DDOST-FRB-mCherry 5 minutes 98 98 
20180416 0.5 DDOST-FRB-mCherry 6 minutes 95 95 
97.67 2.52 20180423 0.5 DDOST-FRB-mCherry 6 minutes 98 98 
20180420 0.5 DDOST-FRB-mCherry 6 minutes 100 100 
20180416 0.5 DDOST-FRB-mCherry 7 minutes 98 98 
98.00 0.00 20180423 0.5 DDOST-FRB-mCherry 7 minutes 98 98 
20180420 0.5 DDOST-FRB-mCherry 7 minutes 98 98 
20180416 0.5 DDOST-FRB-mCherry 8 minutes 99 99 
99.00 1.00 20180423 0.5 DDOST-FRB-mCherry 8 minutes 100 100 
20180420 0.5 DDOST-FRB-mCherry 8 minutes 98 98 
20180416 0.5 DDOST-FRB-mCherry 9 minutes 96 96 
97.33 1.15 20180423 0.5 DDOST-FRB-mCherry 9 minutes 98 98 

















20180416 0.5 DDOST-FRB-mCherry 10 minutes 98 98 
98.00 1.00 20180423 0.5 DDOST-FRB-mCherry 10 minutes 99 99 
20180420 0.5 DDOST-FRB-mCherry 10 minutes 97 97 
20180416 1 mCherry-FRB-Ube2j1 1 minute 28 28 
30.00 6.24 20180423 1 mCherry-FRB-Ube2j1 1 minute 37 37 
20180420 1 mCherry-FRB-Ube2j1 1 minute 25 25 
20180416 1 mCherry-FRB-Ube2j1 2 minutes 50 50 
40.00 12.49 20180423 1 mCherry-FRB-Ube2j1 2 minutes 44 44 
20180420 1 mCherry-FRB-Ube2j1 2 minutes 26 26 
20180416 1 mCherry-FRB-Ube2j1 3 minutes 50 50 
47.00 3.61 20180423 1 mCherry-FRB-Ube2j1 3 minutes 48 48 
20180420 1 mCherry-FRB-Ube2j1 3 minutes 43 43 
20180416 1 mCherry-FRB-Ube2j1 4 minutes 62 62 
61.67 1.53 20180423 1 mCherry-FRB-Ube2j1 4 minutes 60 60 
20180420 1 mCherry-FRB-Ube2j1 4 minutes 63 63 
20180416 1 mCherry-FRB-Ube2j1 5 minutes 73 73 
65.33 7.51 20180423 1 mCherry-FRB-Ube2j1 5 minutes 58 58 
20180420 1 mCherry-FRB-Ube2j1 5 minutes 65 65 
20180416 1 mCherry-FRB-Ube2j1 6 minutes 75 75 
67.33 7.51 20180423 1 mCherry-FRB-Ube2j1 6 minutes 67 67 
20180420 1 mCherry-FRB-Ube2j1 6 minutes 60 60 
20180416 1 mCherry-FRB-Ube2j1 7 minutes 75 75 
68.67 5.51 20180423 1 mCherry-FRB-Ube2j1 7 minutes 66 66 
20180420 1 mCherry-FRB-Ube2j1 7 minutes 65 65 
20180416 1 mCherry-FRB-Ube2j1 8 minutes 80 80 
73.33 5.77 20180423 1 mCherry-FRB-Ube2j1 8 minutes 70 70 
20180420 1 mCherry-FRB-Ube2j1 8 minutes 70 70 
20180416 1 mCherry-FRB-Ube2j1 9 minutes 90 90 
71.67 17.56 20180423 1 mCherry-FRB-Ube2j1 9 minutes 70 70 
20180420 1 mCherry-FRB-Ube2j1 9 minutes 55 55 
20180416 1 mCherry-FRB-Ube2j1 10 minutes 86 86 
74.67 9.87 20180423 1 mCherry-FRB-Ube2j1 10 minutes 68 68 
20180420 1 mCherry-FRB-Ube2j1 10 minutes 70 70 
20180416 1 mCherry-FRB-Ube2j2 1 minute 40 40 
35.00 16.09 20180423 1 mCherry-FRB-Ube2j2 1 minute 48 48 
20180420 1 mCherry-FRB-Ube2j2 1 minute 17 17 
20180416 1 mCherry-FRB-Ube2j2 2 minutes 58 58 
47.67 11.06 20180423 1 mCherry-FRB-Ube2j2 2 minutes 49 49 
20180420 1 mCherry-FRB-Ube2j2 2 minutes 36 36 
20180416 1 mCherry-FRB-Ube2j2 3 minutes 65 65 
54.33 9.29 20180423 1 mCherry-FRB-Ube2j2 3 minutes 50 50 
20180420 1 mCherry-FRB-Ube2j2 3 minutes 48 48 
20180416 1 mCherry-FRB-Ube2j2 4 minutes 69 69 
59.33 10.60 20180423 1 mCherry-FRB-Ube2j2 4 minutes 48 48 
20180420 1 mCherry-FRB-Ube2j2 4 minutes 61 61 
20180416 1 mCherry-FRB-Ube2j2 5 minutes 73 73 
61.33 11.06 20180423 1 mCherry-FRB-Ube2j2 5 minutes 51 51 
20180420 1 mCherry-FRB-Ube2j2 5 minutes 60 60 
20180416 1 mCherry-FRB-Ube2j2 6 minutes 70 70 
64.33 5.51 20180423 1 mCherry-FRB-Ube2j2 6 minutes 64 64 
20180420 1 mCherry-FRB-Ube2j2 6 minutes 59 59 
20180416 1 mCherry-FRB-Ube2j2 7 minutes 69 69 
62.00 7.00 20180423 1 mCherry-FRB-Ube2j2 7 minutes 55 55 
20180420 1 mCherry-FRB-Ube2j2 7 minutes 62 62 
20180416 1 mCherry-FRB-Ube2j2 8 minutes 67 67 
62.00 5.00 20180423 1 mCherry-FRB-Ube2j2 8 minutes 62 62 
20180420 1 mCherry-FRB-Ube2j2 8 minutes 57 57 
20180416 1 mCherry-FRB-Ube2j2 9 minutes 67 67 
66.00 1.73 20180423 1 mCherry-FRB-Ube2j2 9 minutes 67 67 
20180420 1 mCherry-FRB-Ube2j2 9 minutes 64 64 
20180416 1 mCherry-FRB-Ube2j2 10 minutes 57 57 
58.00 1.73 20180423 1 mCherry-FRB-Ube2j2 10 minutes 57 57 










Table S 12: Abbreviations 
Abbreviation Name 
⍺ alpha (in case of antibodies: anti-) 




BFP blue fluorescent protein  
BSA bovine serum albumin 
c-Myc polypeptide protein tag with the sequence EQKLISEEDL 
C-terminus carboxy terminus 
CAML calcium-modulating cyclophilin ligand 
cDNA complementary DNA 
CIP2A Cancerous inhibitor of PP2A 
cNLS classical nuclear localization signal 
DAPI 4´,6-diamidino-2-phenylindole 
ddH2O Deionized distilled water 
DDOST Dolichyl-diphosphooligosaccharide-protein glycosyltransferase 48 kDa subunit 
DNA Deoxyribonucleic acid 
dNTP 2`-desoxynucleoside-5´-triphosphate 
E. coli Escherichia coli 
EDMD Emery-Dreifuss muscular dystrophy 
EDTA ethylenediaminetetraacetic acid 
(E)GFP (enhanced) green fluorescence protein 
EK-RM EDTA/high salt treated rough microsomes 
EMC ER-membrane protein complex 
ER endoplasmic reticulum 
ERAD endoplasmic reticulum-associated degradation 
FBS fetal bovine serum 
FG phenylalanine - glycine 
FGF1/2 fibroblast growth factor 1/2 
FKBP12 12 kDa FK506/rapamycin binding protein 
FLAG polypeptide protein tag with the sequence DYKDDDDK 
FLIP fluorescence loss in photobleaching 
FRAP fluorescence recovery after photobleaching 
FRB domain FKBP12-rapamycin binding domain 
 gamma 
GDP Guanosine-5´-diphosphate 
GET guided entry of tail-anchored proteins 
GST Glutathione S-transferase 
GTP Guanosine-5´-triphosphate 
HA hemagglutinin 
His histidine tag 
HRP horseradish peroxidase 
IBB domain importin  binding domain 
INM inner nuclear membrane 
KASH Klarsicht, ANC-1, Syne homolog 
kDa kilo dalton 
LAP2β Lamina-associated polypeptide 2 beta 
LB Luria-Bertani 
LBR Lamin B receptor 
LEM domain LAP2, emerin, MAN1 domain 
LINC linker of nucleoskeleton and cytoskeleton 
LMAN2 Vesicular integral-membrane protein VIP36 
LMNA gene coding for lamin A and C 
LRR leucine rich repeat 
LRRC59 leucine rich repeat containing protein 59 
M9 PY-NLS initially described for hnRNPA1 
MBP maltose binding protein 
MCS multiple cloning site 
mock control treated sample 
mRNA messenger ribonucleic acid 
mTOR or FRAP FKBP12-rapamycin associated protein 




NE nuclear envelope 
NES nuclear export signal 
NET nuclear envelope transmembrane protein 
NLS nuclear localization signal 
NPC nuclear pore complex 
NPCs nuclear pore complexes 
Nups nucleoporins 
ONM outer nuclear membrane 
op opsin-tag 
op G glycosylated opsin-tag 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PNGase F peptide-N-Glycosidase F 
PP2A protein phosphatase 2A 
Ran Ras-related nuclear protein 
RanGAP RanGTPase-activating protein 
RanGEF Ran guanine nucleotide exchange factor 
RAPIDS rapamycin- and APEX-dependent identification of proteins by SILAC 
RM rough microsomes 
RNA ribonucleic acid 
rpm rotations per minute 
S. cerevisiae Saccharomyces cerevisiae 
SDS sodium dodecyl sulfate 
Sec22b vesicle-trafficking protein Sec22b 
Sec61β protein transport protein Sec61 subunit beta 
SILAC stable isotope labeling by amino acids in cell culture 
siRNA small interfering RNA 
SND SRP-independent targeting 
SRP signal recognition particle 
SV40 simian virus 40 
T-RM trypsin treated rough microsomes 
TA tail-anchored 
TMD transmembrane domain 
TRC40 transmembrane domain recognition complex of 40 kDa (ASNA1) 
Ube2j1 Ubiquitin-conjugating enzyme E2 J1 
Ube2j2 Ubiquitin-conjugating enzyme E2 J2 
v/v volume per volume 
w/v weight per volume 
WRB tryptophan-rich basic protein 
WT wild type 
ZZ protein tag (S. aureus protein A IgG-binding domain) 
 
Table S 13: Measurement conventions 
Measurements of Abbreviation Unit 
atomic mass Da Dalton 
electric current A ampere 
electricity V Volt 
enzyme´s catalytic activity U Unit 
molarity M molar 
temperature °C degree Celsius 
time h hour 
time min minute 
time sec second 
volume l liter 
weight g gram 
   
Prefix symbol Prefix name Multiplier 
n nano- x 10-9 
µ micro- x 10-6 
m milli- x 10-3 
k kilo- x 103 
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